-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 IpN0QConkfciqvm6cS4iAG4UHnttmEDcriKLmBKDUwG0VDBq9Wy9UzADLnTjz/nQ
 q4s32HFOz9zIOkO1x45GAw==

<SEC-DOCUMENT>0000950144-09-004612.txt : 20090527
<SEC-HEADER>0000950144-09-004612.hdr.sgml : 20090527
<ACCEPTANCE-DATETIME>20090527145914
ACCESSION NUMBER:		0000950144-09-004612
CONFORMED SUBMISSION TYPE:	S-1
PUBLIC DOCUMENT COUNT:		14
FILED AS OF DATE:		20090527
DATE AS OF CHANGE:		20090527

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			INTELLIGENT SYSTEMS CORP
		CENTRAL INDEX KEY:			0000320340
		STANDARD INDUSTRIAL CLASSIFICATION:	BOLTS, NUTS, SCREWS, RIVETS & WASHERS [3452]
		IRS NUMBER:				581964787
		STATE OF INCORPORATION:			GA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-1
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-159497
		FILM NUMBER:		09854290

	BUSINESS ADDRESS:	
		STREET 1:		4355 SHACKLEFORD RD
		CITY:			NORCROSS
		STATE:			GA
		ZIP:			30093
		BUSINESS PHONE:		4043812900

	MAIL ADDRESS:	
		STREET 1:		4355 SHACKLEFORD ROAD
		CITY:			NORCROSS
		STATE:			GA
		ZIP:			30093
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-1
<SEQUENCE>1
<FILENAME>g18612s1sv1.htm
<DESCRIPTION>INTELLIGENT SYSTEMS CORPORATION
<TEXT>
<HTML>
<HEAD>
<TITLE>INTELLIGENT SYSTEMS CORPORATION</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="center" style="font-size: 10pt; margin-top: 10pt">As
filed with the Securities and Exchange Commission on May 27, 2009
</DIV>


<DIV align="right" style="font-size: 10pt; margin-top: 6pt">Registration
No. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</DIV>


<DIV style="width: 100%; border-bottom: 2pt solid black; font-size: 1pt">&nbsp;</DIV>
<DIV style="width: 100%; border-bottom: 1pt solid black; font-size: 1pt">&nbsp;</DIV>




<DIV align="center" style="font-size: 14pt; margin-top: 12pt"><B>UNITED STATES<BR>
SECURITIES AND EXCHANGE COMMISSION</B>
</DIV>

<DIV align="center" style="font-size: 12pt"><B>Washington, D.C. 20549</B>
</DIV>

<DIV align="center" style="font-size: 12pt"><B><DIV align="center"><DIV style="font-size: 3pt; margin-top: 16pt; width: 26%; border-top: 1px solid #000000">&nbsp;</DIV></DIV></B>
</DIV>


<DIV align="center" style="font-size: 18pt; margin-top: 12pt"><B>FORM S-1</B>
</DIV>


<DIV align="center" style="font-size: 12pt; margin-top: 12pt"><B>REGISTRATION STATEMENT UNDER<BR>
THE SECURITIES ACT OF 1933</B>
</DIV>


<DIV align="center" style="font-size: 12pt; margin-top: 12pt"><B><DIV align="center"><DIV style="font-size: 3pt; margin-top: 16pt; width: 26%; border-top: 1px solid #000000">&nbsp;</DIV></DIV></B>
</DIV>

<DIV align="center" style="font-size: 24pt; margin-top: 12pt"><B>INTELLIGENT SYSTEMS CORPORATION</B>
</DIV>

<DIV align="center" style="font-size: 10pt">(Exact name of Registrant as specified in its charter)</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 12pt"><DIV align="center"><DIV style="font-size: 3pt; margin-top: 16pt; width: 26%; border-top: 1px solid #000000">&nbsp;</DIV></DIV></DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="33%">&nbsp;</TD>
    <TD width="33%">&nbsp;</TD>
    <TD width="33%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="center" valign="top"><B>Georgia</B>
</TD>
    <TD align="center" valign="top"><B>3452</B></TD>
    <TD align="center" valign="top"><B>58-1964787</B></TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top">(State or other jurisdiction of</TD>
    <TD align="center" valign="top">(Primary Standard Industrial</TD>
    <TD align="center" valign="top">(I.R.S. Employer</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top">incorporation or organization)</TD>
    <TD align="center" valign="top">Classification Code Number)</TD>
    <TD align="center" valign="top">Identification No.)</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 12pt"><DIV align="center"><DIV style="font-size: 3pt; margin-top: 16pt; width: 26%; border-top: 1px solid #000000">&nbsp;</DIV></DIV></DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 12pt"><B>4355 Shackleford Road<BR>
Norcross, Georgia 30093<BR>
(770)&nbsp;381-2900</B><BR>
(Address, including Zip Code, and Telephone Number, including Area Code, of<BR>
Registrant&#146;s Principal Executive Offices)</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 12pt"><DIV align="center"><DIV style="font-size: 3pt; margin-top: 16pt; width: 26%; border-top: 1px solid #000000">&nbsp;</DIV></DIV></DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 12pt"><B>Bonnie L. Herron<BR>
Chief Financial Officer<BR>
Intelligent Systems Corporation<BR>
4355 Shackleford Road<BR>
Norcross, Georgia 30093<BR>
(770)&nbsp;381-2900</B><BR>
(Name, Address, Including Zip Code, and Telephone Number,<BR>
Including Area Code, of Agent for Service)</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 12pt"><B>Copy to:<BR>
Larry D. Ledbetter, Esq.<BR>
Ledbetter Johnson Wanamaker Glass LLP<BR>
1175 Peachtree Street, NE<BR>
100 Colony Square, Suite&nbsp;1100<BR>
Atlanta, Georgia 30361<BR>
(404)&nbsp;835-9503</B></DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 12pt"><DIV align="center"><DIV style="font-size: 3pt; margin-top: 16pt; width: 26%; border-top: 1px solid #000000">&nbsp;</DIV></DIV></DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt"><B>Approximate date of commencement of proposed sale to the public: </B>As soon as practicable after this
Registration Statement becomes effective.
</DIV>




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If any of the securities being registered on this Form are to be offered on a delayed or
continuous basis pursuant
to Rule&nbsp;415 under the Securities Act of 1933, other than securities offered only in connection
with dividend or interest reinvestment plans, check the following
<FONT style="white-space: nowrap">box. <FONT face="Wingdings">&#111;</FONT></Font>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If this form is filed to register additional securities for an offering pursuant to Rule
462(b) under the Securities Act, please check the following box and list the Securities Act
registration statement number of the earlier effective registration statement for the same
offering. <FONT face="Wingdings">&#111;</FONT>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If this form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities
Act, check the following box and list the Securities Act registration statement number of the
earlier effective registration statement for the same offering. <FONT face="Wingdings">&#111;</FONT>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act,
check the following box and list the Securities Act registration statement number of the earlier
effective registration statement for the same offering.&nbsp;&nbsp;<FONT face="Wingdings">&#111;</FONT>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Indicate by check mark whether the registrant is a large accelerated filer, an accelerated
filer, a non-accelerated filer, or a smaller reporting company. See the definitions of &#147;large
accelerated filer,&#148; &#147;accelerated filer,&#148; and &#147;smaller reporting company&#148; in Rule&nbsp;12b-2 of the
Exchange Act. (Check one):
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="22%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="22%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="22%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="22%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="left" valign="top"><FONT style="white-space: nowrap">Large accelerated filer <FONT face="Wingdings">&#111;</FONT></FONT>
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">Accelerated filer <FONT face="Wingdings">&#111;</FONT>
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">Non-accelerated filer <FONT face="Wingdings">&#111;</FONT>
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top"><FONT style="white-space: nowrap">Smaller reporting company <FONT face="Wingdings">&#254;</FONT></FONT></TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top"><FONT style="white-space: nowrap">(Do not check if a smaller reporting company)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 12pt"><B>CALCULATION OF REGISTRATION FEE</B></DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="1%">&nbsp;</TD>
    <TD width="26%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD><!-- VRule -->
    <TD width="1%">&nbsp;</TD>
    <TD width="25%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD><!-- VRule -->
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD><!-- VRule -->
    <TD width="1%">&nbsp;</TD>
    <TD width="21%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD><!-- VRule -->
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>

    <TD width="1%">&nbsp;</TD>
</TR><TR style="font-size: 1px" valign="bottom">
    <TD nowrap align="left" colspan="15" style="border-bottom: 3px double #000000">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">    <TD width="1%">&nbsp;</TD>

    <TD>&nbsp;</TD>
    <TD style="border-right: 2px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD style="border-right: 2px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD style="border-right: 2px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center"><B>Proposed</B></TD>
    <TD style="border-right: 2px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">    <TD width="1%">&nbsp;</TD>

    <TD nowrap align="left">&nbsp;</TD>
    <TD style="border-right: 2px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD style="border-right: 2px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center"><B>Proposed Maximum</B></TD>
    <TD style="border-right: 2px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center"><B>Maximum</B></TD>
    <TD style="border-right: 2px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">    <TD width="1%">&nbsp;</TD>

    <TD nowrap align="center"><B>Title of Each Class of Securities to be</B></TD>
    <TD style="border-right: 2px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center"><B>Amount to be</B></TD>
    <TD style="border-right: 2px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center"><B>Offering Price Per</B></TD>
    <TD style="border-right: 2px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center"><B>Aggregate</B></TD>
    <TD style="border-right: 2px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center"><B>Amount of</B></TD>
    <TD width="1%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">    <TD width="1%">&nbsp;</TD>

    <TD nowrap align="center"><B>Registered</B></TD>
    <TD style="border-right: 2px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center"><B>Registered</B></TD>
    <TD style="border-right: 2px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center"><B>Share</B></TD>
    <TD style="border-right: 2px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center"><B>Offering Price</B></TD>
    <TD style="border-right: 2px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center"><B>Registration Fee</B></TD>
    <TD width="1%">&nbsp;</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD width="1%" style="border-top: 2px solid #000000">&nbsp;</TD>
                    <TD nowrap style="border-top: 2px solid #000000"><DIV style="margin-left:15px; text-indent:-15px">Common Stock, par
value $0.01 per
share</DIV></TD>
    <TD style="border-right: 2px solid #000000; border-top: 2px solid #000000">&nbsp;</TD>
    <TD style="border-top: 2px solid #000000">&nbsp;</TD>
    <TD align="center" valign="bottom" style="border-top: 2px solid #000000">4,478,971 shares</TD>
    <TD style="border-right: 2px solid #000000; border-top: 2px solid #000000">&nbsp;</TD>
    <TD style="border-top: 2px solid #000000">&nbsp;</TD>

<TD align="center" valign="bottom" style="border-top: 2px solid #000000">$0.70</TD>
    <TD style="border-right: 2px solid #000000; border-top: 2px solid #000000">&nbsp;</TD>
    <TD style="border-top: 2px solid #000000">&nbsp;</TD>
    <TD align="center" valign="bottom" style="border-top: 2px solid #000000">$3,135,279.70 (1)</TD>
    <TD style="border-right: 2px solid #000000; border-top: 2px solid #000000">&nbsp;</TD>
    <TD style="border-top: 2px solid #000000">&nbsp;</TD>

<TD align="center" valign="bottom" style="border-top: 2px solid #000000">$174.95</TD>
    <TD width="1%" style="border-top: 2px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD width="1%" style="border-top: 2px solid #000000">&nbsp;</TD>
    <TD style="border-top: 2px solid #000000"><DIV style="margin-left:15px; text-indent:-15px">Rights to purchase
Common Stock, par
value $0.01 per
share</DIV></TD>
    <TD style="border-right: 2px solid #000000; border-top: 2px solid #000000">&nbsp;</TD>
    <TD style="border-top: 2px solid #000000">&nbsp;</TD>
    <TD align="center" valign="bottom" style="border-top: 2px solid #000000">4,478,971 rights (2)</TD>
    <TD style="border-right: 2px solid #000000; border-top: 2px solid #000000">&nbsp;</TD>
    <TD style="border-top: 2px solid #000000">&nbsp;</TD>
    <TD align="center" valign="bottom" style="border-top: 2px solid #000000">N/A</TD>
    <TD style="border-right: 2px solid #000000; border-top: 2px solid #000000">&nbsp;</TD>
    <TD style="border-top: 2px solid #000000">&nbsp;</TD>
    <TD align="center" valign="bottom" style="border-top: 2px solid #000000">N/A</TD>
    <TD style="border-right: 2px solid #000000; border-top: 2px solid #000000">&nbsp;</TD>
    <TD style="border-top: 2px solid #000000">&nbsp;</TD>
    <TD align="center" valign="bottom" style="border-top: 2px solid #000000">$0.00 (3)</TD>
    <TD width="1%" style="border-top: 2px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD width="1%" style="border-top: 2px solid #000000">&nbsp;</TD>
    <TD style="border-top: 2px solid #000000"><DIV style="margin-left:15px; text-indent:-15px">Total</DIV></TD>
    <TD style="border-right: 2px solid #000000; border-top: 2px solid #000000">&nbsp;</TD>
    <TD style="border-top: 2px solid #000000">&nbsp;</TD>
    <TD align="center" valign="bottom" style="border-top: 2px solid #000000">&#151;</TD>
    <TD style="border-right: 2px solid #000000; border-top: 2px solid #000000">&nbsp;</TD>
    <TD style="border-top: 2px solid #000000">&nbsp;</TD>
    <TD align="center" valign="bottom" style="border-top: 2px solid #000000">&#151;</TD>
    <TD style="border-right: 2px solid #000000; border-top: 2px solid #000000">&nbsp;</TD>
    <TD style="border-top: 2px solid #000000">&nbsp;</TD>
    <TD align="center" valign="bottom" style="border-top: 2px solid #000000">&#151;</TD>
    <TD style="border-right: 2px solid #000000; border-top: 2px solid #000000">&nbsp;</TD>
    <TD style="border-top: 2px solid #000000">&nbsp;</TD>
    <TD align="center" valign="bottom" style="border-top: 2px solid #000000">&nbsp;</TD>
    <TD width="1%" style="border-top: 2px solid #000000">&nbsp;</TD>
</TR>
<TR style="font-size: 1px" valign="bottom">
    <TD nowrap align="left" colspan="15" style="border-top: 3px double #000000">&nbsp;</TD>
</TR>

<!-- End Table Body -->
</TABLE>
</DIV>



<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
<TR>
    <TD width="3%"></TD>
    <TD width="1%"></TD>
    <TD width="96"></TD>
</TR>
<TR valign="top">
    <TD nowrap align="left">(1)</TD>
    <TD>&nbsp;</TD>
    <TD>Represents the aggregate gross proceeds from the exercise of the maximum number of rights
that may be issued.</TD>
</TR>

<TR style="font-size: 3pt"><TD>&nbsp;</TD></TR>

<TR valign="top">
    <TD nowrap align="left">(2)</TD>
    <TD>&nbsp;</TD>
    <TD>Evidencing the rights to subscribe for 4,478,971 shares of common stock, par value $0.01 per
share.</TD>
</TR>

<TR style="font-size: 3pt"><TD>&nbsp;</TD></TR>

<TR valign="top">
    <TD nowrap align="left">(3)</TD>
    <TD>&nbsp;</TD>
    <TD>The rights are being issued for no consideration. Pursuant to Rule 457(g) under the
Securities Act of 1933, as amended, no separate registration fee is payable.</TD>
</TR>
</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>The Registrant hereby amends this Registration Statement on such date or dates as may be
necessary to delay its effective date until the Registrant shall file a further amendment which
specifically states that this Registration Statement shall thereafter become effective in
accordance with </B><B>Section 8(a)</B><B> of the Securities Act of 1933 or until the Registration Statement
shall become effective on such date as the Commission, acting pursuant to said section </B><B>8(a)</B><B>, may
determine.</B>
</DIV>


<DIV style="width: 100%; border-bottom: 1pt solid black; margin-top: 10pt; font-size: 1pt">&nbsp;</DIV>
<DIV style="width: 100%; border-bottom: 2pt solid black; font-size: 1pt">&nbsp;</DIV>





<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV style="padding: 5px; border: 3px double #000000; font-size: 11pt; color: #FF0000"><I>The information in this prospectus is not complete and may be changed. These securities may
not be sold nor may offers to buy these securities be accepted until the registration statement
filed with the Securities and Exchange Commission becomes effective. This prospectus is not an
offer to sell these securities and it is not soliciting an offer to buy these securities in any
state where the offer or sale is not permitted.</I>
</DIV>




<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>SUBJECT
TO COMPLETION, DATED ________, 2009</B>
</DIV>


<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><B>PROSPECTUS</B>

</DIV>

<DIV align="Center" style="font-size: 18pt; margin-top: 6pt"><B>Intelligent Systems Corporation</B>
</DIV>

<DIV align="Center" style="font-size: 12pt; margin-top: 6pt"><B>Up to
4,478,971 Shares of Common Stock Issuable Upon Exercise of Rights<BR>to
Subscribe for Such Shares at $0.70 per Share</B>

</DIV>

<DIV align="left" style="font-size: 9pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We are distributing at no charge
to holders of our common stock non-transferable subscription
rights to purchase shares of our common stock. You will receive one subscription right for each
share of common stock owned at the close of business on &#95;&#95;&#95;&#95;&#95;&#95;&nbsp;&#95;&#95;&#95;, 2009. We are distributing
subscription rights exercisable for up to an aggregate of 4,478,971 shares of our common
stock. The net proceeds from this rights offering will be used principally to support our plans
for our subsidiary, CoreCard Software, Inc. (&#147;CoreCard&#148;), including increasing marketing and sales
activities, expanding CoreCard&#146;s management team, and devoting additional resources to CoreCard&#146;s
credit and prepaid card processing services offering. If all the rights were exercised, the total
purchase price of the shares offered in this rights offering would be
$3,135,279.70.
</DIV>


<DIV align="left" style="font-size: 9pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each whole subscription right will entitle you, as a holder of our common stock, to purchase
one share of our common stock at a subscription price of
$0.70 per share. Subscribers who exercise their rights
in full may over-subscribe for additional shares, subject to certain limitations, to the extent
shares are available.
</DIV>

<DIV align="left" style="font-size: 9pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The subscription rights will expire if they are not exercised by 5:00 p.m., Eastern Daylight
Time, on &#95;&#95;&#95;&#95;&#95;&#95;&nbsp;&#95;&#95;&#95;, 2009, unless extended. We, in our sole discretion, may extend the
period for exercising the subscription rights. Subscription rights that are not exercised by the
expiration date of this rights offering will expire and have no value.
</DIV>


<DIV align="left" style="font-size: 9pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;You should carefully consider whether to exercise your subscription rights before the
expiration of the rights offering. Unless our board of directors cancels or terminates the rights
offering, all exercises of subscription rights are irrevocable. Our board of directors is making
no recommendation regarding your exercise of the subscription rights.
</DIV>

<DIV align="left" style="font-size: 9pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The subscription rights may not be sold or transferred.
</DIV>


<DIV align="left" style="font-size: 9pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We may cancel or terminate the rights offering at any time prior to its expiration. If the
total purchase price for the shares subscribed for is less than
$1,400,000, we plan to cancel
the rights offering, but we are not obligated to do so, and our board of directors may modify or
waive this requirement. If we cancel or terminate this offering, we will return your subscription
price, but without any payment of interest.
</DIV>


<DIV align="left" style="font-size: 9pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The shares are being offered directly by us without the services of an underwriter or selling
agent.
</DIV>


<DIV align="left" style="font-size: 9pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Shares of our common stock are traded on the NYSE Amex exchange under the symbol &#147;INS&#148;. On
May&nbsp;12, 2009, the closing sales price for our common stock was
$0.75 per share. The shares
of common stock issued upon exercise of the rights will also be listed on the NYSE Amex exchange under
the same symbol.
</DIV>

<DIV align="left" style="font-size: 9pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Exercising the rights and investing in our common stock involves a high degree of risk. We
urge you to carefully read the section entitled &#147;Risk Factors&#148; beginning on page 13 of this
prospectus and all other information included or incorporated herein by reference in this
prospectus in its entirety before you decide whether to exercise your rights.</B>
</DIV>

<DIV align="left" style="font-size: 9pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Neither the Securities and Exchange Commission nor any state securities commission has
approved or disapproved of these securities or determined if this prospectus is truthful or
complete. Any representation to the contrary is a criminal offense.</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
date of this prospectus is &#95;&#95;&#95;&#95;&#95;&#95;&nbsp;&#95;&#95;&#95;, 2009.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left">
<!-- TOC -->
</DIV>
<DIV align="left">
<A name="tocpage"></A>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>TABLE OF CONTENTS</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="88%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><A href="#101">ABOUT THIS PROSPECTUS</A></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><A href="#102">CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</A></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><A href="#103">QUESTIONS AND ANSWERS RELATING TO THE RIGHTS OFFERING</A></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><A href="#104">SUMMARY</A></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">8</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><A href="#105">RISK FACTORS</A></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">13</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><A href="#106">USE OF PROCEEDS</A></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">24</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><A href="#107">CAPITALIZATION</A></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">24</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><A href="#109">THE RIGHTS OFFERING</A></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">25</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><A href="#110">MATERIAL UNITED STATES FEDERAL INCOME TAX CONSEQUENCES</A></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">33</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><A href="#111">PRICE RANGE OF COMMON STOCK AND DIVIDEND POLICY</A></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">35</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><A href="#112">DESCRIPTION OF CAPITAL STOCK</A></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">36</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><A href="#113">PLAN OF DISTRIBUTION</A></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">38</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><A href="#114">LEGAL MATTERS</A></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">38</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><A href="#115">EXPERTS</A></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">38</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><A href="#116">INCORPORATION BY REFERENCE</A></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">39</TD>
    <TD>&nbsp;</TD>
</TR>
<!-- End Table Body -->
<TR><TD colspan="9"><FONT size="2">&nbsp;<A HREF="g18612s1exv4w1.htm">EX-4.1 FORM OF SUBSCRIPTION RIGHTS CERTIFICATE</A></FONT></TD></TR>
<TR><TD colspan="9"><FONT size="2">&nbsp;<A HREF="g18612s1exv4w2.htm">EX-4.2 SUBSCRIPTION AGENT AGREEMENT</A></FONT></TD></TR>
<TR><TD colspan="9"><FONT size="2">&nbsp;<A HREF="g18612s1exv5w1.htm">EX-5.1 OPINION OF LEDBETTER, JOHNSON, WANAMAKER, GLASS LLP</A></FONT></TD></TR>
<TR><TD colspan="9"><FONT size="2">&nbsp;<A HREF="g18612s1exv23w1.htm">EX-23.1 CONSENT OF HABIF, AROGETI & WYNNE LLP</A></FONT></TD></TR>
<TR><TD colspan="9"><FONT size="2">&nbsp;<A HREF="g18612s1exv23w2.htm">EX-23.2 CONSENT OF TAUBER & BALSER P.C.</A></FONT></TD></TR>
<TR><TD colspan="9"><FONT size="2">&nbsp;<A HREF="g18612s1exv99w1.htm">EX-99.1 FORM OF INSTRUCTIONS</A></FONT></TD></TR>
<TR><TD colspan="9"><FONT size="2">&nbsp;<A HREF="g18612s1exv99w2.htm">EX-99.2 FORM OF LETTER TO STOCKHOLDERS</A></FONT></TD></TR>
<TR><TD colspan="9"><FONT size="2">&nbsp;<A HREF="g18612s1exv99w3.htm">EX-99.3 FORM OF LETTER TO NOMINEE HOLDERS</A></FONT></TD></TR>
<TR><TD colspan="9"><FONT size="2">&nbsp;<A HREF="g18612s1exv99w4.htm">EX-99.4 FORM OF LETTER TO CLIENTS</A></FONT></TD></TR>
<TR><TD colspan="9"><FONT size="2">&nbsp;<A HREF="g18612s1exv99w5.htm">EX-99.5 FORM OF NOMINEE HOLDER CERTIFICATION</A></FONT></TD></TR>
<TR><TD colspan="9"><FONT size="2">&nbsp;<A HREF="g18612s1exv99w6.htm">EX-99.6 FORM OF BENEFICIAL OWNER ELECTION</A></FONT></TD></TR>
</TABLE>
</DIV>

<DIV align="left">
<!-- /TOC -->
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left">
<A name="101"></A>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>ABOUT THIS PROSPECTUS</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Unless otherwise stated or the context otherwise requires, the terms &#147;Intelligent Systems,&#148;
&#147;we,&#148; &#147;us,&#148; &#147;our,&#148; and the &#147;Company&#148; refer to Intelligent Systems Corporation and its subsidiaries,
and the term &#147;common stock&#148; means Intelligent Systems Corporation&#146;s common stock, par value $0.01
per share.
</DIV>






<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;You should rely only on the information contained or incorporated by reference in this
prospectus. We have not authorized anyone to provide you with additional or different
information. If anyone provides you with additional, different or inconsistent information, you
should not rely on it. We are not making an offer to sell securities in any jurisdiction where the
offer or sale is not permitted. You should assume that the information in this prospectus is
accurate only as of the date on the front cover of this prospectus, and any information we have
incorporated by reference is accurate only as of the date of the document incorporated by
reference, in each case, regardless of the time of delivery of this prospectus or any exercise of
the rights. Our business, financial condition, results of operations and prospects may have
changed since that date.
</DIV>

<DIV align="left">
<A name="102"></A>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This prospectus includes forward-looking statements regarding, among other things, our
financial condition and business strategy. Forward-looking statements provide our current
expectations and projections about future events. Forward-looking statements include statements
about our expectations, beliefs, plans, objectives, intentions,
assumptions, and other statements
that are not historical facts. As a result, all statements other than statements of historical
facts included in this prospectus, including, without limitation, statements under the heading
&#147;Risk Factors&#148; and located elsewhere in this prospectus regarding the prospects of our industry and
our prospects, plans, financial position, and business strategy may constitute forward-looking
statements. In addition, forward-looking statements generally can be identified by the use of
forward-looking terminology such as &#147;may,&#148; &#147;could,&#148; &#147;expect,&#148; &#147;intend,&#148; &#147;estimate,&#148; &#147;anticipate,&#148;
&#147;plan,&#148; &#147;foresee,&#148; &#147;believe,&#148; or &#147;continue,&#148; or the negatives of these terms or variations of them
or similar terminology, but the absence of these words does not necessarily mean that a statement
is not forward-looking.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Forward-looking statements are subject to known and unknown risks and uncertainties
and are based on potentially inaccurate assumptions that could cause actual results to differ
materially from those expected or implied by the forward-looking statements. Although we believe
that the expectations reflected in these forward-looking statements are reasonable, we can give no
assurance that these expectations will prove to be correct. Important factors that could cause
actual results to differ materially from our expectations are disclosed in this prospectus,
including in conjunction with the forward-looking statements included in this prospectus and under
the heading &#147;Risk Factors.&#148; These factors include, without limitation, our history of operating
losses, continued uncertainty in the global financial markets, our reliance on a relatively small
number of customers for a significant percentage of our revenue, our software subsidiary&#146;s ability
to develop new products, customers&#146; acceptance of our new and existing products, competition in our
industries, our ability to protect our intellectual property rights, our ability to obtain
financing and the terms and conditions of any financing that is consummated, our ability to meet
the listing standards of the NYSE Amex exchange, the possible
volatility of our stock price, and the
potential fluctuation of our operating results.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All subsequent written and oral forward-looking statements attributable to us or persons
acting on our behalf are expressly qualified in their entirety by the cautionary statements
included in this document. These forward-looking statements speak only as of the date of this
prospectus. We undertake no obligation to publicly revise any forward-looking statement to reflect
circumstances or events after the date of this prospectus or to reflect the occurrence of
unanticipated events except as may be required by applicable securities laws.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->1<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left">
<A name="103"></A>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>QUESTIONS AND ANSWERS RELATING TO THE RIGHTS OFFERING</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>The following are examples of what we anticipate will be common questions about the rights
offering. The answers are based on selected information from this prospectus and the documents
incorporated by reference herein. The following questions and answers do not contain all of the
information that may be important to you and may not address all of the questions that you may have
about the rights offering. This prospectus and the documents incorporated by reference herein
contain more detailed descriptions of the terms and conditions of the rights offering and provide
additional information about us and our business, including potential risks related to the rights
offering, the common stock of the Company and our business.</I>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Exercising the rights and investing in our common stock involves risks. We urge you to
carefully read the section entitled &#147;Risk Factors&#148; beginning on page 13 of this prospectus and all
other information included or incorporated herein by reference in this prospectus in its entirety
before you decide whether to exercise your rights.</B>
</DIV>
<DIV align="left" style="font-size: 10pt; margin-top: 10pt"><B>What is a rights offering?</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
are distributing to holders of our common stock as of 5:00 p.m.,
Eastern Daylight Time, on
&#95;&#95;&#95;&#95;&#95;&#95;&nbsp;&#95;&#95;&#95;, 2009, the &#147;record date,&#148; at no charge, subscription rights to purchase shares of our
common stock. You will receive one subscription right for each share of common stock you owned at
the close of business on the record date. The subscription rights will be evidenced by rights
certificates.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt"><B>What is a right?</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each whole right gives our stockholders the opportunity to purchase one share of our common
stock for
$0.70 per share and carries with it a basic subscription privilege and an
over-subscription privilege.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt"><B>How many shares may I purchase if I exercise my rights?</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We are granting to you, as a stockholder of record on the record date, one subscription right
for each share of our common stock you owned at that time. Each right contains the basic
subscription privilege and the over-subscription privilege. You may exercise any number of your
subscription rights, or you may choose not to exercise any subscription rights.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If you hold your shares in the name of a broker, dealer, or other nominee who uses the
services of the Depository Trust Company, or &#147;DTC,&#148; then DTC will issue one right to the nominee
for each share of our common stock you own at the record date. Each whole right can then be used
to purchase one share of common stock for $0.70 per share.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt"><B>What is the basic subscription privilege?</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The basic subscription privilege of each whole right entitles you to purchase one share of our
common stock at the subscription price of $0.70 per share.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt"><B>What is the over-subscription privilege?</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The over-subscription privilege of each right entitles you, if you have fully exercised your
basic subscription privilege, to subscribe for additional shares of our common stock at the same
subscription price per share. Pursuant to your over-subscription privilege, you may subscribe for
up to 500,000 additional shares. Shares will only be awarded to you, however, if other holders of
subscription rights do not subscribe for all the shares available to them under their basic
subscription privileges.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>How will shares be awarded following the expiration date?</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Shares will first be awarded to rights holders in the amount that each holder subscribed for
under his basic subscription privilege. If available shares remain after the fulfillment of all
basic subscription requests under the
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->2<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 10pt">holders&#146; basic subscription privilege, then shares will be awarded to rights holders who
exercised their over-subscription privilege. If there are sufficient shares available to fulfill
the over-subscription requests of all rights holders, then each rights holder will receive the
number of shares subscribed for under his over-subscription privilege.</div>
<DIV align="left" style="font-size: 10pt; margin-top: 12pt">
<B>What if there is an insufficient number of shares to satisfy the over-subscription requests?</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If there is an insufficient number of shares of our common stock available to  satisfy
fully the over-subscription requests of rights holders, subscription rights holders who exercised their
over-subscription privilege will receive the available shares <I>pro rata </I>in proportion to the number
of shares of our common stock that rights holders who exercised their over-subscription privilege
purchased by exercising their basic subscription privilege. In certain situations, allocating the
remaining available shares on this basis could result in your receiving an allocation of a greater
number of shares than you subscribed for under your over-subscription privilege. If this occurs,
then we will allocate to you only the number of shares for which you subscribed. We will allocate
the remaining shares among all other holders exercising their over-subscription privileges on the
<I>pro rata </I>basis described above.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>What if I do not receive the full number of shares for which I subscribed?</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If you do not receive the full number of shares for which you subscribed, any excess
subscription payment will be returned to you, without interest or deduction, promptly after the
expiration of the rights offering.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>Why are we conducting the rights offering?</B>

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We are making the rights offering to procure funds which we will use principally to support
our plans for our CoreCard subsidiary, including increasing marketing and sales activities,
expanding CoreCard&#146;s management team, and devoting additional resources to CoreCard&#146;s credit and
prepaid card processing services offering. A rights offering provides our stockholders the
opportunity to participate in this transaction and minimizes the dilution of their ownership
interest in the Company.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>How
was the subscription price of $0.70 per share determined?</B>

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our board of directors determined the subscription price after considering the likely cost of
capital from other sources, the price at which our stockholders might be willing to participate in
the rights offering, and historical and current trading prices for our common stock. The
subscription price for a subscription right is $0.70 per share. The subscription price does not necessarily bear any
relationship to the book value of our assets or our past operations, cash flows, losses, financial
condition, net worth, or any other established criteria used to value securities. You should not
consider the subscription price to be an indication of the fair value of the common stock to be
offered in the rights offering.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>Am I required to exercise any or all of the rights I receive in the rights offering?</B>

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No.&nbsp;You may exercise any number of your rights, or you may choose not to exercise any rights.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>What happens if I choose not to exercise my subscription rights?</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If you do not exercise any rights, the number of shares of our common stock you own will not
change. However, because shares are expected to be purchased by other stockholders in the rights
offering, your percentage ownership after the exercise of the rights will be diluted.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>How soon must I act to exercise my rights?</B>

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The rights may be exercised beginning on the date of this prospectus through the expiration
date, which is &#95;&#95;&#95;&#95;&#95;&#95;&nbsp;&#95;&#95;&#95;, 2009, at 5:00 p.m., Eastern Daylight Time, unless extended by
us. If you elect to exercise any rights, the subscription agent must actually receive all required
documents and payments from you or your broker or nominee at or before the expiration
date. Although we have the option of extending the expiration date of the subscription period, we
currently do not intend to do so.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->3<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><B>When will I receive my subscription rights certificate?</B>

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Promptly after the date of this prospectus, the subscription agent will send a subscription
rights certificate to each registered holder of our common stock as of 5:00 p.m., Eastern Daylight
Time, on the record date, based on our stockholder registry maintained at the transfer agent for
our common stock. If you hold your shares of common stock through a brokerage account, bank or
other nominee, you will not receive an actual subscription rights certificate. Instead, as
described in this prospectus, you must instruct your broker, bank or nominee whether or not to
exercise rights on your behalf. If you wish to obtain a separate subscription rights certificate,
you should promptly contact your broker, bank or other nominee and request a separate subscription
rights certificate. It is not necessary to have a physical subscription rights certificate to elect
to exercise your rights.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>May I transfer my rights?</B>

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No.&nbsp;Should you choose not to exercise your subscription rights, you may not sell, give away
or otherwise transfer your subscription rights. Subscription rights will, however, be transferable
by operation of law (for example, upon the death of the recipient).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>Are we requiring a minimum subscription to complete the rights offering?</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Yes. We plan to complete the rights offering only if we receive subscriptions totaling at
least $1,400,000 by the expiration date of the rights offering. This requirement, however, may
be modified or waived by our board of directors.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>Can the board of directors cancel, terminate, amend, or extend the rights offering?</B>

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Yes. Our board of directors may decide to cancel or terminate the rights offering at any time
before the expiration of the rights offering and for any reason. If our board of directors cancels
or terminates the rights offering, we will issue a press release notifying stockholders of the
cancellation or termination, and any money received from subscribing stockholders will be promptly
returned, without interest or deduction.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We may amend the terms of the rights offering or extend the subscription period of the rights
offering. The period for exercising your subscription rights may be extended by our board of
directors, although we do not presently intend to do so. We also reserve the right to amend the
terms of the rights offering.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>Have any stockholders indicated they will exercise their rights?</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Yes. Some of the members of our management team and board of directors have advised us that
they currently intend to participate in the rights offering. One of our largest stockholders and
our Chief Executive Officer, J. Leland Strange, has indicated that he intends to participate to the
full extent of his basic subscription right and may exercise his over-subscription right to some
lesser extent, but he is not obligated to do so.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>Has our board of directors made a recommendation to our stockholders regarding the exercise of rights under the rights offering?</B>

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No.&nbsp;Our board of directors has not, and will not, make any recommendation to stockholders
regarding the exercise of rights under the rights offering. You should make an independent
investment decision about whether or not to exercise your rights. Stockholders who exercise rights
risk investment loss on new money invested. We cannot assure you that the market price for our
common stock will remain above the subscription price or that anyone purchasing shares at the
subscription price will be able to sell those shares in the future at the same price or a higher
price. If you do not exercise your rights, you will lose any value represented by your rights and
your percentage ownership interest in the Company will be diluted. For more information on the
risks of participating in the rights offering, see the section of this prospectus entitled &#147;Risk
Factors.&#148;
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->4<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><B>How do I exercise my rights? What forms and payment are required to purchase the shares of common stock?</B>

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If you wish to participate in the rights offering, you must take the following steps, unless
your shares are held by a broker, dealer, or other nominee:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 4%"><B>&#149;</B> deliver payment to the subscription agent using the methods outlined in this prospectus;
and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 4%"><B>&#149;</B> deliver a properly completed rights certificate to the subscription agent before 5:00
p.m., Eastern Daylight Time, on &#95;&#95;&#95;&#95;&#95;&#95;&nbsp;&#95;&#95;&#95;, 2009, unless extended.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If you send a payment that is insufficient to purchase the number of shares you requested, or
if the number of shares you requested is not specified in the forms, the payment received will be
applied to purchase shares to the full extent of the
payment tendered. If the
payment exceeds the subscription price for the full exercise of the basic and over-subscription
privileges (to the extent specified by you), the excess will be refunded. You will not receive
interest on any payments refunded to you under the rights offering.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>What should I do if I want to participate in the rights offering, but my shares are held in the
name of my broker, dealer, or other nominee?</B>

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If you hold your shares of our common stock in the name of a broker, dealer, or other nominee,
then your broker, dealer, or other nominee is the record holder of the shares you own. The record
holder must exercise the rights on your behalf for the shares of common stock you wish to purchase.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If you wish to participate in the rights offering and purchase shares of common stock, please
promptly contact the record holder of your shares. We will ask your broker, dealer, or other
nominee to notify you of the rights offering. You should complete and return to your record holder
the form entitled &#147;Beneficial Owner Election Form.&#148; You should receive this form from your record
holder with the other rights offering materials.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>May stockholders in all states participate?</B>

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Although we intend to distribute the rights to all stockholders, we reserve the right in some
states to require stockholders, if they wish to participate, to state and agree that upon exercise
of their respective rights that they are acquiring the shares for investment purposes only, and
that they have no present intention to resell or transfer any shares acquired.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>When will I receive my new shares?</B>

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If you purchase shares of common stock in the rights offering, you will receive your new
shares promptly after the closing of the rights offering.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->5<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><B>After I send in my payment and rights certificate, may I change or cancel my exercise of rights?</B>

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No.&nbsp;Unless our board of directors cancels or terminates the rights offering, all exercises of
rights are irrevocable, even if you later learn information that you consider to be unfavorable to
the exercise of your rights. You should not exercise your rights unless you are certain that you
wish to purchase additional shares of our common stock at a price of
$0.70 per share.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>Are there risks in exercising my subscription rights?</B>

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Yes. The exercise of your subscription rights involves risks. Exercising your subscription
rights means buying additional shares of our common stock and should be considered as carefully as
you would consider any other equity investment. You should carefully read the section entitled
&#147;Risk Factors&#148; beginning on page 13 of this prospectus and all other information included or
incorporated herein by reference in this prospectus in its entirety before you decide whether to
exercise your rights.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>What are the United States Federal income tax consequences of exercising my subscription rights?</B>

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A holder should not recognize income or loss for United States Federal income tax purposes in
connection with the receipt or exercise of subscription rights in the rights offering. You should
consult your tax advisor as to the particular consequences to you of the rights offering.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>How many shares of common stock will be outstanding after the rights offering?</B>

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As
of &#95;&#95;&#95;&#95;&#95;&#95;&nbsp;&#95;&#95;&#95;, 2009, we had 4,478,971 shares of common stock issued and
outstanding. Based upon the maximum of 4,478,971 shares that may be issued pursuant to the rights
offering we would have 8,957,942 shares of common stock outstanding after the closing of the rights
offering.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>How much money will the Company receive from the rights offering?</B>

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
we meet the minimum purchase requirement, we will receive proceeds of
$1,400,000,
before deducting estimated offering expenses. If we sell all of the shares being offered, we will
receive proceeds of $3,135,279.70, before deducting estimated offering expenses. See the
section of this prospectus entitled &#147;Use of Proceeds.&#148;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>Will I be charged a sales commission or a fee if I exercise my subscription rights?</B>

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We will not charge a brokerage commission or a fee to rights holders for exercising their
subscription rights. However, if you exercise your subscription rights through a broker or nominee,
you will be responsible for any fees charged by your broker or nominee.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>If the rights offering is not completed, will my subscription payment be refunded to me?</B>

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Yes. The subscription agent will hold all funds it receives in a segregated bank account
until completion of the rights offering. If the rights offering is not completed, we will promptly
instruct the subscription agent to return your payment in full. If you own shares in &#147;street
name,&#148; it may take longer for you to receive payment because the subscription agent will send
payments through the record holder of your shares. Any funds returned will be returned without
interest or deduction.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>Will the rights be listed on a stock exchange or national market?</B>

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The rights themselves will not be listed on the NYSE Amex exchange or any other stock exchange
or national market. Our common stock will continue to trade on the NYSE Amex exchange under the
symbol &#147;INS&#148;, and the shares issued in connection with the rights offering will be eligible for
trading on the NYSE Amex exchange.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->6<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><B>To whom should I send my forms and payment?</B>

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
your shares are held in the name of a broker, dealer, or other nominee, then you should send
your subscription documents and payment to that record holder in accordance with the instructions
you receive from that record holder. If you are the record holder, then you should send your
subscription documents, rights certificate and payment by hand delivery, first class mail, or
courier service to:
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 10pt">American Stock Transfer &#038; Trust Company<BR>
6201 15<SUP style="font-size: 85%; vertical-align: text-top">th</SUP> Avenue<BR>
Brooklyn, New York 11219<BR>
Telephone: (877)&nbsp;248-6417
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;You are solely responsible for completing delivery to the subscription agent of your
subscription documents, rights certificate, and payment. We urge you to allow sufficient time for
delivery of your subscription materials to the subscription agent.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>Whom should I contact if I have other questions?</B>

</DIV>
<DIV align="left" style="font-size: 10pt; margin-top: 10pt">If you have other questions or need assistance, please contact the information agent,
Morrow &#38; Co., LLC, at 470&nbsp;West Avenue, Stamford, CT 06902,
Telephone: (800) 607-0088 or (203)&nbsp;658-9400.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>For a more complete description of the rights offering, see &#147;The Rights Offering&#148; beginning on page
26.</B>

</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->7<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left">
<A name="104"></A>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>SUMMARY</B>
</DIV>

<P>
<DIV style="width: 100%; border: 1px solid black; padding: 11px; padding-top: 0px;">


<DIV align="left" style="font-size: 10pt; margin-top: 3pt"><I>This summary highlights information contained elsewhere in this prospectus or
incorporated by reference therein. This summary is not complete and may not contain
all of the information that you should consider before deciding whether or not you
should exercise your rights. You should read the entire prospectus carefully,
including the section entitled &#147;Risk Factors&#148; beginning on page 13 of this prospectus
and all other information included or incorporated herein by reference in this
prospectus in its entirety before you decide whether to exercise your rights.</I>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><B>Our Company</B>

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We and our predecessor companies have operated since 1973, and our
securities have been publicly traded since 1981. Since the early 1980s,
we have conducted our operations principally through wholly and majority
owned subsidiaries or minority owned affiliates to which we devote
extensive management resources. Depending upon the needs of each company,
we may undertake a variety of roles including day-to-day management of
operations, board of director participation, financing, market planning,
strategic contract negotiations, personnel and administrative roles, and
similar functions.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our current operations are conducted principally through two consolidated
subsidiaries: CoreCard Software, Inc. (&#147;CoreCard&#148;) and ChemFree
Corporation (&#147;ChemFree&#148;). We own 100&nbsp;percent of ChemFree and 95&nbsp;percent
of CoreCard. We also have two wholly-owned subsidiaries, CoreCard SRL and
ISC Software in Romania and India, respectively, that perform software
development and testing for CoreCard. Our affiliate companies (in which
we have a minority ownership) are mainly involved in the information
technology industry.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ChemFree designs, assembles and sells bioremediating parts washers and
associated supplies that are used by commercial, industrial, military and
government agencies to maintain and service machinery or vehicles used in
their operations. The parts washer system, sold under the SmartWasher&#174;
trademark, uses a proprietary advanced bio-remediation process that
cleans automotive and machine parts without using hazardous,
solvent-based chemicals. Our assembled products are shipped to U.S, and
international resellers or direct to domestic customer sites and do not
require set-up or on-site support from us. Customers purchase proprietary
replacement supplies consisting of fluid and filters from us after the
initial parts washer sale. In some cases, we provide equipment to
multi-site corporate users under leases which typically range between
three and four years.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;CoreCard designs, develops, and markets transaction processing software
to accounts receivable businesses, financial institutions (such as banks
and credit unions), retailers and processors to manage their credit and
debit card, prepaid cards, private label cards, fleet cards, loyalty
programs, and accounts receivable and small loan transactions. CoreCard
has developed software applications based on its core financial
transaction processing platform to address the unique requirements of
customers issuing:
</DIV>


<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Credit/Debit Cards &#150; involving revolving or non-revolving credit issued
to consumer or business accounts (with or without a physical card) that
typically involve interest, fees, settlement, collections, etc. Within this
market, CoreCard offers software specifically tailored to handle private label
cards, network branded (i.e. MasterCard or VISA) bank cards, fleet cards, and
short-term consumer loans.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Prepaid Cards &#150; involving pre-loaded funds drawn down for purchase or
cash withdrawal typically involving a variety of fees but no interest.
Numerous examples exist including gift cards, loyalty/reward cards, health
benefit cards, payroll and benefits disbursement, government assistance
payments, and transit cards.</TD>
</TR>

</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our products allow financial institutions and commercial customers to
optimize their credit and prepaid card account management systems,
improve customer retention, lower operating costs, and create greater
market differentiation. CoreCard is also introducing a custom processing
service to provide prepaid card processing services using the CoreCard
software configured to each customer&#146;s preferences, with an option to
license the same software for in-house processing in the future. We
receive software license fees as well as service revenue from
implementation, customization, training, and support services.
</DIV>

</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->8<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<P>
<DIV style="width: 100%; border: 1px solid black; padding: 11px; padding-top: 0px;">


<DIV align="left" style="font-size: 10pt; margin-top: 3pt">We are incorporated under the laws of the State of Georgia. Our principal executive
offices are located at 4355 Shackleford Road, Norcross, Georgia 30093, and our
telephone number is (770)&nbsp;381-2900. Our website is www.intelsys.com. The information
on our website does not constitute part of this prospectus and should not be relied
upon in connection with making any investment in our securities.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><B>Recent Developments</B>

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt">Our board of directors approved and submitted to our shareholders for their
approval a reverse stock split at a ratio of one-for-four, one-for-six or
one-for-eight. The reverse stock split was considered at the annual meeting of
our shareholders on May&nbsp;28, 2009 and was approved by the
shareholders at the annual meeting. The board of directors has the
authority to decide whether and at what ratio the reverse stock split should be effected and to
file an amendment to our articles of incorporation effectuating the split. If our
board of directors elects to effectuate the reverse stock split, then the reverse
stock split will occur after the completion of the rights offering.
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>The Rights Offering</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="25%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="70%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Rights
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">We are distributing to you, at no charge, one
non-transferable subscription right for every
one share of our common stock that you owned on
the record date, either as a holder of record
or, in the case of shares held of record by
brokers, banks or other nominees, on your
behalf, as a beneficial owner of such
shares. We expect the gross proceeds from the
rights offering to be $3,135,279.70,
assuming full participation.</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Basic subscription privilege
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Each whole right gives you the opportunity to
purchase one share of our common stock for
$0.70 per share.</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Over-subscription privilege
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">If you elect to exercise your basic subscription
privilege in full, you may also subscribe for up
to 500,000 additional shares at the same
subscription price per share. Shares will only
be awarded to you, however, if other holders of
subscription rights do not subscribe for all the
shares available to them under their basic
subscription privileges. If there is an
insufficient number of shares of our common
stock available to fully satisfy the
over-subscription requests of rights holders,
subscription rights holders who exercised their
over-subscription privilege will receive the
available shares <I>pro rata </I>in proportion to the
number of shares of our common stock that rights
holders who exercised their over-subscription
privilege purchased by exercising their basic
subscription privileges. In certain situations,
allocating the remaining available shares on
this basis could result in your receiving an
allocation of a greater number of shares than
you subscribed for under your over-subscription
privilege. If this occurs, then we will
allocate to you only the number of shares for
which you subscribed. We will allocate the
remaining shares among all other holders
exercising their over-subscription privileges on
the <I>pro rata </I>basis described above. If you do
not receive the full number of shares for which
you subscribed, any excess subscription payment
will be returned to you, without interest or
deduction, promptly after the expiration of the
rights offering.</TD>
</TR>

<!-- End Table Body -->
</TABLE>
</DIV>

</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->9<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<P>
<DIV style="width: 100%; border: 1px solid black; padding: 11px; padding-top: 0px;">


<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom" style="font-size: 3pt">
    <TD width="25%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="70%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Record date
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">5:00 p.m. Eastern Daylight Time on
&#95;&#95;&#95;&#95;&#95;&#95;&nbsp;&#95;&#95;&#95;, 2009.</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Expiration date
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">5:00 p.m. Eastern Daylight Time on
&#95;&#95;&#95;&#95;&#95;&#95;&nbsp;&#95;&#95;&#95;,
2009, unless extended by us, in our sole
discretion. Any rights not exercised at or
before that time will expire without any payment
to the holders of those unexercised rights.</TD>
</TR>

<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Subscription price
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">$0.70 per share, payable in cash.</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Non-transferability of rights
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">The subscription rights may not be sold,
transferred, or assigned and will not be listed
for trading on the NYSE Amex exchange or on any
stock exchange or market or on the OTC Bulletin
Board.</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">No board recommendation
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Our board of directors makes no recommendation
to you about whether you should exercise any
rights. You are urged to make an independent
investment decision about whether to exercise
your rights based on your own assessment of our
business and the rights offering. Please see
the section of this prospectus entitled &#147;Risk
Factors&#148; for a discussion of some of the risks
involved in investing in our common stock.</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Procedure for exercising rights
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">If you are the record holder of shares of our
common stock, to exercise your rights you must
complete the rights certificate and deliver it
to the subscription agent, American Stock
Transfer &#038; Trust Company, together with full
payment for all the subscription rights you
elect to exercise. The subscription agent must
receive the proper forms and payments on or
before the expiration of the rights
offering. You may deliver the documents and
payments by mail or commercial courier. If
regular mail is used for this purpose, we
recommend using registered mail, properly
insured, with return receipt requested. If you
are a beneficial owner of shares of our common
stock, you should instruct your broker,
custodian bank, or nominee in accordance with
the procedures described in the section of this
prospectus entitled &#147;The Rights
Offering&#151;Beneficial Owners.&#148;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">How rights holders
can exercise rights
through others
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">If you hold our common stock through a broker,
custodian bank, or other nominee, we will ask
your broker, custodian bank, or other nominee to
notify you of the rights offering. If you wish
to exercise your rights, you will need to have
your broker, custodian bank, or other nominee
act for you. To indicate your decision, you
should complete and return to your broker,
custodian bank, or other nominee the form
entitled &#147;Beneficial Owner Election Form.&#148; You
should receive this form from your broker,
custodian bank, or other nominee with the other
rights offering materials. You should contact
your broker, custodian bank, or other nominee if
you believe you are entitled to participate in
the rights offering but you have not received
this form.</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->10<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<P>
<DIV style="width: 100%; border: 1px solid black; padding: 11px; padding-top: 0px;">


<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom" style="font-size: 3pt">
    <TD width="25%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="70%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">No revocation
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">If you exercise any of your rights, you will not
be permitted to revoke or change the exercise or
request a refund of monies paid.</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Issuance of our common stock
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">If you purchase shares of common stock through
the rights offering, we will issue certificates
representing those shares to you or Depository Trust Company on your
behalf, as the case may be, promptly after the
completion of the rights offering.</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">U.S. federal income
tax considerations
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">A holder should not recognize income or loss for
United States federal income tax purposes in
connection with the receipt or exercise of
subscription rights in the rights offering. You
should consult your tax advisor as to the
particular consequences to you of the rights
offering. For a detailed discussion, see
&#147;Material United States Federal Income Tax
Consequences.&#148;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Extension,
cancellation, and amendment
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">The period for exercising your subscription
rights may be extended by our board of
directors, although we do not presently intend
to do so. Our board of directors may cancel or
terminate the rights offering in its sole
discretion at any time on or before the
expiration of the rights offering for any reason
(including, without limitation, a change in the
market price of our common stock). In the
event that the rights offering is cancelled or
terminated, all funds received from
subscriptions by stockholders will be
returned. Interest will not be payable on any
returned funds. We also reserve the right to
amend the terms of the rights offering.</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Minimum
subscription
requirement
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">We plan to complete the rights offering only if
we receive subscriptions totaling at least
$1,400,000 by the expiration date of the
rights offering. This requirement, however, may
be modified or waived by our board of directors.</TD>
</TR>

<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Shares outstanding before the rights offering
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">4,478,971 shares as of &#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&nbsp;&#95;&#95;&#95;, 2009.</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Shares outstanding after
completion of the
rights offering
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Up to 8,957,942 shares of our common stock will
be outstanding immediately after completion of
the rights offering.</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

</DIV>




<P align="center" style="font-size: 10pt"><!-- Folio -->11<!-- /Folio -->
</DIV>



<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">

<P>
<DIV style="width: 100%; border: 1px solid black; padding: 11px; padding-top: 0px;">
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom" style="font-size: 3pt">
    <TD width="25%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="65%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">No stand-by commitment
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">We have no stand-by or backstop commitment with any party to buy shares if the subscription
rights are not fully exercised. Some of the members of our management team and board of
directors have advised us that they currently intend to participate in the rights offering.
One of our largest stockholders and our Chief Executive Officer, J. Leland Strange, has
indicated that he intends to participate to the full extent of his basic subscription
privilege and may exercise his over-subscription privilege to some lesser extent, but he
is not obligated to do so.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Use of proceeds
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">If we meet the minimum purchase requirement, we will
receive proceeds of $1,400,000, before deducting
estimated offering expenses. If we sell all of the
shares being offered, we will receive proceeds of
$3,135,279.70, before deducting estimated offering
expenses. We plan to use the net proceeds of the
rights offering principally to support our plans for
our CoreCard subsidiary, including increasing marketing
and sales activities, expanding CoreCard&#146;s management
team, and devoting additional resources to CoreCard&#146;s
credit and prepaid card processing services offering.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>

<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Fees and expenses
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">We will bear the fees and expenses relating to the
rights offering but not any commissions, fees or
expenses you may incur in connection with the exercise
of your rights.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Subscription agent
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">American Stock Transfer &#038; Trust Company</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Information agent
</DIV></TD>
    <TD>&nbsp;</TD>
   <TD align="left" valign="top">Morrow &#38; Co., LLC&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>

<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Questions
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Questions regarding the rights offering should be
directed to the information agent at
470&nbsp;West Avenue, Stamford, CT 06902, Telephone:
(800)&nbsp;607-0088 or (203)&nbsp;658-9400.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>

<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">NYSE Amex <BR>
trading symbol
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Shares of our common stock are currently listed for
quotation on the NYSE Amex exchange under the symbol
&#147;INS&#148;, and any shares  issued to you in connection
with the rights offering will be eligible for trading
on the NYSE Amex exchange.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>Risk Factors</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt">Exercising your rights and investing in our common stock involves various risks
associated with your investment, including the risks described in the section
of this prospectus entitled &#147;Risk Factors&#148; beginning on page 13 and the risks
that we have highlighted in other sections of this prospectus. You should carefully read
and consider these risk factors together with all of the other information
included and incorporated by reference in this prospectus before you decide
whether to exercise your rights to purchase shares of our common stock.
</DIV>

</DIV>




<P align="center" style="font-size: 10pt"><!-- Folio -->12<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left">
<A name="105"></A>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>RISK FACTORS</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Investing in our securities involves a high degree of risk. You should carefully consider the
specific risks described below, the risks described in our Annual Report on Form 10-K for the
fiscal year ended December&nbsp;31, 2008, which are incorporated herein by reference, and any risk
factors set forth in our other filings with the SEC, pursuant to Sections&nbsp;13(a), 13(c), 14, or
15(d) of the Exchange Act of 1934, as amended, before making an investment decision. See the
section of this prospectus entitled &#147;Where You Can Find More Information.&#148; Any of the risks we
describe below or in the information incorporated herein by reference could cause our business,
financial condition or operating results to suffer. The market price of our common stock could
decline if one or more of these risks and uncertainties develop into actual events. You could lose
all or part of your investment. Additional risks and uncertainties not currently known to us or
that we currently deem to be immaterial also may materially adversely affect our business,
financial condition or operating results. Some of the statements in this section of the prospectus
are forward-looking statements. For more information about forward-looking statements, please see
&#147;Forward-Looking Statements.&#148;</I>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>Risks Related to Our Business and Industries</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt"><B><I>We have a history of losses from operations and there is no guarantee that we will realize or
sustain a profit in the foreseeable future.</I></B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We incurred net losses of $823,000 in 2008 and $2,424,000 in 2007 and may incur net losses in
the future. Our historical losses are principally due to extensive new product development
activities related to our software business and significant legal expenses related to protecting
certain of our patents. Expenses associated with our domestic and offshore software development
activities and the costs of the corporate office more than offset the profitable operations of our
industrial products business. We currently expect our financial performance will improve over the
next twelve to eighteen months but we may not achieve or sustain profitability on a regular basis
and our performance may continue to fluctuate on an annual and quarterly basis for a number of
factors, many of which are outside of our control, including those listed below:
</DIV>


<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="2%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>The number, size and scope of our software contracts;</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="2%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>The volume and mix of products ordered by our industrial products customers;</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="2%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Our customer retention and acquisition rate and satisfaction with our products and
services;</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="2%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>The length of the sales cycle associated with our software products and services;</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="2%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>The efficiency with which we utilize our domestic and international employees;</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="2%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>How we plan and manage our existing and new software development projects and customer
contracts;</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="2%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Our ability to manage future growth;</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="2%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Changes in pricing policies by us or our competitors;</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="2%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Continued high levels of legal expenses related to actions we have undertaken to protect
patents associated with our industrial products; and</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="2%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Changes in cost of materials and production overhead for our industrial products.</TD>
</TR>

</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In addition, it is possible that in some future periods our operating results may be below the
expectations of public market analysts and investors. In this event, the price of our common stock
may fall.
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->13<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 10pt"><B><I>Continued uncertainty in the global financial markets could have a negative impact on our software
business.</I></B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our software subsidiary sells financial transaction processing software and related services
to handle the complex processes involved in account management for credit cards, debit cards,
prepaid cards, loyalty programs, private label cards, fleet cards,
accounts receivable, and small
loan transactions. Its target markets include companies in various segments of the financial
services, retail, and fleet industries that provide credit or prepaid programs to consumers and/or
businesses. The ongoing uncertainty in these market sectors could cause prospective customers to
postpone or cancel plans to purchase our products and services or to choose to outsource their
transaction processing rather than purchase our software and services for in-house management of
their card account programs and processes. If a prospective customer requires financing to be able
to fund the purchase of our software, financing may not be available on acceptable terms, if at
all. Some of our current customers could also be affected negatively by these same trends, which
could reduce demand for our professional services or reduce the monthly fees or additional license
fees they pay to us. The turmoil in the financial markets could cause some of our prospects or
customers to fail which could have a negative impact on sales and collection of accounts
receivables.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt"><B><I>Reluctance by financial institutions to act as sponsor banks for current and prospective customers
could impact our software business</I></B><B>.</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our
current software customers and prospective customers that issue credit, debit, or prepaid
cards to consumers and businesses rely on financial institutions to act as sponsor banks to handle
the flow of funds through the bank and association networks (e.g. MasterCard, VISA, Discover etc.).
In the current banking crisis, financial institutions are more risk averse and more cautious about
acting as sponsor banks, especially for new market entrants. Banks are also increasing the upfront
and ongoing costs associated with providing such services. These factors could make it more time
consuming and expensive for our customers and prospects to secure and maintain a sponsor bank
relationship. It could also prompt some prospects to abandon or postpone plans to enter this
business sector or to choose to outsource their transaction processing rather than purchase our
software and manage their processing in-house. Any or all of these factors could have a negative
impact on our software sales and business prospects and increase cash requirements.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt"><B><I>Our software business intends to offer a new out-sourced processing service as an alternative to
licensing our software to potential customers. There are risks associated with entering a new line
of business and if we fail to manage this opportunity appropriately, it could have a material
adverse effect on our business.</I></B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We believe there is an opportunity to provide a unique alternative to licensing our software
by adding credit and prepaid card processing services to our product and service offerings.
Certain prospective customers that issue credit and prepaid cards may not have the resources to or
interest in purchasing a license for our software in order to process their card transactions
in-house. They may prefer to outsource these functions to a third party processor, at least
initially, until they strengthen their in-house capabilities or want full control over their card
management functions. We plan to offer our custom processing option whereby customers can
outsource their credit or prepaid card processing functions to CoreCard. We will configure our
software for each customer, handle various aspects of their card issuing and processing
requirements, and provide a built-in option for the customer to license the same software and
become their own processor should they desire to do so at some future date. We believe this will
be an attractive offering to a small segment of credit and prepaid card issuers and will ensure we
fully understand the market requirements that our licensed software needs to meet. We have
experience helping our customers set up their card processing operations and compliance activities
using our software; however, we have not previously set-up or operated our own processing business.
There are a number of risks associated with entering this new line of business, including but not
limited to the following:
</DIV>


<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="4%" style="background: transparent">&nbsp;</TD>
    <TD width="2%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Failure to accurately estimate the time and cost to set up a small, secure processing
site;</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="4%" style="background: transparent">&nbsp;</TD>
    <TD width="2%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Failure to achieve compliance with the various regulations governing security,
personal identification, transactions processing and settling within the payment
processing, association networks (such as MasterCard/Visa etc.) and banking industry;</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="4%" style="background: transparent">&nbsp;</TD>
    <TD width="2%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Failure to secure a sponsor bank relationship;</TD>
</TR>

</TABLE>
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->14<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV style="margin-top: 6pt"><TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">



</TABLE>
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="4%" style="background: transparent">&nbsp;</TD>
    <TD width="2%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Failure to attract enough customers through effective marketing and sales activities;</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="4%" style="background: transparent">&nbsp;</TD>
    <TD width="2%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Failure to price our services to support a profitable operation over time;</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="4%" style="background: transparent">&nbsp;</TD>
    <TD width="2%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Failure to implement appropriate internal controls; and</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="4%" style="background: transparent">&nbsp;</TD>
    <TD width="2%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Failure to recruit and retain management with the necessary skills and industry
knowledge to establish and run a successful operation.</TD>
</TR>

</TABLE>
</DIV>
<DIV align="left" style="font-size: 10pt; margin-top: 10pt"><B><I>Our revenue is concentrated in a relatively small number of customers in each of our business
segments. The loss of a significant customer or a substantial decline in the number or scope of
products or services sold to a significant customer could have a material adverse effect on our
businesses.</I></B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We derive and expect to continue to derive for the foreseeable future a significant portion of
our total revenue from a limited but growing number of customers in each of our two business
segments. In 2008, one of our industrial products customers represented approximately 37&nbsp;percent
of our consolidated revenue in 2008 and two distributors in the U.S. and European markets
represented 12&nbsp;percent and 10&nbsp;percent, respectively, of our consolidated revenue. Any change in
the volume of orders or timeliness of payments from such customers could have a negative impact on
revenue, inventory levels and our financial condition. The volume of professional services that we
provide for a specific customer in our software business is likely to vary from year to year,
although our software maintenance and support revenue is generally stable or growing from
year-to-year because our software customers purchase renewable annual contracts for such services.
To the extent that any significant customer uses less of our services or terminates its
relationship with us, as may occur as customers respond to conditions affecting their own business,
our total revenue could decline substantially and that could harm our business.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt"><B><I>We depend on good relations with our customers, and any harm to these good relations may materially
and adversely harm our business or our ability to compete effectively.</I></B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To attract and retain customers, we depend to a considerable extent on our relationships with
our customers and our reputation for quality products and services. Our software products are
often critical to our customers&#146; businesses. We believe that we generally enjoy good relations with
our customers. If a customer is not satisfied with our products or services, it may be damaging to
our reputation and business. Any defects or errors in our products or services or failure to meet
our customers&#146; expectations could result in:
</DIV>


<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="2%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Delayed or lost revenue due to adverse customer reaction;</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="2%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Requirements to provide additional products or services to a customer at a reduced fee
or at no charge;</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="2%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Negative publicity, which could damage our reputation and adversely affect our ability
to attract or retain customers; and</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="2%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Claims for damages against us, regardless of our responsibility for such failure.</TD>
</TR>

</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If we fail to meet our contractual obligations with our customers, we could be subject to
legal liabilities or loss of customers. Although our contracts and warranty policies typically
include provisions to limit our exposure to legal claims for the products and services we provide,
these provisions may not protect us in all cases.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt"><B><I>If we do not effectively manage the risks associated with our software development projects,
customer contracts, and new product or service offerings, our profit margins and financial results
may suffer.</I></B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
may not accurately estimate the time and resources necessary to develop new software
products or enhancements to existing products or to deliver our software products and services. It
can be difficult to judge the time and resources necessary to complete development projects or professional services
contracts for our software customers. A number of different risks must be accounted for,
including, without limitation, the variability and
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->15<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 10pt">predictability of the number, size, scope, cost,
and revenue from professional services contracts; unanticipated cancellations or deferrals of
services contracts; collection of revenue; project personnel costs and customer requirements.
Accurate estimates as to the costs and timing of completion of software development projects or
customer services contracts and the cost of providing customer support and maintenance services are
particularly important for contracts that are performed on a fixed-price basis. Our failure to
accurately estimate these risks could reduce the profitability of, or result in a loss on, our
software projects and contracts and could damage our customer relationships and our reputation.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Particularly with respect to our software business, we have a limited number of customer
implementations in certain of our target markets and we expect to continually add new product and
services to meet the requirements of new or changing target markets. If we do not estimate our
development and marketing costs correctly or fail to accurately understand the market and customer
requirements, our profitability, reputation and future prospects may be negatively impacted.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt"><B><I>Our industries are very competitive and, if we fail to compete successfully, our market share and
businesses will be adversely affected.</I></B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We operate in two highly competitive industries and compete with a variety of organizations
that offer products or services that are similar to or substitutes for those we offer. In the
industrial products market, we compete with other participants that offer similar products or that
provide alternative solutions based on different product and service characteristics. In our
software markets, we compete with a number of participants at various levels of our product and
services offering. New market entrants also pose a threat to our businesses.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Many of our competitors have longer operating histories, more customers, longer relationships
with their customers, greater brand or name recognition and significantly greater financial,
technical, marketing and public relations resources than we do. As a result, our competitors may
have enhanced abilities to compete for specific customers and market share generally. Existing or
future competitors may develop or offer solutions that are comparable or superior to ours at a
lower price. In addition, our competitors may respond more quickly than we do to new or emerging
technologies and changes in market requirements or expectations. They may also develop and promote
their products and services more effectively than we do. If we fail to develop and deliver
products and services which meet market requirements in a timely manner, our business and growth
prospects will be harmed.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt"><B><I>We rely heavily on our management team and our ability to retain our existing professionals is
critical to the success of our business.</I></B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We believe that our success will depend significantly on our ability to motivate and retain
highly skilled management, technical, product development, and other key professional employees. In
our software business, if we fail to retain key software developers and managers who have years of
accumulated experience with our very complex software products or if we fail to attract and train a
sufficient number of new software developers and testers at our off-shore operations, we may not be
able to support our product development and customer projects at projected cost levels or at all.
The software development and services industry in particular continues to be people-intensive and
it may be difficult to find, train and retain qualified personnel with specialized skills and
financial services industry experience. If one or more members of our senior management or
technical team leaves, it could be difficult to replace them and our business could be seriously
harmed.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt"><B><I>We must keep pace with the rapid rate of technological innovation and changing market and customer
requirements in order to build our software business.</I></B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The software industry is characterized by rapid and continually changing technologies, the
introduction of competing new products and services, and changing market and customer preferences.
Our products and services must meet the requirements of and achieve significant acceptance among
our current and prospective customers within this environment. Our future business will depend on
our continuing ability to adapt to and incorporate changing technologies that our customers expect
to deploy in their business environment.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In addition, our future software business depends upon continued growth in the acceptance and
use of licensed software and in-house account processing by our current and prospective clients.
Their acceptance and
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->16<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 10pt">usage in turn may depend upon factors such as: the actual or perceived
benefits of in-house vs. out-sourced card account processing; a meaningful return on investment,
cost efficiencies or other measurable economic benefits; our software&#146;s actual or perceived
reliability, scalability, and ease of use; and their willingness to adopt new business processes in
order to realize the many cost and competitive benefits of running their own card processing
operations, rather than outsourcing this function.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We cannot assure that we will be successful in anticipating or responding to customer and
market challenges on a timely or competitive basis or at all, or that our ideas and solutions will
be successful in the marketplace. In addition, new or disruptive technologies and methodologies by
our competitors may make our offerings uncompetitive. Any of these circumstances could adversely
affect our ability to obtain and successfully complete new software contracts that are important to
maintain and grow our software business.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt"><B><I>If
growth in the use of credit, debit, prepaid, and similar cards declines, demand for our software
products and services may decline.</I></B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We sell financial transaction processing software and services to customers that issue and
manage credit, debit, prepaid and similar cards for both personal and business consumers in
domestic and international markets. There has been significant growth in these markets in recent
years and, more recently, a trend toward increasing use of prepaid cards for a variety of purposes.
However, if the number of users of these various types of cards does not increase or if it
declines, our customers and prospective customers may postpone or cancel purchase decisions or
change their business focus, and demand for our products and services may decrease. Factors that
may affect the use of credit, debit, prepaid, or similar cards and therefore the attractiveness of
this market to our customers include:
</DIV>


<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="2%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Actual or perceived lack of security of information;</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="2%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Lack of access and ease of use;</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="2%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Increased regulatory oversight and costs of compliance;</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="2%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Uncertainty and complexity of future regulatory environment;</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="2%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Increased fraudulent activities and associated losses;</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="2%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Reluctance to adopt new payment or cash access methods; and</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="2%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Continued economic recession and reduced consumer spending.</TD>
</TR>

</TABLE>
</DIV>
<DIV align="left" style="font-size: 10pt; margin-top: 10pt"><B><I>We must maintain our reputation and expand our name recognition to remain competitive.</I></B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We believe that establishing and maintaining a good reputation and brand names is critical for
attracting and expanding our various targeted customer bases. If our reputation is damaged or if
potential customers do not know what products and services we provide, we may become less
competitive or lose our market share. Promotion and enhancement of our brand names will depend
largely on our success in providing high quality products and services, which cannot be assured.
If customers do not perceive our products and services to be effective or of high quality, our
brand names and reputation could be materially and adversely affected.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our software customers use our solutions for critical applications to run their businesses.
Any errors, defects or other performance problems, including those in our proprietary software,
could result in financial or other damages. In addition to any liability we might have, performance
problems could also adversely affect our brand name and reputation.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt"><B><I>Failure to protect our intellectual property rights could impact our success and competitive
position.</I></B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We have developed substantial intellectual property in both our industrial products and
software businesses which we believe are valuable assets and important to our current and future
success. Our ability to protect the
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->17<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 10pt">know-how, formulations, software, methodologies and other
intellectual property is important to our success and our competitive position. We regard our
intellectual property rights as proprietary and attempt to protect them with patents, copyrights,
trademarks, trade secret laws, confidentiality agreements and other methods. Despite our efforts to
protect our intellectual property rights from unauthorized use or disclosure, parties may attempt
to disclose, obtain or use our rights. The steps we take may not be adequate to prevent or deter
infringement or other misappropriation of our intellectual property rights. In addition, we may
not detect unauthorized use of, or take timely and effective actions to enforce and protect, our
intellectual property rights. Existing laws of some countries in which we provide products and
services afford more limited protection of intellectual property rights than laws in the United
States. Furthermore, we have incurred significant legal expense related to an action to protect
certain intellectual property of our industrial products business. There is no guarantee that we
will recover any amount in damages, that the case will ultimately be decided in our favor or that
future profits will not be impacted by significant ongoing expenses.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt"><B><I>Others
could claim that our services, software, or solutions infringe upon their intellectual
property rights or violate contractual protections.</I></B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We believe that our products do not infringe upon the intellectual property rights of others.
However, we or our customers may be subject to claims that our services, products or solutions
infringe upon the intellectual property rights of others. Any infringement claims may result in
substantial costs, divert management attention and other resources, harm our reputation and prevent
us from offering some services, software or solutions. A successful infringement claim against us
could materially and adversely affect our business.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In our software contracts, we generally agree to indemnify our clients for expenses and
liabilities resulting from claimed infringement by our software, excluding third party components,
of the intellectual property rights of others. In some instances, the amount of these indemnities
may be greater than the revenue we receive from the customer.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt"><B><I>Increasing government regulation could cause us to lose customers or impair our business.</I></B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We are subject not only to regulations applicable to businesses generally, but we and the
solutions we offer to our clients also may be subject to United States and foreign laws and
regulations directly applicable to such issues as data privacy,
financial, and credit transactions,
and environmental issues. Laws and regulations in the United States, as well as legislative
initiatives that may be considered in the future, may increase regulation and impose additional
restrictions relating to the privacy of personal data, financial, and credit transactions and
environmental issues. We may be affected indirectly by any such legislation to the extent that it
impacts our existing and prospective customers and requires changes to our products and services in
order that our customers may comply with such regulations. Any such laws and regulations
therefore could affect our existing business relationships or prevent us from getting new
customers.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt"><B><I>Our business is currently concentrated in certain industries and geographically in the U.S. and
Europe.</I></B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our business is concentrated in certain industries and geographically in the U.S. and Europe.
In fiscal year 2008, approximately 89% and 10% of our sales were generated from sales in the United
States and Europe, respectively. Our industrial product sales, which made up 81% of our
consolidated revenue in 2008, are concentrated primarily in industries such as automotive parts and
repair, transportation, manufacturing and the military. Sales of industrial products could be
negatively impacted by the general economic downturn in the domestic market and in Europe, our
second largest market, although it is difficult to predict to what extent sales will be affected.
We also sell proprietary consumable supplies such as replenishment fluid and filters to our
installed base of industrial product customers. We currently believe sales of consumable supplies
are likely to be impacted to a lesser extent than equipment sales since end users require regular
replenishment of such supplies for effective use of the equipment. However, if the business of the
end user declines, the volume of replenishment supplies ordered could be lower and affect our financial performance.
If any of customers experience financial
difficulties or fail, it could reduce future sales and affect our accounts receivable collections.
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->18<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 10pt"><B><I>Price increases may not be sufficient to offset cost increases and maintain profitability.</I></B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In our industrial products business, we may be able to pass some or all increases in the cost
of raw material and other production inputs to customers by increasing the selling prices of our
products; however, higher product prices may also result in a reduction in sales volume. If we are
not able to increase our selling prices sufficiently to offset increased raw material or other
input costs, including packaging, direct labor, overhead and employee benefits, or if our sales
volume decreases significantly, there could be a negative impact on our results of operations and
financial condition.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt"><B><I>We may be adversely affected by any disruption to our manufacturing facilities or our customer,
supplier, or employee base.</I></B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;With respect to our industrial products business, any serious disruption to our facilities
resulting from hurricanes and other weather-related events, fire, an act of terrorism or any other
cause could damage a significant portion of our inventory, affect our distribution of products and
materially impair our ability to distribute our products to customers. We could incur significantly
higher costs and longer lead times associated with distributing our products to our customers
during the time that it takes for us to reopen or replace a damaged facility. In addition, if there
are disruptions to our customer and supplier base or to our employees caused by such events, our
business could be temporarily adversely affected by higher costs for materials, increased shipping
and storage costs, increased labor costs, increased absentee rates and scheduling issues. Certain
key components of our products are available from a limited number of suppliers and a disruption in
supply of even one of these key components could have a serious negative impact on our business.
Any interruption in the production or delivery of our raw materials or key components could reduce
sales of our products and increase our costs.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt"><B><I>The nature of our business exposes us to product liability and warranty claims.</I></B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We may be subjected to product liability and product warranty claims relating to the products
we sell that, if adversely determined, could adversely affect our financial condition, results of
operations, and cash flows. Although we currently maintain what we believe to be suitable and
adequate insurance, we may not be able to maintain such insurance on acceptable terms or such
insurance may not provide adequate protection against potential liabilities. Product liability
claims can be expensive to defend and can divert the attention of management and other personnel
for significant periods, regardless of the ultimate outcome. Claims of this nature could also have
a negative impact on customer confidence in our products and our company.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt"><B><I>Our future capital needs are uncertain and we may need to raise additional funds in the future
which may not be available on acceptable terms, if at all.</I></B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our capital requirements will depend on many factors including:
</DIV>


<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" style="background: transparent">&nbsp;</TD>
    <TD width="2%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Acceptance of, and demand for, our products and services;</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" style="background: transparent">&nbsp;</TD>
    <TD width="2%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>The costs of developing and selling new products or services;</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" style="background: transparent">&nbsp;</TD>
    <TD width="2%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>The extent to which we continue to invest in development of
new software products;</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" style="background: transparent">&nbsp;</TD>
    <TD width="2%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>The costs to manufacture our industrial products;</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" style="background: transparent">&nbsp;</TD>
    <TD width="2%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>The costs associated with the growth of our business; and</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" style="background: transparent">&nbsp;</TD>
    <TD width="2%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>The extent to which we invest in new equipment or new lines
of business.</TD>
</TR>

</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We expect that the proceeds from this rights offering, payments on our notes receivable,
projected customer payments, and working capital borrowings will be sufficient for our operations
for the foreseeable future. However, our line of credit expires June&nbsp;30, 2009 and if the bank does
not renew it, we could experience a cash shortfall. We may not
achieve our current sales and cash flow projections and therefore our existing sources of cash and cash
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->19<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 10pt">flows may not be sufficient to
fund our activities or growth plans. As a result, we may need to raise additional funds which may
not be available on acceptable terms, if at all. Furthermore, if we needed to raise additional
equity capital in the future, such a financing could cause dilution to our existing shareholders or
could have rights, preferences and privileges senior to those of our existing shareholders. If we
need additional funds and cannot raise them on acceptable terms, we may need to scale back
expenditures and may not be able to develop and enhance our products
or execute our business plan.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt"><B><I>Our line of credit contains various covenants that may limit our ability to operate our
business.</I></B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our line of credit contains various provisions that restrict our ability to, among other
things:
</DIV>


<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="8%" style="background: transparent">&nbsp;</TD>
    <TD width="2%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Transfer or sell assets, including the equity interests of our subsidiary, or
use asset sale proceeds;</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="8%" style="background: transparent">&nbsp;</TD>
    <TD width="2%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Incur additional debt;</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="8%" style="background: transparent">&nbsp;</TD>
    <TD width="2%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Pay dividends or distributions on our capital stock or repurchase our capital
stock;</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="8%" style="background: transparent">&nbsp;</TD>
    <TD width="2%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Make certain restricted payments or investments;</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="8%" style="background: transparent">&nbsp;</TD>
    <TD width="2%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Create liens to secure debt;</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="8%" style="background: transparent">&nbsp;</TD>
    <TD width="2%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Merge or consolidate with another company; and</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="8%" style="background: transparent">&nbsp;</TD>
    <TD width="2%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Engage in unrelated business activities.</TD>
</TR>

</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The amount we may borrow under our current line of credit is capped at $1.25&nbsp;million and is
tied to a calculation based on qualifying accounts receivables and inventories. There is no
guarantee that the amount we qualify for under the line will be sufficient for our needs. If we do
not comply with the provisions of the line of credit agreement, it could result in a default under
our indebtedness, which could cause those and other obligations to become due and payable. If any
of our indebtedness is accelerated, we may not be able to repay it. Furthermore, the line of
credit expires June&nbsp;30, 2009 and there is no assurance that it will be renewed on terms acceptable
to us, if at all.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt"><B><I>We are exposed to risks relating to evaluations of controls required by Section&nbsp;404 of the
Sarbanes-Oxley Act of 2002.</I></B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We are required to comply with Section&nbsp;404 of the Sarbanes-Oxley Act of 2002. While we have
concluded that at present we have no material weaknesses in our internal controls over financial
reporting, we cannot assure you that we will not have a material weakness in the future. A
&#147;material weakness&#148; is a control deficiency, or combination of significant deficiencies, that
results in more than a remote likelihood that a material misstatement of the annual or interim
financial statements will not be prevented or detected. If we fail to maintain a system of internal
controls over financial reporting that meets the requirements of Section&nbsp;404, we might be subject
to sanctions or investigation by regulatory authorities such as the SEC, NYSE Regulation, Inc. or
others. Additionally, failure to comply with Section&nbsp;404 or the report by us of a material
weakness may cause investors to lose confidence in our financial statements and our stock price may
be adversely affected. If we fail to remedy any material weakness, our financial statements may be
inaccurate, we may not have access to the capital markets and our stock price may be adversely
affected.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt"><B><I>We are exposed to risks related to our minority ownership positions in privately-owned companies.</I></B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Currently we hold minority ownership positions in four privately-held companies which have an
aggregate carrying value of $1.2&nbsp;million as of December&nbsp;31, 2008. We account for one of these
investments in which we own a 25% interest under the equity method and each quarter we include our
pro rata share of such company&#146;s profit or loss in our reported financial results. Accordingly,
our financial results could be impacted by any operating losses associated with such an investment.
Moreover, the carrying value of our minority owned investments are based on
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->20<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 10pt">our current estimate
of realizability of the value of the investments. Future adverse changes in market conditions,
poor operating results, lack of progress of the investee company, inability of the investee company
to raise needed capital, the price and terms associated with capital raised by the investee company
and potential liquidity events at valuations lower than our carrying value could cause us to
write-down the value of our investment, which could negatively impact our financial performance.
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>Risks Related to the Rights Offering</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt"><B><I>The price of our common stock is volatile and may decline before or after the subscription rights
expire.</I></B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The market price of our common stock could be subject to wide fluctuations in response to
numerous factors, including factors that have little or nothing to do with us or our performance,
and these fluctuations could materially reduce our stock price. These factors include, among other
things, actual or anticipated variations in our operating results and cash flow, the nature and
content of our earnings releases and our competitors&#146; and customers&#146; earnings releases,
announcements of technological innovations that affect our products, customers, competitors, or
markets, changes in business conditions in our markets and the general state of the securities
markets and the market for similar stocks, the number of shares of our common stock outstanding,
changes in capital markets that affect the perceived availability of capital to companies in our
industries, governmental legislation or regulation, currency and exchange rate fluctuations, as
well as general economic and market conditions, such as recessions. In addition, the stock market
historically has experienced significant price and volume fluctuations. These fluctuations are
often unrelated to the operating performance of particular companies. These broad market
fluctuations may cause declines in the market price of our common stock.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We cannot assure you that the public trading market price of our common stock will not decline
after you elect to exercise your rights. If that occurs, you may have committed to buy shares of
common stock in the rights offering at a price greater than the prevailing market price and could
have an immediate unrealized loss. Moreover, we cannot assure you that, following the exercise of
your rights, you will be able to sell your common stock at a price equal to or greater than the
subscription price, and you may lose all or part of your investment in our common stock. Until
shares are delivered upon expiration of the rights offering, you will not be able to sell the
shares of our common stock that you purchase in the rights offering. Certificates representing
shares of our common stock purchased will be delivered promptly after expiration of the rights
offering. We will not pay you interest on funds delivered to the subscription agent pursuant to the
exercise of rights.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt"><B><I>If the rights offering is consummated, your relative ownership interest may experience significant
dilution.</I></B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To the extent that you do not exercise your rights and shares are purchased by other
stockholders in the rights offering, your proportionate voting interest will be reduced, and the
percentage that your original shares represent of our expanded equity after exercise of the rights
will be diluted.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt"><B><I>The subscription rights are not transferable, and there is no market for the subscription rights.</I></B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;You may not sell, give away or otherwise transfer your subscription rights. The subscription
rights are only transferable by operation of law. Because the subscription rights are
non-transferable, there is no market or other means for you to directly realize any value
associated with the subscription rights. You must exercise the subscription rights and acquire
additional shares of our common stock to realize any value from your subscription rights.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt"><B><I>Because we may terminate the offering at any time, your participation in the offering is not
assured.</I></B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We may terminate the offering at any time. If we decide to terminate the offering, we will not
have any obligation with respect to the subscription rights except to return any subscription
payments, without interest or deduction. If the total purchase price for the shares subscribed for is less than
$1,400,000, we plan to cancel the rights offering, but we are not obligated to do so, and
this requirement may be waived or modified by our board of directors.
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->21<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 10pt"><B><I>The subscription price determined for the rights offering is not an indication of the fair value of
our common stock.</I></B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our board of directors determined the subscription price considering the likely cost of
capital from other sources, the price at which our stockholders might be willing to participate in
the rights offering, and historical and current trading prices for our common stock. The
subscription price for a subscription right is $0.70 per share. The subscription price does not necessarily bear any
relationship to the book value of our assets or our past operations, cash flows, losses, financial
condition, net worth or any other established criteria used to value securities. You should not
consider the subscription price to be an indication of the fair value of the common stock to be
offered in the rights offering. After the date of this prospectus, our common stock may trade at
prices above or below the subscription price.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt"><B><I>You may not revoke your subscription exercise and could be committed to buying shares above the
prevailing market price.</I></B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Once you exercise your subscription rights, you may not revoke the exercise. The public
trading market price of our common stock may decline before the subscription rights expire. If you
exercise your subscription rights and, afterwards, the public trading market price of our common
stock decreases below the subscription price, you will have committed to buying shares of our
common stock at a price above the prevailing market price. Our common stock is traded on the NYSE
Amex exchange under the symbol &#147;INS,&#148; and the last reported sales price of our common stock on such
exchange on May&nbsp;12, 2009 was $0.75&nbsp;per share. Moreover, you may be unable to sell your
shares of common stock at a price equal to or greater than the subscription price you paid for such
shares.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If we elect to cancel or terminate the rights offering, neither we nor the subscription agent
will have any obligation with respect to the subscription rights except to return, without
interest, any subscription payments the subscription agent received from you.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt"><B><I>If you do not act promptly and follow the subscription instructions, your exercise of subscription
rights may be rejected.</I></B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Stockholders who desire to purchase shares in the rights offering must act promptly to ensure
that all required forms and payments are actually received by the subscription agent before
&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&nbsp;&#95;&#95;&#95;, 2009, the expiration date of the rights offering, unless extended. If you are a
beneficial owner of shares, you must act promptly to ensure that your broker, custodian bank or
other nominee acts for you and that all required forms and payments are actually received by the
subscription agent before the expiration date of the rights offering. We will not be responsible
if your broker, custodian or nominee fails to ensure that all required forms and payments are
actually received by the subscription agent before the expiration date of the rights offering. If
you fail to complete and sign the required subscription forms, send an incorrect payment amount or
otherwise fail to follow the subscription procedures that apply to your exercise in the rights
offering, the subscription agent may, depending on the circumstances, reject your subscription or
accept it only to the extent of the payment received. Neither we nor our subscription agent
undertakes to contact you concerning an incomplete or incorrect subscription form or payment, nor
are we under any obligation to correct such forms or payment. We have the sole discretion to
determine whether a subscription exercise properly follows the subscription procedures.
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>Risks Related to Our Common Stock</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt"><B><I>Failure to meet the continued listing standards of the NYSE Amex could result in delisting of our
common stock.</I></B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We currently do not meet the continued listing standards of the NYSE Amex exchange due to
losses from continuing operations in three of the last four fiscal years and shareholders&#146; equity
of less than $4&nbsp;million. We have a plan, which has been accepted by the NYSE Amex exchange, to regain compliance by June&nbsp;18,
2010. This rights offering is one element of our plan to regain compliance by increasing our
shareholders&#146; equity. However, if we are not able to complete the rights offering successfully or
if we continue to experience significant losses, we may not achieve compliance with continued
listing standards and the NYSE Amex exchange could initiate delisting of our common stock.
Delisting may have  a negative impact on the market price and liquidity of our common stock.
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->22<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 10pt"><B><I>The price of our common stock historically has experienced significant price and volume
fluctuations, which may make it difficult for you to resell the common stock.</I></B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The market price of our common stock historically has experienced and may continue to
experience significant price and volume fluctuations similar to those experienced by the broader
stock market in recent years. In addition, the price of our common stock may fluctuate
significantly in response to various factors, including, but not limited to variations in our
annual or quarterly financial results and conditions in the economy in general or the information
technology or industrial products industries in particular, including increased competitive
pressures and pricing pressures from the industry and our customers.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt"><B><I>Significant sales of common stock, or the perception that significant sales may occur in the
future, could adversely affect the market price for our common stock.</I></B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The sale of substantial amounts of our common stock could adversely affect its price. Sales
of substantial amounts of our common stock in the public market, and the availability of shares for
future sale, including 4,478,971 shares of our common stock  issuable in the rights offering,
and 221,000 shares of our common stock issuable upon exercise of outstanding options to acquire
shares of our common stock could adversely affect the prevailing market price of our common stock.
We cannot foresee the impact of such potential sales on the market, but it is possible that if a
significant percentage of such available shares are attempted to be sold within a short period of
time, the market for our shares would be adversely affected. It is also unclear  whether or
not the market for our common stock could absorb a large number of attempted sales in a short
period of time, regardless of the price at which the same might be offered. Even if a substantial
number of sales do not occur within a short period of time, the mere existence of this &#147;market
overhang&#148; could have a negative impact on the market for our common stock and our ability to raise
additional capital.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt"><B><I>Provisions in our corporate documents and Georgia law could delay or prevent a change in control of
Intelligent Systems Corporation, which could adversely affect the price of our common stock.</I></B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The existence of some provisions in our corporate documents and Georgia law could delay or
prevent a change in control of the Company, which could adversely affect the price of our common
stock. Our bylaws contain provisions that may make the acquisition of control of the Company more
difficult, including provisions relating to the nomination, election, and removal of directors and
limitations on actions by our stockholders. For example, our bylaws provide that the Board of
Directors be divided into three classes as nearly equal in size as possible with staggered
three-year terms. This classification of the Board of Directors has the effect of making it more
difficult for stockholders to change the composition of the Board of Directors.
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->23<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left">
<A name="106"></A>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>USE OF PROCEEDS</B>
</DIV>



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If we meet the minimum purchase requirement, we will receive estimated net proceeds of
$1,282,325.05, after deducting estimated offering expenses of $117,674.95. If we sell all of the
shares being offered, we will receive estimated net proceeds of $3,017,604.75, after deducting
estimated offering expenses of $117,674.95. We plan to use the net proceeds of the rights offering
principally to support our plans for our CoreCard subsidiary, including increasing marketing and
sales activities, expanding CoreCard&#146;s management team, and devoting additional resources to
CoreCard&#146;s credit and prepaid card processing services offering.
</DIV>


<DIV align="left">
<A name="107"></A>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>CAPITALIZATION</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following table describes capitalization as of March&nbsp;31, 2009, on an actual basis and
on a pro forma, as adjusted basis to give effect to the sale of all 4,478,971 shares offered in the
rights offering (including application of net proceeds as described above) at a price of $0.70&nbsp;per
share. The following information should be read in conjunction with our consolidated financial
statements and the notes thereto incorporated by reference in this prospectus.
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="76%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2" style="border-bottom: 1px solid #000000"><B>Actual</B></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2" style="border-bottom: 1px solid #000000"><B>As Adjusted</B></TD>
    <TD>&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="6"><B>(In Thousands)</B></TD>
    <TD>&nbsp;</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Cash</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left">$</TD>
    <TD align="right">588</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left">$</TD>
    <TD align="right">3,605</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Current liabilities:</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:60px; text-indent:-15px">Short-term borrowings</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">342</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">342</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:60px; text-indent:-15px">Accounts payable</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">938</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">938</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:60px; text-indent:-15px">Deferred revenue</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">980</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">980</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:60px; text-indent:-15px">Accrued payroll</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">425</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">425</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:60px; text-indent:-15px">Accrued expenses and other current liabilities</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">950</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">950</TD>
    <TD>&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:75px; text-indent:-15px">Total current liabilities</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">3,635</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">3,635</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:60px; text-indent:-15px">Long-term liabilities</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">226</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">226</TD>
    <TD>&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:60px; text-indent:-15px">Total liabilities</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">3,861</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">3,861</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:60px; text-indent:-15px">Commitments and contingencies</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Shareholders&#146; equity:</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:60px; text-indent:-15px">Common stock; par value $.01 per share </DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:60px; text-indent:-15px">Shares outstanding at &#95;&#95;&#95;&#95;&#95;&#95; &#95;&#95;&#95;, 2009: 4,478,971</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:60px; text-indent:-15px">Shares outstanding if all shares sold in rights offering: 8,957,942</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">45</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">90</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:60px; text-indent:-15px">Additional paid-in-capital</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">18,459</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">21,431</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:60px; text-indent:-15px">Accumulated other comprehensive (loss)&nbsp;income</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">&nbsp;</TD>
    <TD align="right">(105</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">(105</TD>
    <TD nowrap>)</TD>

</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:60px; text-indent:-15px">Accumulated deficit</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">&nbsp;</TD>
    <TD align="right">(15,828</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">(15,828</TD>
    <TD nowrap>)</TD>

</TR>

<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:60px; text-indent:-15px">Noncontrolling Interest</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">&nbsp;</TD>
    <TD align="right">1,516</TD>
    <TD nowrap>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1,516</TD>
    <TD nowrap>&nbsp;</TD>

</TR>



<TR style="font-size: 1px">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Total shareholders&#146; equity</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">4,087</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">7,104</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Total capitalization</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">7,948</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">10,965</TD>
    <TD>&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->24<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left">
<A name="109"></A>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>THE RIGHTS OFFERING</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt"><B>The Rights</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We are distributing to the record holders of
our common stock as of &#95;&#95;&#95;&#95;&#95;&#95;&nbsp;&#95;&#95;&#95;, 2009,
non-transferable subscription rights to purchase shares of our common stock. The
subscription rights will entitle the holders of common stock to purchase shares of common stock for
an aggregate purchase price of $3,135,279.70. See below for additional information regarding
subscription by DTC participants.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;You will receive one subscription right for each share of our common stock that you owned at
the close of business on the record date. Each subscription right will entitle the holder thereof
to purchase at the subscription price, on or before the expiration time of the rights offering, one
share of common stock. Stockholders who elect to exercise their basic subscription privilege in
full may also subscribe, at the subscription price, for up to 500,000 additional shares of our
common stock under their respective over-subscription privileges to the extent that other rights
holders do not exercise their basic subscription privileges in full. If a sufficient number of
shares of our common stock are unavailable to fully satisfy the over-subscription privilege
requests, the available shares of common stock will be sold <I>pro rata </I>among subscription rights
holders who exercised their over-subscription privilege as described
in &#147;Subscription Privileges&#148; in proportion to the number of shares of
our common stock that such subscription rights holders purchased by exercising their basic
subscription privileges.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We intend to keep the rights offering open
until &#95;&#95;&#95;&#95;&#95;&#95;&nbsp;&#95;&#95;&#95;, 2009, unless our board of
directors, in its sole discretion, extends such time.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt"><B>Reasons for the Rights Offering</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Prior to approving the rights offering, our board of directors carefully considered current
market conditions and opportunities as well as the dilution of the ownership percentage of the
current holders of our common stock that may be caused by the rights offering before concluding
that the rights offering was in the best interest of the Company.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;After
weighing the factors discussed above and the effect of the $3,135,279.70 in additional
capital, before expenses, that may be generated by the sale of shares pursuant to the rights
offering, our board of directors believes that the rights offering is in the best interests of the
Company. As described in the section of this prospectus entitled &#147;Use of Proceeds,&#148; the net
proceeds of the rights offering will be used principally to support our plans for our CoreCard
subsidiary, including increasing marketing and sales activities, expanding CoreCard&#146;s management
team, and devoting additional resources to CoreCard&#146;s credit and prepaid card processing services
offering.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt"><B>Expiration of the Rights Offering and Extensions, Amendments, and Termination</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;You may exercise your subscription rights at any time before 5:00 p.m.,
Eastern Daylight Time,
on &#95;&#95;&#95;&#95;&#95;&#95;&nbsp;&#95;&#95;&#95;, 2009, the expiration date of the rights offering, unless extended. We may, in
our sole discretion, extend the time for exercising the subscription rights.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We will extend the duration of the rights offering as required by applicable law, and may
choose to extend it if we decide that changes in the market price of our common stock warrant an
extension or if we decide to give investors more time to exercise their subscription rights in the
rights offering. We may extend the expiration date of the rights offering by giving oral or
written notice to the subscription agent and information agent on or before the scheduled
expiration date. If we elect to extend the expiration of the rights offering, we will issue a
press release announcing such extension no later than 9:00 a.m., Eastern Daylight Time, on the next
business day after the most recently announced expiration date.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We reserve the right, in our sole discretion, to amend or modify the terms of the rights
offering.
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->25<!-- /Folio -->
</DIV>




<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If you do not exercise your subscription rights before the expiration date of the rights
offering, your unexercised subscription rights will be null and void and will have no value. We
will not be obligated to honor your exercise of subscription rights if the subscription agent
receives the documents relating to the exercise of your subscription
privileges after the rights offering expires, regardless of
when you transmitted the documents.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>Subscription Privileges</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Your subscription rights entitle you to a basic subscription privilege and an
over-subscription privilege.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Basic Subscription Privilege</I></B><I>. </I>The basic subscription privilege of each whole right entitles
you to purchase one share of our common stock at the subscription
price of $0.70 per share. You
will receive one subscription right for each share of our common stock you owned at the close of
business on the record date. You are not required to exercise all of your subscription rights
unless you wish to purchase shares under your over-subscription privilege.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Over-Subscription Privilege</I></B><I>. </I>The over-subscription privilege of each right entitles you, if
you have fully exercised your basic subscription privilege, to
subscribe for up to 500,000
additional shares of our common stock at the same subscription price per share. Shares will only
be awarded to you, however, if other holders of subscription rights do not subscribe for all the
shares available to them under their basic subscription privileges.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Pro Rata Allocation</I></B><I>. </I>Shares will first be awarded to rights holders in the amount that each
holder subscribed for under his basic subscription privilege. If available shares remain after the
fulfillment of all basic subscription requests under the holders&#146; basic subscription privilege,
then shares will be awarded to rights holders who exercised their over-subscription privilege. If
there are sufficient shares available to fulfill the over-subscription requests of all rights
holders, then each right holder will receive the number of shares subscribed under his
over-subscription privilege.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The allocation process may involve a series of allocations to assure that the total number of
remaining shares available for over-subscriptions is distributed on a <I>pro rata </I>basis. The formula
to be used in allocating the available excess shares is as follows:
</DIV>


<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="42%">&nbsp;</TD>
    <TD width="14%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="42%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="left" valign="top"><DIV style="margin-left:0px; text-indent:-0px">Rights Holder&#146;s Rights Ownership as of the Record Date
<DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
Total Rights Ownership as of the Record Date of
Rights<BR>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Holders Exercising Their Over-Subscription
Right
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">x
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">Shares Available for Rights Holders<BR>
Exercising Their Over-Subscription Right</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In certain situations, allocating the remaining available shares on this basis could result in
your receiving an allocation of a greater number of shares than you subscribed for under your
over-subscription privilege. If this occurs, then we will allocate to you only the number of
shares for which you subscribed. We will allocate the remaining shares among all other holders
exercising their over-subscription privileges on the <I>pro rata </I>basis described above.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Full Exercise of Basic Subscription Privilege</I></B><I>. </I>You may exercise your over-subscription
privilege only if you exercise your basic subscription privilege in full. To determine if you have
fully exercised your basic subscription privilege, we will consider only the basic subscription
privilege held by you in the same capacity. For example, suppose that you were granted
subscription rights for shares of our common stock that you own individually and shares of our
common stock that you own collectively with your spouse. If you wish to exercise your
over-subscription privilege with respect to the subscription rights you own individually, but not
with respect to the subscription rights you own collectively with your spouse, you only need to
fully exercise your basic subscription privilege with respect to your individually owned
subscription rights. You do not have to subscribe for any shares under the basic subscription
privilege owned collectively with your spouse to exercise your individual over-subscription
privilege.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;When you complete the portion of your subscription rights certificate to exercise your
over-subscription privilege, you will be representing and certifying that you have fully exercised your
basic subscription privilege as to
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->26<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">shares of our common stock that you hold in that capacity. You must exercise your
over-subscription privilege at the same time you exercise your basic subscription privilege in
full.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Return
of Excess Payment; Delivery of Certificates</I></B><I>. </I>If you exercised your over-subscription privilege and are allocated
less than all of the shares of our common stock for which you wished to subscribe, your excess
payment for shares that were not allocated to you will be returned to you by mail, without interest
or deduction, promptly after the expiration date of the rights offering. We will deliver to the
holders of record who purchase shares in the rights offering certificates representing the shares
of our common stock that they purchased promptly after the expiration date of the rights offering
and after all allocations and adjustments have been completed.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>Method of Subscription&#151;Exercise of Rights</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If you are a record holder of shares of our common stock, you may exercise your subscription
rights by delivering the following to the subscription agent, at or before 5:00 p.m., Eastern
Daylight Time, on &#95;&#95;&#95;&#95;&#95;&#95;&nbsp;&#95;&#95;&#95;, 2009, the expiration date of the rights offering, unless
extended:
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Your properly completed and executed subscription rights certificate with any required
signature guarantees or other supplemental documentation; and</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Your full subscription price payment for each share subscribed for under your subscription
privileges.</TD>
</TR>

</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If you are a beneficial owner of shares of our common stock whose shares are registered in the
name of a broker, custodian bank, or other nominee, you should instruct your broker, custodian bank
or other nominee to exercise your rights and deliver all documents and payment on your behalf
before 5:00 p.m., Eastern Daylight Time, on &#95;&#95;&#95;&#95;&#95;&#95;&nbsp;&#95;&#95;&#95;, 2009, the expiration date of the rights
offering, unless extended.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Your subscription rights will not be considered exercised unless the subscription agent
receives from you, your broker, custodian or nominee, as the case may be, all of the required
documents and your full subscription price payment before 5:00 p.m., Eastern Daylight Time, on
&#95;&#95;&#95;&#95;&#95;&#95;&nbsp;&#95;&#95;&#95;, 2009, the expiration date of the rights offering, unless extended.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>Method of Payment</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Your payment of the subscription price must be made in United States dollars for the full
number of shares of common stock for which you are subscribing by either:
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>cashier&#146;s or certified check drawn upon a United States bank payable to the subscription
agent; or</TD>
</TR>




<TR>
    <TD style="font-size: 6pt">                                                       </TD>
</TR>
<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>wire transfer of immediately available funds to the subscription account maintained by the
subscription agent at JP Morgan Chase Bank, 55 Water Street, New York, New York 10005, ABA #021000021, Account No. 957-341326 American Stock Transfer FBO Intelligent Systems Corporation.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">                                                        </TD>
</TR>


</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For wire transfer of funds, please ensure that the wire instructions include the identity of
the subscriber paying the subscription price and the subscription rights certificate number, and
send your subscription rights certificate via overnight courier to be delivered on the next
business day following the day of the wire transfer to the subscription agent. You are responsible
for any wire transfer fees.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Personal checks will not be accepted.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->27<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>Receipt of Payment</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Your payment will be considered received by the subscription agent only upon:
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Receipt by the subscription agent of any cashier&#146;s or certified check drawn upon a United
States bank payable to the subscription agent; or</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Receipt of collected funds in the subscription account designated above.</TD>
</TR>

</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>Delivery of Subscription Materials and Payment</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;You should deliver your subscription rights certificate and payment of the subscription price
to the subscription agent by one of the methods described below:
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 10pt">American Stock Transfer &#038; Trust Company<BR>
6201 15<SUP style="font-size: 85%; vertical-align: text-top">th</SUP> Avenue<BR>
Brooklyn, New York 11219<BR>
Telephone: (877)&nbsp;248-6417
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Your delivery to a different address or by any method other than as set forth above will not
constitute valid delivery.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>Calculation of Subscription Rights Exercised</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If the aggregate subscription price paid by you is insufficient to purchase the number of
shares you subscribed for, then you will be deemed to have exercised the Basic Subscription
Privilege and Over-Subscription Privilege to purchase shares to the full extent of the payment
tendered.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If the aggregate subscription price paid by you exceeds the amount necessary to purchase the
number of shares for which you have indicated an intention to subscribe, then the remaining amount
will be returned to you by mail, without interest or deduction, promptly after the Expiration Date
and after all allocations and adjustments contemplated by the terms of the Rights Offering have
been effected.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If you do not indicate the number of subscription rights being exercised, then you will be
deemed to have exercised your subscription rights with respect to the maximum number of whole
subscription rights that may be exercised with the aggregate subscription price you delivered to
the subscription agent. If you do not indicate the number of subscription rights being exercised
and your aggregate subscription price is greater than the amount you owe for exercise of your Basic
Subscription Privilege in full, you will be deemed to have exercised your Over-Subscription
Privilege to purchase the maximum number of shares of common stock with your over-payment.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If we do not apply your full subscription price payment to your purchase of shares of common
stock, the Company or the subscription agent will return the excess amount to you by mail, without
interest, as soon as practicable after the expiration date of the rights offering.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>Your Funds Will Be Held by the Subscription Agent until Shares of Our Common Stock Are Issued</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The subscription agent will hold your payment of the subscription price in a segregated
account with other payments received from other subscription rights holders until we issue your
shares of our common stock to you upon consummation of the rights offering.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>Medallion Guarantee May Be Required</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Your signature on each subscription rights certificate must be guaranteed by an eligible
institution, such as a member firm of a registered national securities exchange or a member of the
Financial Industry Regulatory Authority, Inc., or a commercial bank or trust company having an
office or correspondent in the United States, subject to standards and procedures adopted by the
subscription agent, unless:
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->28<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Your subscription rights certificate provides that shares are to be delivered to you as
record holder of those subscription rights; or</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>You are an eligible institution.</TD>
</TR>

</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>Notice to Brokers and Nominees</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
you are a broker, a trustee, or a depositary for securities who holds shares of our common
stock for the account of others on &#95;&#95;&#95;&#95;&#95;&#95;&nbsp;&#95;&#95;&#95;, 2009, the record date, you should notify the
respective beneficial owners of such shares of the rights offering as soon as possible to find out
their intentions with respect to exercising their subscription rights. You should obtain
instructions from the beneficial owner with respect to their subscription rights, as set forth in
the instructions we have provided to you for your distribution to beneficial owners. If the
beneficial owner so instructs, you should complete the appropriate subscription rights certificates
and submit them to the subscription agent with the proper payment. If you hold shares of our
common stock for the account(s) of more than one beneficial owner, you may exercise the number of
subscription rights to which all such beneficial owners in the aggregate otherwise would have been
entitled had they been direct record holders of our common stock on the record date, provided that
you, as a nominee record holder, make a proper showing to the subscription agent by submitting the
form entitled &#147;Nominee Holder Certification&#148; that was provided to you with your rights offering
materials. If you did not receive this form, you should contact the information agent,
Morrow &#38; Co., LLC, at 470&nbsp;West Avenue, Stamford, CT 06902,
Telephone: (800)&nbsp;607-0088 or (203)&nbsp;658-9400, to request a copy.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>Beneficial Owners</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If you are a beneficial owner of shares of our common stock or will receive your subscription
rights through a broker, custodian bank, or other nominee, we will ask your broker, custodian bank
or other nominee to notify you of the rights offering. If you wish to exercise your subscription
rights, you will need to have your broker, custodian bank, or other nominee act for you. If you
hold certificates of our common stock directly and would prefer to have your broker, custodian bank
or other nominee act for you, you should contact your nominee and request it to effect the
transactions for you. To indicate your decision with respect to your subscription rights, you
should complete and return to your broker, custodian bank, or other nominee the form entitled
&#147;Beneficial Owners Election Form.&#148; You should receive this
form from your broker, custodian bank, or
other nominee with the other rights offering materials. If you wish to obtain a separate
subscription rights certificate, you should contact the nominee as soon as possible and request
that a separate subscription rights certificate be issued to you. You should contact your broker,
custodian bank, or other nominee if you do not receive this form, but you believe you are entitled
to participate in the rights offering. We are not responsible if you do not receive the form from
your broker, custodian bank, or nominee or if you receive it without sufficient time to respond.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>Instructions for Completing Your Subscription Rights Certificate</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;You should read and follow the instructions accompanying the subscription rights certificates
carefully.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;You are responsible for the method of delivery of your subscription rights certificate(s) with
your subscription price payment to the subscription agent. If you send your subscription rights
certificate(s) and subscription price payment by mail, we recommend that you send them by
registered mail, properly insured, with return receipt requested. You should allow a sufficient
number of days to ensure delivery to the subscription agent prior to the time the rights offering
expires. You must pay, or arrange for payment, by means of a certified or cashier&#146;s check or wire
transfer of funds. Personal checks will not be accepted.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>Determinations Regarding the Exercise of Your Subscription Rights</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
will decide all questions concerning the timeliness, validity, form, and eligibility of the
exercise of your subscription rights and any such determinations by us will be final and binding.
We, in our sole discretion, may waive, in any particular instance, any defect or irregularity or
permit, in any particular instance, a defect or irregularity to be corrected within such time as we
may determine. We will not be required to make uniform
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->29<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">determinations in all cases. We may reject the exercise of any of your subscription rights
because of any defect or irregularity. We will not accept any exercise of subscription rights
until all irregularities have been waived by us or cured by you within such time as we decide, in
our sole discretion.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Neither
we, the subscription agent, nor the information agent will be under any duty to notify
you of any defect or irregularity in connection with your submission of subscription rights
certificates, and we will not be liable for failure to notify you of any defect or irregularity.
We reserve the right to reject your exercise of subscription rights if your exercise is not in
accordance with the terms of the rights offering or in proper form. We will also not accept the
exercise of your subscription rights if our issuance of shares of our common stock to you could be
deemed unlawful under applicable law.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>Material United States Federal Income Tax Consequences</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A holder should not recognize income or loss for United States federal income tax purposes in
connection with the receipt or exercise of subscription rights in the rights offering. You should
consult your tax advisor as to the particular consequences to you of the rights offering. For a
detailed discussion, see &#147;Material United States Federal Income Tax Consequences.&#148;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>Regulatory Limitation</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We will not be required to issue shares of our common stock to you pursuant to the rights
offering if, in our opinion, you would be required to obtain prior clearance or approval from any
state or federal regulatory authorities to own or control such shares if, at the time the rights
offering expires, you have not obtained such clearance or approval.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>Questions about Exercising Subscription Rights</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If you have any questions or require assistance regarding the method of exercising your
subscription rights or requests for additional copies of this document or the Instructions for Use
of Intelligent Systems Corporation Subscription Rights Certificates, you should contact the
information agent, Morrow &#38; Co., LLC, at 470&nbsp;West Avenue, Stamford, CT 06902, Telephone: (800)&nbsp;607-0088 or (203)&nbsp;658-9400.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>Subscription Agent and Information Agent</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We have appointed American Stock Transfer &#038; Trust Company to act as subscription agent and
Morrow &#38; Co., LLC to act as information agent for the rights offering. You should direct any
questions or requests for assistance concerning the method of subscribing for the shares of common
stock or for additional copies of this prospectus to the information agent.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>Fees and Expenses</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We will pay all fees charged by the subscription agent and the information agent. You are
responsible for paying any other commissions, fees, taxes or other expenses incurred in connection
with the exercise of the rights. Neither we nor the subscription agent will pay such expenses.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>No Revocation</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Once you have exercised your subscription privileges, you may not revoke your exercise.
Subscription rights not exercised before the expiration date of the rights offering will expire and
will have no value.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>Procedures for DTC Participants</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We expect that the exercise of your basic subscription privilege and your over-subscription
privilege may be made through the facilities of the Depository Trust Company. If your subscription
rights are held of record through DTC, you may exercise your basic subscription privilege and your
over-subscription privilege by instructing DTC to transfer your subscription rights from your
account to the account of the subscription agent, together with
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->30<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">certification as to the aggregate number of subscription rights you are exercising and the
number of shares of our common stock you are subscribing for under your basic subscription
privilege and your over-subscription privilege, if any, and your subscription price payment for
each share of our common stock that you subscribed for pursuant to your basic subscription
privilege and your over-subscription privilege.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>Subscription Price</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
subscription price is $0.70 per share. For more information with respect to how the
subscription price was determined, see &#147;Reasons for the Rights Offering&#148; and &#147;Questions and Answers
relating to the Rights Offering&#148; included elsewhere in this prospectus.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>Non-Transferability of the Rights</B>

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Except in the limited circumstances described below, only you may exercise the basic
subscription privilege and the over-subscription privilege. You may not sell, give away or
otherwise transfer the basic subscription privilege or the over-subscription privilege.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding the foregoing, your rights may be transferred by operation of law; for
example, a transfer of rights to the estate of the recipient upon the death of the recipient would
be permitted. If the rights are transferred as permitted, evidence satisfactory to us that the
transfer was proper must be received by us before the expiration date of the rights offering.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>Cancellation Rights</B>

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our board of directors may cancel the rights offering, in whole or in part, in its sole
discretion at any time for any reason before the time the rights offering expires  (including a
change in the market price of our common stock). If the total purchase price for the shares
subscribed for is less than $1,400,000, we plan to cancel the rights offering, but we are not
obligated to do so, and this requirement may be waived or modified by our board of directors. If
we cancel the rights offering, any funds you paid to the subscription agent will be promptly
refunded, without interest or deduction.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>No Stand-by Commitment to Purchase Additional Shares</B>

</DIV>
<DIV align="left" style="font-size: 10pt; margin-top: 10pt">We have no stand-by or backstop commitment with any party to buy shares if the subscription rights
are not fully exercised. Some of the members of our management team and board of directors have
advised us that they currently intend to participate in the rights offering. One of our largest
stockholders and our Chief Executive Officer, J. Leland Strange, has indicated he intends to
participate to the full extent of his Basic Subscription Privilege and may exercise his
Over-Subscription Privilege to some lesser extent, but he is not obligated to do so.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>No Board Recommendation</B>

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;An investment in shares of our common stock must be made according to each investor&#146;s
evaluation of his own best interests and after considering all of the information herein, including
the &#147;Risk Factors&#148; section of this prospectus. Neither we nor our board of directors make any
recommendation to subscription rights holders regarding whether they should exercise or sell their
subscription rights.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->31<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>Listing</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The rights will not be listed on the NYSE Amex exchange or any other stock exchange or
national market. The shares of common stock issuable upon exercise of the rights will be listed on
the NYSE Amex exchange under the symbol &#147;INS&#148;.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>Shares of Common Stock Outstanding After the Rights Offering</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Based
on the 4,478,971 shares of our common stock currently outstanding as
of &#95;&#95;&#95;&#95;&#95;&#95;&nbsp;&#95;&#95;&#95;,
2009 and assuming that all 4,478,971 shares of common stock offered in the rights offering are
issued, 8,957,942 shares of our common stock will be issued and outstanding following the rights
offering, excluding any shares that may be issued pursuant to the exercise of stock options.
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->32<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left">
<A name="110"></A>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>MATERIAL UNITED STATES FEDERAL INCOME TAX CONSEQUENCES</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following discussion is a summary of the material United States Federal income tax
consequences of the rights offering to holders of our common stock. This discussion assumes that
the holders of our common stock hold such common stock as a capital asset for United States Federal
income tax purposes. This discussion is based on the Internal Revenue
Code of 1986, as amended, or the Code,
Treasury Regulations promulgated thereunder, Internal Revenue Service rulings and pronouncements
and judicial decisions in effect on the date hereof, all of which are subject to change (possibly
with retroactive effect) and to differing interpretations. This discussion applies only to holders
that are United States persons and does not address all aspects of United States federal income
taxation that may be relevant to holders in light of their particular circumstances or to holders
who may be subject to special tax treatment under the  Code, including, without
limitation, holders who are dealers in securities or foreign currency, foreign persons, insurance
companies, tax-exempt organizations, banks, financial institutions, broker-dealers, holders who
hold our common stock as part of a hedge, straddle, conversion, or other risk reduction transaction,
or who acquired our common stock pursuant to the exercise of compensatory stock options or
otherwise as compensation.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We have not sought, and will not seek, an opinion of counsel or a ruling from the Internal
Revenue Service regarding the United States Federal income tax consequences of the rights offering
or the related share issuance. The following summary does not address the tax consequences of the
rights offering or the related share issuance under foreign, state, or local tax laws. ACCORDINGLY,
EACH HOLDER OF OUR COMMON STOCK SHOULD CONSULT ITS TAX ADVISOR WITH RESPECT TO THE PARTICULAR TAX
CONSEQUENCES OF THE RIGHTS OFFERING AND THE RELATED SHARE ISSUANCE TO SUCH HOLDER.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The United States Federal income tax consequences to a holder of our common stock of the
receipt and exercise of subscription rights under the rights offering should be as follows:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.&nbsp;A holder should not recognize taxable income for United States Federal income tax purposes
in connection with the receipt of subscription rights in the rights offering.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.&nbsp;Except as provided in the following sentence, a holder&#146;s tax basis in the subscription
rights received in the rights offering should be zero. If either (i)&nbsp;the fair market value of the
subscription rights on the date such subscription rights are distributed is equal to at least 15%
of the fair market value on such date of the common stock with respect to which the subscription
rights are received or (ii)&nbsp;the holder elects, in its United States Federal income tax return for
the taxable year in which the subscription rights are received, to allocate part of its tax basis
in such common stock to the subscription rights, then upon exercise of the subscription rights, the
holder&#146;s tax basis in the common stock should be allocated between the common stock and the
subscription rights in proportion to their respective fair market values on the date the
subscription rights are distributed. A holder&#146;s holding period for the subscription rights received
in the rights offering should include the holder&#146;s holding period for the common stock with respect
to which the subscription rights were received.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.&nbsp;A holder which allows the subscription rights received in the rights offering to expire
should not recognize any gain or loss, and the tax basis in the common stock owned by such holder
with respect to which such subscription rights were distributed should be equal to the tax basis in
such common stock immediately before the receipt of the subscription rights in the rights offering.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.&nbsp;A holder should not recognize any gain or loss upon the exercise of the subscription
rights received in the rights offering. The tax basis in the common stock acquired through exercise
of the subscription rights should equal the sum of the subscription price for the common stock and
the holder&#146;s tax basis, if any, in the rights as described above. The holding period for the common
stock acquired through exercise of the subscription rights should begin on the date the
subscription rights are exercised.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.&nbsp;A holder will recognize ordinary dividend income upon the receipt of any dividend or other
distribution on the shares of common stock it acquires upon exercise of the rights to the extent of
our current and accumulated earnings and profits. If the holder is non-corporate, dividends paid
out of current or accumulated earnings and profits will be qualified dividends and under current
law will be taxed at preferential rates applicable to long term capital
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->33<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">gains. If the holder is corporate, dividends deemed to have been paid out of our current and
accumulated earnings and profits will be eligible for the 70% dividends received deduction under
Section&nbsp;243 of the Code, subject to certain holding period requirements and the limitation
regarding debt-financed portfolio stock. A distribution in excess of our current and accumulated
earnings and profits will constitute a non-taxable return of capital to the extent of the holder&#146;s
adjusted tax basis in its shares of common stock acquired upon exercise of the rights, and
thereafter will constitute capital gain. If the holder is corporate, it will be required to reduce
its basis in such shares of common stock (but not below zero) in the event any dividends on such
shares of common stock constitute &#147;extraordinary dividends,&#148; as defined in Section&nbsp;1059 of the
Code, if it has not held such shares of common stock for more than two years at the time of such
extraordinary dividend; if the amount of the required reduction exceeds the holder&#146;s basis in such
shares of common stock, such excess would be treated as capital gain.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.&nbsp;If a holder sells or exchanges shares of common stock acquired upon exercise of the
rights, the holder generally will recognize gain or loss on the transaction equal to the difference
between the amount realized and the holder&#146;s basis in the shares of common stock. Such gain or loss
upon the sale of the shares will be long-term or short-term capital gain or loss, depending on
whether the shares have been held for more than one year. Under current law, non-corporate holders
are taxed at a maximum rate of 15% on long term capital gains. The deductibility of capital losses
is subject to limitations.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>Information Reporting and Backup Withholding</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Under the backup withholding rules of the Code, a holder may be subject to backup withholding
with respect to payments of dividends and proceeds from the sale, exchange or redemption of our
shares unless the holder: (i)&nbsp;is a corporation or comes within certain other exempt categories and,
when required, demonstrates this fact; or (ii)&nbsp;provides a correct taxpayer identification number and
certifies under penalties of perjury that the taxpayer identification number is correct and that the
holder is not subject to backup withholding because of a failure to report all dividends and
interest income. Any amount withheld under these rules will be credited against the holder&#146;s U.S.
federal income tax liability. We may require a holder to establish its exemption from backup
withholding or to make arrangements satisfactory to us with respect to the payment of backup
withholding.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>THE FOREGOING SUMMARY IS INCLUDED FOR GENERAL INFORMATION ONLY. ACCORDINGLY, YOU ARE URGED TO
CONSULT WITH YOUR OWN TAX ADVISOR WITH RESPECT TO THE PARTICULAR FEDERAL, STATE, LOCAL AND FOREIGN
TAX CONSEQUENCES OF THIS OFFERING AND RELATED SHARE ISSUANCE APPLICABLE TO YOUR OWN PARTICULAR TAX
SITUATION.</B>
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->34<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left">
<A name="111"></A>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>PRICE RANGE OF COMMON STOCK AND DIVIDEND POLICY</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Trading Prices</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following table sets forth, for the fiscal quarters indicated, the high and low sales
prices for our common stock as reported by the NYSE Amex exchange (formerly known as the American
Stock Exchange (Amex)) from April&nbsp;1, 2006, through May&nbsp;12, 2009.
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="76%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3" style="border-bottom: 1px solid #000000"><B>High</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="center" colspan="3" style="border-bottom: 1px solid #000000"><B>Low</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">2006</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Second Quarter</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2.40</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1.95</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Third Quarter</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2.70</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1.92</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Fourth Quarter</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">3.30</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2.26</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">2007</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">First Quarter</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">4.48</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">3.05</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Second Quarter</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">4.46</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">3.42</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Third Quarter</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">3.75</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">3.25</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Fourth Quarter</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">3.75</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2.85</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">2008</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:30px; text-indent:-15px">First Quarter</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">3.99</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2.90</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Second Quarter</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">3.75</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2.90</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Third Quarter</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">3.60</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2.10</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Fourth Quarter</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2.12</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">0.66</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">2009</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">First Quarter</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1.40</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">0.55</TD>
    <TD>&nbsp;</TD>
</TR>

<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Second
Quarter (through May&nbsp;12, 2009)</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">0.95</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">0.57</TD>
    <TD>&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Dividend Policy</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
have not paid regular dividends in the past and does not expect to pay any regular
dividends in the foreseeable future. Any future determination relating to dividend policy will be
made at the discretion of our board of directors and will depend on a number of factors, including
restrictions in our debt instruments, as well as our future earnings, capital requirements,
financial condition, prospects and other factors that our board of directors may deem relevant.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->35<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left">
<A name="112"></A>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>DESCRIPTION OF CAPITAL STOCK</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt">The following is a summary of the material terms of our capital stock. You are strongly encouraged,
however, to read our articles of incorporation and bylaws, copies of which are
available from us upon request.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>General Matters</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Our articles of incorporation provide that we are authorized to issue 20,000,000 shares of common
stock, par value $0.01 per share, and 2,000,000 shares of Series&nbsp;A preferred stock.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt">As of
May&nbsp;12, 2009, we had outstanding 4,478,971 shares of common
stock held by 321&nbsp;stockholders of record. As of &#95;&#95;&#95;&#95;&#95;&#95;&nbsp;&#95;&#95;&#95;, 2009, we had outstanding options (including vested
and unvested options) to purchase 221,000 shares of our common stock.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>Common Stock</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Shares of
our common stock have the following rights, preferences, and privileges:
</DIV>


<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD><I>Voting rights. </I>Each outstanding share of common stock entitles its holder to one vote on
all matters submitted to a vote of our stockholders, including the election of directors. There are
no cumulative voting rights. Generally, all matters to be voted on by stockholders must be approved
by a majority of the votes  cast by all shares of common stock present or represented
by proxy.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD><I>Dividends. </I>Holders of common stock are entitled to
receive dividends as, when, and if
dividends are declared by our board of directors out of assets legally available for the payment of
dividends.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD><I>Liquidation. </I>In the event of a liquidation,
dissolution, or winding up of our affairs,
whether voluntary or involuntary, after payment of our liabilities and obligations to creditors,
our remaining assets will be distributed ratably among the holders of shares of common stock on a
per share basis. If we have any preferred stock outstanding at such time, holders of the preferred
stock may be entitled to distribution and/or liquidation preferences. In either such case, we will
need to pay the applicable distribution to the holders of our preferred stock before distributions
are paid to the holders of our common stock.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD><I>Rights and preferences. </I>Our common stock has no
preemptive, redemption, conversion, or
subscription rights. The rights, powers, preferences and privileges of holders of our common stock
are subject to, and may be adversely affected by, the rights of the holders of shares of any series
of preferred stock that we may designate and issue in the future.</TD>
</TR>

</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><B>Listing</B>

</DIV>
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Our common stock is listed on the NYSE Amex exchange under the trading symbol &#147;INS&#148;.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>Preferred Stock</B>

</DIV>
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Our articles of incorporation provide that the board of directors has the authority, without action
by the stockholders, to designate and issue up to 2,000,000 shares of preferred stock and to fix
the powers, rights, preferences and privileges of each class or series of preferred stock,
including dividend rights, conversion rights, voting rights, terms of redemption, liquidation
preferences and the number of shares constituting any class or series, which may be greater than
the rights of the holders of the common stock. In 1997, our board of directors designated 200,000
shares of preferred stock as Series&nbsp;A Preferred Stock to be issued pursuant to a Rights Agreement
dated November&nbsp;25, 1997 between us and American Stock Transfer Company, as rights agent; however,
the Rights Agreement has expired. There will be no shares of preferred stock outstanding immediately after
the closing of this offering. Any issuance of shares of preferred stock could adversely affect the
voting power of holders of common stock, and the likelihood that the
holders of preferred stock will receive dividend
payments and payments upon liquidation could have the effect of
delaying, deferring, or preventing a change in control. We have no present plans to issue any shares of
preferred stock.
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->36<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>Anti-Takeover Effects of Certain Provisions of Our Articles of Incorporation and Bylaws</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Our articles of incorporation and bylaws contain provisions that are intended to enhance the
likelihood of continuity and stability in the composition of the board of directors and which may
have the effect of delaying, deferring, or preventing a future takeover or change in control of our
company unless the takeover or change in control is approved by our board of directors. These
provisions include the following:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><I>Staggered Board of Directors. </I>Our bylaws provide for a staggered board of directors, divided into
three classes, with our stockholders electing one class each year. Between stockholders&#146; meetings,
the board of directors will be able to appoint new directors to fill vacancies or newly created
directorships so that no more than the number of directors in any given class could be replaced
each year and it would take three successive annual meetings to replace all directors.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><I>No Shareholder Action Through Written Consent. </I>Our articles of incorporation do not
provide for stockholder action other than at an annual or special meeting of stockholders; accordingly,
stockholder action cannot be taken by written consent in lieu of a
meeting unless all stockholders consent.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><I>Advance Notice Procedures for Stockholder Proposals. </I>Our bylaws establish an advance notice
procedure for stockholder proposals to be brought before an annual meeting of our stockholders.
Stockholders at our annual meeting may only consider proposals brought before the meeting by or at
the direction of our board, the Chairman of our board of directors, our President, our Chief
Executive Officer, or a stockholder who was a stockholder of record on the record date for the
meeting, who is entitled to vote at the meeting and who has given to our secretary timely written
notice, in proper form, of the stockholder&#146;s intention to bring that business before the meeting.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><I>Nominations to Board of Directors. </I>Our bylaws establish an advance notice procedure for stockholder
nominations to our board of directors. A stockholder may only make a nomination to the board if he
or she complies with the advance notice requirements of the bylaws and is entitled to vote on such
nomination at the meeting.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><I>Removal of Directors; Board of Directors Vacancies. </I>Our bylaws provide that members of our board of
directors may not be removed without cause. Our bylaws further provide that only our board of
directors may fill vacant directorships, except in limited circumstances. These provisions would
prevent a stockholder from gaining control of our board of directors by removing incumbent
directors and filling the resulting vacancies with such stockholder&#146;s own nominees.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">The foregoing provisions of our articles of incorporation and bylaws could discourage potential
acquisition proposals and could delay or prevent a change in control. These provisions are intended
to enhance the likelihood of continuity and stability in the composition of our board of directors
and in the policies formulated by our board of directors and to discourage certain types of
transactions that may involve an actual or threatened change of control. These provisions are
designed to reduce our vulnerability to an unsolicited acquisition proposal. The provisions also
are intended to discourage certain tactics that may be used in proxy fights. However, such
provisions could have the effect of discouraging others from making tender offers for our shares
and, as a consequence, they also may inhibit fluctuations in the market price of the common stock
that could result from actual or rumored takeover attempts. Such provisions also may have the
effect of preventing changes in our management or delaying or preventing a transaction that might
benefit you or other minority stockholders.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>Transfer Agent and Registrar</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The transfer agent and registrar for our common stock is American Stock Transfer &#038; Trust
Company, and its telephone number is (877)&nbsp;248-6417.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->37<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left">
<A name="113"></A>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>PLAN OF DISTRIBUTION</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On or about
&#95;&#95;&#95;&#95;&#95;&#95;&nbsp;&#95;&#95;&#95;, 2009, we will distribute the rights, rights certificates and
copies of this prospectus to individuals who owned shares of common stock on
&#95;&#95;&#95;&#95;&#95;&#95;&nbsp;&#95;&#95;&#95;, 2009. If you wish to exercise your rights and purchase shares of common stock, you should complete the
rights certificate and return it with payment for the shares, to the subscription agent, American
Stock Transfer &#038; Trust Company, at the following address:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 0pt; margin-left: 25%">American
Stock Transfer &#038; Trust Company<BR>
6201 15th Avenue<BR>
Brooklyn, New York 11219<BR>
Telephone: (877) 248-6417
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;See further the section of this prospectus entitled &#147;The Rights Offering.&#148; If you have any
questions, you should contact the information agent, Morrow &#38;
Co., LLC, at
470&nbsp;West Avenue, Stamford, CT 06902, Telephone: (800)&nbsp;607-0088 or (203)&nbsp;658-9400.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other than as described herein, we do not know of any existing agreements between any
stockholder, broker, dealer, underwriter or agent relating to the sale or distribution of the
underlying common stock.
</DIV>
<DIV align="left">
<A name="114"></A>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>LEGAL MATTERS</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The validity of the shares of common stock issuable upon exercise of the subscription rights
will be passed upon for us by Ledbetter Johnson Wanamaker Glass LLP.
</DIV>
<DIV align="left">
<A name="115"></A>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>EXPERTS</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The consolidated financial statements of the Company for the year ended December&nbsp;31, 2008
appearing in the Company&#146;s most recent Annual Report (Form 10-K) have been audited by Habif,
Arogeti &#038; Wynne, LLP, an independent registered public accounting firm, and the consolidated
financial statements of the Company for the year ended December&nbsp;31, 2007 appearing in the Company&#146;s
most recent Annual Report (Form 10-K) have been audited by Tauber &#038; Balser, P.C., an independent
registered public accounting firm, as set forth in their reports thereon, included therein, and
incorporated herein by reference. Such consolidated financial statements are incorporated herein
by reference in reliance upon such reports given on the authority of such firms as experts in
accounting and auditing.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->38<!-- /Folio -->
</DIV>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left">
<A name="116"></A>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>INCORPORATION BY REFERENCE</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Securities and Exchange Commission, or the SEC, allows us to &#147;incorporate by reference&#148;
the information we file with it, which means that we can disclose important information to you by
referring you to those documents. The information we incorporate by reference is an important part
of this prospectus. The documents we incorporate by reference include:
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>our Annual Report on Form 10-K for the fiscal year ended December&nbsp;31, 2008;</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>our Quarterly Report on Form 10-Q for the fiscal quarter ended March&nbsp;31, 2009; and</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>our Definitive Proxy Statement on Schedule&nbsp;14A, filed April&nbsp;16, 2009.</TD>
</TR>

</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Any statement contained in a document that is incorporated by reference will be modified or
superseded for all purposes to the extent that a statement contained in this prospectus modifies or is
contrary to that previous statement. Any statement so modified or superseded will not be deemed a
part of this prospectus except as so modified or superseded.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;You may request a copy of any of these filings at no cost, by writing or telephoning us at the
following address or telephone number:
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt">Intelligent Systems Corporation<BR>
4355 Shackleford Road<BR>
Norcross, Georgia 30093<BR>
(770)&nbsp;381-2900
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We have filed with the SEC a registration statement under the Securities Act of 1933, as
amended, with respect to the shares of common stock offered hereby. As permitted by the rules and
regulations of the SEC, this prospectus does not contain all the information set forth in the
registration statement. Such information can be examined without charge at the public reference
facilities of the SEC located at 100 F Street, N.E., Washington, D.C. 20549, and copies of such
material can be obtained from the Securities and Exchange Commission at prescribed rates. The
Securities and Exchange Commission telephone number is 1-800-SEC-0330. In addition, the SEC
maintains a web site (<I>www.sec.gov</I>) that contains periodic reports, proxy and information statements
and other information regarding registrants that file electronically with the SEC, including
Intelligent Systems Corporation. The statements contained in this Prospectus as to the contents of
any contract or other document filed as an exhibit to the registration statement are, of necessity,
brief descriptions of the material terms of, and should be read in conjunction with, such contract
or document.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In addition, we make available, without charge, through our website, <U><I>www.intelsys.com</I></U>,
electronic copies of our filings with the SEC, including copies of annual reports on Form 10-K,
quarterly reports on Form 10-Q, and amendments to these filings, if any. Information on our website
should not be considered a part of this prospectus, and we do not intend to incorporate into this
prospectus any information contained in the website.
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->39<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>PART II</B>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>INFORMATION NOT REQUIRED IN PROSPECTUS</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>Item&nbsp;13. Other Expenses of Issuance and Distribution.</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The expenses relating to the registration of the securities registered hereby will be borne by
the registrant. Such expenses are estimated to be as follows:
</DIV>


<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="88%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Securities and Exchange Commission Registration Fee</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">174.95</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">NYSE Amex Listing Fee</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">45,000.00</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Subscription Agent Fees and Expenses</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>

<TD colspan="1" align="right"><FONT style="white-space: nowrap">20,000.00</FONT></TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Information Agent Fees and Expenses</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD colspan="1" align="right">6,500.00</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Printing Costs</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD colspan="1" align="right">6,000.00</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Accounting Fees and Expenses</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD colspan="1" align="right">3,000.00</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Legal Fees</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">35,000.00</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Miscellaneous Expenses</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">2,000.00</TD>
    <TD>&nbsp;</TD>
</TR>


<TR style="font-size: 1px">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 1px solid #000000">&nbsp;
</TD>
</TR>




<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Total</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">117,674.95</TD>
    <TD>&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>Item&nbsp;14. Indemnification of Directors and Officers.</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following summary is qualified in its entirety by reference to the complete text of any
statutes referred to below and to the articles of incorporation and the bylaws of Intelligent
Systems Corporation, a Georgia corporation.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Georgia Business Corporation Code</U>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;14-2-851 of the Georgia Business Corporation Code (the &#147;GBCC&#148;) empowers us to
indemnify a director (including a former director and including a director who is or was serving at
our request as a director, officer, partner, trustee, employee or agent of another foreign or
domestic corporation, partnership, joint venture, trust, employee benefit plan or other enterprise)
against liability arising from official acts, provided the director acted in good faith and
reasonably believed that his or her conduct was in our best interests. We may indemnify a director
with respect to criminal proceedings if the director acted in good faith and had no reasonable
cause to believe the conduct was unlawful. Pursuant to Section&nbsp;14-2-851, we may not indemnify a
director in connection with a claim by us or in our right, or if the director is adjudged liable
for conduct involving receipt of an improper personal benefit.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In addition, Section&nbsp;14-2-856 of the GBCC permits our articles of incorporation, bylaws, a
contract, or resolution approved by the shareholders, to authorize us to indemnify a director
against claims to which the director was a party, including claims by us or in our right (e.g.,
shareholder derivative action). However, we may not indemnify the director for liability to us for
any misappropriation of a business opportunity belonging to us, intentional misconduct or knowing violation of the
law, unlawful distributions or receipt of an improper benefit.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;14-2-852 of the GBCC provides for mandatory indemnification against reasonable
expenses incurred by a director who is wholly successful in defending an action to which the
director was a party due to his or her status as our director on the merits or otherwise. Section
14-2-854 allows a court, upon application by a director, to order indemnification and advancement
of expenses if it determines that the director is entitled to indemnification under the GBCC, or it
determines that indemnification is fair and reasonable even if the director has failed to meet the
statutory standard of conduct provided under Section&nbsp;14-2-851. However, the court may not order
indemnification in excess of reasonable expenses for liability to us or for receipt of an improper
benefit.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;14-2-857 of the GBCC permits us to indemnify an officer (including a former officer
and including an officer who is or was serving at our request as a director, officer, partner,
trustee, employee or agent of another foreign or domestic corporation, partnership, joint venture,
trust, employee benefit plan or other enterprise) to the same extent as a director. We may
indemnify an officer who is not a director to a further extent by means of our
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->II-1<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">articles of incorporation, bylaws, board resolutions, or by contract. However, we may not indemnify an officer
for liability arising from conduct involving misappropriation of a
business opportunity of ours, intentional
misconduct or knowing violation of the law, unlawful distributions, or receipt of an improper benefit. An officer
who is not a director is also entitled to mandatory indemnification and may apply for court-ordered
indemnification.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;14-2-858 of the GBCC permits us to purchase and maintain insurance on behalf of our
directors and officers against liability incurred by them in their capacities or arising out of
their status as our directors and officers, regardless of whether we would have the power to
indemnify or advance expenses to the director or officer for the same liability under the GBCC.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Articles of Incorporation and Bylaws</U>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Article&nbsp;Six of our articles of incorporation exculpates our directors from personal liability
for money damages to us or our shareholders to the maximum extent permitted by the GBCC, as it may
be amended from time to time.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Article&nbsp;8 of our bylaws provides that we will indemnify any of our directors who was or is a
party, or is threatened to be made a party, to any threatened, pending or completed action, suit,
or proceeding, whether civil, criminal, administrative, or investigative, whether formal or
informal, including any action or suit by or in the right of the Company (a &#147;Proceeding&#148;) because
he or she is or was a director, officer, employee, or agent of the Company, against any judgment,
settlement, penalty, fine, or reasonable expenses (including, but not limited to, attorneys&#146; fees
and disbursements, court costs, and expert witness fees) incurred with respect to the Proceeding.
The indemnification covers any claim or liability against the person if the person acted in a
manner that he or she reasonably believed to be in, or not opposed to, our best interests, and,
with respect to any criminal action or proceeding, had no reasonable cause to believe his or her
conduct was unlawful. No indemnification shall be made for: (a)&nbsp;any appropriation by a director,
in violation of the director&#146;s duties, of any business opportunity of the corporation; (b)&nbsp;any acts
or omissions of a director that involve intentional misconduct or a knowing violation of law; (c)
any liability in connection with an unlawful distribution; or (d)&nbsp;any transaction from which the
director received an improper personal benefit.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Article&nbsp;8 of our bylaws also authorizes our board of directors to cause the Company to provide
to officers, employees, and agents of the Company, and of directors, officers, employees and agents
of other corporations, partnerships, joint ventures, trusts, employee benefit plans or other
companies, all or any part of the right to indemnification permitted for such persons by the GBCC.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In addition to the foregoing, Article&nbsp;8 of our bylaws also obligates us to indemnify each of
our directors and such of our officers as have been designated by the board of directors to the
full extent permitted by action of the board of directors without shareholder approval under the
GBCC and other laws of the State of Georgia.
</DIV>
<DIV align="left" style="font-size: 10pt; margin-top: 10pt">&nbsp;&nbsp;<U>Indemnification Agreements between Company and Directors and Certain Officers; Insurance
Policies</U>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We have entered into indemnification agreements with our directors and certain officers
providing contractual indemnification by us to the maximum extent authorized by law.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We maintain an insurance policy on behalf of the Company and its subsidiaries, and on behalf
of the directors and officers thereof, covering certain liabilities that may arise as a result of
the actions of such directors and officers.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be
permitted to our directors, officers or controlling persons pursuant to the foregoing provisions,
we have been informed that in the opinion of the Securities and Exchange Commission, this
indemnification is against public policy as expressed in the Securities Act and is therefore
unenforceable. In addition, indemnification may be limited by state securities laws.</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><B>Item&nbsp;15. Recent Sales of Unregistered Securities</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;There have been no sales of unregistered securities by the Company during the period between the
filing of the Company&#146;s Annual Report on Form 10-K for the fiscal year ended December&nbsp;31, 2008, and
the filing of this registration statement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>Item&nbsp;16. List of Exhibits.</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Exhibits to this registration statement are listed in the Index to Exhibits.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->II-2<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>Item&nbsp;17. Undertakings.</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt">(a)&nbsp;Intelligent Systems Corporation hereby undertakes that, for purposes of determining any
liability under the Securities Act of 1933, each filing of the Company&#146;s annual report pursuant to
Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934 (and, where applicable, each
filing of an employee benefit plan&#146;s annual report pursuant to Section 15(d) of the Securities
Exchange Act of 1934) that is incorporated by reference in the registration statement shall be
deemed to be a new registration statement relating to the securities offered therein, and the
offering of such securities at that time shall be deemed to be the initial bona fide offering
thereof.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt">(b)&nbsp;Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be
permitted to directors, officers and controlling persons of the registrant pursuant to the
foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the
Securities and Exchange Commission such indemnification is against public policy as expressed in
the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification
against such liabilities (other than the payment by the registrant of expenses incurred or paid by
a director, officer or controlling person of the registrant in the successful defense of any
action, suit or proceeding) is asserted by such director, officer or controlling person in
connection with the securities being registered, the registrant will, unless in the opinion of
counsel the matter has been settled by controlling precedent, submit to a court of appropriate
jurisdiction the question whether such indemnification by it is against public policy as expressed
in the Securities Act and will be governed by the final adjudication of such issue.
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->II-3<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left">
<A name="118"></A>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>SIGNATURES</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant
to the requirements of the Securities Act of 1933, the registrant has
duly caused this registration statement to be signed on its behalf by the undersigned,
thereunto duly authorized, in the City of Norcross, State of Georgia
on May&nbsp;27, 2009.
</DIV>

<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="48%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">INTELLIGENT SYSTEMS CORPORATION<BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">/s/ J. Leland Strange
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="2" align="left">J. Leland Strange&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="2" align="left">President and Chief Executive Officer&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
</TABLE>

<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>POWER OF ATTORNEY</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each person whose signature appears below hereby constitutes and appoints Bonnie L. Herron as his
true and lawful attorney-in-fact and agent, with full power of substitution and re-substitution,
for him in his name, place and stead, in any and all capacities, to sign any and all amendments to
this registration statement and any additional registration statement pursuant to Rule 462(b) under
the Securities Act of 1933 and to file the same, with all exhibits thereto, and other documents in
connection therewith, with the Securities and Exchange Commission, and hereby grants to such
attorney-in-fact and agent, full power and authority to do and perform each and every act and thing
requisite and necessary to be done, as fully to all intents and purposes as he might or could do in
person, hereby ratifying and confirming all that said attorney-in-fact and agent or his substitute
or substitutes may lawfully do or cause to be done by virtue hereof.
</DIV>



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to the requirements of the Securities Act of 1933, this registration statement has
been signed by the following persons in the capacities and on the dates indicated.
</DIV>


<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="2%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="40%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="23%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD nowrap align="center"><B>Signature</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center"><B>Title</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center"><B>Date</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom"><!-- Blank Space -->
    <TD>&nbsp;</TD>
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD>&nbsp;</TD>
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">/s/ J. Leland Strange
<DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">Chairman of the Board,<br>
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">May 27, 2009</TD>
</TR>
<TR valign="bottom">
    <TD>&nbsp;</TD>
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">J. Leland Strange
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">President and Chief Executive Officer<br>
(Principal Executive Officer and Director)<br></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD>&nbsp;</TD>
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom"><DIV style="margin-left:0px; text-indent:-0px">/s/ Bonnie L. Herron
<DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">Vice President,

</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">May 27, 2009</TD>
</TR>
<TR valign="bottom">
    <TD>&nbsp;</TD>
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">Bonnie L. Herron
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">Chief Financial Officer and Secretary<br>(Principal Financial and Accounting
Officer)</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD>&nbsp;</TD>
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD>&nbsp;</TD>

<TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">/s/ James V. Napier
<DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">Director&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">May 27, 2009</TD>
</TR>
<TR valign="bottom">
    <TD>&nbsp;</TD>

<TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">James V. Napier</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD>&nbsp;</TD>
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD>&nbsp;</TD>
<TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">/s/ John B. Peatman
<DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">Director&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">May 27, 2009</TD>
</TR>
<TR valign="bottom">
    <TD>&nbsp;</TD>
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">John B. Peatman</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD>&nbsp;</TD>
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD>&nbsp;</TD>

<TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">/s/ Parker H. Petit
<DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">Director&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">May 27, 2009</TD>
</TR>
<TR valign="bottom">
    <TD>&nbsp;</TD>

<TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">Parker H. Petit</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD>&nbsp;</TD>
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>

<TR>
    <TD align="left" valign="top">&nbsp;</TD>
<TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
<DIV style="font-size: 1pt; border-top: 0px solid #000000">&nbsp;</DIV>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD>&nbsp;</TD>

<TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->II-4<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left">
<A name="119"></A>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>INDEX TO EXHIBITS</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="9%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="78%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Exhibit</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" style="border-bottom: 1px solid #000000"><B>Description</B></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top">3(i)</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">Amended and Restated Articles of Incorporation of the
Registrant dated November&nbsp;14, 1991, as amended November&nbsp;25,
1997 (incorporated herein by reference to Exhibit&nbsp;3.1 to the
Registrant&#146;s Annual Report on Form&nbsp;10-K for the year ended
December&nbsp;31, 1991 and to Exhibit&nbsp;3.1 to the Registrant&#146;s
Report on Form&nbsp;8-K dated November&nbsp;25, 1997).</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">3(ii)</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">Bylaws of the Registrant dated December&nbsp;7, 2007
(incorporated herein by reference to Exhibit&nbsp;3.2 of the
Registrant&#146;s Form&nbsp;8-K dated December&nbsp;7, 2007).</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">4.1*</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">Form of Subscription Rights Certificate.</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">4.2*</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">Subscription Agent Agreement, dated as of<U> </U>, 2009, by
and between Intelligent Systems Corporation and American
Stock Transfer &#038; Trust Company.</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">5.1*</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">Opinion of Ledbetter Johnson Wanamaker Glass LLP regarding
the validity of the securities being registered.</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">10.1</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">Lease Agreement dated June&nbsp;1, 2004, between the Registrant
and ISC Properties, LLC (incorporated herein by reference to
Exhibit&nbsp;10.1 of the Registrant&#146;s Form&nbsp;10-K for the year
ended December&nbsp;31, 2004).</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">10.2</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">Management Compensation Plans and Arrangements:</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">(a)
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Intelligent Systems Corporation 2003 Stock Incentive Plan</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">(b)
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Intelligent Systems Corporation Change in Control Plan for Officers</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">(c)
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Intelligent Systems Corporation Outside Director&#146;s Retirement Plan</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">(d)
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Non-Employee Directors Stock Option Plan.</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">Exhibit&nbsp;10.2(a) is incorporated herein by reference to Exhibit&nbsp;10.2(a) to the Registrants
Form&nbsp;10-K for the year ended December&nbsp;31, 2003. Exhibits 10.2(b) and (c)&nbsp;are incorporated
herein by reference to Exhibit&nbsp;10.4 to the Registrant&#146;s Form&nbsp;10-K for the year ended
December&nbsp;31, 1993. Exhibit&nbsp;10.2(d) is incorporated herein by reference to Exhibit&nbsp;10.3 to
the Registrant&#146;s Form&nbsp;10-K for the year ended December&nbsp;31, 2000.</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">10.3</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">Loan Agreement by and among Intelligent Systems Corporation
and Fidelity Bank dated October&nbsp;1, 2003 (incorporated herein
by reference to Exhibit&nbsp;10.3 to the Registrant&#146;s Form&nbsp;10-K
for the year ended December&nbsp;31, 2003).</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">10.4</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">Security Agreement by and among Intelligent Systems
Corporation and Fidelity Bank dated as of October&nbsp;1, 2003
(incorporated herein by reference to Exhibit&nbsp;10.4 to the
Registrant&#146;s Form&nbsp;10-K for the year ended December&nbsp;31,
2003).</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">10.5</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">Form of Security Agreement by and among majority owned
subsidiary companies of Intelligent Systems Corporation and
Fidelity Bank as of October&nbsp;1, 2003 (incorporated herein by
reference to Exhibit&nbsp;10.5 to the Registrant&#146;s Form&nbsp;10-K for
the year ended December&nbsp;31, 2003).</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">10.6</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">Negative Pledge Agreement by and among Intelligent Systems
Corporation and Fidelity Bank dated October&nbsp;1, 2003
(incorporated herein by reference to Exhibit&nbsp;10.6 to the
Registrant&#146;s Form&nbsp;10-K for the year ended December&nbsp;31,
2003).</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">10.7</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">Commercial Promissory Note and Rider thereto of Intelligent
Systems Corporation in favor of Fidelity Bank dated October
1, 2004 (incorporated herein by reference to Exhibit&nbsp;10.7 to
the Registrant&#146;s Form&nbsp;10-K for the year ended December&nbsp;31,
2003).</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">10.8</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">Form of Guarantee of majority owned subsidiaries of
Intelligent Systems Corporation in favor of Fidelity Bank
dated October&nbsp;1, 2003 (incorporated herein by reference to
Exhibit&nbsp;10.3 to the Registrant&#146;s Form&nbsp;10-K for the year
ended December&nbsp;31, 2003).</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">10.9</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">Seventh Modification to Loan Documents by and among
Intelligent Systems Corporation and Fidelity Bank dated
December&nbsp;1, 2008 (incorporated herein by reference to
Exhibit&nbsp;10.9 to the Registrant&#146;s Form&nbsp;10-K for the year
ended December&nbsp;31, 2008).</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">21.1</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">List of subsidiaries of Registrant (incorporated herein by
reference to Exhibit&nbsp;21.1 to the Registrant&#146;s Form&nbsp;10-K for
the year ended December&nbsp;31, 2008).</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">23.1*</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">Consent of Habif, Arogeti &#038; Wynne, LLP.</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">23.2*</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">Consent of Tauber &#038; Balser, P.C.</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">23.3*</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">Consent of Ledbetter Johnson Wanamaker Glass LLP (included
as part of Exhibit&nbsp;5.1).</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">24.1*</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">Power of Attorney (included on signature page hereto).</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">31.1</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">Certification of Chief Executive Officer Pursuant to Section
302 of the Sarbanes-Oxley Act of 2002 (incorporated herein
by reference to Exhibit&nbsp;31.1 to the Registrant&#146;s Form&nbsp;10-K
for the year ended December&nbsp;31, 2008).</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">31.2</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">Certification of Chief Financial Officer Pursuant to Section
302 of the Sarbanes-Oxley Act of 2002 (incorporated herein
by reference to Exhibit&nbsp;31.2 to the Registrant&#146;s Form&nbsp;10-K
for the year ended December&nbsp;31, 2008).</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">32.1</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">Certification Pursuant to 18 U.S.C. Section&nbsp;1350, as Adopted
Pursuant to Section&nbsp;906 of the Sarbanes-Oxley Act of 2002
(incorporated herein by reference to Exhibit&nbsp;32.1 to the
Registrant&#146;s Form&nbsp;10-K for the year ended December&nbsp;31,
2008).</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">99.1*</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">Form of Instructions for Use of Intelligent Systems
Corporation Subscription Rights Certificates.</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">99.2*</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">Form of Letter to Stockholders who are Record Holders.</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">99.3*</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">Form of Letter to Nominee Holders Whose Clients are
Beneficial Holders.</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">99.4*</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">Form of Letter to Clients of Nominee Holders.</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">99.5*</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">Form of Nominee Holder Certification.</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">99.6*</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">Form of Beneficial Owner Election.</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>



<DIV align="left">
<DIV style="font-size: 3pt; margin-top: 16pt; width: 18%; border-top: 1px solid #000000">&nbsp;</DIV>
</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
<TR>
    <TD width="3%"></TD>
    <TD width="1%"></TD>
    <TD width="96"></TD>
</TR>

<TR valign="top">
    <TD nowrap align="left">*</TD>
    <TD>&nbsp;</TD>
    <TD>Filed herewith.</TD>
</TR>

</TABLE>


<P align="center" style="font-size: 10pt"><!-- Folio -->II-5<!-- /Folio -->
</DIV>




</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>2
<FILENAME>g18612s1exv4w1.htm
<DESCRIPTION>EX-4.1 FORM OF SUBSCRIPTION RIGHTS CERTIFICATE
<TEXT>
<HTML>
<HEAD>
<TITLE>EX-4.1 FORM OF SUBSCRIPTION RIGHTS CERTIFICATE</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="right" style="font-size: 10pt; margin-top: 12pt"><B>Exhibit&nbsp;4.1</B>
</DIV>



<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><IMG src="g18612s1g1861220.gif" alt="(CERTIFICATE)">
</DIV>

<TABLE width="90%">
<TR><TD style="font-size: 1pt; color: #FFFFFF">RIGHTS CERTIFICATE #: NUMBER OF RIGHTS : THE TERMS AND CONDITIONS OF THE RIGHTS OFFERING ARE SET FORTH IN THE COMPANY&#146;S PROSPECTUS DATED&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2009
(THE &#147;PROSPECTUS&#148;) AND ARE INCORPORATED HEREIN BY REFERENCE. COPIES OF THE PROSPECTUS ARE AVAILABLE UPON REQUEST FROM MORROW &#038; CO., LLC., THE INFORMATION AGENT.
Intelligent Systems Corporation Incorporated under the laws of the State of Georgia NON &#151; TRANSFERABLE SUBSCRIPTION RIGHTS CERTIFICATE Evidencing Non &#151;
Transferable Subscription Rights to Purchase Shares of Common Stock of Intelligent Systems Corporation Subscription Price: $0.70&nbsp;per Share THE SUBSCRIPTION
RIGHTS WILL EXPIRE IF NOT EXERCISED ON OR BEFORE 5:00 P.M., EASTERN DAYLIGHT TIME, ON&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2009, UNLESS EXTENDED BY THE COMPANY REGISTERED OWNER:
THIS CERTIFIES THAT the registered owner whose name is inscribed hereon is the owner of the number of non-transferable subscription rights (&#147;Rights&#148;)
set forth above. Each whole Right entitles the holder thereof to subscribe for and purchase one share of Common Stock, with a par value of $0.01 per
share, of Intelligent Systems Corporation, a Georgia corporation, at a subscription price of $&nbsp;&nbsp;per share (the &#147;Basic Subscription Privilege&#148;), pursuant
to a rights offering (the &#147;Rights Offering&#148;), on the terms and subject to the conditions set forth in the Prospectus and the &#147;Instructions for Use of
Intelligent Systems Corporation Subscription Rights Certificates&#148; accompanying this Subscription Rights Certificate. If any shares of Common Stock
available for purchase in the Rights Offering are not purchased by other holders of Rights pursuant to the exercise of their Basic Subscription
Privilege (the &#147;Excess Shares&#148;), any Rights holder that exercises its Basic Subscription Privilege in full may subscribe for a number of Excess Shares
pursuant to the terms and conditions of the Rights Offering, subject to proration, as described in the Prospectus (the &#147;Over- Subscription Privilege&#148;).
The Rights represented by this Subscription Rights Certificate may be exercised by completing Form&nbsp;1 and any other appropriate forms on the reverse side
hereof and by retuning the full payment of the subscription price for each share of Common Stock in accordance with the &#147;Instructions for Use of
Intelligent Systems Corporation Subscription Rights Certificates&#148; that accompany this Subscription Rights Certificate. This Subscription Rights
Certificate is not valid unless countersigned by the subscription agent and registered by the registrar. Witness the seal of Intelligent Systems
Corporation and the signatures of its duly authorized officers. Dated: President, Chief Executive Officer Vice President, and Principal Executive
Officer Chief Financial Officer and Secretary </TD>
</TR>
</TABLE>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><IMG src="g18612s1g1861221.gif" alt="(FORM)">
</DIV>

<TABLE width="90%">
<TR><TD style="font-size: 1pt; color: #FFFFFF">DELIVERY OPTIONS FOR SUBSCRIPTION RIGHTS CERTIFICATE Delivery other than in the manner or to the addresses listed below will not constitute
valid delivery. American Stock Transfer &#038; Trust Company 6201 15th Avenue Brooklyn, New York 11219 Telephone: (877)&nbsp;248-6417 PLEASE PRINT ALL
INFORMATION CLEARLY AND LEGIBLY. FORM 1-EXERCISE OF SUBSCRIPTION RIGHTS To subscribe for shares pursuant to your Basic Subscription Right,
please complete lines (a)&nbsp;and (c)&nbsp;and sign under Form&nbsp;4 below. To subscribe for shares pursuant to your Over-Subscription Right, please also complete
line (b)&nbsp;and sign under Form&nbsp;4 below. To the extent you subscribe for more Shares than you are entitled under either the Basic Subscription Right
or the Over- Subscription Right, you will be deemed to have elected to purchase the maximum number of shares for which you are entitled to subscribe
under the Basic Subscription Right or Over-Subscription Right, as applicable. (a)&nbsp;EXERCISE OF BASIC SUBSCRIPTION RIGHT: I apply for
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares x $ =$0.70 (no. of new shares) (subscription price) (amount enclosed) (b)&nbsp;EXERCISE OF OVER-SUBSCRIPTION RIGHT If you have
exercised your Basic Subscription Right in full and wish to subscribe for up to 400,000 additional shares of Common Stock: I apply for
shares x $ =$0.70 (no. of new shares) (subscription price) (amount enclosed) (c)&nbsp;Total Amount of
Payment Enclosed =$ METHOD OF PAYMENT (CHECK ONE) ?? Cashier&#146;s or Certified Check or bank draft drawn on a U.S. bank, or postal
telegraphic or express. ?? Wire transfer of immediately available funds directly to the account maintained by American
Stock Transfer &#038; Trust Company, LLC, as Subscription Agent, for purposes of accepting subscriptions in this Rights Offering
at JPMorgan Chase Bank, 55 Water Street, New York, New York 10005, ABA #021000021, Account # American Stock Transfer
FBO Intelligent Systems Corporation, with reference to the rights holder&#146;s name. FORM 2-TRANSFER TO DESIGNATED TRANSFEREE To transfer your
subscription rights to another person, complete this Form&nbsp;2 and have your signature guaranteed under Form&nbsp;5. For value received
of the subscription rights represented by this Subscription Rights Certificate are assigned to:
Social Security # Signature(s): IMPORTANT: The signature(s) must correspond with the name(s) as printed on the reverse of this
Subscription Rights Certificate in every particular, without alteration or enlargement, or any other change whatsoever.
FORM 3-DELIVERY TO DIFFERENT ADDRESS If you wish for the Common Stock underlying your subscription rights, a certificate representing unexercised
subscription rights or the proceeds of any sale of subscription rights to be delivered to an address different from that shown on the face of this
Subscription Rights Certificate, please enter the alternate address below, sign under Form&nbsp;4 and have your signature guaranteed under Form&nbsp;5. FORM 4-SIGNATURE TO SUBSCRIBE: I acknowledge that I have received the Prospectus for this Rights Offering and I hereby irrevocably subscribe for the number of shares indicated above on the terms and conditions specified in the Prospectus. Signature(s): IMPORTANT: The signature(s) must correspond with the name(s) as printed on the reverse of this Subscription
 Rights Certificate in every particular, without alteration or enlargement, or any other change whatsoever. FORM 5-SIGNATURE GUARANTEE This form must be completed if you have completed any portion of Forms 2 or 3. Signature Guaranteed: (Name of Bank or Firm) By: (Signature of Officer) IMPORTANT: The signature(s) should be guaranteed by an eligible guarantor institution (bank, stock broker, savings &#038; loan association or credit union) with membership in an approved signature guarantee medallion program p
ursuant to Securities and Exchange Commission Rule&nbsp;17Ad-15.</TD>
</TR>


</TABLE>




<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>




</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.2
<SEQUENCE>3
<FILENAME>g18612s1exv4w2.htm
<DESCRIPTION>EX-4.2 SUBSCRIPTION AGENT AGREEMENT
<TEXT>
<HTML>
<HEAD>
<TITLE>EX-4.2 SUBSCRIPTION AGENT AGREEMENT</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="right" style="font-size: 10pt; margin-top: 12pt"><B>Exhibit&nbsp;4.2</B>
</DIV>


<DIV align="center" style="font-size: 14pt; margin-top: 18pt"><B>SUBSCRIPTION AGENT AGREEMENT</B>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt">&#95;&#95;&#95;&#95;&#95;&#95;&nbsp;&#95;&#95;&#95;, 2009
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt">American Stock Transfer &#038; Trust Company<BR>
59 Maiden Lane<BR>
New York, New York 10038
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Ladies and Gentlemen:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">In connection with your appointment as Subscription Agent in the transaction described herein,
Intelligent Systems Corporation (the &#147;Company&#148;), hereby confirms its arrangements with you as
follows:</DIV>


<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left">1.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD><U><B>Rights Offering</B></U> &#151; The Company is offering
(the &#147;Rights Offering&#148;) to the holders of  shares of its
Common Stock, par value $0.01 per share (&#147;Common Stock&#148;), on &#95;&#95;&#95;&#95;&#95;&#95;&nbsp;&#95;&#95;&#95;, 2009 (the
&#147;Record Date&#148;), the right (&#147;Rights&#148;) to subscribe
for Units (&#147;Units&#148;), each Unit consisting of
one share of Common Stock. Rights shall
cease to be exercisable at 5:00 p.m., New York City time, on &#95;&#95;&#95;&#95;&#95;&#95;&nbsp;&#95;&#95;&#95;, 2009 or such later date
of which the Company notifies you orally and confirms in writing (the
&#147;Expiration Date&#148;). One
Right is being issued for each share of Common Stock held on the Record Date. One Right and
payment in full of the subscription price of $0.70 (the &#147;Subscription Price&#148;) is required to
subscribe for one Unit. Rights are evidenced by non-transferable subscription certificates in
registered form (&#147;Subscription Certificates&#148;). Each holder of Subscription Certificate(s) who
exercises the holder&#146;s right to subscribe for all Units that can be subscribed for with the
Rights evidenced by such Subscription Certificate(s) (the &#147;Basic Subscription Right&#148;) will
have the right to subscribe for additional Units, if any, available as a result of any
unexercised Rights (such additional subscription right being referred to hereafter as the
&#147;Additional Subscription Privilege&#148;). The Rights Offering will be conducted in the manner and
upon the terms set forth in the Company&#146;s Prospectus dated &#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;, 2009 (the
&#147;Prospectus&#148;), which is incorporated herein by reference and made a part hereof as if set
forth in full herein.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left">2.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD><U><B>Appointment of Subscription Agent</B></U> &#151; You are hereby appointed as Subscription Agent to
effect the Rights Offering in accordance with the Prospectus. Each reference to you in this
letter is to you in your capacity as Subscription Agent unless the context indicates
otherwise.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left">3.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD><U><B>Delivery of Documents</B></U> &#151; Enclosed herewith are the following, the receipt of which you
acknowledge by your execution hereof:</TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="4%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(a)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>a copy of the Prospectus;</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="4%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(b)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>the form of Subscription Certificate (with instructions); and</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="4%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(c)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>resolutions adopted by the Board of Directors of the Company in connection with the
Rights Offering, certified by the secretary of the Company;</TD>
</TR>

</TABLE>
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->1<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As soon as is reasonably practical, you shall mail or cause to be mailed to each holder of
Common Stock at the close of business on the Record Date a Subscription Certificate evidencing the
Rights to which such holder is entitled, a Prospectus and an
envelope addressed to you. Prior to mailing, the Company will provide you with blank Subscription
Certificates which you will prepare and issue in the names of holders of Common Stock of record at
the close of business on the Record Date and for the number of Rights to which they are entitled.
The Company will also provide you with a sufficient number of copies of each of the documents to be
mailed with the Subscription Certificates.
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left">4.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD><U><B>Subscription Procedure&nbsp;&nbsp;&#151;</B></U></TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="4%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(a)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Upon your receipt prior to 5:00 p.m., New York City time, on the Expiration Date (by
mail or delivery), as Subscription Agent, of (i)&nbsp;any Subscription Certificate completed and
endorsed for exercise, as provided on the reverse side of the Subscription Certificate, and (ii)&nbsp;payment in full of the Subscription
Price in U.S. funds by check, bank draft or money <I>order </I>payable at par (without deduction
for bank service charges or otherwise) to the order of American Stock Transfer &#038; Trust
Company, you shall as soon as practicable after the Expiration Date, but after performing
the procedures described in subparagraphs (b)&nbsp;and (c)&nbsp;below, mail to the subscriber&#146;s
registered address on the books of the Company certificates representing the securities
underlying each Unit duly subscribed for (pursuant to the Basic Subscription Right and the
Additional Subscription Privilege) and furnish a list of all such information to the
Company.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="4%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(b)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>As soon as practicable after the Expiration Date you shall calculate the number of Units
to which each subscriber is entitled pursuant to the Additional Subscription Privilege. The
Additional Subscription Privilege may only be exercised by holders who subscribe to all the
Units that can be subscribed for under the Basic Subscription Right. The Units available
for additional subscriptions will be those that have not been subscribed and paid for
pursuant to the Basic Subscription Right (the &#147;Remaining Units&#148;). Where there are
sufficient Remaining Units to satisfy all additional subscriptions by holders exercising
their rights under the Additional Subscription Privilege, each holder shall be allotted the
number of Remaining Units subscribed for up to a maximum of 500,000 Remaining Units. If the
aggregate number of Units subscribed for under the Additional Subscription Privilege exceeds
the number of Remaining Units, the number of Remaining Units allotted to each participant in
the Additional Subscription Privilege shall be the product obtained by multiplying the
number of Remaining Units by a fraction of which the numerator is the number of Units
subscribed for by that participant under the Basic Subscription Right and the denominator is
the aggregate number of Units subscribed for under the Basic Subscription Right by all
participants who are exercising their Additional Subscription Privilege. However, no holder
shall be allocated more Remaining Units than such holder subscribed for. Any fractional
Unit to which persons exercising their Additional Subscription Privilege would otherwise be
entitled pursuant to such allocation shall be rounded to the next whole Unit.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="4%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(c)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Upon calculating the number of Units to which each subscriber is entitled pursuant to
the Additional Subscription Privilege and the amount overpaid, if any, by each subscriber,
you shall, as soon as practicable, furnish a list of all such information to the Company.
</TD>
</TR>
</TABLE>
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->2<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV style="margin-top: 6pt"><TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="4%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(d)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Upon calculating the number of Units to which each subscriber is entitled pursuant to
the Additional Subscription Privilege and assuming payment for the additional Units
subscribed for has been delivered, you shall mail, as contemplated in subparagraph (a)
above, the certificates representing the additional securities which the subscriber has been
allotted. If a lesser number of Units is allotted to a subscriber under the Additional
Subscription Privilege than the subscriber has tendered payment for, you shall remit the
difference to the subscriber without interest or deduction at the same time as certificates
representing the securities allotted pursuant to the Additional Subscription Privilege are
mailed.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="4%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(e)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Funds received by you pursuant to the Basic Subscription Right and the Additional
Subscription Privilege shall be held by you in a segregated account. Upon mailing
certificates representing the securities and refunding subscribers for additional Units
subscribed for but not allocated, if any, you shall promptly remit to the Company all funds
received in payment of the Subscription Price for Units sold in the Rights Offering.</TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left">5.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD><U><B>Defective Exercise of Rights; Lost Subscription Certificates</B></U> &#151; The Company shall have
the absolute right to reject any defective exercise of Rights or to waive any defect in
exercise. Unless requested to do so by the Company, you shall not be under any duty to give
notification to holders of Subscription Certificates of any defects or irregularities in
subscriptions. Subscriptions will not be deemed to have been made until any such defects or
irregularities have been cured or waived within such time as the Company shall determine. You
shall as soon as practicable return Subscription Certificates with the defects or
irregularities which have not been cured or waived to the holder of the Rights. If any
Subscription Certificate is alleged to have been lost, stolen or destroyed, you should follow
the same procedures followed far lost stock certificates representing Common Stock you use in
your capacity as transfer agent for the Company&#146;s Common Stock.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left">6.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD><U><B>Intentionally Deleted.</B></U></TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left">7.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD><U><B>Delivery</B></U> &#151; You shall deliver to the Company the exercised Subscription Certificates
in accordance with written directions received from the Company and shall deliver to the
subscribers who have duly exercised Rights at their registered addresses certificates representing
the securities subscribed for as instructed on the reverse side of the
Subscription Certificates.
</TD>
</TR>

</TABLE>
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->3<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left"><B>8.</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD><U><B>Reports</B></U> &#151; You shall notify the Company by telephone on or before the close of
business on each business day during the period commencing 5 business days after the mailing
of the Rights and ending at the Expiration Date (a &#147;daily notice&#148;), which notice
shall thereafter be confirmed in writing, of (i)&nbsp;the number of Rights exercised on the day
covered by such daily notice, (ii)&nbsp;&nbsp;the number of Rights for which defective exercises
have been received on the day covered by such daily notice, and (iii)&nbsp;the cumulative total of
the information set forth in clauses (i)&nbsp;through (ii)&nbsp;above. At or before 5:00 p.m., New
York City time, on the first NYSE trading day following the Expiration Date you shall certify
in writing to the Company the cumulative total through the Expiration Date of all the
information set forth in clauses (i)&nbsp;through (iii)&nbsp;above. You shall also maintain and update a listing of holders who have fully or partially
exercised their Rights, holders who have transferred their Rights and their transferees, and
holders who have not exercised their Rights. You shall provide the Company or its designees
with such information compiled by you pursuant to this paragraph 9 as any of them shall
request.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left">9.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD><U><B>Future Instructions</B></U> &#151; With respect to notices or instructions to be provided by the
Company hereunder, you may rely and act on any written instruction signed by any one or more
of the following authorized officers or employees of the Company:</TD>
</TR>

</TABLE>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 8%">J. Leland Strange, President and Chief Executive Officer
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 2pt; margin-left: 8%">Bonnie L. Herron, Vice President, Secretary and Chief Financial Officer
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left">10.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD><U><B>Payment of Expenses</B></U> &#151; The Company will pay you compensation for acting in your
capacity as Subscription Agent hereunder in the amount of $20,000.00 plus your reasonable
out-of-pocket expenses. The Company will pay an additional fee equal to one-third of the
Subscription Agent fee for each extension of the Offering, plus any out-of-pocket expenses
associated with such extension.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left">11.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD><U><B>Counsel</B></U> &#151; You may consult with counsel satisfactory to you, which may be counsel to
the Company, and the advice or opinion of such counsel shall be full and complete
authorization and protection in respect of any action taken, suffered <I>or </I>omitted by you
hereunder in good faith and in accordance with such advice and opinion of such counsel.</TD>
</TR>

</TABLE>
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->4<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV style="margin-top: 6pt"><TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">



</TABLE>
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left">12.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD><U><B>Indemnification</B></U> &#151; The Company covenants and agrees to indemnify and hold you
harmless against any costs, expenses (including reasonable fees of legal counsel), losses or
damages, which may be paid, incurred or suffered by or to which you may become subject
arising from or out of, directly or indirectly, any claim or liability resulting from your
actions as Subscription Agent pursuant hereto; provided that such covenant and agreement
does not extend to such costs, expenses, losses and damages incurred or suffered by you as a
result of, or arising out of, your own gross negligence, misconduct or bad faith or that of
any employees, agents or independent contractors used by you in connection with performance
of your duties as Subscription Agent hereunder.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left">13.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD><U><B>Notices</B></U> &#151;  Unless otherwise provided herein, all reports, notices and other
communications required or permitted to be given hereunder shall be in writing and delivered
by hand or confirmed telecopy or by first class U.S. mail, postage prepaid, shall be deemed
given if by hand or telecopy, upon receipt or if by U.S. mail, three business days after
deposit in the U.S. mail and shall be addressed as follows</TD>
</TR>


</TABLE>
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="4%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(a)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>If to the Company, to:</TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="8%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Intelligent Systems Corporation<BR>
4355 Shackleford Road<BR>
Norcross GA 30093<BR>
Attn: Bonnie Herron<BR>
Telephone: 770-564-5504<BR>
Telecopy: 770-381-2808</TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="4%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(b)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>If to you, to:</TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="8%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>American Stock Transfer &#038; Trust Company<BR>
59 Maiden Lane<BR>
New York, N.Y. 10038<BR>
Attention: George Karfunkel<BR>
Telephone: (718)&nbsp;921-8200<BR>
Telecopy: (718)&nbsp;236-4588</TD>
</TR>

</TABLE>
</DIV>





<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">


<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left">14.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD><U><B>Prior Agreements</B>.</U> Nothing herein contained shall amend, replace or supersede any
agreement between the Company and you to act as the Company&#146;s transfer agent which agreement
shall remain of full force and effect.</TD>
</TR>

</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt">Yours truly,
</DIV>


<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="48%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">INTELLIGENT SYSTEMS CORPORATION<BR><BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
<TR><TD align="left">&nbsp;</TD>
    <TD valign="top">Name:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
<TR><TD align="left">&nbsp;</TD>
    <TD valign="top">Title:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>

</TABLE>

<P align="center" style="font-size: 10pt"><!-- Folio -->5<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="50%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>

</TABLE>

<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="48%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<TR>
    <TD colspan="3" align="left">Agreed &#038; Accepted:<BR><BR>
AMERICAN STOCK TRANSFER &#038; TRUST COMPANY<BR>
&nbsp;</TD>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
</TABLE>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt">By:_______________________________<BR>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Name:____________________________<BR>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Title:___________________________
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->6<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">






<DIV align="center" style="font-size: 13pt; margin-top: 18pt"><U><B>Fee Schedule</B></U>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt">Flat fee of $20,000.00<BR>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Plus reasonable out-of-pocket expenses.
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->7<!-- /Folio -->
</DIV>



</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>4
<FILENAME>g18612s1exv5w1.htm
<DESCRIPTION>EX-5.1 OPINION OF LEDBETTER, JOHNSON, WANAMAKER, GLASS LLP
<TEXT>
<HTML>
<HEAD>
<TITLE>EX-5.1 OPINION OF LEDBETTER/JOHNSON/WANAMAKER/GLAS</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="right" style="font-size: 10pt; margin-top: 12pt"><B>Exhibit&nbsp;5.1</B>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt">May&nbsp;27, 2009
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt">Intelligent Systems Corporation<BR>
4355 Shackleford Road<BR>
Norcross, Georgia 30093
</DIV>


<DIV align="left" style="margin-top: 12pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; background: transparent; color: #000000">
<TR>
    <TD width="3%"></TD>
    <TD width="1%"></TD>
    <TD></TD>
</TR>
<TR valign="top">
    <TD nowrap align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Re:</B></TD>
    <TD>&nbsp;</TD>
    <TD><B>Registration Statement on Form&nbsp;S-1</B></TD>
</TR>
</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt">Ladies and Gentlemen:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We have acted as counsel for Intelligent Systems Corporation, a Georgia corporation (the
&#147;<B><I>Company</I></B>&#148;), in connection with the
preparation and filing of its Registration Statement on Form&nbsp;S-1
(the &#147;<B><I>Registration Statement</I></B>&#148;) with the Securities and Exchange Commission
on May&nbsp;27, 2009 for the purpose of registering the shares of the Company&#146;s common stock, par value $0.01 per share
(the &#147;<B><I>Common Stock</I></B>&#148;) issuable upon exercise of rights (the &#147;<B><I>Rights</I></B>&#148;) to be distributed to holders
of record of the Common Stock as of the record date for the rights offering (the &#147;<B><I>Rights
Offering</I></B>&#148;).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In that connection, we have reviewed originals or copies certified or otherwise identified to
our satisfaction of (1)&nbsp;the Registration Statement, (2)&nbsp;the form of certificate representing the
Rights, (3)&nbsp;the Articles of Incorporation of the Company, (4)&nbsp;the By-Laws of the Company, (5)
resolutions, minutes, and records of the corporate proceedings of the Company with respect to the
Rights Offering and the issuance of the shares of Common Stock upon exercise of the Rights, and (6)
such other documents, certificates, corporate records, opinions and other instruments as we have
deemed necessary or appropriate for the purposes of this opinion.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In such examination, we have assumed the genuineness of all signatures, the legal capacity of
natural persons, the authenticity of all documents submitted to us as originals, the conformity to
original documents of all documents submitted to us as certified or photostatic copies and the
authenticity of the originals of such copies. As to any facts material to the opinions hereinafter
expressed which we did not independently establish or verify, we have relied, to the extent we deem
such reliance proper and without independent investigation, upon certificates, statements and
representations of officers and other representatives of the Company and upon certificates of
public officials.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Based upon and subject to the foregoing, it is our opinion that:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.&nbsp;the Rights have been duly authorized and, when issued, will be the valid and binding
obligations of the Company, enforceable against the Company in accordance with their terms, except
to the extent that enforcement thereof may be limited by (a)&nbsp;bankruptcy, insolvency,
reorganization, fraudulent conveyance, moratorium, or other similar laws now or hereafter in effect
relating to creditors&#146; rights generally and (b)&nbsp;general principles of equity (regardless of whether
enforceability is considered in a proceeding at law or in equity);
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.&nbsp;the shares of Common Stock issuable upon exercise of the Rights are duly authorized, and
when such shares are issued upon the exercise of Rights in accordance with their terms as described
in the Registration Statement, such shares will be validly issued, fully paid and nonassessable.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The opinion expressed herein is based upon and limited to the laws of the State of Georgia. We
express no opinion herein as to any other laws, statutes, regulations or ordinances.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We hereby consent to the filing of this opinion letter as Exhibit&nbsp;5.1 to the Registration
Statement and to the reference to our firm under the caption &#147;Legal Matters&#148; in the prospectus
included in the Registration Statement. In giving such consent, we do not thereby admit that we are
within the category of persons whose consent is required under Section&nbsp;7 of the Act or the rules
and regulations of the Commission.
</DIV>

<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="43%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="40%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">Very truly yours,<BR><BR>
<BR>
LEDBETTER JOHNSON WANAMAKER GLASS LLP<BR><BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>

<TD colspan="2" style="border-bottom: 1px solid #000000" align="left">/s/&nbsp;&nbsp;Larry D. Ledbetter</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="2" align="left">Larry D. Ledbetter&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
</TABLE>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>



</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>5
<FILENAME>g18612s1exv23w1.htm
<DESCRIPTION>EX-23.1 CONSENT OF HABIF, AROGETI & WYNNE LLP
<TEXT>
<HTML>
<HEAD>
<TITLE>EX-23.1 CONSENT OF HABIF, AROGETI & WYNNE LLP</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="right" style="font-size: 10pt; margin-top: 12pt"><B>Exhibit&nbsp;23.1</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">We consent to the incorporation by reference in this Registration Statement on Form S-1 of our
report dated March&nbsp;25, 2009, relating to the consolidated financial statements of Intelligent
Systems Corporation and subsidiaries (the &#147;Company&#148;) as of and for the year ended December&nbsp;31,
2008, appearing in the Annual Report on Form 10-K for the year ended December&nbsp;31, 2008 filed with
the Securities and Exchange Commission, and to the reference to us under the heading &#147;Experts&#148; in
this Prospectus, which is part of this Registration Statement.</DIV>


<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="35%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="48%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="3" style="border-bottom: 1px solid #000000" align="left">/s/ Habif, Arogeti &#038; Wynne, LLP
&nbsp;</TD>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="3" align="left">Certified Public Accountants<BR>
Atlanta, Georgia<BR>May 27, 2009&nbsp;</TD>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>

</TABLE>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.2
<SEQUENCE>6
<FILENAME>g18612s1exv23w2.htm
<DESCRIPTION>EX-23.2 CONSENT OF TAUBER & BALSER P.C.
<TEXT>
<HTML>
<HEAD>
<TITLE>EX-23.2 CONSENT OF TAUBER & BALSER P.C.</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="right" style="font-size: 10pt; margin-top: 12pt"><B>Exhibit&nbsp;23.2</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">We consent to the incorporation by reference in this Registration Statement on Form S-1 of our
report dated March&nbsp;28, 2008, relating to the consolidated financial statements of Intelligent
Systems Corporation and subsidiaries (the &#147;Company&#148;) as of and for the year ended December&nbsp;31,
2007, appearing in the Annual Report on Form 10-K for the year ended December&nbsp;31, 2008 filed with
the Securities and Exchange Commission, and to the reference to us under the heading &#147;Experts&#148; in
this Prospectus, which is part of this Registration Statement.</DIV>


<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="35%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="48%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="3" style="border-bottom: 1px solid #000000" align="left">/s/ Tauber &#038; Balser, P.C.
&nbsp;</TD>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="3" align="left">Certified Public Accountants<BR>
Atlanta, Georgia<BR>May 27, 2009&nbsp;</TD>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
</TABLE>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>



</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>7
<FILENAME>g18612s1exv99w1.htm
<DESCRIPTION>EX-99.1 FORM OF INSTRUCTIONS
<TEXT>
<HTML>
<HEAD>
<TITLE>EX-99.1 FORM OF INSTRUCTIONS</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="right" style="font-size: 10pt; margin-top: 12pt">Exhibit&nbsp;99.1
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>FORM OF<BR>
INSTRUCTIONS FOR USE OF<BR>
INTELLIGENT SYSTEMS CORPORATION<BR>
SUBSCRIPTION RIGHTS CERTIFICATES</B>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>CONSULT THE INFORMATION AGENT, YOUR BANK,<BR>
OR YOUR BROKER AS TO ANY QUESTIONS</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following instructions relate to a rights offering (the &#147;<B><I>Rights Offering</I></B>&#148;) by Intelligent
Systems Corporation, a Georgia corporation (the &#147;<B><I>Company</I></B>&#148;), to the holders of record (the &#147;<B><I>Record
Holders</I></B>&#148;) of its common stock, par value $0.01 per share (the &#147;<B><I>Common Stock</I></B>&#148;), as described in the
Company&#146;s Prospectus, dated &#95;&#95;&#95;&#95;&#95;&#95;&nbsp;<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>, 2009 (the &#147;<B><I>Prospectus</I></B>&#148;). Record Holders of Common
Stock at 5:00 p.m., Eastern Daylight Time, on &#95;&#95;&#95;&#95;&#95;&#95;&nbsp;&#95;&#95;&#95;, 2009 (the &#147;<B><I>Record Date</I></B>&#148;) are
receiving non-transferable subscription rights (the &#147;<B><I>Rights</I></B>&#148;) to subscribe for and purchase shares
of the Company&#146;s common stock (the &#147;<B><I>Underlying Shares</I></B>&#148;). An aggregate of 4,478,971 Underlying
Shares are being offered by the Prospectus.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each Record Holder will receive one Right for each share of Common Stock owned of record as of
the Record Date. Each whole Right allows the holder thereof to subscribe for one share of Common
Stock (the &#147;<B><I>Basic Subscription Privilege</I></B>&#148;) at
the cash price of $0.70 per share (the
&#147;<B><I>Subscription Price</I></B>&#148;). The Rights are evidenced by Rights certificates (the &#147;<B><I>Subscription Rights
Certificates</I></B>&#148;).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In addition, each holder of Rights who exercises his Basic Subscription Privilege in full will
be eligible to subscribe (the &#147;<B><I>Over-Subscription Privilege</I></B>&#148;) at the same Subscription Price of
$0.70 per share for up to 500,000 additional shares of Common Stock if any shares are not
purchased by other holders of subscription rights under their Basic Subscription Privilege as of
the Expiration Date (the &#147;<B><I>Excess Shares</I></B>&#148;). Underlying Shares will only be awarded to you, however,
if other holders of Rights do not subscribe for all the Underlying Shares available to them under
their Basic Subscription Privilege.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If there is an insufficient number of Excess Shares available to fully satisfy the
over-subscription requests of holders of Rights, holders who exercised their Over-Subscription
Privilege will receive the available shares <I>pro rata </I>in proportion to the number of Underlying
Shares that holders of Rights who exercised their Over-Subscription Privilege purchased by
exercising their Basic Subscription Privilege. In certain situations, allocating the remaining
Excess Shares on this basis could result in your receiving an allocation of a greater number of
shares than you subscribed for under your Over-Subscription Privilege. If this occurs, then we
will allocate to you only the number of Underlying Shares for which you subscribed. We will
allocate the remaining Excess Shares among all other holders exercising their Over-Subscription
Privilege on the <I>pro rata </I>basis described above. For the purposes of determining their eligibility
for the Over-Subscription Privilege, holders will be deemed to have exercised their Basic
Subscription Privilege in full if they subscribe for the maximum number of whole Underlying Shares
available under their Basic Subscription Privilege.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If you do not receive the full number of Underlying Shares for which you subscribed, any
excess subscription payment will be returned to you, without interest or deduction, promptly after
the expiration
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 10pt">of the rights offering.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The number of Rights to which you are entitled is printed on the face of your Subscription
Rights Certificate. You should indicate your wishes with regard to the exercise of your Rights by
completing the appropriate portions of your Subscription Rights Certificate and returning the
certificate to American Stock Transfer &#038; Trust Company (the &#147;<B><I>Subscription Agent</I></B>&#148;).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;THE RIGHTS WILL EXPIRE, IF NOT EXERCISED, BY 5:00 P.M., EASTERN DAYLIGHT TIME, ON
&#95;&#95;&#95;&#95;&#95;&#95;&nbsp;&#95;&#95;&#95;, 2009, UNLESS EXTENDED IN THE SOLE DISCRETION OF THE COMPANY (such date, as it
may be extended, is hereinafter referred to as the &#147;<B><I>Expiration Date</I></B>&#148;). After the Expiration Date,
unexercised Rights will be null and void. The Company will not be obligated to honor any purported
exercise of Rights received by the Subscription Agent after 5:00 p.m., Eastern Daylight Time, on
the Expiration Date, regardless of when the documents relating to such exercise were sent. The
Company may extend the Expiration Date by giving oral or written notice to the Subscription Agent
and Morrow &#38; Co., LLC (the &#147;<B><I>Information Agent</I></B>&#148;) on or before the Expiration Date, followed
by a press release no later than 9:00 a.m., Eastern Daylight Time, on the next business day after
the previously scheduled Expiration Date.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;YOUR SUBSCRIPTION RIGHTS CERTIFICATE AND SUBSCRIPTION PRICE PAYMENT, BY CERTIFIED OR CASHIER&#146;S
CHECK DRAWN UPON A UNITED STATES BANK OR BY WIRE TRANSFER OF IMMEDIATELY AVAILABLE FUNDS, MUST BE
ACTUALLY RECEIVED BY THE SUBSCRIPTION AGENT ON OR BEFORE 5:00 P.M., EASTERN DAYLIGHT TIME, ON THE
EXPIRATION DATE. ONCE A HOLDER OF RIGHTS HAS EXERCISED THE BASIC SUBSCRIPTION PRIVILEGE AND THE
OVER-SUBSCRIPTION PRIVILEGE, SUCH EXERCISE MAY NOT BE REVOKED. RIGHTS NOT EXERCISED PRIOR TO THE
EXPIRATION DATE OF THE RIGHTS OFFERING WILL EXPIRE WITHOUT VALUE.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If you have any questions, require assistance regarding the method of exercising rights or
require additional copies of relevant documents, please contact the Information Agent at
Morrow &#38; Co., LLC, 470&nbsp;West Avenue, Stamford, CT 06902, Telephone
(800)&nbsp;607-0088 or (203)&nbsp;658-9400.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>1. How to Exercise Your Rights.</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To exercise Rights, complete your Subscription Rights Certificate and send the properly
completed and executed Subscription Rights Certificate evidencing such Rights, with any signatures
required to be guaranteed so guaranteed, together with payment in full of the Subscription Price
for each Underlying Share subscribed for pursuant to the Basic Subscription Privilege and the
Over-Subscription Privilege, to the Subscription Agent so that it will be actually received by the
Subscription Agent on or prior to 5:00 p.m., Eastern Daylight Time, on the Expiration Date.
Payment of the Subscription Price will be held in a segregated account to be maintained by the
Subscription Agent.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;When making arrangements with your bank or broker for the delivery of funds on your behalf,
you may also request such bank or broker to exercise the Subscription Rights Certificate on your
behalf. Banks, brokers, and other nominee holders of Rights who exercise the Basic Subscription
Privilege and the Over-Subscription Privilege on behalf of beneficial owners of Rights will be
required to certify to the Subscription Agent and the Company, in connection with the exercise of
the Over-Subscription Privilege, as to the aggregate number of Rights that have been exercised and
the number of Underlying Shares that are being subscribed for pursuant to the Over-Subscription
Privilege, by each beneficial owner of Rights (including such nominee itself) on whose behalf such
nominee holder is acting. If more Excess Shares are subscribed for pursuant to the
Over-Subscription Privilege than are available for sale, the Excess Shares will be allocated as
described above, among beneficial owners exercising the Over-Subscription
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 10pt">Privilege in proportion to the number of shares purchased by such owners pursuant to their
Basic Subscription Privilege.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If the aggregate Subscription Price paid by you is insufficient to purchase the number of
Underlying Shares subscribed for, then you will be deemed to have exercised the Basic Subscription
Privilege and Over-Subscription Privilege to purchase Underlying Shares to the full extent of the
payment tendered.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If the aggregate Subscription Price paid by you exceeds the amount necessary to purchase the
number of Underlying Shares for which you have indicated an intention to subscribe, then the remaining amount will be returned to you by mail,
without interest or deduction, promptly after the Expiration Date and after all allocations and
adjustments contemplated by the terms of the Rights Offering have been effected.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If you do not indicate the number of Rights being exercised, then you will be deemed to have
exercised your Rights with respect to the maximum number of whole Rights that may be exercised with
the aggregate Subscription Price you delivered to the Subscription Agent. If you do not indicate
the number of Rights being exercised and your aggregate Subscription Price is greater than the
amount you owe for exercise of your Basic Subscription Privilege in full, you will be deemed to
have exercised your Over-Subscription Privilege to purchase the maximum number of shares of Common
Stock with your over-payment.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If we do not apply your full Subscription Price payment to your purchase of shares of Common
Stock, the Company or the Subscription Agent will return the excess amount to you by mail, without
interest, as soon as practicable after the expiration date of the Rights Offering.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If you exercise less than all of the Rights evidenced by your Subscription Rights Certificate
and you wish to receive a new Subscription Rights Certificate evidencing your unexercised Rights,
please contact the information agent, Morrow &#38; Co., LLC, at
470&nbsp;West Avenue, Stamford, CT 06902, Telephone: (800)&nbsp;607-0088 or (203)&nbsp;658-9400, who will arrange for a new Rights Certificate to be issued to you
evidencing your unexercised Rights. Requests for a new Subscription Rights Certificate should be
made well in advance of the Expiration Date to permit you to exercise the Rights evidenced thereby
by the Expiration Date.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>2. How to Properly Execute Your Subscription Rights Certificate.</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. <I>Execution by Registered Holder</I>. The signature on the Subscription Rights Certificate must
correspond with the name of the registered holder exactly as it appears on the face of the
Subscription Rights Certificate without any alteration, enlargement or change whatsoever. Persons
who sign the Subscription Rights Certificate in a representative or other fiduciary capacity on
behalf of a registered holder must indicate their capacity when signing and, unless waived by the
Subscription Agent in its sole and absolute discretion, must present to the Subscription Agent
satisfactory evidence of their authority so to act.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b. <I>Signature Guarantees</I>. If you are neither a registered holder (or signing in a
representative or other fiduciary capacity on behalf of a registered holder) nor an eligible
institution, such as a member firm of a registered national securities exchange or a member of the
National Association of Securities Dealers, Inc., or a commercial bank or trust company having an
office or correspondent in the United States, your signature must be guaranteed by such an eligible
institution.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><B>3. How to Deliver Your Subscription Rights Certificate and Subscription Price Payment.</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Subscription Rights Certificate and payment of the Subscription Price must be delivered to
the Subscription Agent by one of the methods described below:
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 10pt">American Stock Transfer &#038; Trust Company<BR>
6201 15<SUP style="font-size: 85%; vertical-align: text-top">th</SUP> Avenue<BR>
Brooklyn, New York 11219<BR>
<I>Telephone Number for Confirmation</I>: (877)&nbsp;248-6417
</DIV>



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ALL PAYMENTS MUST BE MADE IN U.S. DOLLARS FOR THE FULL NUMBER OF UNDERLYING SHARES BEING
SUBSCRIBED FOR BY CASHIER&#146;S OR CERTIFIED CHECK DRAWN UPON A UNITED STATES BANK PAYABLE TO AMERICAN
STOCK TRANSFER &#038; TRUST COMPANY, AS SUBSCRIPTION AGENT, OR BY WIRE TRANSFER OF IMMEDIATELY AVAILABLE
FUNDS, TO THE SUBSCRIPTION ACCOUNT MAINTAINED BY THE SUBSCRIPTION AGENT <FONT style="white-space: nowrap">AT
JP MORGAN CHASE BANK, 55 WATER STREET, NEW YORK, NEW YORK 10005, ABA #021000021,</FONT> ACCOUNT NO. 957-341326 AMERICAN STOCK TRANSFER FBO INTELLIGENT SYSTEMS CORPORATION. Please reference your Subscription Rights
Certificate number on your check. Payments will be deemed to have been received by the
Subscription Agent only upon receipt by the Subscription Agent of a cashier&#146;s or certified check
drawn upon a United States bank or a wire transfer of immediately available funds.
</DIV>



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;DELIVERY TO ANY ADDRESS OR BY A METHOD OTHER THAN THOSE SET FORTH ABOVE WILL NOT CONSTITUTE
VALID DELIVERY.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The method of delivery of Subscription Rights Certificates and payment of the Subscription
Price to the Subscription Agent will be at the election and risk of the Rights holder, but, if sent
by mail, it is recommended that such certificates and payments be sent by registered mail, properly
insured, with return receipt requested and that a sufficient number of days be allowed to ensure
delivery to the Subscription Agent and the clearance of payment prior to 5:00 p.m., Eastern
Daylight Time, on the Expiration Date. Neither the Company nor the Subscription Agent are liable
for deliveries that are not timely received.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>4. Special Provisions Relating to the Delivery of Rights through the Depository Trust Company.</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In the case of Rights that are held of record through the Depository Trust Company (the
&#147;Book-Entry Transfer Facility&#148;), exercises of the Basic Subscription Privilege and of the
Over-Subscription Privilege may be effected by instructing the Book-Entry Transfer Facility to
transfer Rights from the Book-Entry Transfer Facility account of such holder to the Book-Entry
Transfer Facility account of the Subscription Agent, together with certification as to the
aggregate number of Rights exercised and the number of Underlying Shares thereby subscribed for
pursuant to the Basic Subscription Privilege and the Over-Subscription Privilege by each beneficial
owner of Rights on whose behalf such nominee is acting, and payment of the Subscription Price for
each share of Common Stock subscribed for pursuant to the Basic Subscription Privilege and the
Over-Subscription Privilege. See the Company&#146;s &#147;Letter to Stockholders Who Are Record Holders&#148; and
the &#147;Nominee Holder Certification.&#148;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>5. Sale, Transfer, or Assignment of Rights.</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Rights may not be sold, transferred, or assigned; provided, however, that Rights are
transferable by operation of law (for example, the transfer of Rights to the estate of a recipient
upon the recipient&#146;s death).
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><B>6. Commissions, Fees, and Expenses.</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company will pay all fees and expenses of the Subscription Agent related to their acting
in such roles in connection with the Rights Offering. The Company has also agreed to indemnify the
Subscription Agent from certain liabilities that it may incur in connection with the Rights
Offering. However, all commissions, fees, and other expenses (including brokerage commissions and
fees and transfer taxes) incurred in connection with the exercise of Rights will be for the account
of the holder of the Rights, and none of such commissions, fees, or expenses will be paid by the
Company or the Subscription Agent.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>7. Issuance of Common Stock.</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Promptly after the closing of the Rights Offering and the valid exercise of Rights pursuant to
the Basic Subscription Privilege, and after all allocations and adjustments contemplated by the
terms of the Rights Offering have been effected, the following deliveries and payments will be made
to the address shown on the face of your Subscription Rights Certificate unless you provide
instructions to the contrary in your Subscription Rights Certificate:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. <I>Basic Subscription Privilege</I>: The Subscription Agent will deliver to each exercising Rights
holder the number of shares of Common Stock purchased pursuant to the Basic Subscription Privilege.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b. <I>Over-Subscription Privilege</I>: The Subscription Agent will deliver to each Rights holder who
validly exercises the Over-Subscription Privilege the number of shares of Common Stock, if any,
allocated to such Rights holder pursuant to the Over-Subscription Privilege.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c. <I>Excess Cash Payments</I>: The Subscription Agent will mail to each Rights holder who exercises
the Over-Subscription Privilege any excess amount, without interest or deduction, received in
payment of the Subscription Price.
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><B>8. Cancellation.</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our board of directors may cancel or terminate the rights offering in its sole discretion at
any time on or before the expiration of the rights offering for any reason (including, without
limitation, a change in the market price of our common stock). If the total purchase price for the
shares subscribed for is less than $1,400,000, we plan to cancel the rights offering, but we
are not obligated to do so, and our board of directors may modify or waive this requirement. In
the event that the rights offering is cancelled or terminated, all funds received from
subscriptions by stockholders will be returned. Interest will not be payable on any returned
funds.
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>




</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>8
<FILENAME>g18612s1exv99w2.htm
<DESCRIPTION>EX-99.2 FORM OF LETTER TO STOCKHOLDERS
<TEXT>
<HTML>
<HEAD>
<TITLE>EX-99.2 FORM OF LETTER TO STOCKHOLDERS</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="right" style="font-size: 10pt; margin-top: 12pt">Exhibit&nbsp;99.2
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>FORM OF LETTER TO STOCKHOLDERS WHO ARE RECORD HOLDERS</B>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 6pt"><B>INTELLIGENT SYSTEMS CORPORATION</B>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 6pt"><B>4,478,971 Shares of Common Stock</B>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 6pt"><B>Offered Pursuant to Rights Distributed to Record Stockholders of<BR>
Intelligent Systems Corporation</B>
</DIV>


<DIV align="right" style="font-size: 10pt; margin-top: 12pt"><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>, 2009
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt">Dear Stockholder:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This notice is being distributed by Intelligent Systems Corporation (the &#147;Company&#148;) to all
holders of record of shares of its common stock, par value $0.01 per share (the &#147;Common Stock&#148;), at
5:00 p.m., Eastern Daylight Time, on &#95;&#95;&#95;&#95;&#95;&#95;&nbsp;&#95;&#95;&#95;, 2009 (the &#147;Record Date&#148;), in connection with
the distribution in a rights offering (the &#147;Rights Offering&#148;) of non-transferable subscription
rights (the &#147;Rights&#148;) to subscribe for and purchase an aggregate of 4,478,971 shares of the
Company&#146;s Common Stock (the &#147;Underlying Shares&#148;). The Rights are described in the Company&#146;s
Prospectus, dated &#95;&#95;&#95;&#95;&#95;&#95;&nbsp;&#95;&#95;&#95;, 2009 (the &#147;Prospectus&#148;).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Rights will expire, if not exercised, by 5:00 p.m., Eastern Daylight Time, on
&#95;&#95;&#95;&#95;&#95;&#95;&nbsp;&#95;&#95;&#95;, 2009, unless extended in the sole discretion of the Company (as it may be
extended, the &#147;Expiration Date&#148;).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As described in the accompanying Prospectus, you will receive one Right for each share of
Common Stock owned of record as of the close of business on the Record Date.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each whole Right will allow you to subscribe for one share of Common Stock (the &#147;Basic
Subscription Privilege&#148;) at the cash price of $0.70 per share (the &#147;Subscription Price&#148;).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In addition, each holder of Rights who exercises his Basic Subscription Privilege in full will
be eligible to subscribe (the &#147;Over-Subscription Privilege&#148;) at the same Subscription Price of
$0.70 per share for up to 500,000 additional shares of Common Stock if any shares are not
purchased by other holders of subscription rights under their Basic Subscription Privilege as of
the Expiration Date (the &#147;Excess Shares&#148;). Underlying Shares will only be awarded to you, however,
if other holders of Rights do not subscribe for all the Underlying Shares available to them under
their Basic Subscription Privilege.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If there is an insufficient number of Excess Shares available to fully satisfy the
over-subscription requests of holders of Rights, holders who exercised their Over-Subscription
Privilege will receive the available shares <I>pro rata </I>in proportion to the number of Underlying
Shares that holders of Rights who exercised their Over-Subscription Privilege purchased by
exercising their Basic Subscription Privilege. In certain situations, allocating the remaining
Excess Shares on this basis could result in your receiving an allocation of a greater number of
shares than you subscribed for under your Over-Subscription Privilege. If this occurs, then we
will allocate to you only the number of Underlying Shares
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 10pt">for which you subscribed. We will allocate the remaining Excess Shares among all other holders exercising their Over-Subscription Privilege
on the <I>pro rata </I>basis described above. For the purposes of determining
their eligibility for the Over-Subscription Privilege, holders will be deemed to have exercised
their Basic Subscription Privilege in full if they subscribe for the maximum number of whole
Underlying Shares available under their Basic Subscription Privilege.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If you do not receive the full number of Underlying Shares for which you subscribed, any
excess subscription payment will be returned to you, without interest or deduction, promptly after
the expiration of the rights offering.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Rights are evidenced by Rights certificates (the &#147;Subscription Rights Certificates&#148;).
Rights may not be sold, transferred, or assigned; provided, however, that Rights are
transferable by operation of law (for example, a transfer of Rights to the estate of a recipient
upon the recipient&#146;s death).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Enclosed are copies of the following documents:
</DIV>


<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="8%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">1.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Prospectus;</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="8%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">2.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Subscription Rights Certificate;</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="8%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">3.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Instructions for Use of Intelligent Systems Corporation
Subscription Rights Certificates; and</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="8%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">4.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>A return envelope addressed to American Stock Transfer
&#038; Trust Company, the Subscription Agent.</TD>
</TR>

</TABLE>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Your prompt action is requested. To exercise your Rights, you should properly complete and
sign the Subscription Rights Certificate and forward it, with payment of the Subscription Price in
full for each share of Common Stock subscribed for pursuant to the Basic Subscription Privilege and
the Over-Subscription Privilege, to the Subscription Agent, as indicated in the Prospectus. The
Subscription Agent must receive the Subscription Rights Certificate with payment of the
Subscription Price on or prior to 5:00 p.m., Eastern Daylight Time, on the Expiration Date. <B>All
payments must be made in U.S. dollars for the full number of Underlying Shares being subscribed for
by cashier&#146;s or certified check drawn upon a United States bank payable to American Stock Transfer
&#038; Trust Company, as Subscription Agent, or by wire transfer of immediately available funds, to the
subscription account maintained by the Subscription Agent</B>
<B>at JP Morgan Chase Bank, 55 Water Street, New York, New York 10005, ABA #021000021, Account No.
957-341326 American Stock Transfer FBO Intelligent Systems Corporation. Failure to return the properly completed Subscription Rights Certificate with the correct
payment will result in your not being able to exercise your Rights. </B>A Rights holder cannot revoke
the exercise of his Rights. Rights not exercised prior to the Expiration Date will expire without
value.
</DIV>




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Additional copies of the enclosed materials may be obtained from the information agent,
Morrow &#038; Co. LLC, at 470 West Avenue, Stamford, CT 06902, Telephone: (800) 607-0088 or (203) 658-9400.
</DIV>



<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 50%">Very truly yours,

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 50%">INTELLIGENT SYSTEMS CORPORATION

</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.3
<SEQUENCE>9
<FILENAME>g18612s1exv99w3.htm
<DESCRIPTION>EX-99.3 FORM OF LETTER TO NOMINEE HOLDERS
<TEXT>
<HTML>
<HEAD>
<TITLE>EX-99.3 FORM OF LETTER TO NOMINEE HOLDERS</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="right" style="font-size: 10pt; margin-top: 12pt">Exhibit&nbsp;99.3
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>FORM OF LETTER TO NOMINEE HOLDERS<BR>
WHOSE CLIENTS ARE BENEFICIAL HOLDERS</B>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 6pt"><B>INTELLIGENT SYSTEMS CORPORATION</B>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 6pt"><B>4,478,971 Shares of Common Stock</B>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 6pt"><B>Offered Pursuant to Rights Distributed to Record Stockholders of<BR>
Intelligent Systems Corporation</B>
</DIV>


<DIV align="right" style="font-size: 10pt; margin-top: 12pt"><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>, 2009
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt"><B>To Securities Dealers, Commercial Banks,<BR>
Trust Companies and Other Nominees:</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This letter is being distributed to securities dealers, commercial banks, trust companies and
other nominees in connection with the rights offering (the &#147;Rights Offering&#148;) by Intelligent
Systems Corporation (the &#147;Company&#148;) of shares of its Common Stock, par value $0.01 per share (the
&#147;Common Stock&#148;), pursuant to non-transferable subscription rights (the &#147;Rights&#148;) being distributed
to all holders of record (&#147;Record Holders&#148;) of shares of Common Stock at 5:00 p.m., Eastern
Daylight Time, on &#95;&#95;&#95;&#95;&#95;&#95;&nbsp;&#95;&#95;&#95;, 2009 (the &#147;Record Date&#148;). The Rights are described in the
Company&#146;s Prospectus, dated &#95;&#95;&#95;&#95;&#95;&#95;&nbsp;&#95;&#95;&#95;, 2009 (the &#147;Prospectus&#148;).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Rights will expire, if not exercised, by 5:00 p.m., Eastern Daylight Time, on
&#95;&#95;&#95;&#95;&#95;&#95;&nbsp;&#95;&#95;&#95;, 2009, unless extended in the sole discretion of the Company (as it may be extended,
the &#147;Expiration Date&#148;).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As described in the accompanying Prospectus, each Record Holder will receive one Right for
each share of Common Stock owned of record as of the close of business on the Record Date. In the
Rights Offering, the Company is offering an aggregate of 4,478,971 shares of its Common Stock (the
&#147;Underlying Shares&#148;) pursuant to the Prospectus.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each whole Right will allow the holder thereof to subscribe for one share of Common Stock (the
&#147;Basic Subscription Privilege&#148;) at the cash price of $0.70 per share (the &#147;Subscription
Price&#148;).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In addition, each holder of Rights who exercises his Basic Subscription Privilege in full will
be eligible to subscribe (the &#147;Over-Subscription Privilege&#148;) at the same Subscription Price of
$0.70 per share for up to 500,000 additional shares of Common Stock if any shares are not
purchased by other holders of subscription rights under their Basic Subscription Privileges as of
the Expiration Date (the &#147;Excess Shares&#148;). Underlying Shares will only be awarded to such holders,
however, if other holders of Rights do not subscribe for all the Underlying Shares available to
them under their Basic Subscription Privilege.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If there is an insufficient number of Excess Shares available to fully satisfy the
over-subscription requests of holders of Rights, holders who exercised their Over-Subscription
Privilege will receive the available shares <I>pro rata </I>in proportion to the number of Underlying
Shares that holders of Rights who exercised their Over-Subscription Privilege purchased by
exercising their Basic Subscription Privilege. In certain situations, allocating the remaining
Excess Shares on this basis could result in a holder receiving an allocation of a greater number of
shares than he subscribed for under his Over-
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 10pt">Subscription
Privilege. If this occurs, then we will allocate to such holder only the number of Underlying Shares
for which he subscribed. We will allocate the remaining Excess Shares among all other holders
exercising their Over-Subscription Privilege on the <I>pro rata </I>basis described above. For the
purposes of determining their eligibility for the Over-Subscription Privilege, holders will be
deemed to have exercised their Basic Subscription Privilege in full if they subscribe for the
maximum number of whole Underlying Shares available under their Basic Subscription Privilege.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If a holder does not receive the full number of Underlying Shares for which he subscribed, any
excess subscription payment will be returned, without interest or deduction, promptly after the
expiration of the rights offering.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Rights are evidenced by a Rights certificate (a &#147;Subscription Rights Certificate&#148;)
registered in your name or the name of your nominee. Each beneficial owner of shares of Common
Stock registered in your name or the name of your nominee is entitled to one Right for each share
of Common Stock owned by such beneficial owner as of the Record Date. Rights may not be sold,
transferred or assigned; provided, however , that Rights are transferable by operation of law
(for example, the transfer of Rights to the estate of a recipient upon the recipient&#146;s death).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We are asking persons who hold shares of Common Stock beneficially and who have received the
Rights distributable with respect to those shares through a broker, dealer, commercial bank, trust
company or other nominee, as well as persons who hold certificates of Common Stock directly and
prefer to have such institutions effect transactions relating to the Rights on their behalf, to
contact the appropriate institution or nominee and request it to effect the transactions for them.
In addition, we are asking beneficial owners who wish to obtain a separate Subscription Rights
Certificate to contact the appropriate nominee as soon as possible and request that a separate
Subscription Rights Certificate be issued.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Please take prompt action to notify any beneficial owners of Common Stock as to the Rights
Offering and the procedures and deadlines that must be followed to exercise their Rights. If you
exercise the Over-Subscription Privilege on behalf of beneficial owners of Rights, you will be
required to certify to the Subscription Agent and the Company, in connection with the exercise of
the Over-Subscription Privilege, as to the aggregate number of Rights that have been exercised
pursuant to the Basic Subscription Privilege, whether the Basic Subscription Privilege of each
beneficial owner of Rights on whose behalf you are acting has been exercised in full and the number
of shares of Common Stock being subscribed for pursuant to the Over-Subscription Privilege by each
beneficial owner of Rights on whose behalf you are acting.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All commissions, fees and other expenses (including brokerage commissions and transfer taxes),
other than fees and expenses of the Subscription Agent, incurred in connection with the exercise of
the Rights will be for the account of the holder of the Rights, and none of such commissions, fees
or expenses will be paid by the Company or the Subscription Agent.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Enclosed are copies of the following documents:
</DIV>


<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="8%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">1.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Prospectus;</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="8%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">2.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Instructions for Use of Intelligent Systems
Corporation Subscription Rights Certificates;</TD>
</TR>

</TABLE>
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV style="margin-top: 6pt"><TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">



</TABLE>
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="8%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">3.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>A form of letter that may be sent to your clients
for whose accounts you hold shares of Common Stock registered in your name or
the name of your nominee, with an attached form of instruction;</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="8%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">4.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Nominee Holder Certification; and</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="8%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">5.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>A return envelope addressed to American Stock
Transfer &#038; Trust Company, the Subscription Agent.</TD>
</TR>

</TABLE>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Your prompt action is requested. To exercise Rights, you should deliver the properly
completed and signed Subscription Rights Certificate, with payment of the Subscription Price in
full for each share of Common Stock subscribed for, to the Subscription Agent, as indicated in the
Prospectus. The Subscription Agent must receive the Subscription Rights Certificate with payment
of the Subscription Price on or prior to 5:00 p.m., Eastern Daylight Time, on the Expiration Date.
<B>All payments must be made in U.S. dollars for the full number of Underlying Shares being
subscribed for by cashier&#146;s or certified check drawn upon a United States bank payable to American
Stock Transfer &#038; Trust Company, as Subscription Agent, or by wire transfer of immediately available
funds, to the subscription account maintained by the Subscription Agent at Morrow &#038; Co. LLC,
Account No. 957-341326 American Stock Transfer FBO Intelligent Systems Corporation. Failure to return the properly completed Subscription Rights Certificate with
the correct payment will result in your not being able to exercise the Rights held in your name on
behalf of yourself or other beneficial owners. </b>A Rights holder cannot revoke the exercise of his
Rights. Rights not exercised prior to the Expiration Date will expire without value.
</DIV>



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Additional copies of the enclosed materials may be obtained from the information agent,
Morrow &#038; Co. LLC, at 470 West Avenue, Stamford, CT 06902, Telephone: (800) 607-0088 or (203) 658-9400.
</DIV>



<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 50%">Very truly yours,

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 50%">INTELLIGENT SYSTEMS CORPORATION

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;NOTHING IN THE PROSPECTUS OR IN THE ENCLOSED DOCUMENTS SHALL CONSTITUTE YOU OR ANY PERSON AS
AN AGENT OF INTELLIGENT SYSTEMS CORPORATION, THE SUBSCRIPTION AGENT, OR ANY OTHER PERSON MAKING OR
DEEMED TO BE MAKING OFFERS OF THE SECURITIES ISSUABLE UPON VALID EXERCISE OF THE RIGHTS, OR
AUTHORIZE YOU OR ANY OTHER PERSON TO MAKE ANY STATEMENTS ON BEHALF OF ANY OF THEM WITH RESPECT TO
THE OFFERING EXCEPT FOR STATEMENTS EXPRESSLY MADE IN THE PROSPECTUS.
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>




</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.4
<SEQUENCE>10
<FILENAME>g18612s1exv99w4.htm
<DESCRIPTION>EX-99.4 FORM OF LETTER TO CLIENTS
<TEXT>
<HTML>
<HEAD>
<TITLE>EX-99.4 FORM OF LETTER TO CLIENTS</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="right" style="font-size: 10pt; margin-top: 12pt">Exhibit&nbsp;99.4
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>FORM OF LETTER TO CLIENTS OF NOMINEE HOLDERS</B>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>INTELLIGENT SYSTEMS CORPORATION</B>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>4,478,971 Shares of Common Stock</B>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>Offered Pursuant to Rights Distributed to Record Stockholders of<BR>
Intelligent Systems Corporation</B>
</DIV>


<DIV align="right" style="font-size: 10pt; margin-top: 12pt">_______________, 2009
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>To Our Clients:</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Enclosed
for your consideration are the Prospectus, dated &#95;&#95;&#95;&#95;&#95;&#95;&nbsp;&#95;&#95;&#95;, 2009 (the
&#147;Prospectus&#148;), and the &#147;Instructions for Use of Intelligent Systems Corporation Subscription Rights
Certificates&#148; relating to the offering (the &#147;Rights Offering&#148;) by Intelligent Systems Corporation
(the &#147;Company&#148;) of shares of its Common Stock, par value $0.01 per share (the &#147;Common Stock&#148;),
pursuant to non-transferable subscription rights (the &#147;Rights&#148;) being distributed to all holders of
record of shares of Common Stock, at 5:00 p.m., Eastern Daylight
Time, on &#95;&#95;&#95;&#95;&#95;&#95;&nbsp;&#95;&#95;&#95;, 2009 (the
&#147;Record Date&#148;). The Rights are described in the Company&#146;s Prospectus.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Rights will expire, if not exercised, by 5:00 p.m., Eastern Daylight Time, on
&#95;&#95;&#95;&#95;&#95;&#95;&nbsp;&#95;&#95;&#95;, 2009, unless extended in the sole discretion of the Company (as it may be extended,
the &#147;Expiration Date&#148;).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As described in the accompanying Prospectus, you will receive one Right for each share of
Common Stock carried by us in your account as of the close of business on the Record Date. In the
Rights Offering, the Company is offering an aggregate of 4,478,971 shares of its Common Stock (the
&#147;Underlying Shares&#148;) pursuant to the Prospectus.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each whole Right will allow you to subscribe for one share of Common Stock (the &#147;Basic
Subscription Privilege&#148;) at the cash price of
$0.70 per share (the &#147;Subscription Price&#148;).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In addition, each holder of Rights who exercises his Basic Subscription Privilege in full will
be eligible to subscribe (the &#147;Over-Subscription Privilege&#148;) at the same Subscription Price of
$0.70&nbsp;per share for up to 500,000 additional shares of Common Stock if any shares are not
purchased by other holders of subscription rights under their Basic Subscription Privilege as of
the Expiration Date (the &#147;Excess Shares&#148;). Underlying Shares will only be awarded to you, however,
if other holders of Rights do not subscribe for all the Underlying Shares available to them under
their Basic Subscription Privilege.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If there is an insufficient number of Excess Shares available to fully satisfy the
over-subscription requests of holders of Rights, holders who exercised their Over-Subscription
Privilege will receive the available shares <I>pro rata </I>in proportion to the number of Underlying
Shares that holders of Rights who exercised their Over-Subscription Privilege purchased by
exercising their Basic Subscription Privilege. In certain situations, allocating the remaining
Excess Shares on this basis could result in your
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 10pt">receiving an allocation of a greater number of shares than you subscribed for under your Over-Subscription
Privilege. If this occurs, only the number of Underlying Shares for
which you subscribed will be allocated to you.  The remaining Excess
Shares will be allocated among all other holders
exercising their Over-Subscription Privilege on the <I>pro rata </I>basis described above. For the
purposes of determining their eligibility for the Over-Subscription Privilege, holders will be
deemed to have exercised their Basic Subscription Privilege in full if they subscribe for the
maximum number of whole Underlying Shares available under their Basic Subscription Privilege.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;If you do not receive the full number of Underlying Shares for which you subscribed, any
excess subscription payment will be returned to you, without interest or deduction, promptly after
the expiration of the rights offering.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Rights are evidenced by Rights certificates (the &#147;Subscription Rights Certificates&#148;).
Rights may not be sold, transferred or assigned; provided , however , that Rights are
transferable by operation of law (for example, a transfer of Rights to the estate of a recipient
upon the recipient&#146;s death).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;THE MATERIALS ENCLOSED ARE BEING FORWARDED TO YOU AS THE BENEFICIAL OWNER OF COMMON STOCK
CARRIED BY US IN YOUR ACCOUNT BUT NOT REGISTERED IN YOUR NAME. EXERCISES OF RIGHTS MAY BE MADE
ONLY BY US AS THE RECORD OWNER AND PURSUANT TO YOUR INSTRUCTIONS. Accordingly, we request
instructions as to whether you wish us to elect to subscribe for any shares of Common Stock to
which you are entitled pursuant to the terms and subject to the conditions set forth in the
enclosed Prospectus. However, we urge you to read the Prospectus and other enclosed materials
carefully before instructing us to exercise your Rights.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Your instructions to us should be forwarded as promptly as possible in order to permit us to
exercise Rights on your behalf in accordance with the provisions of the Rights Offering. The
Rights Offering will expire at 5:00 p.m., Eastern Daylight Time, on the Expiration Date. Once you
have exercised your Basic Subscription Privilege and your Over-Subscription Privilege, such
exercise may not be revoked.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If you wish to have us, on your behalf, exercise the Rights for any shares of Common Stock to
which you are entitled, please so instruct us by timely completing, executing and returning to us
the instruction form attached to this letter.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;<B>With respect to any instructions to exercise (or not to exercise) Rights, the enclosed
Beneficial Ownership Election must be completed and returned such that it will be actually received
by us by 5:00 p.m., Eastern Daylight Time, on &#95;&#95;&#95;&#95;&#95;&#95;&nbsp;&#95;&#95;&#95;, 2009, the last business day prior to
the scheduled expiration date of the Rights Offering of &#95;&#95;&#95;&#95;&#95;&#95;&nbsp;&#95;&#95;&#95;, 2009 (which may be
extended by the Company in its sole discretion).</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ANY QUESTIONS OR REQUESTS FOR ASSISTANCE CONCERNING THE RIGHTS OFFERING SHOULD BE DIRECTED TO
THE INFORMATION AGENT, MORROW &#38; CO., LLC, AT 470&nbsp;WEST
AVENUE, STAMFORD, CT 06902, TELEPHONE: (800)&nbsp;607-0088 or (203)&nbsp;658-9400.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>FORM OF BENEFICIAL OWNER ELECTION</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The undersigned acknowledge(s) receipt of your letter and the enclosed materials referred to
therein relating to the offering of shares of Common Stock of Intelligent Systems Corporation (the
&#147;Company&#148;).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;<B>With respect to any instructions to exercise (or not to exercise) Rights, the undersigned
acknowledges that this form must be completed and returned such that it will actually be received
by you by 5:00 p.m., Eastern Daylight Time, on &#95;&#95;&#95;&#95;&#95;&#95;&nbsp;&#95;&#95;&#95;, 2009, the last business day prior to
the scheduled expiration date of the Rights Offering of &#95;&#95;&#95;&#95;&#95;&#95;&nbsp;&#95;&#95;&#95;, 2009 (which may be extended
by the Company in its sole discretion).</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This will instruct you whether to exercise Rights to purchase shares of the Company&#146;s Common
Stock distributed with respect to the shares of the Company&#146;s Common Stock held by you for the
account of the undersigned, pursuant to the terms and subject to the conditions set forth in the
Prospectus and the related &#147;Instructions for Use of Intelligent Systems Corporation Subscription
Rights Certificates.&#148;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt">Box 1. <FONT face="Wingdings">&#111;</FONT> Please DO NOT EXERCISE RIGHTS for shares of Common Stock.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Box 2. <FONT face="Wingdings">&#111;</FONT> Please EXERCISE RIGHTS for shares of Common Stock as set forth below.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The number of Rights for which the undersigned gives instructions for exercise under the Basic
Subscription Privilege should not exceed the number of Rights that the undersigned is entitled to
exercise.
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="46%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="11%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2"><B>Number</B></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2"><B>Per Share</B></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2"><B>of Shares of Common</B></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2"><B>Subscription</B></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2" style="border-bottom: 1px solid #000000"><B>Stock Subscribed For</B></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2" style="border-bottom: 1px solid #000000"><B>Price</B></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2" style="border-bottom: 1px solid #000000"><B>Payment</B></TD>
    <TD>&nbsp;</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Basic Subscription Privilege:</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">x</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left">$</TD>
    <TD align="right"><B>0.70</B>=</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left">$</TD>
    <TD align="right">(Line 1)</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Over-Subscription Privilege:</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">x</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left">$</TD>
    <TD align="right"><B>0.70</B>=</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left">$</TD>
    <TD align="right">(Line 2)</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="top" style="background: #cceeff">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Total Payment Required:</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">$</TD>
    <TD align="right" nowrap>(Line 3; sum of <BR>Lines 1 and 2)</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right" nowrap colspan=2>Line 3 must equal<BR>
 total of amounts in<BR>
 Boxes 3 and 4 below.</TD>

    <TD>&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt">Box 3. <FONT face="Wingdings">&#111;</FONT> Payment in the following amount is enclosed $________________.
</DIV>


<DIV align="left" style="margin-top: 12pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; background: transparent; color: #000000">
<TR>
    <TD width="3%"></TD>
    <TD width="1%"></TD>
    <TD></TD>
</TR>
<TR valign="top">
    <TD nowrap align="left">Box 4. <FONT face="Wingdings">&#111;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>Please deduct payment of $_________________ from the following account maintained by
you as follows:</TD>
</TR>
</TABLE>
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="45%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="45%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR><TD>&nbsp;</TD></TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
Type of Account
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
Account No.
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Amount to be deducted: $<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Date:<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>&nbsp;<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>, 2009
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><DIV style="font-size: 1pt; border-top: 0px solid #000000">&nbsp;</DIV>

</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
Signature(s)
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Please type or print name(s) below:</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.5
<SEQUENCE>11
<FILENAME>g18612s1exv99w5.htm
<DESCRIPTION>EX-99.5 FORM OF NOMINEE HOLDER CERTIFICATION
<TEXT>
<HTML>
<HEAD>
<TITLE>EX-99.5 FORM OF NOMINEE HOLDER CERTIFICATION</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="right" style="font-size: 10pt; margin-top: 12pt">Exhibit&nbsp;99.5
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>FORM OF<BR>
NOMINEE HOLDER CERTIFICATION</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The undersigned, a bank, broker, trustee, depositary or other nominee of non-transferable
rights (the &#147;Rights&#148;) to purchase shares of common stock, par value $0.01 per share, of Intelligent
Systems Corporation (the &#147;Company&#148;) pursuant to the rights offering described and provided for in
the Company&#146;s Prospectus dated &#95;&#95;&#95;&#95;&#95;&#95;&nbsp;&#95;&#95;&#95;, 2009 (the &#147;Prospectus&#148;), hereby certifies to the
Company and to American Stock Transfer &#038; Trust Company, as Subscription Agent for such rights
offering, that (1)&nbsp;the undersigned has exercised, on behalf of the beneficial owners thereof (which
may include the undersigned), the number of Rights specified below pursuant to the Basic
Subscription Privilege (as defined in the Prospectus) and, on behalf of beneficial owners of Rights
who have subscribed for the purchase of additional shares of common stock pursuant to the
Over-Subscription Privilege, the number of shares specified below pursuant to the Over-Subscription
Privilege (as defined in the Prospectus), listing separately below each such exercised Basic
Subscription Privilege and the corresponding Over-Subscription Privilege (without identifying any
such beneficial owner), and (2)&nbsp;to the extent a beneficial owner has elected to subscribe for
shares pursuant to the Over-Subscription Privilege, each such beneficial owner&#146;s Basic Subscription
Privilege has been exercised in full:
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="1%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center"><B>Number of Shares Subscribed</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center"><B>Number of Shares Subscribed</B></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center"><B>Number of Shares Owned on</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center"><B>for Pursuant to Basic</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center"><B>for Pursuant to</B></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="center" style="border-bottom: 1px solid #000000"><B>the Record Date</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" style="border-bottom: 1px solid #000000"><B>Subscription Privilege</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" style="border-bottom: 1px solid #000000"><B>Over-Subscription Privilege</B></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR><TD>&nbsp;</TD></TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">1.
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom"><DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom"><DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom"><DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">2.
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom"><DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom"><DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom"><DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">3.
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom"><DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom"><DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom"><DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">4.
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom"><DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom"><DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom"><DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">5.
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom"><DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom"><DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom"><DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">6.
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom"><DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom"><DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom"><DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">7.
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom"><DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom"><DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom"><DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">8.
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom"><DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom"><DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom"><DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">9.
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom"><DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom"><DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom"><DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="bottom">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 12pt">Provide the following information if applicable:
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="48%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="50%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
Depository Trust Company (&#147;DTC&#148;)<BR>
Participant Number
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt">Participant
Name: <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="37%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="60%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">By:</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Name:</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Title:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="48%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="50%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR><TD>&nbsp;</TD></TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
DTC Basic Subscription Confirmation Number(s)
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.6
<SEQUENCE>12
<FILENAME>g18612s1exv99w6.htm
<DESCRIPTION>EX-99.6 FORM OF BENEFICIAL OWNER ELECTION
<TEXT>
<HTML>
<HEAD>
<TITLE>EX-99.6 FORM OF BENEFICIAL OWNER ELECTION</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="right" style="font-size: 10pt; margin-top: 12pt">Exhibit&nbsp;99.6
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>FORM OF BENEFICIAL OWNER ELECTION</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The undersigned acknowledge(s) receipt of your letter and the enclosed materials referred to
therein relating to the offering of shares of Common Stock of Intelligent Systems Corporation (the
&#147;Company&#148;).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>With respect to any instructions to exercise (or not to exercise) Rights, the undersigned
acknowledges that this form must be completed and returned such that it will actually be received
by you by 5:00 p.m., Eastern Daylight Time, on &#95;&#95;&#95;&#95;&#95;&#95;&nbsp;&#95;&#95;&#95;, 2009, the last business day prior to
the scheduled expiration date of the Rights Offering of &#95;&#95;&#95;&#95;&#95;&#95;&nbsp;&#95;&#95;&#95;, 2009 (which may be extended
by the Company in its sole discretion).</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This will instruct you whether to exercise Rights to purchase shares of the Company&#146;s Common
Stock distributed with respect to the shares of the Company&#146;s Common Stock held by you for the
account of the undersigned, pursuant to the terms and subject to the conditions set forth in the
Prospectus and the related &#147;Instructions for Use of Intelligent Systems Corporation Subscription
Rights Certificates.&#148;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt">Box 1. <FONT face="Wingdings">&#111;</FONT> Please DO NOT EXERCISE RIGHTS for shares of Common Stock.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Box 2. <FONT face="Wingdings">&#111;</FONT> Please EXERCISE RIGHTS for shares of Common Stock as set forth below.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The number of Rights for which the undersigned gives instructions for exercise under the Basic
Subscription Privilege should not exceed the number of Rights that the undersigned is entitled to
exercise.
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="42%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2"><B>Number</B></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2"><B>Per Share</B></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2"><B>of Shares of Common</B></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2"><B>Subscription</B></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2" style="border-bottom: 1px solid #000000"><B>Stock Subscribed For</B></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2" style="border-bottom: 1px solid #000000"><B>Price</B></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2" style="border-bottom: 1px solid #000000"><B>Payment</B></TD>
    <TD>&nbsp;</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Basic Subscription Privilege:</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">x</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left">$</TD>
    <TD align="right"><B>0.70</B>=</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left">$</TD>
    <TD align="right">(Line 1)</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Over-Subscription Privilege:</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">x</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left">$</TD>
    <TD align="right"><B>0.70</B>=</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left">$</TD>
    <TD align="right">(Line 2)</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="top" style="background: #cceeff">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Total Payment Required:</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">$</TD>
    <TD align="right" nowrap>(Line 3; sum of<BR>
 Lines 1 and 2)</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right" nowrap colspan=2>Line 3 must equal<BR>
 total of amounts in <BR>
Boxes 3 and 4 below.</TD>

    <TD>&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt">Box 3. <FONT face="Wingdings">&#111;</FONT> Payment in the following amount is enclosed $________________.
</DIV>


<DIV align="left" style="margin-top: 12pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; background: transparent; color: #000000">
<TR>
    <TD width="3%"></TD>
    <TD width="1%"></TD>
    <TD></TD>
</TR>
<TR valign="top">
    <TD nowrap align="left">Box 4. <FONT face="Wingdings">&#111;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>Please deduct payment of
$<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U> from the following account maintained by
you as follows:</TD>
</TR>
</TABLE>
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="45%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="45%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR><TD>&nbsp;</TD></TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
Type of Account
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
Account No.
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Amount to be deducted: $<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Date:<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>&nbsp;<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>, 2009
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><DIV style="font-size: 1pt; border-top: 0px solid #000000">&nbsp;</DIV>

</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
Signature(s)
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Please type or print name(s) below:</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>



</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>g18612s1g1861220.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g18612s1g1861220.gif
M1TE&.#EAS@(G`O<``````(````"``("`````@(``@`"`@,#`P,#<P*;*\```
M`!86%AP<'"`@("@H*"DI*2LK*S`P,#0T-#@X.#DY.3L[.ST]/4!`0$%!04)"
M0D5%149&1DA(2$E)24Q,3$]/3U!04%-34U5555=75UA86%E965I:6EM;6UU=
M75Y>7E]?7V!@8&%A86)B8F-C8V1D9&5E969F9F=G9VAH:&EI:6MK:VQL;&UM
M;6YN;F]O;W!P<'%Q<7)R<G-S<W1T='5U=79V=G=W=WAX>'EY>7IZ>GM[>WQ\
M?'U]?7Y^?G]_?X"`@(&!@8*"@H.#@X2$A(6%A8:&AH>'AXB(B(F)B8J*BHN+
MBXR,C(V-C8Z.CH^/CY"0D)&1D9*2DI.3DY24E)65E9:6EI>7EYB8F)F9F9J:
MFIN;FYR<G)V=G9^?GZ"@H*&AH:*BHJ2DI*6EI::FIJ>GIZBHJ*FIJ:JJJJNK
MJZRLK*VMK:ZNKJ^OK["PL+*RLK.SL[2TM+6UM;:VMK>WM[BXN+FYN;JZNKN[
MN[R\O+V]O;Z^OK^_O\#`P,'!P<+"PL/#P\3$Q,7%Q<;&QL?'Q\C(R,G)R<K*
MRLO+R\S,S,W-S<[.SL_/S]#0T-'1T=+2TM/3T]34U-75U=;6UM?7U]C8V-G9
MV=K:VMO;V]S<W-W=W=[>WM_?W^#@X.'AX>+BXN/CX^7EY>;FYN?GY^CHZ.GI
MZ>KJZNOKZ^SL[._O[_#P\/'Q\?+R\O/S\_3T]/7U]??W]_KZ^OO[^_S\_/__
M_P``````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M`````````````````````````````````````````/_[\*"@I("`@/\```#_
M`/__````__\`_P#______R'Y!```````+`````#.`B<"AP```(````"``("`
M````@(``@`"`@,#`P,#<P*;*\````!86%AP<'"`@("@H*"DI*2LK*S`P,#0T
M-#@X.#DY.3L[.ST]/4!`0$%!04)"0D5%149&1DA(2$E)24Q,3$]/3U!04%-3
M4U5555=75UA86%E965I:6EM;6UU=75Y>7E]?7V!@8&%A86)B8F-C8V1D9&5E
M969F9F=G9VAH:&EI:6MK:VQL;&UM;6YN;F]O;W!P<'%Q<7)R<G-S<W1T='5U
M=79V=G=W=WAX>'EY>7IZ>GM[>WQ\?'U]?7Y^?G]_?X"`@(&!@8*"@H.#@X2$
MA(6%A8:&AH>'AXB(B(F)B8J*BHN+BXR,C(V-C8Z.CH^/CY"0D)&1D9*2DI.3
MDY24E)65E9:6EI>7EYB8F)F9F9J:FIN;FYR<G)V=G9^?GZ"@H*&AH:*BHJ2D
MI*6EI::FIJ>GIZBHJ*FIJ:JJJJNKJZRLK*VMK:ZNKJ^OK["PL+*RLK.SL[2T
MM+6UM;:VMK>WM[BXN+FYN;JZNKN[N[R\O+V]O;Z^OK^_O\#`P,'!P<+"PL/#
MP\3$Q,7%Q<;&QL?'Q\C(R,G)R<K*RLO+R\S,S,W-S<[.SL_/S]#0T-'1T=+2
MTM/3T]34U-75U=;6UM?7U]C8V-G9V=K:VMO;V]S<W-W=W=[>WM_?W^#@X.'A
MX>+BXN/CX^7EY>;FYN?GY^CHZ.GIZ>KJZNOKZ^SL[._O[_#P\/'Q\?+R\O/S
M\_3T]/7U]??W]_KZ^OO[^_S\_/___P``````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M`````````/_[\*"@I("`@/\```#_`/__````__\`_P#______PC^`'T)'$BP
MH,&#"!,J7,BPH<.'$"-*G$BQHL6+&#-JW,BQH\>/($.*'$FRI,F3*%.J7,FR
MI<N7,&/*G$FSILV;.'/JW,FSI\^?0(,*'4JTJ-&C2),J7<JTJ=.G4*-*G4JU
MJM6K6+-JW<JUJ]>O8,.*'4NVK-FS:-.J7<NVK=NW<./*G4NWKMV[>//JW<NW
MK]^_@`,+'DRXL.'#B!,K7LRXL>/'D"-+GDRYLN7+F#-KWLRYL^?/H$.+'DU:
M,(#2J%.KOG@Z(X#3KV/+GDV[MNW;N'/KWLV[M^_?P(,+'TZ\N/'CR),K7\Z\
MN?/GT*-+)^[K]>KKV+/[A#V]N_?OX,/^BQ]/OKSY\^C3JT=>?2/W]?#CRY]/
MO[[]^_CSUV^OD?M`_0`&*."`!!9HX($(ME:==0IBY)]V$$;X66S\N;;@?Q)F
MJ"%DK5'8(&L+=IC@B"26:.*)**8(H$`>NA<BBQO&*.-A(L+F(H45SJCCCGO5
MF".(.'[(XY!$PN6CD!6]!V.13#:YUI$W6O>CDU16Z164_;TXI95<=DD5EA8&
MZ>689$8%IH-:(EGFFFP&=2:04JK9YIQTWO2F14KRMX=L,TP2FR<'4`!`"'L<
M$-N>M>TQ`P!C[#'0`2$`,,,>1,@VQFP'7)JH;8!&.JDLOOAY@"^&WC;&0'ND
M.FJ=K%8:@BS^EU8*0*JRY2*0H9'&-JEL(<CZVJD"R;*HI*AH^AH1OGC"*RJ'
MHC+L)'ODBBAM8UPZPQM$W9EDF@.-$4*H`*!BJ"=^GIH+$9XH"ZJW!TRB+*"!
M)HMML@`@ZPL1LO0ZR1MCR`+`J#-4\88L>_K2[ZR^[)G+&$2,JZR]^!H,0!6D
MN@L`O/KR.]`;J%2!"JL@5R&IP;Z$`.RIESI:\FG1TCO)I;`B:[(O;U`P4`BO
MYAO"N404"ZRALN0RJ[][R$+!#+:^X>B_I`(@"[9#5XJ*+!0/I2U%>2JH:0@?
MCRNRK0,I&]NW]'KBB]&3#O0U0;F.ZN^OJ+9&=,+'-NW)V@/E\@;^WN\*U':W
ML3%L+\AM%LKHJ3.3/,8,WWI2*=UU:PILKD@+I.R\ESK^FLI-O^;VK'M.4M!L
MH%:G\@P4C)&+LD)=/5'6W8;PQL5V/QXBT`:3W;<O"X<P@T"5@OVQOI_O0<'@
M!9^-L,*GCAN\0!]/J_+NQ`,.-^%T.CK[MXFC'#JM"7^;,LSSFHRZ\`!@?C$1
M/7-NZ)Z.$KVGV;(:.BKNIJ.*>NENLLA@E!V*G2\8EXMQ&>I4_DJ7TW)G.=H=
MP%&&NA6C?.&LDMEK$OYJ%\+H%JSE*<B`$W36P@1"`=W1SH("$1T%Q^")>6%O
M3BHCPK=D>#9DJ>YHX&N9G_9P*>CEJU_^%*A:R7*&LWL-3H)/"Q?1_%4Y0E7G
M?@O,GRR0E4"K^<]&61(3Y/`U&T\8;W-OF]6OQ.:T!WHN;@"@@.9T]:=+->HU
MWSH4'.GU&B^^1HV1.D"IT!6;*?))(*DJE!%?N*9*.>I<R1*4&O=D,@KX:5!\
MFM:Q-H>K8`UK!L6Z'AU/DZO->6)85<B%M.88FP,0+%(LE%-.7"<1V!'RE;`<
M"2LCXLI8VO*6%GJ1*FG)+5SZ\I>\U"4`EP3,8AKS(+.$2"U!0\9Z@8I69YR6
MKQ@&1W]];!)<BY0+<^%(:]ZK5"?TA*<*^!I,ANN;?S)<;/!5*G-^K&>5(@+8
MVBDTN/F*AW[^$]EKGODG=E*``J,B&_L.%<]YEK.>C%IGX&3UJA!`RE8[*VC8
M`+"Z0^ES@>>J%[/@*)LKCH&>#+WGY(#GS8B)U&^"&I0E!X4*5$0JFX?\5VQ$
M1P1LC8%BRMK9)`3ETO1)\#638"BLX+:]GDIJ6F9DU#U5YM!_KDHTR7S(,D,C
MR(@%TB#X<MQ`(O91GU:A5XZ*6/CP5<)S/9""-AN@V=Z`S755H:P-<Q0J*"#(
MJKK4K7#=0R@%*<IUO8%L;$O6Y-!%$$%FJF'R/)<H25JRA.UU5'TUV%]O9KG!
M<152@:*8ODC%.1GNP1,([)794/78(PK2;P*)[!C><-G&@A:U]S+^6D3YU[C)
M?4AIH5*4V0[`N-_M*5/)JH(X*;`PNH*V"F-P)/O""BK@WHVKE.)=GUX%VE?=
M*U6IM:X\&WO6E7DB%[\;350=,E705%6.^]RJ+,AX`*'*\%S9]*G?/$>$*E0A
MKK`%[&MK6-_[=I=0HZHJ</EK7WC6RU;[]6-Z44O&7LT1<NO#[GW#N,!O972[
M"?95&,'9WFHZ]*_1.DU05?8V1Q+TP1=^)--.>SM@35&HKAT;2?LKUAAS]'HU
M!BS./$:$&8`3M)M[(P]%.:^>SNO'##WM`XN:*R(@%5B4_6^@`$J:\3:DO)^I
MZC.Q6Y"L6I9@^*II%2"U,V'MUJ;L$^7^O^1*MAF8C8?6O:D\\\CFNHZJ9W&^
MKYJ%N[!#QGFR!:FMWPB+J@/<M6&G<I8X&?LM/C>*=W_6<675&UV'[H%9.`M:
M=`TF.H>J+@2.&ZU`'+UI0#Z5;*IE+9@9/-+8SCF*KK5M07#[23>3BG&30"ZB
M+4DJD]D19:,MLZT''%M*!56ZV*64=1.FLL@2H=/)0M;#*+C+S%B9(5CVC):9
MW:MGJ]<3QW-RQ.[;,^(ZM%>5FP&H_(4L9OW8<H)"6CM1T6Z9UM'.L9UWO5TJ
MPX]U#FF`I>Q^T<V^9P9X!OA:W`P`SF@*]HIK/V4X;,&]W'&SRU'1XC>5%]OK
M1!\/X1'C-Z'^PHWQ4S_JH!:/-6S#3&W:"G:^[*N:L-+8TI>ZU!=JW#7-5A4I
MLR'78*.%5(]M16R+2PZ\,H14Z:+%/FA=3Z!U5#B40W/MA62;-*M+%]@(DBY/
M\`\AZ\7)ZK8^D?6F2R&H$#5"Q@Z1KG]][5YGB-E%S7:WOR3MGO#W2,(ND;@3
M).O?=4A+2U-UA5S]F(B_9>$3<OC$.YZ0BT=(XQ]/>59%'IF]K+SF(7_%+6$M
M\Z/9VC-_=\]2'JHCCZ34:^8Z*$-1P-].7^>6`Q=M&9:3C'L`K^>,#,YI]6M1
MA.(5(%4_9T*ID%X%W%G)1*\_"/N>I.?$ESX/H/LU_XER$F,4[I'^7WK/G3YA
MHP)M2D%MT5)6"Z<(/)03KP5A<,.1C"EUVCHO6E*J>8[^!T$4RGX%3FQNE%%3
MMBK5EU2P!E6=5VU2!7JBP4*.)4IJA%I<-D60IG<;(2R_PU;8@G#K-2_AM6V%
M<D2HH%?:A4_Y@EMSY63?="H4MS&.`BW@UUC,]ECV-4!;!6!!M'QO5C4.Z$7W
MTRM=)EOG$EU48X)T=3_>`BKB)ETO<S8SY$2-%8'((DK1$WX]9#FA16B@E5R?
MA4#2=FFITX%&J"#[16@P*%K!DE=4=%]J5Q#.=FS@A4]W`VJ#<S'@)1!$R&*$
M=X##Y'F>P8!3M$<0V$?VPH`=\8'@%U;^>Y(Z%%0UY^5]9W0SQX)[8M4HVO1C
MI51C+T@VJ2)1H[9N=[0'(.9K-?133O8GI31C!<9BDS@MXG0L2B8])091$":!
M0`=AQI)*F\-060@_Z?<:V&(\2V>*8P1'#!4B`S4H4Y2*3U6,!K%?+\A9U\=>
M`<A8!J-_J'%Y!C%YFL&`<)8+_@(JWP*%D/9V%Y$+5>`HW\)6IU(Y^[*(IA9;
MX'=$-U,ZH"5*+217924L`Z95=N@HG_2"A%4IW_5HG<AI)?-`F,:-D^.-LV)H
M#B6/8:9F0F@R^%@H=[5L;M@GGP9:G190S!8L46A=@@1D8;.16%@MOS:*^3**
MIG978@@L9-C^:)0R6E,DD51DAFNG71F)3W[#C_1&;?V(5GA897J817&"&EO#
MD]7RA-TF/1I!-K,S*++"34>%C`(!AO!8*"3'-O3H<<[B.4(W*<!"<4XV<Z_W
M@F*#9_TV$+_#<>\3/LRWA!)S</6"@J[6<O4S@'7%./PC.:^U4;?"/6-5BIOS
MCD`6<W_Y<>R3*0SX<QO&DB^H*'4I7#`)<BNI9I99;PK67B#77@9AC9)#;*!&
M<E*76L/R0$^5A\)DE`&D(8!'=IND&PHV&_+H$-UU$'8G$7S'=>E"CG"W=7MP
M?!B1FROQF@N!=Q1X-EV'$<A)$'-7$,^9$-%I$78W>!F"C:.C@)O^MYUT@IT$
MH8W<&9Y5XIT8HD7B>9YE0IXP8IY0=2A4.'X"H2D`=2@#R'LS-7XS%WPR!GY%
MU7RL")^`]#M^B"PU=9>IU4WF9S;_UVKJE#X]!5//.']]%("T2)C_4E2R83:!
MLT[9]U%II3'>A$UZV4_5U$Z@B'/8HHGU$C;C1$\%,:!J\X@01D/7=8I9B'X,
M]:#T5DWGA$W<=RBJ<YH/!8,)TY8%17_1EZ'76)1A<I2E\5HC687=$F`D*#OX
MB(*[=C<*@ELN*$B:J'3[M8.&):79I490>@##=2ZT.%82Z$4,R(^4!7YD<S2[
MQ3BO=UID@Y..DPMF!3%<)D[KI8)0)FG^)3,(4;@KHJ.(_H(M7W6'1@A=<59?
M:&..=L@P;+E6;259+VHVM'AL5/.#,.ADG"-86@A:8C5L&F@PAL*H3<A4@G6'
M-XAJ(9!SHO-`A`:$635U1+F:3=J:I`&E&WH]6]-[JUB)PJA47^>EIM:?G6.A
M9/0S=8,T2*,IE+*F;1,;_&(V[`5;#=HR?D,HLK,JZY1D*K.)P#,M201QSMA'
MZ_2*]A547!A1O5(Z;U1'##5@4Q0"T`)0\])C7*9?+B:/,/J,6`4JLH&NI,J+
M]:-C[B6OL1AKDW@`H4B*(B9NU41C@:H:ZMD>["D:9RI8'_)15FB/1"ALQ+:E
M_NA;=T8_R6;^+V76D"X9:`Q),/PB++W&<J2"9C?YIA#)LH"%JHW&-(UUCH26
M*;F@5X'"IW15KA@G;8-*6>>XDY2R:U.T-Y#BJ(<&9JF&7!WC;2]C-*?S9D>H
MJ00QL)ZJ?.H5JEQFA2RT)PQ3.JB*+]4J9I`R!AT9:W=X:2I5,@SI-$?+/C3Y
M:AF;&AL+GICQL8=97_&Y*HGYE?\2ECQ9'3%GEE-(1_*$<`X5*B>S8HL2<YH;
MGP?30CPG?^7DB>87&UMIN2L)/39G89G;6)A9<-YR;YO#=,^&N508I[#K:?RW
MB:\U17,E2GIY<!9'3\8#+K:B>XP#;Y)"3LU[,9M;+R3Z+S46,0+^9;NBDX4^
M][:LRU+CQC[!6T2]%FL#>%8Z=#(R1`0`U6,%IYE0.JI4QZ1HTK&KT9P0L9L#
M8;\-X7=HER[)R1'$B1'1V5+6F5I=AV"^>12HX$(+$4H*89PUL3KKMIP14KC:
MB9X83"463+\9W,%%LL%.ZL$B_,'R"R>^.L(HK",@?,(IW,(:LL+$Y,(R7,$E
MC"<7/,,X3+@UO"T<G,,^+%X[_'D]_,-$[!DPS(=%G,36%L2O<\-*_,26<<0(
M",54W!A27,58',5,W$I.G,5>G!A7_,5B;,5;S$M#/,9H'!AAG,9L3!AKC'@(
M]1I"A!"3()R%54[_9RN7DIH7H:N!F4;^%AD1;P";':$W@?,TA+P2@WR5%)#`
MZ/G&B:<I:V@0HF3'!%$IOO4:MB(R?%P1BM*,")-1_ZL0RI+(&K%3\C4)BV+*
M*%'**.7(YPG)B!>5HWS)`&#),9K)%(5Z(_.BL(9)#Y$ON_P11K-!!\K*)B',
MR-S!LGQ,M$PSQ^(J2(BZO",R5.8+(J/+YEB8T"P;HH,HV()0->-3*F;,$@/,
MI!*"V%I/W2K,<DQ!F/PQ^L1:Q"(K*F0LR6G-!K'(CJLR^D0KXSPQOO@H@O*Z
M*;6CWYQ2\=-);[5Z=G@L'Q.5`[5LC]?,QO3,`S0HNF<N0,7(223/(X,HMB(H
MVC,Q5!G1_[+^0^`R*X\$*K,37ERW3L=W*6FUA'25,-CR2,E[-`,TIR-S29?2
M.+3C;001;SFY,_!#0O7B.&\@-AF(,-,F,MHZ1OHZ.WE71RN-8`Z=U#AC*\"W
MT95GT<6$T8M",2)#,?64O2-3+M@<TIJ,<P@3*8ZR*-@B*'RJ4H_44@[]T@>!
MRIHDUPFC/!"70F^])]@R.Z-"TFW]*HG8--M5$!LUQW=,,<R25H("91L5/2IE
M2'13;T)+-X/<T3I-;>?$4VT]UQ/3UI*->&(-3&2=VF?-.QTM22N:S9`STG&-
M,(OR6;-A,WF=V=`,T_NLT`^=CO')S:/M*X6IV+'=V!GM2-!93@C^$=O`K=C0
MX]!^8C.*W=C`31`==LM93=IZ?4ZQ7=:J'=9EK$Q=_$NO;=:IG=9TDU:Y?-MP
M7=*A]$_KY=`#\=M[W<ME:\OA]3;"A4:GDMRI7=0(T]QI%*.?/5_R71#4[=#6
M+=[@HMT>9#/=#3RO(MIOG=G`7=ZP?>`5G=X)>,;LK=_F'=OP72H4:-LB7=^`
MA,?*8\[\?4Y\71!]DK\K.FI[.Q#YXMMO'=0%P=RI[=R$+=FE`K^_F-J5K=2<
M`]R,="\>Y-EZ)S*JP^&[7-WDK=LAOMK'U-J_),E7N:+QI-1G%2E4=&<JA2B@
MHMAS91`B8UTY74=B\V8L)9R[?=RBYB?^\Z*F@R0V!+-1.6TVBEWFC9UK)`2_
MT'S3H9+CW(34\C7A@B[E+4CFX%WG`R$H8W9&@,[;M#,[N3>K7FWIM?GE)$Y>
MZWU+<3PQ40E)A<E(']//,ZHK%Y5KLW%(LH+6J)M2-@/6!!%*FI+C;.-O1VLM
MI2,RVQ4H@R(Z%V4LOM(G0;7C!F'K$)V_PS(O%X4^Z3/0MZ)(JY)2,,U(O'5@
M;2U/\9<T,M[JG:3HQ@3F3VQ4?U(2I1X4&=[&DG?J5Y;J2CR##83+'1&"2%'O
M]IZ-^(YM^I[$O0(VWAH2O3(P2('I`W_OO#J_(2S&.RK'L)P1E<+`11%__C[P
M[C[&E!H2>F3^$B7_$">?6EX>\597\"UOXN'YC1\!*?DW[UC%[GZC1P$7:)TL
M>+WL4#2/$&(S/*D9]`G!+.&EH_=;@#(<\MN90;&1=JLG-IZ.*$A#]8@BZ'(=
MU$.UX]^HG[-2?3R$C)C<.<J^,UR?\]8\5^\2+HO2R#&^/A-4*F>_,%9),[[S
M!BSNBUM_]XBB.9/#J*'4N9"C.3Z61O+74\*=PDZ_>5`_5[P%BE4P*<KB)R&X
M,XY$^;-B,_9W;F$T/Y:J//D"/\BU4Z(D/8J;\X'"+/_'5`^41ZE3+SL#@*EU
M,;JE($#_>N'R??3F8P?9^4IW>D+C16ZF(+;?>C-E^PA',=<"-$[^$Y49_\@N
M;W@'[_@RE2^\]09OL'"\[2<)0UR9S]O1M3A_%?S@YB<O8R_61%?_4BU^<OH7
MHUR<`_0;/B[0?9`R=0#([J`3<]/#?_L`X4M@B`,'0L@"<`"`)PJ3!%:I\F:&
M+X)C9KPA>'!A0U^Y%NZ9X0F`0%\7?>TA2$&D1T\@B>PI^48A0H4S2=[$F5/G
M3IX]??X$&E3H4*)%C1Y%BG2D+P!-F2;%.;+ITJ50K5[%FE7K5JY=?=$$((N@
MR(5D]X@\20'`C%QF]Q#Q-0E`"`JH`+P9L]977@!P.X9HNB?AF#&Y9@3.._$E
MR2H`4"+TE)@DP<,A]L@5Z3!O78&"RU;^;?QXH62!9GTUEDO7+EZ]G9MZ0BL0
M%6`*>PS?/?EZ<6.U"&51`(S*ZW#BQ8T?1WZ3JM.J5J4Z?9I<^G3JU:T'?7M=
M^W:?9,=P!Q]>_/B<RZ5F?4Z5_'KV[=V_AQ]?_GSZQ\U'OYI>8//Z_?W_!S!`
M`0<D$+[[^$M*/_P*9+!!!Q^$,$()XSL0/::@0W!"#3?DL$,//YRP0JP4S!!$
M$T]$,4455^Q*Q/PN5(]%&6>DL48;3731.1CWN[%''W\$,LCU<H2*1"&/1#))
M)9<LBL@$=UR022FGI+)*&9U4"LH2K>2R2R^__`_+HXP$4RN/FCJ@HZ8H$.B`
MP^:"Z<R$U`3^@$V>[)IJJAG>G(J@FW*IC:0WFIK(ET$=RX6(N29YP[,\`>`K
M3[8>[4LXD@"%2:!#]41%3MPTI;1000.SC<\W2J*T*2)RZ4C1$!@EZ0!%(94%
MI$?]Y'///`-5B])(`6`5E5D_??,[5`&P=-.I8))K*H?2:FH,60YH-K`\'<WS
MU$/WL`TG5!JK]`UE"?545>'`?;3:5-?*539PB4#E5))F\"LW7U-]MLR?Q#2*
M3'VS4I0"63ISS:^\JA`HX(%/\BE>7^R:*)?O\F*VJ85S"^&F2=0R=I)S_:HB
MXJ:>754N.V4Q-CA#Y[I)L(Q)D@MAEP4ZS%*8ZQ0(Y98/RHW503/^-=1GQWQ1
M%.$J0"YT4"(&%O94BN.R>&5Y!7OC-\<0]D4M5JO(1:Y"1>)9(;;L39/AFQ1"
M6*PYSV25Z*%],2C.IMI6"Y7+<CO5[L=ZUGC1CD*&^N24D5TYXZI/`\"AR]B&
M&MBOOAM4WM0<R@5PV:(^27'<[$8UT[O_]8G?)K4$/:NWYF(5)CPO5DMQ5U,/
M"N*;?A:H=9+&4,L3F#UC5C@*ZOWNS'P#SZGFA^>^/?>;@X_:^+[MS*D*GH->
M&>@WA$XSM:R!/YZ"MCN"B?:L$Y?:M5,/DW?\[[T>:,Z$<>/V-;-OQKJQ4QD?
M%&O9Y'9\?)NI9LSTKG<3P`SO.R8K'N'^\/0]U%P*><WZ7ODH0K[;D<160#/?
M30Z#P=+U1'1$\5<'DP*3P\`%)H*!GMN^0\*^S*]AK0%5Q>IEM[P8*RZH4,A"
M/(8X"J1/>)/(%`+UARKA1(XD-(34S;0%`*PY[V9L&J)K:#4JZPG-(8J""6_2
M=S"=T$XN?C$BWJP&-*W=;")D^1_+8)*7$.2"@S'[2@AXQCC`E`TGC/.?!3]E
M+VGA1"$I?.)I-$BX,#Z$@G1B%03?D"S<_)$G,F%9R_;8N9:(T(/[88Z%IL(C
M2X[P*VKAULI$A3B9?=(Q'+P3#%?FK-GY0B3>$\@.V7@`2X&+(YX*XE12R"=8
M"LJ5=6J;NI;^1C/"]6U-.G%4IL1G-F79T)8.05\7\Y2O,#HJ4"0I8RSU`D$]
MLBE3)7QCMAP(+.'II%Q-26/Z[/4V4(WR9L><ERXCB+A\,4Y=C%RB.V.E.]OI
M49U\0F4G.;G)+8UNDU$2Z%`RE<,51O)]*VQ3M&*GRI\IJE[C6U8L+748SN2,
M-[D07B6)-\3#>`(P&.Q58+1Y*K$(C(BQZAK.HCB[D57/@J!R"/L\"LRB2?-T
M]:KF)+'9/ZA-9'5ZS%BFK/8R^KFL;8Q32]G0Q37DY3&#.#E4OE"H$R$.TJ3L
M-&0]'SBW/>`S-X`DR;"8*,E_.D:D"54.)L\S(M+!M2A`XR*@PC+^5.'@=:VC
MJNE-9$?%7)RT,[K+3:%V:$KAV%`PG0JL-E,(3621!;%G<8UB/Q6:ER:,>##S
MY>5.R$YC#>I9=7,LLF9VJ8']K+!O"ZHZA[J^UAS&CEB<GR/[AC"+"H1QC4DM
M_^A63+R%]GA`PY/-7/G96!+1LC=IH&_'2M3R)?<FNN/<+WM9W'@"S8YP_>!0
M0FA7[-R$"%@3#,B2Z,+S3G243[.L+$2EU^S93"2^P]H8,E;.0"9,=X#1G5/E
M>ZFH0NU4&R/<89ZU!S8AT+^,&:9"A`.QU,G+M!C+6GY?UMNXS&!@\)5?;'62
MS:+*!C@#$TRA,,A@/[;PM<+MR`9=`V/^JW+W-!$F;F(')@LB9`]G#P8PQAAX
M2'M6%5136\N.>TPTFQTFM6T-XDP[&5ZAC)>\/3D3]'*1/C<UQ3)TTK)L=X(M
MX?!)9FOZ<4H!P\ZR[F4VE<(6UL8UMVNY39>UZ].C9G"`<ZYESD2MFJOL>(!>
MR8M/YG(S8.!EP34/T\SVRA4O!5MG905K6(9&)V-H>DRRK#FPFUJRNK"5Q3L;
MBL=S^6Z;9C4#A_P9EW9V2$H1IJY'?5-/JB:40\!UKJF<"EULZK.8IRQ7A&;I
MH`6]<K*5O6PA43DH5F9VM*4];18Y&RC0IG:VM;UM"%E[7W7E=KC%/>XP$1O9
MX@4WN=6];G;^A\?;H4MWN^4];WH/Y]V7/':]];UO?F=I1^>N<KS[/7""%_S>
M/,%VP16^<'8??"<)9WC$)9YMA^L$XA/7$"HNAI7A'7'C3.KX5=H"%8T+9>37
M"?F7*EX>@8-I6#;<2]E,"I3I[80A*`[H3M3Z<9X@1)]16=@!8)Y6E9HWU3NI
M.=$B<_2H3$7HWQ4Z23)$!,1>=RH7U8E8[JHJBO"\*`J15P['EA6UJ<036#=O
MU7'B\X%L/)0D$8O0Q\#TG%`]9[11>\MRWA.^#+TH9]>ZOE8>E99_R>XT`^D,
MYNZR$*`"E%9#UA]G0VC4I?AE(C'A'G)8$+6T4>>ZHSQ?\*(6K@'^9@8G92/*
M@/.FU"1$Z(Y_V\Q_,YN3O`4P8\#3]9R,N],3F@*UF<O<V8@*W/TU.K):_%HR
M`B=(F;XTJ$93:?PR`Y34GO>)<3QJF]*HD<$>:'MEM1P=`WN!M:Z$KQ75\.4W
M^[U`TO6*KIGX#W8;MM#E;7LX(+T&,Q<<UDE8CXVHA#"LKK,_ST"%$HH[PI"5
MM<`]4**\5XDD_.NPB"@)SV@6[_L-X`@-"VP3MC",2=@\WIN+A("]N0,E0E$4
M@Z`_V,LQ)AF\N,JWTAF6`VB4/<`+0JN5$*@"/FN\L!@#!K,;C#`(BM@8N[D\
M(K`,;JF+C1G"$,B[M`(]49D$Q9.6A>#^F;.C/1L<@_01EX0P*:';P<)B%</X
MP3BJ/2(HC-KPBSW@&@K80HJ8"3:DNKEKHS>H`L)`"*ESNA^L"Y1H0I$PJ8TC
M@B+<&.FCF>KCEBV<C401#)0)(GK)E##TO+VX0U8A"%F9%\%PH^^H@DFH.9/:
MLBIX.QLD,%1@0K90B49YE;?P"#:LP$OTBP.<.U>BNCJL@CY\`]SJB"54B7HY
M"%CD%@FL@D&H"#JLG#&0Q.ISPL.3Q33!04CL##;D0<?CL<L@@L5@C'KBQ3?T
MPM_9@]\`"0>:A*6Q#(2A/A_<NR-Y0:DK/"\YO+B`B$F@0U<2/S1)*L&8C*CK
ML8P)/"QTP^K^8PI]!#WH>+"H.YT0F,614)0]Z[&KFT6)@)2]&@Q/JSJ):;Q[
M7+(>*Z$RC#DXS)BSF\.H.[N$9$>0D)@A3$"E4\@D2Y@AC`ZRZ`NM2\2"\`N9
MY!9780C'H,B6"8F#`+SB&\)(.1T/@YOO.+M13)_`&XRNXY:#B#I(29.FE(6S
M$ZPQH+H>,TI%(3IC44JJ;#N??`G\FPHW*,:H$SI/$\AW?!BK](B(R,E@1,N,
MF;NS>\N'R!>E3,B!F8N!P4I7X@M9$8M9;,K:JY)UY)$8!)UW+*PV,D$CW,&[
MJ[VZD)6*()HB!$BJ_!E>%,C/*TJ/R,&$G,*2D!7:$XBY\T2BR8O^29A",/RN
M[(!#[Q%%(J@:-[R>JZ$(/TD)61"7D+1%DN2DE^!#(Q3(Q)F(/4L80K03K_RD
MRL$_6F),1&Q$E&`U3WS,(^*9'P1+O(B[I.J8XDP34+3#MV,_PM#,[S@(J7Q*
M5Z0^L'P(F(",6@Q%R;S&-X`E0#'%7IP,L9C*L)3`.)([%;S#ZDQ+Q!+%KQB)
MQCA`U4S"ZM2ZN22"Z7P9-TD\(-P8T)S"EP#'[]@SD0#,<GQ%PJ02PWP*Q/R7
M88$+B(@YA9`CV)N!+-0\=*),JK,\0Z2(%W6][U#+M"M*5+E%DCP,5H.+OYP[
MJX&($?2$UU.+L;F-)'(5VW,,JRF,P[C^PS1)B;VL(:'C/]^,#KOH,<L3R!!X
MT+5HF[S8/!I]'\N8Q>&[1REM"#1AT3$E%[`TF9?8K\HX0#$M3?Y[.TB;%C2)
MNO-\C*>DO\+:3]E8LP-`"+%LO!P2%I-:*#11SE_<3X68PKFXA+)L#,5C40F<
MPZ5XLSDIQ&8I",=(4MIS4%%E#*X+P32IDX4HP:@;E-.S"Y18P7LL3'/3)`SA
M-]=4D9G#"EZ5N`*]*V'CBKUB-A&].'%[DR<T$5^%BF65N*7R.I^P">,PUF5#
MUG;$N&WE5O#"5;HBT6X5UW&UI&P-5W)%UW3U$G/5575UUW<-T6]]D7.%UWJU
MUQYAUQBY5S#^*;E]W;=\Y21_11&R($H+\CN=2+I:G%8I8J>D`XI9B8RBBQ2#
MR#2AF!7-.UB!=1"`+3:-Y9`E$Q>P1`DQ-;W;,$$X,;W4:+P?+2Q0BL9/8C`K
M%=,2ZDB<,"EC$1A/&"+Y<M&$N;W;6!K;D;W:``S&W+[KVTN/+;=_RU5]55H/
M<1/<Z[JCS)A]1+$V#$?+J-JW<%1S]$-,)$QPG(B+9$1.3+GW.961"+S2/`"J
MC#K4Q!1.U$3?4CR8^,-84KQ%2BIB?5KWX%B`ZUL'D97'.,H5&DIL_%,)O$F3
M6C*I],ID^E.P%4J^VT*U92JM<UMCR4A/`\A+T2].;0E7F;L<:J'^P)V/OS7=
M#E$)N$'"T`U'5BM.5Z1,RRC.<>S:5RQ4$-U1LOW!C(49A&1#[Q$6"\J;B7@[
MV<Q0R.P,OXA1N?A,YTS=^D#=Z-60'&H\EZ'3%F)9*4U<M0A2_F-9]M3=/T49
MU+'36:P[_^.+;Y3+LEDSQ"("4+J-B[R48A%(-DW3Z*/>]YC>_?V1_JP.W^V)
M)?-?$.G?`KX1`)X/`D;@#CG@!H;@")Z.!Y;@"K;@%I%7':'7"^;@#AZ3#"X2
M;?7@$2;AAP/A)]G@$E;A%8X.@FK:@&7A&%YA"I;A&N9@&K;A'(Y@'`ZW86E$
MW^B3NWO2L`!BKG,J.SO27B,,OJ``TH7^E#'(22>4,)>,%'G$O:+%H8PQ"!\^
MXJQA%&0I4I?T#0):EC:B/B8NXB0+XKW0+R\K3<:4EC<Y'95"""^SP]E#RUY#
MXB'L*4^KX_6R,X3103B4(@^KXO;92S^>"BCNO(@=F8E]GZIP,E0Q%M)]%L"H
MG(7`"4C.BX%!(Q_NDRK6+XDQ%KYH/`/%41)JQ(%PSBR=F%_1'5`&.RZ%9-#A
MX7!#"]\`XHV+&0\CXK`("[LP#-10008;0H-88O.$B<4@S_#9L[Z@XE<FC!#P
MM1W4XH]<BAF(KI?8H',4XVLEY#>>",*H46"6A5V^B6G^+HHAC*.!FK:HBC$>
M"&H.YV/."#?^:N(V8B)@\1,#E06[Z*N#^`U/M,(TL0O=N0AR)F=";HA^EN=`
MD0B%7F*<X`BF`,3$60C'"4JL*2#E26<;`I0OPPB3R&5CE6AV+F5.E!FZR`6Q
ME>>,J&:)/HF+*FFQ2:^%[J!;YK:2GHH_-A:)J0U=!F9"@1MZL9MZ(5W\(PPO
MX\LUZN1?,@@=?!DFCHR\:`GH<^/8<)-%,Q1%L4ID$<"<`><UP^8T,>4T7II%
M+LTV?ANK_!VK+)O/@#NU7F6R3FI>'4(&*PRR'F,G/`G-18D']1-??0NJ1F2!
MX>NI$`E/CL@Z<>2]PI.Q,0B:T(B!(5W$HHOXU>1T[FDW&4)A,4[^GG[B-8F,
M^$7#M69=(O23QWIIA;AJA*1KFE;;A/#>M^[ITM'I;2OI<S;GEFE3EK@OB60(
MD)`)[R&TR=ZS9#8OI^XA0]DS)XPDPK@YPC`)/[SF7ZH=XI8LB*%LL=ZX?BX)
M)"1E[PX+-)3GM09O-A8,9)P(N8#GN5Z8WVBO?D9NSLN%X^[!S'#H7^XK@1EH
M@DC!XX$FO&#DA?$3.BV;A]86*IQNF'-O3;YHS-!HIAJ(QFB,O,/I8='9B#BC
MV5X8Z188PEAOU$9&F(2+W6;EZD;(5YYIJS-0@Y!2-!3@=3UA8VO7=MOM-%X*
MM4&8OOMCMC!`.RN(C'$\Y4XKIX[B(ZW^VJE>(1E_L]JP9^RV%TMIRZRIFH1P
M.K6>H,"`"SM<Z%TN+"=&[W5.PSA6J=@PT*M3Y;A\&.^9E2%WFS;*8XF*9$%N
M6_?Q#$-N\L/^5"Q?F"0GY\+.*+>9%$^8Y$F&&Z;*",$0C)HPF&79*^D^\]E>
MY"8G#$`I92_[EN_P#='6KU:N#9D&UIJF9C442L!UP1K_X!36X0NFP1,9L'_)
M[5:G]<"=]5H/9(JP<^[X44JVF@-PF>^F4H.P<V/U8P$;P#]^%3/&EHD=8I]6
M=E.VE$@YR@I<)R0<=C^.Y%ANBBI@NZABI9K8"SA>#.H;X5NG]<?X[X+>#@EW
M;<>@/MN230+^RO:"-G8[TN;$Z67OOIT0*!1FYDK_,V>`-FF51NV($%OE^*]L
MA[HV8C!U![Z,#FMD)!HPW0O'P,/:^+D*1O=6[T\Z%6RZFPYDG.R^H,-#@3G<
MW.+>,W8WWNI.P1VE4FL.39@UZNF^:(R^)MV)EEQ6`D"I^R^G(^OE-=B:KQ/-
MOFR$L`N4,>V&4JX;5O5^$6%<3XMS;N@%%/GDL,I?$@F0`(F+F/=,!!1/Q/I[
MQR;B9C#W]N=Y$6^B<6JQACVA7GH2SZ\]1_/]6'B/A#KCK@W_!CX+#VN&5>H1
MO_L.[OA6GQ4[I_GJ\&O2E2]:B:K4<,0`K+\[WWF*-$`>%^MEZ7+^WK)Y:ZF5
MH::5/)'V/(V^PM=DE=])(0_D1'6,P,\:9UQQ3)?R<X]Z@[IQJC\*M5J7WN\+
MW^_]@A6*,3A;W4>2PS?^Y$=7Y%?^YN=6YG?^Z(\XZ)?^ZB<XZK?^[-<W[-?^
M[F\W[O?^\!\W\!?_\M<V\C?_](\V]%?_XB`H@FQ_%6'_^'=_^I^1^;=_KT#U
M_)<0_.?_K0`(`+X&$BQH\"#"A`H7,FSH\"'$B!(G4JQH\2+&C!HW%A3H"P#(
MCQP%@O3HD2/*E"I7LFSI\B7,@2=CTJQI\R;.G#I1F@PY$R/)D")W$BUJ]"C2
MEC^3,FWJ]"G4E#U)COPH=&G4K%JW<IW^B+4KV+!BQ_*4Z;-J29EDU[)MN_.K
MV[ARYT:=.E1C4)-T]_+MZQ"NW\""!V>T"UAB7K6$%S,>>[@QY,B$#:.]*ODR
MYJ./,W/N');RQL1W/9,N7=8TZM1US5(-;56OZMBR&VZ>;?MVU=>C@>K>C?LW
MZMK`AQ-G"!IO;^'%E_M5SOSY\..%DT.OWMBY]>RJI?-.ZUL[^+C8PY//S/VB
MZ/'EUQM-ZYT]_-+G+::/;_\^_OS(=:M'6%\_@`$**.!\%?TW((()*IA=@10=
MN""$$4H86X->43<AAAEJ&%F%B%VX(8@ABNA6AQ$]F)`L)<W@2P@ER8)*BR&@
M<D`(OA`!0!7^-I:T1XL@I0C2BCT"($N/,^0R(I))CE@B1"<BE*(L4(9P`$$A
MO.%+%570F`N.`!SIB4=3#@2EE%0.-&4N(>RA))MM2LCD0TX>]",`1+`(4HT`
M>+('`%/6N`<%8WP9)IYTVMECC6*.L::;C3H*()Q_?:@0E$2,P:*9OLQP)8\T
MHJ(G`)/X`N:99E9ZJ9BELLCHHZVZ6EZDM$V*XI!I>B*D)S`"0,$>-.H8PJ!G
MEG1`K2'<6M*Q`!CY*K/-5A>K<;,Z.RVUK4*[D)S5:KNMB-<JE"VWX8H+H;<)
M@3LNNNGF5ZY_TG)T(XZ^4##)&P"@4L4;(>0X);$@C3%&2:*J.S#^P22R]IV!
M[FK$8Y3S$K''#`!`/$F+MQ[@ZT#_^O(OJ05[_/%6[!YT[D5[7&KC'F_<.,:-
M:1(Q`[_#`KRK)R#;?+-3(AM$LD6`-CS))+M^&N0!-UY<8\9C>$*!+#@[_?1;
M!_<WLL(:P9LCESE2<.648%Y<DJ67[D%$QU";?39+.G=4-=IMN]V7V@3Q_#;=
M=3LF=66PV;TWWV3%K99W4_<]..$T_2U2X(4KOGA2A\_-..212X6W:XE+?CGF
M:5..G.69>_XY>IM/USGHI9LN*W]Y*W8ZZZVOG7KEEKD^.^N.LTT[[HS;3GKN
MO4>^N^R^"Z^[Z-T%/SSR@P.O=_+-V[W^_.K.2^\V]`A/?_W-U0N./??3:M\]
M^-D7'SKOX9N?[O?GJX_^^/3=OC[\KZ8?/_W4SE\__O*WGW#Y^?O?YOW^)T`E
M!7"`!@Q1`0^H0`PE<($.7%`#'RA!`NW/0>^;(`;C$\$,<A`^&^P@",/SP1"2
M\%D5M%#_2JA"$\*.<\=;(0RA,\(8TG`V,ZPA#H-S0@^E,(<^3,T-?RC$RP1Q
MB$9D3!&/J,3`)'&)3J1+$Y\HQ;9$<8I6%$L5KZC%D.W01!?<(AC!DL4PDK%Q
M76S2%\NHQIR=,4YI7",<-=-&2?4PCG8T8PM']\([\A&/[E&=]?HHR)R,<9"&
M=$T>C<>\0S+^TB:%;"0D/91(\NTQDI94R2,OJ4ESS5%6==PD*"TT2?=],I2F
ME-0H^5?)4[(2E7^,W2);*<MHI=*"I9PE+C.)2TCJ<I>,[*4O#0G,8`IRF,3D
MHS&/:<=D*A..S&RF&I\)33)*<YI@K*8UM8C-;%IQF]R4HC>_Z<1PBE.)Y"RG
M$<^)3B&J<YT^;*<[<0C/>-)PGO2$H3WOJ<)\ZI.$_.PG"/\)4`X*=*`8+*A!
M)8C0A#IPH0Q5H$,?:L"(2E2`%*VH_RZ*4?QI=*/TZZA'X:=.67BBI$WSA2QR
M<214U(P@J$`%2DOZTI+Z@J6Y:EI)/:%2F^(4IC$UZ9@&`E.;^E3^I4=ZB$H)
M<E1*9>2D*$FJ4I>*(J@:Y*1.C<A5?7&DK&:DI48-J2O/`LOHT01B%"`"V3ZR
MAY3-8`8G&T-;638#(E2A3INJ0@CTI:>S/HQ/:(48$<1D5K363"#$D@5>]:55
M7KT!IB]R:91\Z@E97&RF1D)%TS#[V%Q\:B"YJ%G3C,I2K8(6IE^5!1$.T+3'
MDI2T!"'IEU0:V96>M+(^K6S-/JO2TCZLL2@U;6<_@HK8UC2RKGW12<=`TI.F
MUE[$'8A.0_O;ENJ4LT?5*9](.H.4.=:G,.'J0;S*U:N65*JO#>]5P7M>I:HW
MIMYU:DK-BY`CY0*\L@6J1":+4H?4EZK^#2%I=`MR4O..-ZCSY:I\%^+?@WP5
MB9V,UBU5X@D[68I/:WW#=M>$BA7YHFB+"IK)<K36C]QJK6N5V!XV7(5>09?"
MBQ+(#/#EBQ'[`L1Y!93$1L4K"DB,92A6U@QX!9*EX1AB$=-J6U\VMC<`RJT1
M0^L,9)&RA\T59C":$@6V^V29O*RMV\UK6_M5LQ//8,Q-QG`(B)!EE44,4&KB
ML9%-\C*`S6O'$HOKRT+0M)=EN;YGM2N=CR374%'@`!18,YUY)"JYYE46;^#5
MC>&,$<TF];$O_:PL!*7342T5NTSS1,2&^]M,MW9I+_MM3#-=W(',54:KU1-T
M,QNE"7,VI8'^2BEH-VVCMJ88%<I%:5\_&^M5HW3%]1(U9ED-Y8>9EM/.UJ]^
M-178L5&WOL--]DMI-+:""!NVJQW(R^8<V4FDE0B3:*V-5.M:@6QXLD.%*:B=
M^]M<4."ZG-5J<6O]HHNU5MBZ[7#1)O'2R3P86V_DR(1M].*UCF$2@*HIASV\
MAZ`]NFDCUI.:3(QB5+SA`&/(T:A<S*=/[6K&K$+Q6M-\J0GSR%("Z6L('-;E
MHK4\S2))N+(HD%=R@^FL<\VMSD/P\[Y.^$:`.C7BU(QBLMEU!E1*^;Q,3C8B
MU*M.(0?36L&49IOK!22!I?G6[52G"=<LM3K?,ZF\KF>1\'GG4Z_^4\;5TM>0
MF[CE)ZM(OPY0!2*@`LYGS7*5]17HC>5Y18^V:]\E=B,BD%1-(:#8CK?[L$9K
M:@Q,?CM:'_WE%AD]YD$+55SM"NZU'OJL>F[16I_\,@"(>6,':*M=6W^Q"F]X
MRJ$/5);'T.?*,WG-7E8R2(*V79V.P51YK5>>B;3G19UU:6^.,06JD.4UY7G#
M;KVSG0&5H\._#/)!6_2N%M5<B;TYX]-_,LQ$[&9EM92)!?_6P3>2\+2B.%]N
MS1C,V$Q7@;R!4VO2DYV87)U0&<R8R?P55O&Y'HW)2]T)'95,&(PXG8^EWIOQ
MB.1%8)PAF5OMP8I5`=F%&\NTU(H]S-3^\8B:Q-5<G0Q)P-Y:,1V-S`!,4:"H
MM."$[1V8J0S6Z9P%9B#BP)6Y\9W0&5D(EMO8K-W>D80/"MK+]-W2?*`/TIA<
MC5C?-:#37<3,A<"BA%W"31CRP5W3O-R(31A)U-R-0-<)$@NO&!UA@5;'D:`8
M?H2AI5E)C:'&39U5#,7+C."$>1S`D-[J?<3,V<B>\`D@AAE!T-YA"028?)W.
MQ6&4M"&UH16/31VO>=Y`T!B]_1D<TA6XZ1ZYU=W4_6".31W.C=WD!58`OB&H
M"!F7Z5FA=5G=2=G82(S/(9_4\4C4"08\?1M*)=5HN91CR915:=56[1<Q\M2H
M>-=^6=6`-=C^O,G6>Z%:Q-0;9PU5K2TC<`V85^';:G6;4G$C-L:4:P45K@U7
M?>U7LAUC49TCKNW6,EH;JEWC,CK;:ID6:!DC3@U8LN%4I]$7./(C557749DC
M-&($C4P)7&$@$:1)DNV=DP$+X6583?&8<`5A&>K8M,4<7"49Q*S=7!6:T"V>
M^)U@BZA57B7>)(0>'M;,!]H*BLT5E+%>7M5,\4$,21QD^X7;V'`@E,&5FDQ;
M8#7-1WX@[)$-3L*,P-0D2H$95:0*V:0DV>C@U%7!1E[)U*7D];T>I$F>4%%D
MJ,3<HRT:S"S*YF7=C0DA3#JDR55!6SW>8(`46/Q;VV@6,;+6<?W^FZYQ&E3M
M(ZI%"4&45TUIUCVFXZBL5I2@FW[1I93]VF;=XS"2(S<:5<UL63HBUJK)FH"9
MU+=M&F?FXU]^6SF>%+85U4)>R6_M(\4<%3,:FIYTXZQ!IC<.G%T*U;>]5)38
M6VW&US/V6VYMFE&]B#+2!&5=3*981"YP#"?5$@JM$EAIQ()EA+`QF%,D&'LI
M!&$2QP$\``MXP`2TET.<PA%D@B9D@2.TBW+R$'/NA'?^)5+]EWH]YD)XYU6=
MHT)0E5/)EVC1U'T>U5+UEX()E7G19U5%1$XQ&'5F%5?9E#$2HV?59VBMIRS1
MR"2,`1!`Z$(P`J-X@AF8YRNY4"S!1#7^+N.+W!NLY5LZ>EIF51MR05>4L>1.
M!2.]-59*:19+P:!(/)90[2.HV6-LO91R#1>HV0FV>=6,/"!JJ1:HR2637=_+
MJ$Q@<A>]5:.VF29>YD+*C$JH8!9GO9Z\05<N/`Q].::S01=?K>AG<5=0J13/
M>2G91&<A4N63-E:4>BERT=L8]!W9-"9U0@1+@5=6R>6"/@FWJ==GM1]\02B"
M-J.%"BJE^.FBHHA[_M2CYFB@K@1_,IA]C44L``$02,$2[,)%R$(3E((L8`%X
MJ9,)\MR-P,SC#6"_\,B:,-J*+,VFR%7R^0+W`9X)-IF%@02L>M[TV8ND"1\`
MTFI'.F20\57^D.F>3#X?IV3<ZN69].E<CA!)+AP`B'T<^4%:JPK?'NB41PK>
MK@@=KH*DX^V*Z&E*DL%,+B39Z0W>J&0<AE%`WT7,SF$)H/1>K89;2EJ=6NG>
MY''K]VW,KN09GX2*K\)9^@%%4+(69JW<F*29C:+6'M!635D;XPW7E)GH2;5<
MQC(>L.5I:"5;2Y&:5T4?2K6@5F&6J`58I3F62L%:=-;,PY;HR;[!B(J:F\HF
M2HUH2=GHJ*`::<7HKCW,;?JE7V+;2:'9ZW47JO6F9^WC3AE7?+%6S=0;EDQ"
M=$Y9Q5[L0%#C4`%GTDXJ3#C"D=#"&X`"=/Y+<,K-^W%2A*$$*(K^(<L18M/1
M&!BNR0>^'`"V2-&\')R9F-'=[;?N2B22GZ745,P5Z]1UX=41%N8-HAW6'4F0
M(M597<+)1,69(N7"2"ZF51=.F]X2EHFI(KA-X@=^!%P12U":H<910,+578W%
MG,.\X8V8&H<!P*,530EJ7"N2XMC5B=W9(GHP3,PU6=%MRE+V']/EV22<7Y79
M%19&S$&:H,4I#8_5U>D%+Z'!).:NZI5\'M9MFPFVE?T57_')0I;5[0#R6I>E
MX0`N7HV1G^.)2O[I6*LF+^!-W^*]3$JU9:@H7(K=6%[UR_/.P`$?B<KTB@YZ
M'HXL'J_-V$SV5>35K0/'6`!/[_WY(*_^[4I]$1HMNAG,--F>X@00.)P$A(`I
M8$2:N$&^K`*'BI6'DE5,4.'M]E6=%-]99HR2C>Z$V2K9322,M9F)F6^SKA7D
M!9G3V4L0C@JK!AFMZEVXA5ORPB"/5>_D"NZ3L5STG1J1N&W_;6O=S0M2GDG3
M.*1/0DS(56^*>26KH=]"QM72'.<(XQ1?L>57$C&CN)4'3IVM0F4`\M]<X>(8
MBZ4<1N5>D=]VJ67QFIOAJAFY*6*-I5SSLEQ>D0W9<:Y?#2*U2;`C_VM=39[3
M8=ZLWC"7C:^=T*#N\AB14",DX_!'U`LA[JU5(!V*81VKG17=\4G1@<DBBB$5
MA]P="K"O+<K^M^[@25)>PP'LB;&B7<FRR;5@"WZIPS0S+U^D'0J$*M_J7J%B
MW4[>VB%%*M2`!N``(^@"1DQ"'0Q$)YCFSKQMN\0M1QA5?1UF+]972VEI/T+5
M9K(C9)$60>(S.NJF;?(LC@9F82)TE:X6F*X:7X:643U9;2IIR8Y)IAT:/<^H
M9%$I9ZY44.GS97K63>GL-G*:4Q5HKNP6/3=H,?)C:!FJ1>L>-<H6;H:CPPXM
MPY:?3Y);DRZEFL&5]*;D"?Z<75'9$7<RWGZ$2X+S`5L*6H4<`&HN$:<RM0$`
M4!\GUHSPC0T@6[+9T`T@RP3RE=&8T)5RZL&D+^_*=H5U6K7K]8'^VR`?;S(;
M2P'"3-.@V4ZZ6;T0'ETIKP6.=1P[7OG5RX1%'57&U8P1]4$>"1E+WC>#6C@S
MQ28@,$:8@I'D0A4(S#N?IQ?)LW60K9O69T+DY7PM!FGO1)\6%]4&K4A_R6PY
M-#LVM-+*EF>IYGYME6&J;XX9*B_F(VW3-J[)PO.6;'<)],R**'6=UXBJ9F6*
M%M*>)G0MJ#?^%*4A+682IFQ.K5\&[=8RYG#5X[QIEF'2%Z[]<V:IYDZ]XSE>
MYU%TP@KL0A:40D:``A=P`2,D9X?JT8>Z$]G^5]M>Q+WAQG.F1FB!:D08.+>9
MV`I3#6>CD6<W9P;E`@W$0!APPD"(`A#^,(*&OT(,M\8,!U)+".B`"MAZ&40Q
M\E=1_5=\#KBH/<2B]G=\YM=GLK!^)5A[G99SEC"`ZM,DK%@)4`F&TE)^*Q(-
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MK@:9H>TKK`56K0/*F36=^08KK%T9ZUX?UD*[5L^+75F=6_NDE%U)+DRHDH'9
MYH59I"DOD5B>FIE@O=9+`D+<DIW8F<UNU(%)JUF)_WI<T1P?#;H<ULJ5)QIG
MKJU4F8EY=.WCH@B[G<-60KO6J:6,O*5CN,W5;ZVIN0U<ATFLL8]6EJ_HB,HY
M.\*:<NDIUIH;CM::OKW;DO=*MY&VU;I4F0V];A4IT&Y:N]G(BB9V6HTIW.4*
MD`XMRRO]O'>CKIE;J%FLM-'($M;EN]%%+L!`&`P"AVO5`:"!VJO^+8/G.BFE
M)TOT\BFN7/,"8M85K$22&.9!:YB)75J=F"#BZ@"F;ITH'I:J5>&J7,B1C<K.
M&,V\7>`S_MS:2=HI71P&8M:5H=K=]>`SG9#AKC"CV(S1>]"@3%5OL^0FG,/M
M).ENF]8M59"=)>-BJ;;CW*$1UM=:\5E%O!>R7>92!)%8B5V9U9A=\LG[R4_"
MV:`U:9^YM9I=25$N\;<SWUX]G_2U2,9C;;T<FM`5/@1CF9H0!,PT7_\^C-_!
M3*BH+[@_G5R;H*$EEO3=&9-R&,+S:F)GW_1E69^0WEH;+A07(D"$D.5KQ@P*
M,]Z,`4`AER\`GL;LH4"DX)@9(2A0"+'^1R&%/2$PSB#BB6*(*KX.C'E#`0#%
M`P`>HCS`T-<;`"DE`I!XTE=/GS^!!A4ZE&A1HT0/)#TP$%25*D0HZ!$*H"=,
MJE2/9G7H$&95K5^SHF))\N.,`[Y(DJQ(Y&,(BD0B[NGI<21<D7OV'`@Q`]5:
M3[X^$J'8\"E"@YX`S+"H>*]-AQ(W[CU+4N]&(CW?S``PJ>X8(C&)@&R[ATBN
MQE<+Z@RMEZ\O5"!?.K18VE?ANI,PVLPE<HROW8KQ^A9)89+G&7A'ZB2-N/+R
MR[(FAA#;]C7"FU7D`L:.7:)S7[@IO$&;./3>D3U)RP)YO*Q=VL8Y@P6:*^-G
MAW7_CD3LZS/^6;RDV=J#*OMNTD@6DN[["Z^K*#*+OS&(4PXYDMC":!)?:'J#
M-+PFTBS!`(/##*:Z&`S,K?%Z"A#!_UA$K+3Z`KRL*ZS&HTLG_LARRS/5`/N/
MQ-#P^U!!YUH2Z+XQ.$,0`)M:(JE(_28DPJ;+\'+ROH+.FJLA#2\RD8B7>I-/
M3)]:T4*3,8_:98PC4,#@DIYR:8,,4(;"RJJMT`SJJJ[PS!--5%#Q92!9`NUI
MT%S^&E0661#UK2%!%Q44K5PH=6V@1@?JZ2]/'D6T(4\&3?0O3`7-A5!!"Y44
ME4%]\@054R4%-<4]!EH55E(9=16M6C-%5=*!.(634U8!C;1181W^;3533BD]
M%%9>?Q6VUEQ6]2U1U\2#TU%3(\VT6+1F2/1;GQHB]%5N@7UT4DG15&^OJPXX
M#+"+!!.)K"Z)J$(GXZXB3:#?/%/0PYM`RL^3233S1"/GJB@HA`OUHH@SO$0B
M$+^%PWQ*(Y%:\JRLLE:Z\"G8`!-MC]=".(`(=V?0=X^*KIKD0O`6$R]>C_9Z
MF3'-_CLHI2[E;?*\ESN[J"&L2`*X,(U^WJC+C?.E"*4QQ(*W8)\BGB$7MJHC
MS4\TM3C@DZ^'HJ^*27;I"10*L,#+E*FJFI%LG_:T<^Z[\<Y;;Z-ZW=OOO_'N
M&_"OS"4VU6J'_?551E^=E%59K6774E7^,ZU<EID>.M1<GPXTE%)<!\4<(F'1
M/1"Z50/%M"%N"^6(T7(#'110:BF]5A:9>RJV\]QCCWU49BD%5-.&A(=4\FK3
M-93SR!%%N-!@JUUU44]3I)98P7=_]%3!!_<I$3[^WH4.)7)8H1-!&4E?$$7@
MYNHJO.OVJOOYZ:_?_OOQSU__OZO%NW^C4I652NTO?]P[BKH(."8M_"T78W`@
MU8"""C.T[TXT(EO\^G2_SATK<LHCG)BZ-1]R<<LHZD+%7X*"0+ZA4#[E`@NB
M#!B4&(K)A0+4R@PEYYL<$@6'"?3A#X$81"&230>`4\I2?*&)C&1D@GJ*V_ON
MAD$+UF\2&<G^3,MZ4I"3O.$ROCD5I@K5.0`T+GJ+"B"JZ-.;D1PH%QR9U(+&
ML*CIC0I0GM!:32IR*$Y]J5&L^U2FLF8]5!'J4\0S(WUDT1MF%:]5CQ(+5"9Q
MK#):+XZG,E3O!ADIY+TJ/RJ;W`DC>*`[KLM:G\M%DDKI.%10C9`42&0?BT=(
M:E5R6GG2U0B+TC=8#>6$J>K5ZW(9*1EZ@I@#!`HQ8_>33*DP;\RLG%`^YT%R
M04Z:T%17#86"S!PN,X7!$J$<#<C,H_1P?EK0A=]D,0$3/.`#9^D%+>#9B28"
MQ4YRBZ+[Y'>_*K)%1FB1D2R>@IZ%::9>BSJ(@"B2&0K,)"?9<8W^:&Z4G`:Y
M92$+JI!;"-H6"^$1+R'PQ%Y,TJ&6M*4@*[DC329!'0#HBR+PP5F$2&.<MEPH
MBP7IR=E.^;*6-,<CJ2$">"ZDL,BD;*7E46D50%*%B1!L(P?)%AXIH-0+%60&
M630)BQ)C$9,TZ"V0$1!I*C)3_G0I!`^!*$W$))*4#6H/;PB4\$ZU*EIR)([(
M\V9+CD.HE0DJ+L>2%:'40Q'NO6PB;<4D6J(3GU6A\DN,Y!PG(<4X4_DN<H"U
M(_4N=YFT1,N.AGUEL`(KG4%]"5B\HE9>"/DE10;O>8G5[(%&@LCBO28TJ$.5
M*R$$%[^V<;6&RM7P6,4?)/[O?I%`)Q#^]!*'L\2"16]S(CZGZ"<IY@\5'YG(
M5I3D3_3L`3$=.L_6=-*OA>0(+CZIDGUPU"^$;@2A55H(15C4121U)P1OF-)(
M.C2A`AD)I2-9T%;L@Y^*/B3`+/()5+!R-H2]UUY12E!%>R2+\P[($P*JL(#H
M,Q&)7K@NYAUO%Q$L(A!Y;4DMH4I:5-2?ECSF/SB*T7DO0DZAM"PO_5I88H1:
M10"!!`!NJ0PJ\%J5"NM+7P)Q"\4Z]IF&NBHEV:22:%@BEX]NB&`>.8A281(N
M>E*D)49MJDX.2M"2*+6L%$"99LESG-ZL9*9C%E0(5.*<\D#E.*)A;TM8DN0Z
M/PPMEA'0CA3^=I'P:OELKJF:@&"":-(XE:KT6DA#*,+HBE1Q($:%"0OMUP>_
MY4(.IF"#(\['""PDH0]]F.=/Z@G%N4T7?]V5"$)HY53M`F:@</EN2:^2F<T0
MH3H'H-5#B9JB_>@$HP$:*4C>$A<.7>@->XGC&`MCF[@DQU\#88U90`+D*\'G
MI[FABTS_$Z;4$"\ZLQE#<TKC4_"(YZ-#C8V7I0,`ECV%J<X)DZXE,E7-$$9B
M$%6,;=Y"%J;1):PM[NIR8`,2<?+M#2G1%XM)@A&\9)9"%R;-0_YKIWQI>Z7'
M"9!(^1.8,"$H*"OZCX[ZW+`$1:E"Q*&GP@+.(ATIV;LH+M)YM5O^I*".6$HK
M3NF&ZN)?R$#I/P,B\(`,_%&5=P4_GWF-RPM=71U=Q4DN\F>4UUMIQ%!H+'L1
MMH"PE+\Z_.V(`V'$'LP`J%/3[8D9_!JK\8>*LY"*@YGB2.JN92C;H65QOOJU
MKY[YN$DUZW)1[N/G&N<:@962=J-ZUJXXAT+D.218H#4T.`?_N3`A*E4P["#R
MH-.26O5O>\ED"[1D]ZHR_BI,?*>=M0I%/5MML/+/NGMD#U\IMGQ.4:Y9^%$<
M%B^:I^PBN'E8T.W\I6Q#D4949TB`>+.CLF0I):UO%95.[B`$S6`256988OB,
MZMW8VF1=JPAOZ@(9D9QY/(J92>X\XJ/^P@@J.M41C&A"\S+V6I1CMF9/<+:O
M^P"M+GJ*SVC+S"2#*FPDX@R#9XH-TK:N00#`-++#RUH#?Q!A$_8F%X#``SR@
MG7SA$RX!%'*!%AZ!@NQIU?#)[88(3G[O?AR+;UYP3&1L;W;GAEK0!;.B!L5$
M5ZQGL@P-\`3E]"!O\IY)>2ZE5&J'(![-DG9#F(#B4GC/EQPED<;B4`#EC"2E
M44ZO4K;G=Z*%D\I%F#I'2GSB7)J%>JQ%43!/5FSE<QXB>-+%E)2G632#(=B0
MD3`KF3#OMS@/+4B)57(%%7##<J!%?T#`;U:!`L9`N7R!N?[#N>BI[:(K3^`N
M!S$Q$S5Q$SG^<8?F1@V5Z6ZH"2QX$"RT4&]*<9IF<'YV28B*:&\\`"IHX$*:
MH@6<8NWDIX+@9P4KT7X:YY2&1U-TQ9M(42M69X9JAQB7)YOZ!AFOR9BRR9M^
MR1/)!9@^\2=6<1F318>(`K)"L2B:I1/%<1S)L1SIIQ4L06]H00F*`PMHP2=\
M0.U04-4NB!?UAU`08Q+4PZF@8@@O@HLHX+%@)PCU;K,P95/4!:#::HP*R;S,
MHD,^:97,Z"?4ZER<A_'^HKH.0'C88C),A1AA3CHDTC?.3;.(YZTNQS*BL.\8
MIW`41_'X@Z;H0Y"F29D0!%`,:R9'<5400R)`Z7+J2G;4Y0WV"8G^+"D'9^@(
MVP4;9^B$E)&'QJF%4A$'R64^3E$J`4<I=7`'<6@J[\:XF@DD0.)"8B$$F*`*
MQD`JGDL7[^E.6'!^4"8C%F4L*4S8ZG*LS"S*HLI0#NK*0.*^'JTGSLVG%",P
M7</7(D.AP.XA-(*F""+.>N8XZ.4@#`+,OHPCN$QJ-"5<1$(S4D8A2*(CK.LE
M=()3SNTG(BW]-B(Q"`RHKBP\>J+[J,-0_I)NE$SBZ#(D'J4RH&)C3*S++F(F
M-H(VNP_\#NU^<&5R""D_9"]T-.L\@JN/1N60Y"AI%,2!LM`W^J?+]+%W""E5
MNJ\F`4M0/`GP$J=7.`4SC?*PMF=Z2@_^4S3ILP"CM_@C!,!HCC0%/5D+/3QC
M/<]P(A\G>#SO*(M%D4:B?PRKLE`2C1@Q=T+E4\XC?_"`*,3@J4@Q#N+@%`R%
M$5XA#^@@;=8R!>O1+7MQ<-SK,MH((^JR+P`,A5032,A%R0APJ>[#2'`DXXJD
M;Z;L."I*12>N<AJ.YTB"29Z3Y?Z+0%JEL.HB7MS"28#$2<*N1U"SZ@+DZ0C,
MU8*.A9HD1#*LB[9":+!*.#-%Z#Z.RRINQ#1%1E[4^KIG-SJ&RAX"SZSC(JJ`
M--L"S1CCHWSC(!8C(M9#K2R#H.AEIE*C*O`"95Y"7RXB_!SCS>JK)-@/J/`*
M25S)%XP#V2[^XM!6ZCLLQ*B8!J\4PU/]I;X<#0\[)%0[TZE,JB%D:BP)`J.D
M(\H0JZ&,3#1!XB".L_O"Q=9NXM)*YF'$S"P2#:+D0J%D85+[0W\<82A@00?2
M8$QHP(&JZA%39B_H)$3I\>WL,>Y@`T7K0V-D)C@TYL`*HFN\]#?LI3P\1*L>
MY=QT2C:,YB="LF$V0]#:S3&'P_A>[0!&9B_N`C+X=5^XK$](KNGLC:P6ZFHL
MU=?(53$,HDH6U2#`(UVKX*EP1CIHT^N\@MCBCT.JK2?0C6($@\`N9CC?#$,(
M[&/L!^9F`#I4!DL(;#SNJR!P3DD^@MV>D\4V;$'R:T-\!$\DA+O^",0_V&Y/
M-<P_$,35J$YCD<XY1`YI*DKHA#9FM]0YZL.BC*3#A"8"Q13`#"Q*1,Z?1*YA
MU@LOA#-LGXXSC"[L6*3F&F3"T&.\]@1']&<6%B@HS,`4`D%,:,$(>B(-&L$7
MSHX.(J$3UF`>WQ)-+M%^M@=.L@-X!H@8=T\((^]77)*4!.4D)N\IT:+R5&^3
MCLFTA,=35.<B7^\\OY%57"A=((0A^F=K<N&I)A=4*D5XW%!Z2N67:/*2J-`*
M&8+W/.\_E1!TR',L?.(-0(4/KY*!HF]#]@+(3,,Z"H,UV`\Q%.-84\?9"DZB
M\(\W`H-%"A5/$)7J`J1H648U3V3=WL?^9%M5-84U-G/#4XD*8(RJ+M8C,$0"
MTA`F5-,B94-C(,`M.`(C1[2/UR1#81KH7_VEU\#E^':$>GM$9`.&>F$#*W0M
M/`$`T/9'"83B"WS!$,8$!0*%!@8B%B8".E8!<4M43!97'+T2'(/HA8V"<U5(
MAOV$<_V$N+@Q@9)S\E0'>MA0[^:E)@]OM'[MMW8%\5BBBWZ)#Y50&UTRB"]O
M4`JQD2!/=HYG54[O]BXE/XX84FPW$"LK6DJKD>CPBGT%"6-O>"KEKPXGF=QP
MF4PI[T`7/5D2\O8G#3CX)TR!$WS!#\:D#\SN#.EDX5(M<<>DA<UQD1FYD1UY
M![.1&H7B!NW^IQ5I<"NC\)$U&4U^H!5^XA9Z`H1;B`9B(`S\V!=2`0U4&0VN
M=1*A:Q=)=)-E>99IN99M^99QF6S`)R@,X93!8A*PHP2RI('<JDXH$9;Y9(4!
M)QF3:1G%Z98XY8R@T;=JT)*Q<6YB:!I32%OF8YIO2`HC^9JU,X6:,86\6?&6
MMX3D@YML.)?=^9T9F0V$PA!.$"QV00E`@`B@((59(0<L01.8(!VQ%9%9>%OO
MYV5F(C04ZW;.@[10Z#?@;+W`*"E`:5?&8",L%)9:IS^Q&%P$";!43U!8Z#[)
MLXO@:@B70CXMQ8T0R9(ZJY@Y:+>H)76`;#!1RSOQN#DOJSYA23W^,X5JBN>E
M#^M*:,4;:?>+)$_"XDA5#J=64&BSOH0A)R=/9$R<D#&&1MJ:QZ2&EZD&NQ(;
MSWF2AP(*!8B9PGHH6"@&QP24K/H;-=D3)A0H#"%+OB(7P@"!SJX27`,7@59$
MM366XPXQJ4POK*QE)N*@`"-;-(/!@)-#$`+0_L)&`4:LZ"53997-+FVEP*^I
MCL-1N2A3D>T[<(Q!NO?8,$(@9)-DV&PL"6I/'QN^6%M0XZ];Z?0@&H).25-B
MH:-!_!13LU:L5OLRA6P/6*HB3,JK,NI6F_2G<`RJ9N*U,V>I7,)7%?>.?24]
MEYIQY&H\;64^22N-!82M!.22#,F4``O^B]G(C1BT-WQZJI,8#L^E]@BEDCAE
MH0Z`I+T()<=`.N&$$4OODH)Q51(T/Q,4C#`W/>7-4BMB7<X[D\SS4:X(0B9R
M4M:(K\;SD>_`,4.9KK5B%Z;@PW'@?%B!!EQ@%9I``P=:F<%"D>E'Z:JJ:H-.
M;>6BK;)H0FHN2NXR0FVVQ<`6Y2@$9BDO1FZD2]-/:!\J0E9.0&KNP@S5R/V#
M0Z0F:9L6.3[D/\ZT:V?6+$!LQZ/$BUOLR</V/JH`R)3D;+F+P8A.-5U.R6V.
M;I/C2AQ$<5N*TL;J,S1BN=NL)`A;+BH[5F^$7OQ#XQQVH=Z@3C?&SQ'*80B%
M6%]5SWWUN(O^KB2VJB`"#OR48RUBC-92AB[XM+53.V4$Z]"H:C1<];CM[%$Y
MAB8N52!8=&HDYM"%$[2)2C,S8T':XF6CSY]*HIU_"`[DFL._@B1(V%!8H2@.
M6<6_@L7G)P"]KRX*`R&$XR*F#6%LC<-",UE]02#D8K)Y',\EPS5PAB_(EV*@
M_7QSY$3L"%@_HWZ]EZP&XF+/8CK^@S=\HS$"6&=&:K9!G2S^MS9<XGE=[J<*
M;H`;VL#DO:/BO/DF._]J+2+(JF$H(-V933.2A%?_@MX<`H(5%T<TEGO!UD=(
MA,E[O+P^WF[88B$6;&*<%R[4JT>LI$=().S,_$@)ZL2:CBNH?&O^7;Y)5HQE
MF[SB2L;6EIB8#&SF)>)H<]1KY:+5W\T_BCS%H&B^L,Y*G"10SA33%OD`0.`"
MWG'#Q00.&/%1(-%M5!B9[69_I-`*,Z=4>%)>4^=6KB4<9>$.&Z*M8A=9SOBO
MTMCWC%`);S"*(XMWM!.<\D62@(6:#\>48OJI%=]ZI@4('V>9@-CWMM#QT'AX
M'<F\J;`.GUJI\<Y!`?%V6^6.(>>CW3N1!\-D1V(V/@+BXVM))2[H"?@L\$(Q
MQWO;*'X,JL#IIZ]?6+V"T6.Y(=A?1@.OZN7X^U<QXL\OAH9I[-=AR\LA$/4\
M>BTU].]K\^_DS`,B\M=2X2L[M"HA)";^1G@?^"W8V>#]^%\&401CLQK9$K2`
M%UK!`>;@;1P!V(^"%DQ@"K`3??(@!@`"""A?!`OZ`D`0@,*#!ALZ?-@0H4*$
M#"%:O(@QHR=9&3L:S.4I%T&.'DN:-(E*Y,F5+%NZ[)A+Y<N9'66EG!2"),F0
MOCSUE!4SIBR.LL90`.#SIR^BJ`C&_"DT(4]/J%"%F+0TJLVE7)-N):F4(RJP
M&WV-S64SYE2T2SW-\)D6)%>2>\8T)2I7[LBE=PMN!=GT;%""&X.BK;I39LBG
M!*L2%@F4;62F<PNB@CNT:4_)(XG2_.S24$$YL+#42/)E$TU9.S0_I#BQXF>)
M"V6#OHT[M^[^W;Q[^_Z]DJW+LB[!6@9^TKA%QLB;.W_NDDU!.+<(HN$@9R:H
M%E;0H!GH$/9"BK,/UB;_/*I#F>N5/TRY'G+&H;Z8U_>[U/U'OSS7>Y25U$G"
M04250?H5Q)Q\#X%4%EB,L=>8:Q^)99]3#]$'788:;LAAAQYR*!I!*Q1DR`%H
MG*3')*C\05`L>[RXARFO)33>;;3!EN$>,QQ`A$T<;527CUR-5=<80EY6WU0`
M'#"661R]Z`L15-WE6EH4C.'+BP#F4I=<4A)!A).'M94+$0?X@A,1,_0%)):+
M9282<0>$H&8N38X%8)+UI3266T9^U=\,1(1P`%%F_LB4G7L4FI+^F6$NYEB6
M=.;DIBQ[O''9#""1-,8,,V!YYP&?'K`DHWSE0D%F;<E"YX?)L<31@/55Z)2L
M""YWH$$!&KC717;.>JM?D?EJF83!SK=K2;8:N"NM",JDH$,`AF2<@ZYB=*8O
MN#Q!X@%BF)2+#9)0\$,GOC""11)]]&'&C.9)9..["66(R@%[@#E#"%50D"^=
M@GI"Q!XAA$`!G7.&L`>_;^1;A2]O4"`PPA!GN4>4DP`P0\(`5&P5PAM3#(":
M^1X%)L!+$JSQ'B%30$&8.+WQQAB34+!OOT0``/'`GCZLJ2\4B#1)Q`FK_*FG
M8T0\`\U'14RJF@3-4,6B$@U*)[\S(XS^L,I$D`S`&&I&C-6]`M_K]<8#$TRP
MIJC,0-`!I")UU%%)OU@P3A1<G#*_>Q3XH5YK;9;6VAL%EM3?@\D2\!L`P(?J
MI4WII2./1Z)R*8">$5F%FX>)I5G"2.;)$,`@J86@3TZ_B"01D\@5LMM*G545
MJB(MC#!D6_Y\%IQF:39GG;`CIF>>(>V1.>!-HAG"IT0%V=:I]3+95,":"QFE
MH,JGM3B7;X!^K4..$)0&+=WZ<8JR3%0Q@Q%8,;*'&56U&QZ-\()VX[P:`OSE
M`06_^*7)GGC"/Z3P#V"*>U3)^$<0*`4,973"THM,ED"5'81N:OI2R``H,"*,
M86H^V4/0L+;^H_UI+6M26E+!./(S-$EI@&$*V01?A#/\/?!F#)'%&PXPABIP
MD&Y9LQ2,$'(S3RPD8##*DIK>`$$B\D]_.5E;VT3&(_P!#$:R(!7$S*;!FU7,
M5:P*P1M$)C*O64]'=R/8S&;P1:/A3'L0TZ&G0L8VO`UL$C-P8;WNI2:/>:J.
M-#1;VK)H/3WZ)%]J[%'H\J@F%^;"4UM[`\7XM:].A2QD_*OCV\`&`*Q\<5%C
MX)'>-J80I,W@8F_Q&="$AK6[%9)?>P1D'CF"$QA.<&#ZR]C^LK8_?KDR7QS1
M8,*DM#\X)DUOW7-(B'1@D!+I`@3B\X@&EI0#@K!/#S:!7T3D9YO^F=0OF\Z1
M8L`&E4%/+`QB^<K@P>X%L"HX#6#G#)-9_$5'$)ZI8Z2*H$0$UC*OF6Q..=N1
M1-2)II9IBH18J^``-S8HCLS)4^T48M$^]:*%;6QIM)R?IP@EJ)`-[%Z$VN@/
M*W@S,<*H8EHB5!8W!B.()=07G?+B0N^%BJ-,$6P$>YC`,K:S:Z&J90@18D^`
MB)3^X0R=-!1B0G=Z-Y3.#Z449!MA2K9`B$F0@QBD81"C&K9[F:<@/26"XG"V
MSA9*B6)?`F8BB3@U3XV4(C++8?)0H45A'M0J=S.E"C$X4JT.<6GW`BK`.ABT
MH[PP@%H::5F3&%33&6422IPJ88O9$$'^^"(//A$$%>[0!"WH00L3>(,E=&&0
M77!B$IS814%<D9(Y-,(7G\""=]!`"'?%!CW:E!<WG4,?1"GE=;IM$E[Z(Q;/
MC(0GCMG*2/HR*\^$!"[Y,0I2OI(5S6P))[KUR6(X0YSF.:DMI<Q+G/A$I<H0
MYG%XHD^#4A(4I,2D2==]RE.(4L>?!24EV8V4;W>7E3$A9BB`ZEX7!0723U70
M$Z(JHR[QIZ:6BB1S%)A@'2LBU1<!N"#>=`O"'IQ1'5W8E7_-5U;56)"6'D"=
MR0-3?8PV5A9F#L"4O)<E/4HW399S3HM$8\Y(*$0+8V6A.X+QP-;V*82\44<<
M'BM.K*?%M^[^$<8)(Q3ZBFPZ3]`1F!Z;94XA6Y`T^&(+(H"`C'P1(H(T80$-
MR%;"-A""#4Q,%A-9TKFVB`IK&D0\\RM/;&Z+Y3Q3.%<-6=9,^,P;0$-D='K^
MC4V:\C=J16AWN=V,H^\CG_OF-RC):K1CFF2GX&Y7T9RKE5R,4Z#1Z25XM<(+
M4#`3$SZ**2A`673`F@<4P5RN2DD1#/,^G:3`_(@SP]U3K(D"%_3F@HZ/,R^O
M=5)%F5Z.>WGN@A#`T`J#**(AED###'Y@B%6LXA2F($4C+D$04XB[DZQM`BQB
M40<_R+9&]+,M;0L-[WC+>][TKC=H1IT18\W$6;X1]'O\#=D[/"3^S!:)P<"Z
M1A!0#"RV!)D$"!`&$3KCF27;?+>]+X[QC&M\XQSON,<O\CUCUH0&1-`,#3('
M@I)(W.(MJ?C'<S48KC2$;[6ZB'%BOI[_";=7$$I2S^NC6__8W"P_MPC`'1*@
M[+H$2?>15DUD#BRH4_CC5*^ZU7DC"4J('"-.`$$:)B$C6AB!(&=8;2\RLO)X
MW9GEAGZ<3_*":LQH^G-+L4MQS9LQ3!6%T+X0%*&6AZGF?1JNAT&5V_(2J0SF
MY%$`&JN9[#LI^NZI2%I3E954]1HA9@M2?2%)5?[Z&"?]I3]R41E0_'XFGOB(
M*;FE$DD6!E'-\45T*A%,5GS222*4'E/^`'NTZ2%5]'SK&^B[[;.T2+*LX']&
M.!7B>Z\@<O,#,6A8S^]YI/83ZYXK_^KP1F9#"`X1-XQA_-D:PEAT`,L9J,8B
M:6_WVC-DMS,:Y:%B5!C5U$2!6KXA!)Z@$RI;95-SE$<-TW=1$T4!4S"UE#!H
M!``ZU&0J(V$0-4=&)#"HT#5!!$E'@3$^4058415\%#'^0B>>4#=F-%$?$QX/
M@Q5[)#09@R6D1()HM$<DF#(,<V)%DQ.74A^3($97DR],E"_T]$H.DS$:AB]7
M,V5-,4XXQ",#\T4`XX1-QB,;E$+Y@B\"@Q4KT2F?8CR7@H!APE[:XV@;,0;\
MARJ'<BHIM%W^=Q)<:!$7OG47G%8?+5,HAZ=Z_A*':R)X/E$51M)!7R0FB3<I
MKK,1A^(6?+>%8_!I4^0U^;<97K(ZR<)]\'8+*R!9R9017K`!3V!:!($(*[`"
M?5`0J\`#:)`%X'%-\L)V*^%RT"%$*M43!G00)21%,$0!?[5`FS12O3=3_%-`
M2W%#.?0E,Z1%CW)/>Z-%>C521H1&6]4_8()/6-&!9O%+1<@_U[@'53146(0E
MX=%[4<)7_',5[W0W9253"Z1!O]A[*)4ECC1L0#13PR@VR-@_+!58LD1$VDB`
M*G.+_!)3+?,E+$-$1J513R)!1,023N0+.`16A(0Q@A(QK*1&5V+^-3YQ,1B3
M2A<C8S?&-!NE,QEC1B;X2CEQD>6D80W#*C#3/WK#DIXBD!@C,B>#->,H-B3$
M1PS#,OIB%DZE(Y.T-8*R-/@W,)&D:I,H;VD`;M^7$5,0`C$`%@H7`HE@$%RP
M-9JP;G5&$ZWX''93AI^2/(E(BV`R,(G$6`##9G`U4F-I%A%V+^KD5!=U`./T
M@$:3/(HS00DH54:SC"7%9F6#BVXTCE:Q-6OC2R_B?^@T1S753_:B'$'U-'4T
M4OI#&![V)6_$6%:Q(VYY@T=3,8NT-3RH)HS%0M=(2_6X?Q)XA`)X-$282??R
M7U^B,U*H08(B$B\B4EMT$@K9-",(0_S^(R4`PU<:Q41@<4$E=$4)A#-(\5=_
M!2,EM%;'N21$0(#%&5$N%#3A](S%&(L0I%0KM)=')$O%24!VY%3ZDTA1(D,2
M-#,`28).8Y3Q]@4#EQ%_T`1A4!"[(`23,`E)L`J^L`DAP`1[L`FS<)43QXKN
MIB&(`7>D9BC9V!,IL3QL$QE<LC2-81BGIAB:41C]A6N68A>GXEWN)1^R$%^2
M82?71VC>!162$1CE!5T-(5R`81A>52QS`1ASX78JH:*$D1CYA1<L*EYF43B.
M!ET[P3A\X5N'-B:[5G/7U1(M%3-6"$"0*38C`YDXR%%@<8YVHX*LJ6$:=D[H
MY$?X9)<(02C^!'&.+Z*9K+(UG=*/..65C&0R$/5B60,E)55)U$DS[ME2G0(F
M"/%D1`0F!9,\*P:-1_>>&>)(6W<1NS`)+:`3WA<'9P(*5:!.%*`'!;J*)Z&5
MA98KK=80U[<;_(81SH=EPY>HSA$IBK9J;5@@B!8GU=(7^Z425)%I:S@92\$\
M^[44.*$27T%I.CH5G98G'8H4C=&&@_%>J18RE^-\CH%K;C@LU!([IR9UJ5I,
M</`0>)`10#`#@&`0*-`4-/"4$*>I:G<>V*JNZ\JN&<)O?@8:B%HZ[4JO]ND0
M6H81@1`#2-")OD`(G6`*B0`97)`$D0`*!!H_JHBN.`)9I`JCQJ?^'],G==82
MJK6&;\^W;R4!<#I1JM?Z$1`"%AL+;*K'*TUW;\=B(?)*KRO+LL7D!]EB$/AZ
M$2!`!*'@%VU&J99JJ5:9L+.UL/8#'7F"%WQB*8'G-YI6=]1C)MFS79*24&`(
M%-D3)`'2E:,$2EMRHGXH$F>!K'SQ:$*R%6;2:T.;::`WAI1A)Q1Q*(:!K(8W
M5H\('XZC)U)218^R7IMB&4!Q)=6C)D7Q$W^%*H?F%$5J)WC[6WN2$JF2);(7
M):0"'\?3LI$KN5@V`:K0$#!K$;:@"6+0KZO0`A0@<*SE6M[!<*GHL^Z7KJZ(
M,1LT2_\7,3#S2<>*/[PD"SRE)F_300O^9('\I#5O1$P*J3B$>C,YPUAPQ+M$
MF"H-2(4BD4?TU#(_%62M2TL*LT<\$U,;\T8$03674@5G<DX3A494B(62<A4H
M%C$:-%0#PR\B\;T5XTNW>%(Q&`*@5$I2>$_J.TJPZ4685#%66">U>S.WJQ"2
M.+D%;,#.X0A:X!"8ZQ&Y8`%5(`M`T!3LTQARQE78M*DFT:G-L8['^)LC)9!,
M!$6Q6(\E-(L,Q8R.=$'A^5C`.X\:-4,[1%(Q-#4Y@9X#63*QN%4H]9NXN#4F
M5%"MHK885$?,BT&)%<!9$T$(U&(F`TZ+<D+H*4M1LEA)A(N+8T84PYTOPD0'
M*)!K94_HB9[^:;4C!VS&9PP<9/`0#'P1IC`0N;`((R$CGV!NZ*9N/<MN=I:Z
MS^%0?LI4)FF8R<-1"X5H4,6!?43(%,,J;,:[]ZLP!%&UHED7$(F,$G&\$G4Q
M+$6;-\PT`-7'&29A)@4P0S8HF*DC#Q8E/Y9#;?-C*@4P?@HE%!.!7G.^L"R.
M"O5C0TQ'KWQ5P*EA89.`H)RE)1:;*452=%(GOJ!.EOQ6:.S,SWP;:-!,!O$(
M'H$&$P,1#F>N>(R5M?5^KMA=MB<80N$890&YC>9K0X)\(^I<#?*W!L%TTWHX
M1-'.XR4<P(6C>](3X3PL]W5JB(:VQ\-?K)*%V\5?71%SAM&AQO;^%/4E7!Q+
MHFM$%)G1.1^::0T]T11]H3OQ:+>*M-`,TB%]$IZ@!(Q:<"%@`:CJ$>VGQPP;
MM*ZB=*`1T[#2&RK-(:8:'R*MTSO](;4P!A>`L`41QQB1"9.@!$#`LT%A!ZO5
M$2R=E0C*TU$MU5--U1=W"2)@"0]!P`V!$]1T)FPV$6?B(C#R9::;QT_]S56M
MUFO-UFW='+>@!&7=$)*0$4,P"3D@$^)F"N0F"XR@+NQRKJCKTFY-V(5MV(>=
M$:TPS28-$69"`S+A-@<0"&#A`>\3V"T-M(BMV9O-V6J]U00!?@_Q!RN@!@@"
M!![@`1]P)JG0!`?`!6.P?F;=S2^QP9W^;=NWC=L[O:@7\0``P``RL0I7,JF^
M,-8O(M<7K+""G=FYS=S-[=R2>R(800L1+!,>L#4TL#XST`*6:L'V<[J8;:#/
M+=[C3=X>%]T7$00K@`(K$%NRD`*KX`B(($WM8]G<'-X:#-7EK=_[S=_V=MX6
M<0D4@`:@J@,X,P?S34UQ=MEHO<?O:=,>\>"AFF\M$>&XM7TT4>$M`:HSD>$E
MT>']S=R?<(D7X06:8`<R,0E#$`8=L%JY0`N3H`FTT*]SAL$_>]^\(403X4YC
MD"R*$P*NX0G="!'V4A`X%`(6D>,;P^,%,5:LXA`ZY&8&0B@IL\!"/A+N=!$X
M!'V#<N46L>3^-&'#:XR;1N=.1RXM2MP1AN3E`;)X,T%N%_'E6QYB;-P02Q[D
M(([;!Q#:S!((?28!+;-^NQ`":/`PL;#@WMS@.7(`)+BZ^O,Q_0<@K,OC\^M5
M`.`Q)R@P(7,S/[XT"J&X=\XJ1Y.3/ZPR"A$"0!,FLM"]`ZR!4A!*/;G,/(6[
M2U'IIQXE"L&#EAY$?<<EI<Y1_^A."'$T"A$S-=B`/LZ^"G&]$C3L&`-'FGY%
M*"6^Q+Y!G/Z\/E,P'7CG$'@4,6/IL!1*83(I)J3DEF[JF:XUZ'OIBUKJ=(0S
MN*L0=:2VVP@`WGZ+/7$4E&Y%^-*`"E'MO[0T5&A=E*XIBX+GB*W^YQ@Q"4Q]
MGW,0"N(&-&C`"K[0";M-X\D-WAGL&XO2?S[#XY^B&3YN@2SE%E'B2S/P)#>D
M(U%2%R'02:P"`*IN71,QR8MN,(;I2PD$L_+.+ZQB+U/>C3TYR0J!DF"RFHUK
MF`Y3%P3Q!G14O"1V0]\H['4!5Y*$,U<RA5N$\BQ5*//+4E0/3CH>-(5YY-(#
M5SC[C:FBIDV_%`AC%S<32D8D,^*N.C%H%V8.`+EP-&^0"P.#.$?^!F#_5):N
MB"SCZ4>.]0D$F6]?]M9EM1-A*8/:2<V^,3`S$8V_SRRO(Q=^\#H]S0>0U0)R
M-@QP)IHP!E>0)9EJWQJ_TOFM(1PO[CS^CD-L<Z=;4R:]MR8M99#V$B8NZ/)=
M+^S6I8C\URDV+R4_K_>CI$)M_^.QZ/,"8R]8(CL[TBE5HGN=@A7'+S!*WXU6
M@3[B))91[TX_DX^S"6=EF/PKR!$O3S!EHB7@1(`IMB_;7_ZV+OYHF@N!7P5F
MSBKO;^L%`1![JA"9D8L"$4^3JAP8$R*$+U\`?(W9LT>60UE$'KZIF!'B#$]O
M0HPQ2`&5+T]$?(T\X,M@KAD=-?I"B)*(PH^R]A`A@JHAQ1"Y?%7DZ/)AS92^
M9J":407B4ZA1I4ZE6M7J5:Q9M6[EVM7K5[!AQ79=H43+EQ6.P*:D(<O7+@H4
M)@6=*C$B`(G^=L="S(N7[UZQ>PXD94D!P!Z7,S0>J`(@A*<0`*J\<7P`;\4#
M>R*/0>48E>$]$L=X0CG&UV<B>PSS])39L&.W-/$>L`S@@$H*4C1GG@&`X&7;
MLWUEI!S"+<+,8SP#(+WR`&7)&C\?A-@XA$R*AL?T)E+<;6W5AZW+'-A;<<+9
M>Y0?MDA$N<FX*GW%#:K^*07L`$SZFH1W;OS(/CM,N<@FTLRV@=QS3":(H/LM
M.-M4NLZNWMC+Z#W24H()@)@N^RTU`-ZK2,`Q,$0I,J>(:`DP%EMT\4488Y1Q
M1HAP^0,//P3QQ!0[T%BA"C_NX.(+.=!8)"HPIIAB!4)<:J&$,1S^H<6E2R@!
M!919ZN+++[WVZLNN+FD4RY/8MO+$M*_ZLTU,-MN\RCRAM`KM)!D%ZTH6[5ZD
M;+^Q-(K334`#%7100KWZ0XL5HSI`#"U@>8H6.$`0P9*G9*&A)Y=*+/$D4*KP
MM`I-M+PKKQ:__*M05%-5=5566W7U55ACE=7%6?`0I:H#=-'%E#?^P,01/PR)
M1(P5T/`!A#0F,06B*S"Y(@FA<OD"DBR\*!,J,+DL==13"97ESZ^^_8I.K<B5
MT5RMQ+U*73'1]<I=K]@%"]YXP9WU7GSSU7<O):RZY(!3RM"T)5ET.(`"-EIB
M9(]!]D#%#%'Q(I5%4R-"-83;N,KL*>/^K))E!E^J`+DQAK8:PS*O'H*J,\2(
M*//DIS*;R:J.<R'"-WM7NM:JQM;LZF25-4:,H9JJ&HWFG;%B^<)$H0K:HZLP
MED^JH*4Z&JJ#\&IN7ZZ[]EK,?K&"(ZI=7M#`BQ]6\>43(*I@A0FUI,IV8L`J
M#A-03_`R;(;:2%.-"-#>XTT_O;/&CSJ('@J!`IM#N%GB2;@KCD"A)(Y+0,3P
M'+`RO$2"B$"M::JM0@)E#F&ZD1;$B[NAJLB%J)(.\XT[P+-6\Z1)5)*E"@+#
MBTQ%K>GC$*_30=/;K=``4)-O_5K66WG6E9(L.PHBTV]TO"0$'`W0>G-J0XV8
MRVAUR1+3#[G^G0JR\V;\++*<0\P-<^BRP/4CK3;K'8M\=M\`3Y[>KP50@`/T
M1=B\L@K2[.(IJ`"%2Z@R-XM1C%L1)!3&'D*!"CEE#V^`CF-$IQJ@'0!D>^C-
M!J%2!4]X2H08&X.**B(Q]^R$(I^SS.XJ1`&4S(`S$E,/AQYR$5]P!$TJNB!%
M>+B3$+QA,/E3#RHTXA:;X6P&D=,A*B:4O>=41(9"L=-P-K)!3X#L9K*8!`:#
MJ)T#L.0B`-A=AFXV@PO.0"=#:V%FD@>`DU#@9-M9(AL7HAPX9LQQDX!.7&!6
MLIB8AFEZ;,DD2'*0UNR$-UPL87LL.)^3K3$7#Q'9>CQ8$^,HY#'^)7(D?V`X
MB2T24)6K_!H>A`81VM!F9[+00\2T)4&)=6M04EO)4IY"%,1L\H,^<<AM7A(3
MQ/R2(CL1"=$BZ91,37$[DY@(RK:33%@VA"X<F<L/OSA$00)%**93(F3H(I..
MH3`7RSP=0^`H$(@@1#!VG`Q_=.=!CNPA*;TAXT%RAR<B9K)`1P.)2"0DQXKX
MPIF9@29$B,E'R(@F)MUDBD$04I33-"07B+0/TXB9"T<:I`JHW`E,OL>XF+PA
M);Q48X%&8IRB"!.49*S"*,=02IS0Q&_U9&5/?2HK`UHE#W'`P14:F`L@F.`!
M'VC)*\SPU"M`3&Y;HIN7)G@W0#5&0K7^:<F(M+.>P1%!J])C3U).@\=<*.]T
M6AN<#AUC'>3Y)3LA&D[]\*,WE94.G!(*C8B0*"`%M2\C`SF-XTX'&<T)Y#?G
MF6?RFO,XABQ(GYOIF\M>$YKBR6XBI"GD5IMW5N:T52C<F>O-)J(F"@QD<9`D
M$>O`=Z;A@,BUO;GK=52BHH\`QW%CS6QH1G68K]I/H5JSZ?X6BQ`UF?6GRV5N
MH8):%3>,`3]026,<6K(+5&1W$E*-"@2Q"A:[[0M.S:6*FIHVE5QX(KV'>1%L
M667>5/F)O/.E;WVG\ERJC$T57*BE+TQQB4`48A0NN1(H(M&DJ7+KNU\)KWT=
M_&`(1UC"$Y;^T07");$U,6(&+?`4=[%%50I:-9<AIG")37QB%*?XI[@`P548
M$84:``$'46#$<'H0B!`DS!<+,T-V/?P4[VYKQ`M6<9&-?&0D)YE&<L#O5$9Q
M@$Y4"@C55=@>]""+A]FRJF-IL)*]_&4PAUG,46$R6):5BU6X)19ERED$<TGD
MKG1YS'.F<YWM/-]7N.`/7\G%"OR\@BBG`@U50`,:$-Q=$,.9*W*^<Z,=_6A(
MQTH7"W!EN$J$AD3U.,L)?K.0_4+B2(=:U*,F]8M$<%Z3E8`&4VB$2^(@@SX0
MX@U:!G58&%UJ7.=:U[N&RA?`(@L@3*0)$`$%8DK4YB#C\M.*YG7^LYW];%TK
M$"J?P`*A#4UK9FOEUJH"(+2]_6UP?XW'/L:VI\%4J-HP)V9H<AJ->G-%WUF&
M3^&F=[V__073Q&G<FT:T@LVMRT!M##7G@]#^($DCY8!T!K-6C"Q"8F^(1US7
MM+!!#BQP@E"LS<J7.'"YE7UN0FUL)20<4(5"9!`Q940ED&E9:/0H<9C'/-(@
M.`@#2*/A3_WX5)W^.,`!)?#%P<2=N'LDC1B3$3+J4"E"(:3,G?[TGYJB$+&`
MT2YN@(5=1'G'R>3WA_W=\UJW*=UA!`YX:%NT%CTDK<!1WMXPFS2HQUWN^P("
M!8[`IEB$H!,I"16G;UFWJW[MCA@F_&S^"D_XJ<U=\8M792YXP`0?M!DPI%!;
M+D;QABDTT..`'S+C/?]YT$]B#I(?BRQ,CVE?@(*SDD\VYY<->MC'/NY_.+:+
M9(%A5#\PT?\.N^Q]__MG=^()DYB$M%MD"N3#+"NM%_'K@?]\Z#=[$E/./8N,
MCQ7F<SGPT>=^]T==B#@4@?1\_C.@M;U[L&?;^^MGOY%E01L3P%TLLKAT]?V^
M9;%LN_W[Y[^*N_D`^0N+5=`CZSJ_KW,]D.L_!5S`%).#\=N**W$)%A@$&@`"
MM5D^]$-`GV-`#NQ`\O*)V@L+6C"]$G&H6`K`?N,Y#>P]#VQ!%Q0@6G`$`'"$
MZ_.*(/`S"\C^-Q$``AY<%@P\P.9+P!<<0B+T&ED(!``(!!8IP8+QBNS+O^TK
M0BF<PEE9A2,(@2BHP:Y(!>0+!:KSA2O@02#0.NS+P"#<0"I,0S4<E((Y@"'8
M"BWTA0>0&#31@TE`A3TS0!4\0Q9<0S_\0Q@Y@#CP!2!`0:B(G$B("EK8`S0H
M0:7P!`K8`$,$,C/4OLX#1$S,1!A9!2*(`R.(0_32@PA0@B:@%%_H@Q@(`B!(
M`U^@A2%H`Q#0@E;[P3VT1.?31%S,Q7D!`@"8@@>$"EGP@,@8!(@(MB9H*`VP
MC1S8BB>TM2C416B,1JN@!4,``!*81&+3`2K0A"_TA1XP@3@`!6G^<P54R(4Y
MF,4R!$);%$)I;$=W]`4=J!YL;,58.H`+-(40X!Y%PCT]_#L^5+]W#$@J[`1+
M``5$V`I9B(,NV``).!)?8(,'0`(=T#SD,P7E2\=:A,)+%$B.U$00)`FMV(4]
M`(&F00-Z`<7-^\>.7$E,_,A?A(C^4((2T;Q&B*5NNXIF!*]G9$F>G,(#X`%0
MN((IR8I6H`.CI`,?S`,T2`$+0+"$C(-38,9*U,A;[$FK),(#0`,XFD<UP8M!
M](5$H("Q>0H:*!&0Z4?\<\:-O$JV;,%+R())Z("AQ(J0>IVO!`*9A!E:,`*(
M2`-TQ,FI5,NJ;$O"7,`#H`$`T(!Y-`7^"@@$S:`F_M@#2,`F%#B)MD#+/ERT
MG2Q,SFR_K`2`&IA'7]`$*`@#1I"V,50!&J`#B(@$-(@#AZ1%?UQ'-.Q,VX0^
M!CH`1WC)JHB"/6"")(((&N"=%L-,@`3,M;Q-Y<1-3>%-JC"!$)$CEV`"B.`"
MR,3(V:1*=EQ.[I2]`YB"26"!>2R%\HN;3V@$4C"%*<F%(*"%7+`",@1,==3.
MVNQ.^U0\3Y`"8./-72@85-B#KYQ#O$`3*<"+8#-.WCO.^US0B/L#(#A(K<@%
M-O``/3@#.X`(76"%'G!$4J"-4.#-G&2PS610$HV^W&&*@GB*7'"$A-HDAW@`
M^TO![!3,[33^LL.[41R%H1M]G!SMT1WU42!U#`SC4<0+4A_-']^X47;C-2(=
M4B-]TB9]4BG-GBF]422-4BJMTL*KFOH"A5RX%:T@SS^+FQOTLR;9!2L8`S*(
M@[F4SXRDT?HL43FU-T]@@AD``=YT)#2HB*]L`E30`4<T!#@*@WD,42<<49ES
MF5=1U#EEDX<+MP,@`P"(`:X<`^L21(B8`F`KP74:@RJ`401-/TB3F(ZYBKR)
M&2++FYU)GH*H(8@X5>K2#X@8O*]0U=3`BHAB+^6H*<U:PQ"@)H/HC*VABCO"
M)JNXU<0Q5JEP#WJSHAV0`I2,BE(@!"OP`MV$B#S(!3X@A#,]2CK^8(5074$%
M/3+;V*0>PB/660]4.-7W$`W8:`C]<"(/JA3EV20E(IQ)8%?8R)Y9?1IT=1C0
MF(AX;8B1NQG'$0BG6#@"B0V#,`W+2!['<E>3P)S;*Y\.?`.GF(N(:(W9`)]?
M>HC0J-B%T!H!21&`;1[,68G(F"+A`#>7C%`*4(*;\<&:I(V3J-B6Q<ZTU,GD
MM+-RO0[I&HJ@D`OQ0"$\8@[*Z`SBD*[;TR<V@@K5B-4P,EJE[0[-^"48$MB@
MX)V\$59/(=CKL-4]Z(_.J-I90PD\@@C\8%;;Z%KF^)31.%IE7<#/,)"-;1_\
M&%K(O-J092\*X(W'Q*/4&`@\$8BXW:3^FQ#<)?6V7:B"*5B#K;"$*<`$7]"#
M"P5#$_@`#T`3<]4QV=Q9$>W9.I,8.6HA@;T,Z'!:5;6,=',/OE)5J,4A5*4_
MA(`0W[C:?ET9`)BU_('=B5`<I\V(/;"HO\U:M*63M36-MF6.IUT)B;&,8>7`
M*=H/YET13TJF8KT],L$PIH"-U&#6Z^C=Z]!>9H54-L@%'9A'4+"[CR%&HX@#
M1]P%Z9+$<%7)1_.9B5`)S4BK_D"EQSA:0F+>CWD#TPW;YG6H>F4)-FJAO%'5
MA<-=H3VAN+@0LF6.%GH#"FA:L0V9W77@LVW8X4H)Y1V,HST3GKBI$G9!S3A+
MYL"/@]E?Y<G^78C07H-XCH4#F0@1"#E*WOXP5_)=7&@[A1$8@R'@SS"X@EA@
M`VDK@D%X@1P(E5R@@1@`@KFM"D.-,T2=,_PU78]-'A(66,/06MH=.8-P"&QB
MU8U:X-H58P@>O(/9'<X(6)?++KT9WNJYU?X@C85]BEQMF1$^U3FF6'5K09;A
M"T_(FW*-G@B>877KFS4JB-00$/Q(V?%ECM!`&7"[A'+<"HO4%,W+&878@Q*(
M4:][4YX=S+CSI4:=L)SRMI?-"E!P"(=P7RV,',"Y3C>=T5.NT57NY6^CA3[(
M@2.(5JB8!2#@`R#0@0M,`G`41Y>`@3`8A%>0ROF$T\PLPB[RY9_^8E0C0X4-
MR&:ZK((X4**OQ$=]A*43K%_:O&91PV39")U7354BVPD@XR$&^V*LZ!DYJEB7
M0U;?ZQG3(-A933R!A28>O8TJQM4PH>=7M9ZAT8_(\"T6T5Z(V!"ZX`K?-;)&
MF($OB`-B7J`2^(!`:`%3A$B);*!=B(,OB($,B$^KN&+-%-U&TYPJN+W-`&.]
M8-:!``^)F)]6G0U5)9Q9@X[_G)HM'BG&65@K"I';HPW9"8ZH?8.E"-A9-0F3
M(E*><)B;7EAUC;LW[@Q',HP,+BGN0.1D*E^:4(_(,`F:MFFZ>H]UE0BB9F@0
MMHS.P#!]M6K66>NG>#<7Y9`T-HSFZ%_^786-I1X#D:TLV#",FJ925.AA":N[
MNT/(C/L3DXP*.-`CYX1IJ93I.^.@_FA:#!96RG@*G0:>N%Z)Q/V,BJ"`H!8,
M`$@KF*@(HY:8[3T,LQV(LK4-E%E>_KT.KHWM>(*FT%#5JQW<GCC:I97=N/,4
MJ&!:]D@-O45K'DUKZ-Z@-PCMPQCMMS5:V48F^>A:M:V(AUA>KZV"_96+$&BH
MR$DKR%AM_,AC1EZXLR(.W9;;^>`-505M-F*OZW@#@K8OQX,\WNR%7#CP`\@#
MB$`#(NB!*Q`*6C"!*=@4=:9/=A:S,\$+[85>-G+GQW%ME#G52LZ;%0GJ0T;:
MWJ`(HVZ:QDC^X^PIWZ;N[2_F"3SJW>&>50$^;AF")1@R7;ES[J<`6]J^7NIF
MM]0H8'U:CPT7X'@.HA1G:/&>#_*."!+VW>N]CDJ1+ML8<=N@Z%=5CI.!(1@7
M'[QFHPSO;\Z:@>F*,-%S3E.2F*^,@G@ZVZ>H!%Q^Z<#<Y3BELZ:HH=`"X-*.
M)W8+\9YV'T@4#*)M6LL@VY%@:"I?(/U0*39:.,)5GLVA<D#F$)I`X3A1C7(\
M#S;2\4KW8!^/.]7`,ML0\IV`X=PQ<B-7#[[J<S2W:PNN7497\8I^.>B]6O.N
M=5;'\@;)X"TW=`K([D&FC(^IW0&N=.BM8:EVX)&E:$06S>4Z7ZW^H(58>H.O
MG((]``5'A*5YRV70/53/MC/*Z`UAM2;",>U!EP@1-W1$)N';`PW-:0I'Q[`+
M5MJ%72/3:(PPOAF422O$2-FGT&>'"_6CL(BM?M<`=SJ`_MV1(VO?V'1V-VU8
M'[ES+V&4F6-5W1OTGIH^CN#E'8IX]5A@-Z7JT0Q#E[=!_IC0V??-H.B^*>.,
M%U:U/<L(&P4EP8!YW!7DNU9?N`$+N(,6."H@R`$*F`-J-N70167&\W)M+K4U
MI[!"U(JN!("OS`59T$)9L(`[M^(\;WI>5CRHCWI1TP]J[ZE<N((QX($"IX43
M8(5`^,HR91):J`,W@`A;:%,\KV8]OW#^LP_\1\-4KL@[QR&"_O)30`7BI==E
ML=]SP8]\1UN%(5"2CX:(1=B!3M`#/9`V306";S]4OW]\P)=\T]>U6'BCX86(
MFG489QQ]<G?ZTY]].WOEK)"%%6B(KXR!^6'\"K?F<:5]X5<Q:K3&>90%+JB`
M(Z@!4H"(4^`"*1@$OM=,V,?B<A]^[%>R>"Q5K`"%-^A&B-@`';I(T6?ZV!_[
M[$]_([L$,W`#K-,*GT<^6X"(3"`^97E]\[=^V5=__D^QPTQ,@)#E:R#!@@4G
M`4@((([!/7L,0HQ($,!`A;XH2LR8D:+%BQH_@@PI<B3)DB9/HDRI<B7+EBY?
MPHPI<R;-FC;^;^+T=0`-@!H"0_:B=8)5((:^K@`!XF%,2HP6,;;DF+!BSJI6
MKV+-JG4KUZY>OX(-&Q(5J`..<HF,%2($$2)Z!C8Z<(`(4Y1.IT)E*=6IV+Y^
M_P(.+'@PX<*&6TXB@FK&#+0%Q]0]>9?CR[U4#V/.K'DSY\Z>/W?=I7&7:+L5
M\5:^.-4CZ-:N7\..+7OV[,FLHZKF2WLW[]Z^?P,/+M)VWI66;PM/KGPY\^;.
MLQ)/W;'X\^K6KV//SCRZR^/4M8,/+WX\^;_<<4\OKWX]^_;N]9ZFW#WWY??V
M[^//+_X\_/3Z_P,8H("T\6<<?<@-F*"""S(H5H$J>=>@A!-26*'^3`\V=>!W
M%G+8H8<=8FB:?Q^26**)"88HF88GLMBBB^RE:%*$+])8HXW-Q5C2C#?RV*./
ML.5(THX_$EFDD8,%.=*01S+9I)-8)3G<BD]26:65,$49TI)7<MFEEQ)E"=*6
M7Y)99I5A?C2FF6NR^2.:&JG9IIQSMOCF1E/2F:>>)MH))IY[`AKHA'U&%*>@
MAR)Z'Z$0&9JHHX^.MZA!C4):J:7/25H0I9=RVNEOF4[TIZ>CDNH;J%1-IY"J
MJ[+:JJNOPAJKK+/26JNMM^*:JZZ[\MJKK[\"&ZRPPQ);K+''(INLLK/&AR"$
MJI4:K;2]G>K1:KDMFZVVVW+;K;??@AMPKKCCDENNN<PVNZ&*Y[+;KKOOPANO
MO//26^^\SF9HK[[[\MNOO_\"'+#`LN(+X<`'(YRPP@LSW/#!,:D[K<03OQ:Q
MD`YCG+'&&W/<L<>VSD>QR".[9C'))Z.<LLHKL]RRRR_#'+/,,]-<L\TWXRQQ
#0``[
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>g18612s1g1861221.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g18612s1g1861221.gif
M1TE&.#EA5@)M`O<``````(````"``("`````@(``@`"`@,#`P,#<P*;*\```
M`!,3$SDY.3\_/U-34VAH:'IZ>HN+BYF9F:*BHJ>GIZVMK;2TM,#`P,;&QL?'
MQ\S,S-?7U^'AX>SL[/7U]?___P``````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M`````````````````````````````````````````/_[\*"@I("`@/\```#_
M`/__````__\`_P#______R'Y!```````+`````!6`FT"AP```(````"``("`
M````@(``@`"`@,#`P,#<P*;*\````!,3$SDY.3\_/U-34VAH:'IZ>HN+BYF9
MF:*BHJ>GIZVMK;2TM,#`P,;&QL?'Q\S,S-?7U^'AX>SL[/7U]?___P``````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M`````````/_[\*"@I("`@/\```#_`/__````__\`_P#______PC^`#\('$BP
MH,&#"!,J7,BPH<.'$"-*G$BQHL6+&#-JW,BQH\>/($.*'$FRI,F3*%.J7,FR
MI<N7,&/*G$FSILV;.'/JW,FSI\^?0(,*'4JTJ-&C2),J7<JTJ=.G4*-*G4JU
MJM6K6+-JW<JUJ]>O8,.*'4NVK-FS:-.J7<NVK=NW<./*G4NWKMV[>//JW<NW
M+U4'```<Z!`8@`0)'01"L&#A@X<'@`$X.%!8@X/$#S@(E`"`P0;"@3D4!F#A
M``?`$#Y(:&QA@X7.FC^\EJRZ\P;*@34(W!#XP('&KG$_^``!P`,/CP&DCCP<
M`F@`H@N7/JU<->L-'YY3^.!`=N#;P"W^%.\-6,)`W+<+'V`^F[1S]=TY7_Y`
M@8'WP!8B=_?+OS_#[ATXP$%JFR5&'`<1?/#;?@H"1\$!$!Q@W@<;#'=:!ZEM
M8-YOLD&H6P02`M!!:\=MD*!LV%%HX60.;K:!!RQ26-H!Q&$HFP44-$:!98IY
MX%R&&[+FX0<@<C8B=C9^,)R`QW7P`(>N99<:AQ!H!F,'&'(HT'X0>,"=8DER
MIT%J&FSW0)5;ING?FFP:M)\$T0F&&)@.>!`!=88)YR4$#!AH@6Y$VJAA@QT.
M]P$'ASD006L49#;0;(P!"F)@QPED&8U0EA98=P]$L*>76_96(Y"$EF8HHA(H
MVEIVFVKF0&G^YTDG978,-+;;=@+A)F)D-'Y98V'<_3D0AHRI&=F$;2;+WYL#
M#C1GC1+PR.!O%IRH`;+"!EJ89AR:*A"J!S#P`';AIKBJ;))2>^*W#Y06GF^J
M84?!95T.5"<#FKT76JD'G'I8N.-*N8%]P0[66WBS.@8!@1O@2NB6'N"KYH_V
M9GLC@L8JJW%_``I(H&H&.C=F@M-:$#%V@^YV'`</A,EOA*I)Z!H`EB6VW[D5
M>L#R;R<+%'"$J>4(;[1`YDA??K*E1O%Y0L(L@<RO(:ET8P[DS%VFLQH-ZY4!
M:OFE>!.'Z<"8'V@0002!$;P?@QNWG1>OSQV&GW,>D,;=IMV2ZJS^;2YW:QIJ
M\7(WL]TH[NU9WKLQ4%UQE^DYWHL/&`>C8YXMG:N0U*4F`795SSKPY)!B;:.3
MDAF(FV_P4<XYF!_')]EI`MWIJWYNUV[[[;CGKOONO/?N^^_`!R_\\,07;_SQ
MR">O_/+,-^_\\]!'+_WTU%=O_?5M@R;Q0(OU"E'5R!X$_D(I,^W<25X+1*SW
M"FVN)D4.G.]B05JR+1"L#KTJ84+N/P0^V^E#B(;.YS*VE29\V/N=C<C&/0-%
M9'P)@2!$?B._D@1P?0WIG_T>6)#^,>U]CV(?0P[(OQ3E#X0!/$CY"D@0_"4P
M>$G*C.(VL)AJ7:UT#F!`G>"D(,E0)C+^%.#`##FS`=X`D3<T*TZ?*,09XRA&
M.9WI`&<(9`$&,*`X-#0.$G.4FRD2)C7)T51CBO/#Q+QF-M>J3G8`PT4`F"@P
M7XR<IOK41>6`!E#QNZ-DIA@=6P'F.')DC!PC0!@>$4<#;HR`_B9$*2&ZD3:U
M>9(/`_.@SOP0,`Y`S,($4[J++<J2$J@2X(@4F#`>L#MW&J)D-)#"%[8IAA0(
M3`2Z)Z`(1(XT#SB,(5O&F*H)R`&Q!$`$)+`CP?T2B>+!D6XTY,9*41!'[=$,
M8Z8)H>\P23QI#,T#MG,`"L!(0HWY#2\;0RP(9!,Z:U1.RYY4I3Y!)FV\<8X#
M'H#(T,PS17G^O&>T"@,!#=DJ,XM)6VF\"<PJVE!)!LT/"3_0S&B9R'V34]*(
M\L.R>`9(0^#+D@5NV1@$3?,[H?P-A*0DQ'K62D)W`J8LB5DFV;ER8PN$P(,4
M<\#5M$PQAP*FSR8Z/F#VZED]W1P%1T0CC-:H0<[I90M]P]3E#$I_1LW.A+KY
MS5Z)<Z)2*DU4+X>A=4)(B%*\UE*9R+:4Y9&)T7J3/WTV(`M,:*`PTD"G7B60
M1BGR-`OMSL(T\%#L3,X!EV&,>6ZV'HR:"$)7)4BG8+>YD)8F-1@JZ5LEA-*9
M@DQ)AGJIQK3'`4="J#2(Y`!E\$6@SO607IGDCF>?!8'43D8Y%$C^:E%3=52+
M'E!R'6+J>L0E5JC*+3,3"B.\*,3)^41,J[_U$F'.-)LWBD@"R5D-;.J8F=QL
MJ4JYR0]GJDLXU$17D*2I6]0L11H`%&Q">G6D:]X$@$I.9K"OZ5-K0RD!Q?63
MD]NK3VW,&<K,Q:Z4D5N-A,2[VL2LQE>:)=X&$XP4ES)X>#)]\%(V*N$*6_C"
M&,ZPAC?,X0Y[^,,@#K&(1TSB$IOXQ"A.L8I7S.(6N_C%,(ZQC&=,XQK;^,8X
MSK&.=\SC'OOXQT#&,*"0,N0@&QE^#FO(_AZ"Q);1,"%/'@@2`X/`A5`FR09!
M6_A&L^""F#=6N#VRF`680R^E2I@Z]`#^>CJ@.+=ZUI%]RB'AB$,C"L163J^+
M+@W/1I`HYU`"MV2EXNJ$-CK2+'*:$]=`1$0P@GRYOI#I``VCP\4)L5DSQ$S.
M<0!K&&$R%#"F45R?ZBM,"AMMS"Q>E-,H\+EQ]8EEA%&S!!95H8'0<S(CS54N
M-4/##=2)`HOR%`,06:<^EW;(=EZ/X-QX/\$2Z5I)CH!G#/+H[5R&AF`3R)=E
MDV0;MFMLXJD;0P\P,%M?"S$B@DZQ4:WBN@5&<X/1JZYVI:!4I4B*BEN/I#^6
MJ\70<'\T/#!Q163L+26F47DR3S_CZQJW2N=ICX+`-FVUZ,W0Z-K.031#'Y5D
MB/>R`_LS+\'^GYMOB)NW4YEE-XIM&#%$Q9LX`S-0@.J]*#8?IFL8'\BT(=3K
M7P=;<!*G.(5*VP$>0>!I"M=`GRBP&F=;G'N#80"6'WUQU\C4F^D>EL0.X^W\
M@-P\(M>`7)G>-9-[1^@J-_'8-L/TE_<3-XCICH0<^:?.+";GN6H581PNH.1$
MX-\,`-70#<YF818)YK'$%V.2(R"([T:6@7?TTU^31\4-]F.S:9FFKQ1RALX0
MD5=T*XW,6[?8I/WT:B$X^5*.^M:71?4)(8P(74][BTC1P;7/O5HH4YPJZ_[W
M14%F;?"%FQ.YM2#'_X#B`)"!A?&&(#H%OO2!XJB<RF;6!YC<O,+^MWW'G.J*
MS]]-F96$'!G:3<XD["?=I\_^DG1&,,[B.7<2L^3SF$?IDN-`8ARHZCHS!MC9
M5R>X%B$*=U@P(GCMEX`=(2(194/]-'_U1C_A4RP%X6[583818!F%X6O[MC_]
M%!G,IH`BN!&7\1C$,2$9J'RY@D#[@R/H8A`LAR\P0FC>@W$0`B.'-8(ZN!%(
M=`#UE"?OMH(2Z'UJ5!!KIQK;P6>.M&G[%B"2L0%+B(`[.(546(56>(58F(5'
MUAZS=Q#;-A\C9"@/R!#M<BCH!(-H1R2]<B7#%QL@XAW3IH4J5RS=5'ARE7^6
MQU#Y`2.BX0%F@W[(9S?JUV:1`@!V$AO^8%6&\H$HXH(C=.4SD[%&K]8=QP<9
M-!)X3B*'<U@8%!!K7;<8E[8OE_$J:>4;_'9]T-%/(!)7G^1K+31/%.)SQ.0=
MZ_)T!A=_3V=>KJB)J%8LHC%S'N=U,"<JEQ%;@8=WCR)('U@9#'`VLU80$@-P
M1T<CE-=!->@GZ^)QG=%EO.ACQ<)F,_>)%A"*L35_HD$R^X9\C1$Y.>@SM5(K
M1I@8ON8!P.9QL61",6,OB7%T!.%XV5&+W1AD7#ASF^=(8$<8'(A0\]=SR<@J
M4*@XQS$OHE%D$%@;C4>-;L5O_G@9/S@A$,<9VQ.0(A@Q4N@C(GF2+Y%:*+F2
M+-F2+OF2=3'^989!$#.'$#5Y$:R&'DTD&""((8('DK$!-NA!$(QC((MR/X-5
M&`X$DS0696M6)QK76H;!9HK367F(?LDQ)0AD(\YA(NI3*122(!0(.\?'9DHC
M:>MB-@01+CJBDF')E#<69:_6,J3X;$?7<L^53)<V@,>7@FAX'X"RD8G!,M:(
M4*F!1H\"D1[@)*=6?V`(ETT)6:,1(#LI'C02(90HC!^X;Y5Y$!!G'YEXD_6W
M;;(AEJV1&J`I2:1A'@]R)Q2X9/4'F3,FES)7EXK1B?B2F:"8F_N6?`CQF=DQ
M'"X8.T.V;?Q('.J1FO9''S](<$OFE[(YFP0"=P'">`/29N%H`0;^N9!=$CD"
M$ILWTD/,)ICL0EY4MAM3\AU$&6:OB5Y+&9T_!C,;D8D.08'PF87RN1&LYA#U
M<I_^^9\`&J`".J`$6J`&>J`(FJ`*NJ`,VJ`.^J`0&J%7&"?:^644>D;T(4L,
M=9X;VEX4"AV&(1KM`2@8>H9G:(:B`2<@BA^#UEG201O%P0$8VAZOX4@"DJ*B
M\2V`T1@F>IXE2DDY2A]Z97QV@Z.C47T]&J*1XQDKZFGH-"_$`9`2&A;/QQOA
M%W[(F1INY`$\BH]N)'NZ^!VY$:;KJ:4I$H+$A42(%'[;1!_C$J:E-$/%P3!A
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MZN.MU`H66'JE7X8VLM2)=8.0CI8B"<L`E,$;H$&NI"1+^9JFZ8:I2K(==VJ(
M&MMIB5<8"7+^J7;ZIAVK)*;AK*'Z7R!K&>!ZL38K3!R[@:IA*/G:IDADI81A
ML36+CPW;%4%JAO@Q&CI27NW5H8R$B.953SE:'&:X:$_[HOB!HN85HQ8J:BZJ
MKY,J?+&4M:(!9V.+M122;QW:'IRQM2XZHO>J;4][M5P6&UP;HL?2I&#7M>A$
MJ4D[N(1;N(9[N(B;N(J[N(S;N([[N)"K<I,IL;Q4&-S%I44X7D_T;O$3,9^T
MMR6"28CB.M`ADQ@;&=>Z*8/JG<E*<*\R'C/91-)$*3Y2&$\SLI+1'JH[&U5#
M&1=G*[![NR`'3QP;+*-QNW,6N6$!?[(A@YV"-'N7&VA#1>S(/<C^(AHY-"(,
M`KTTHU.VE"KBU2G%BZH,L"'EM92(A$C7:C/B81Y5%+Z$1#,P$EOF^QJR!R-C
M9![V!G_U]4/!HACUFVXTLK_L*QO[<2;ZI;QBP4\00*3M@5U29T4?8[3(V;6Q
MQ!K\],!IZRS=\6>2-AJ/%QNU(BNL(K2N*QZVRQWE.R*-5L'M11GW2U?\F"I5
M]"W%M1[`RXF44</H*BM(4QL>I,!?P;P-?#^D(2#M11C2)DP3[$:S<9RAXK[;
MB\1!=**TA6]5`WO$)<+V6Q#,M#DGS(^\H7_U]2HM?'2OP4JX>U,S;,8V[+M6
M!+S2I<8UW$0P_+\_[*9:+,1<P;Q5Q`'^CW%WM1&]N=3$?HHM]:H!>8PT1B)U
M1)))8R,8]ZC%$6.^XUM7(G(F$\EF[4M<K]%-^PHC],4=KR5[1*F_63S`(XPA
MA,./@`7#\.>[)VS`P;I/2(L64W89MY0@P4L9PX$VMB(?#E08`J*[/PRF7C(P
ML!M0E+*FW-&RQ\N[&&NYH@RWHS%O4T9:_&0DT:L>`Z%(VM8J4W8<P6NZLBN>
M::@[S/NQO`0@5^1&4A=*_NJGHQ&UBF3,[KPYHDM;XY&ZHA*+^'')P:F>343.
M*=S/]T'.]\=)IFR]JD&)FY(>'RS'^@K#X1+0L_S#3^P6XRMQ.E,K_+C#<5JD
MCT1Q\,=<4[S^L/VB(Z-\/P"21(NQ1"Y-7*K\>%A2*YF4Q\P[OL4+3%#,&>B&
M'5`<K)USTO=UTYU,&8AD(/"K)#+5PGQLJ2]J*[,$NY4TPO#X1(('?P:5P?LA
M>S94-;#+&/RTF%W[*)1(,+)*7(EQ-CF]@?QDNI8[(`]G159Z@BVT*&!'C4S:
MUK/$B3*IPG,"U+<<U5\QOH13U7-,&=(&&4+7P$W+UXO\U8+!I_8!Q105M?0!
MU4C#PVM=O&Z]&@RRTZHWQK#XTZ\"&$(=/D\B1'7#UZ`]2W-\R5A<5Y'SGH;M
M%1V],B`]6*_U&O/2&$O=*8MVF8(\TZQRF3J%V:YC1O:#-,2J&I'^Q[''E=.C
MW2L\+2*^B]H1PVQ0'"><9-S4W=ND/+Z(!,J;ZLRY3:6J1SJ>QH_GO:^/6)2+
M1BDCXK3\Q-7H!+NI32M2C'PW$]&96AW67=P#SM!*$C_$3%OCA=G&![M.QD]X
M'=_J@=`;O=X8GN$:ON$<WN$>_N$@'N(B/N(D463).A44N1$I/N*ZVX4)L<<(
M(2'YB1"`(84Q[GLM09KVB1%3AN,1>!`7+F7<&(_&=I,*$;Q&GH_:MA"/N>$4
MN(@#06D>:$25_4>11'>A5!ZDNC<1TAL7#2I2CDD>T$0/4I5M1DHR31SED9V0
M5FA2-'K)03.D]DG(HDUAIGP:0)*1PX3^@&>(Z!F<M>&AE#1W;KMHF'$MHS<P
M5B2CN>%9%WT9DB$89`25DC/G1(DDN^*$3W)F=`[@DG,9P@QG'>#F0^FXQ3*/
MP!9Q0GA?Y.9+@UDG`25K=]DG<^EH+:=T_=)"T]G!*2)7N;Z*=<*PLTZ6;K4=
MTCIZ`V%G-R=R+<08"5*&FP$B.?+L7O=O*3?.`R%7V892)-*/PV1FB2XB&4G5
M))+KD$YNE1,@7;?LZTEEZNXI[X5N&P?@Q$%1E.@P]!2"M6[JX60>43;0!#B,
MB?&UQI%K,R?CESEOCE:3<D*3B#;E*/Q>=_,=#`=U=):9VN@99H=P_[)Q.BYZ
MX6DI5X3H-V+^@^'S9#@8\:1#@*8%@^-B<J[8:VUF6OL#Z0-/0Y2)D6;'/0^I
M?YDTP)3E\3#HOOFA*\Y!:K]A22!<%"L>$R>N%D^OXCAQZCZ7[%AW@UDL=O0T
M'-\VYD@CX[@9,;B-LAR`Z]QW]4DG[A+_AI33`4S'/;CIVGJ=?4O'=1.I5QW/
M[,G8=01A1:6)4%5CF2=?6K^8'W;VVK,VCI&74P;F5A4:<W9&3Y91<[4R6(4D
M5SC_*M2^\XJ!'>+Q[M]D=J1Y/UQO&;!35W%716Y?7[@]+)#.>A?QF$D>*UAF
M$)FO9+3[$4[H&3M><!(!X_4W^R2QBPOACS=B_`P1FZ,Y]<'\.EK^-Y681.78
ML>=C_CIRE^5V`W>2=SJQ67A(!W.1(VW[$X6)9WI\(HBY"W'E3^6%YXS('C^Q
M<H=@65<)LGF4%_`]/)/A3^L)MWY[(SD`L0&``P`;&#!PT$$#```'.#``8.&`
MA`\)`4#<T"&B`P\/`#SP(.'`!P`?3'Z`L.&#!P<'.!)\,'%D20<0((PT:0$B
MA(H=)#`\L)`!!`L4+G(XP)#BR9,='!"TP)0#``\:(OQTP"'A!IY,+5A8Z"$"
M`*T?.QPDRU0C``T>'SQDRQ1"0[1(&:I4RX##!PD4DC9T"0""QX<(QUJ`*Q(B
M1Z8?+%!LRY"#VY`?-4"($*&Q4\<6'$#^M""0X&3!9R/.K1JAY6(/<Q\L/1F!
MPH>W$$52O`E1`U.6'R>B-'B0PU@&'9+J79R4X-^;?R="U)PWH@0+'UL2=%!=
M`LS&)W\"F-U=_'CRY<V?1Y]>_?KQ-]F_)P]A-WSZ];L#Z&"_.TN\C2GT?TR_
M[ISBJKOL)-"`(PI4ZZ!`IC:(H+H-GG(I/XU\BLJKKS1[H#H/&N/J0NJ*FZRQ
MHD[R0"\-&#@`)`8VH$"G#HBZC*BS/*NH/Y,F$ZDS"SCTK+6%&%/+@<Y:.@`S
MAZ;[($*J)CK0,Y=RY.BJQ@XH[@$;&0CP)JI`3.B#WU+"[[&"3-+K1ZI$:LB@
MKT;D8$4))-#^:+,G)4CSNAP+"K.\M@0$5+WY`B6T//<*36\[1!<E#[]`%Q(,
MO0`+);`KIBB`@$N*N-K*4I-2S$P"!EWC["L3'QOI*R-!A*#4ZA@JR:OP/N",
MI-\24I6O`SC-[R;<=#R)`PF(0K6SK@1RM,@C&X0@3,%@Q7$B3/5J";???N,-
M`-G"]!6E*;MS;<P)/^"J.A9CY8S-_")"=54`>HRU*2.3--(I<4LB53P+YEJ5
M40%K/2G>[D3J5ST(/CSI8/7&E0MA6J-+[]`K8:M/8O&0'0B^?;VBV#N<V)L+
MUOS28]B\B2P6CR"'R:NTNZDBF-"#!1W88./&'N"2R^P>H&U*4S7^_)$V'%EU
MM3CQSMIK3A59I`A7'$7B:LLN@8V05G:#[I`CZ@;+L"D&Q/*,V0BGFI2SB5ZV
M]]<J.VZ2+*D/UK.Q/V."VZ`.*,#S;CR1:E97MMIZ4Z<X&8!WLWGWEO)7MGB.
M:;\R"_;7NX\JR^JI=[7U[".M.A),N[]T)!C+@3SX_-5!Q40,HN)^-NFOF%BK
M[BFF#HCJ)Y!@1M$CMO#4UJF!/NXM)@E$8Y$U>8\$S?=J!W**@5D=_"`QT;?3
M%J&5S_(T<Y"P\ND`YXQ\@(+AS$LI>MND8@COF8+3BSCCC@)M6((DX-S3GR#`
M2BOG!Z39TY,ZY,M`.!`[_WV``EEA2T+^W**5SIR*<V^!G-5P])6_L.U5#W@?
M8)K6@5Q!#0+2^U5CR@*8Q4T.*Y?!TLI0,I"P<>4AH_%(Y<1$D0ZE#3AC>4UW
M5F2^=RGO6S?3'':"DQ"CZ.4O#&031I3C/:`43ED3J<X#J@6<FE`F6?^K7N1$
MR!'Y*$@U&MB7!S:"$L\$*`(+^0")>.8Q/=%,C43I#NY,\@`-E*@Q8L21&SE8
M,)AM3CXG\@_>Z#0=EGQL0ODY&6(:8B2:'4]5WB,*_;)CI*(XX'082Y(%;L2S
MOABD(SKJ4/:,1!1*XDUP*_I@Y[K6'I5L:2\YZ0J\!,+!G^`E36,AW;#HIZDF
MG8Y/,OLB>U+^I$(M%M.8QUS)U\A3-1/-"IDD&9F`;!8?8CZS=5WY#:]^PR15
M?2<B^(&5P$)GK7`:)"),28A/(#*3!WUG3%,J64^2=!+H&=`C<YI)CRP6KNWD
M9XKE,XFK.J7/OPBF3R:!'K=^(Q+.`+0S]0S05V"%OV^!1U0,B,`KXZ,2;O6G
M`QZA*$G&5:Z+)"6@AW-/LZ#%E(9LJEG13(\#V&9-FM:4/C(]VF)@*J8K/K.G
M]-$=L&QZGLU1QXL)V:8%&%=&V)3$:(T9)W">2L<$H5-O]B()4V(B$''ER:I%
M#8VEJHH_>/VHD">96R*G(BZO@:U39IWD20Y*+DM)C2(,'65_0M;^D),H56C]
M@M.*5G3`"(*KE9K4RTDH0`$Q$F4J=L-;<2++-Y12X$8S_>7,=HH>#FQV/*<K
MI@>$.E1D@E8_ID4/:DF[6O-@A7):,0Y%(K(3IW"N<EYZ%U.BFI(*0NIC3=J`
M4!R[1I,818I34PX?5>):0-(*.E>9B6U_ZY;'3.4S;$T8"SLE77?.%7H@U%5#
M@051@O#$G2)QCA@/$`&>S;4QY4N,=(8WD((<A(A'.2)*H6);C68U?^Y%3TIN
MP[SQ"*R8;_IM,;'5*,_*)<%'@QQ^"CN>'GD,H04\#U<6K,6?=B<ISF0M>R9U
MS`.`F'7O*7%C,EJHJ838Q2\V#^<D`!?^B4!D(&QBGNW@PJ5W?<YK)4S)0:A%
M.)`&KWZF(0M#;O*9B!`OFO`2G=8$^**^<.\S$K@G%!FB@<^)YHKNZY1*9YP^
M&>,)(=JK3K,>")>T!#0Y490I02(PEU<YTSEX(NY<`L,1'R-4R/K#\N2.(RSF
M=9F^4P'/[(!R%\E9]+FS>0N,'3/3R"DL8=4TF,,Z`#$!&>6<D@:UI,TZE`.P
MQ*\"3M*$_#@?.CJU`W:TF@?,N!`.?G'683)C=3"$8"391)%/GLF4XEH4SU#+
M,0<$8P12]!@XIO'5#XC`DJ)YIIY$;9<V&W5?G((CHD@8:[JF3E/6)#C/S$DC
MY?)?B@;7EP?^+3E':J1GF6P-I#3UK2AJC#;9TKVT$YND+>:FRT=#_<S.HG7@
M]2EXH41[<&&.EE'AK@BLQ"62E+2D*^IL"#AA=3QOXHA7'7?-7B?XE78Q*TP'
MA3(YE4P2B4PT(1"?B#E?Q1!G1=-<AXS:2&X"4HCC-:*ZEFFJ1L[Q*3E%EJT"
MZ?%(4N$+OS.<]#32QX4>JX+NE<#X2?I)3<(NK_`+7F*434T!MEJ`UM,^W[%T
MAAF"P0=-V'#OW0#3VP,K.D&N3_V>':77(_=`S17ON@(PN$8\8WUIYKJM^Q7%
M52WENIOTJ8Y<"F0/2$M_+W4IKN(ULQQ[1>JL%3=#<\Q3&&@27!G^?B)4_<S(
MQI:L%.F-9ON"@&4)Q]B(&+XEVV8<K;,#)$IV+5WD#KI(8T_[D:E;3K_5\*\>
M[^>[3?[;1NP;FE2O2-F(L?C\[IKUR\W.L?17B\$["T0([>B8W,5T.8$)`]^$
M$)BXRG51'I))])P_DX3]+0OL/9Y;QW;\@:0C-#:-^7"/Q9*E/S,=N'`)C)HD
MR[@Q)FHIZ$@8E;B0A(`)EX`*AH`I^O*>&0,-SF$+T^DS#]0`D7`?YY"<[1$@
MR_D)F/DSI+H+R<@ZP$,R#J"QDZ`=[?$`#L`PSLDHB.B0N^JQBO.)@1`NS\`M
MV.`,V]()YDD(_J*,&%*_EKL.9K&NQ_/^LHD#BN*()*!H0H^(-@0!B@IZH2LJ
MH@$:")N`"M.@'R_TN9VH"#7#OP;2.I&`,WC1B"6DF#O[K3O\E0JB)YWJ0D&3
M#'<20X3`C_.Q0:`X,2\D'';:(60Z)*O!D,ICMS=:)6X;N4X*$U?YE#'J'[S@
MBIA9D-;)DF_+OUDYHT]QGJ]8D%)#((=I$<*3I3(9E@R)D`V0(@W8ME':E[@[
M)<(9I.Q2BFU3MNN`I'YK$Z:)-I9`F,5J-GB[%/4Y$^-C@!WAH@0!)DL*HX*0
MMX10(Y*CB%240?R@CF4D$ICAMI%0IA"+)Q8S,(8SCQ&SCVDJIG8,L>8Z)E+I
MO7UIP+6X"]#^R`F*R!4$6R$,ZKVX:R+@*+MN<1"P4Y\CZ0RF$\<4L8HS(@@N
MC+@,R219BKH@VPB\2*<#,9:XJR@G`HZ'Z*S@(QAF0<9U@1)8@9%[DKFG*ZY[
MHL.2<I=K0CRZ0BK9&JF7"J<W62D9[+V+I#9<$<BH<*C5LD<4<3CS\+2N0:V$
M<S&JY!C]"*ICTH"F)*H&^P#50H^D\,I%2:O>>YP>F2H-J"K'6*JOB1"12"NW
M5*I=:2F%!,6*`Z;8((OG`QNF:Y%>D:0JP8FQ>Q$QP1]%DCS4BY"S"$F_HB,!
M^T63+)]](<9">JM5(@FU%)YH\[=1PC*U3#VF&*LYD9')>D2P.JK^V!(IR9J\
MIP)'J*J0WN-,JW+,W5C*\M@P\?@P\N!*V-00OJ.PWV*Z=P2.[NC-A/DM"GR/
M0[E-^"B9#D./ECJ.1$N/>-G-B"%)\2#.P`NQ./P*1NR1W@**G'!#?BD6RC!/
MXQ))`4.7Z1`@M*K&!VH-%I([3U.8S.`A"%(T`?*R(5((H*"QQG3#GT"O)F(G
M^5,)RPR>"M$P/@D8)>)`S7DNW_)#Y](6Z"I#$S0)U_HOU:PO)LP@-HF,K-C0
MV.P,N`")^JN9\D(38D(TOUB[LP'(#14@1GO1KA(.][$=/,02X5`R!WP.;7&S
MWZE#.=,.[B"7WQE/<OFS/O,A*W,*"MC^C=J("-$!0.P8"=&(KY70G029T1WC
MH(&@&0T$#?/;,O=!*`VTNLAH%=``C2C3#JNABV]J*3FSGB2-,VW9L3AUC"VS
MG-1YEXRB@/9B,LR$QTFC*7QD.'G4#_[8#TN!3G9T.P%),:G@M+[R%#P2%5?\
M$%&,D`RQF7NAI3/Q([]2EQ\)G*4!N(`:MSQ953Z!*?E8FC2E)6A\#%,K)0JT
MBLDP1[_J54G"B91PI6CLM9M9D3W*MX;@&4O<.AU)5B@BN5RCBEYE)('H*XEP
MD77[CZ]Y`+P0L&"<(S22OPSI-:GAQ^$HUD.]RF<22W5%5`&!%`QKC$AEK>,4
MD+3C"^\+*)#^0L@ZA<D9HJN?^2C!$)>.-)=Y`EB""=AVV3HG2I>B"[Z2P!>S
MD+^*0JB.I$F"<KG:XI(#DKBF@966\!8$[:B:?)=."2C>@:>G<,E!@DG0N#G2
M:]EH[3A&^EC@B!<*JKN&/0#Q0E`[5-EXD;E.X1:KJ`FC8A9W55J;`LOS:-JF
M7=H06RPQ8A&NVM2V`Z:?F=J&J!O)RAM,T9H`48SF2]5U.]#?<U5V6IR>D;\5
M&1SF6ZSE@RO04\YF@1"<^(W9A*M@+1>D^4K/1%D#:KP\6;W?2$LOU9OZ4R1H
M?4U:,9+9O)=KG0AJQ*OB!`YXP1M[B1?4"S/$>HC7H):D=3&4D5G^_:!7DA`9
M86JD@!0/X#R/<"JL$)G41BD/XJR/TSTI1KT2ZD245VF5V4T/-53/ZO)!A,D?
M@;4-Y?'/,L0*L8VR]T$2`\TJQ]65.F2G*IH<&M50_ZQ0[N+"4JE&%`T0%)4N
M&MU2T\B,P"W"Y!K#:U$*WRK#'3%$QK4`_C(2\56;KM!9GI).GPT@>"G"FO"W
M[W6A\WD-#PE<8Q)!WHD`']++XD@(U]B.&078W)`,+R,-GOB,68F7-0.-\B(,
MW2I,]#.A'`-2\!&?2YW7UEG2%>I1LN@S+A6,%.E7'(L[Z.#3J4@-/9S>E6@_
MLUR.`UPG,UM`D'#2+:.,#78SPX@(Z1'^/PJ&)J&IB_=[XB9.GX.S5TF1UZCE
MXBY&)@(<I%L5V68E/9<0B^V`)!LD)PQ)UEOS):7XMB=Q$1B1RCD#$%XLI<`:
MBJD@EMI-IK>],!&1$5B;M6(3(V?CD6`4F`-QV^/KX4ATE3:I"5L,C=>PK+C*
MC6>[5E,<E+.8$;#PM4UJ$D[UCJOP`$'N1%]U17H,M2PNCZSTXEB692T:U'>!
M%X+JJXN8D&OI)^AYIZ)<%Y&;JWCID5RY%0[*D(YH#0!)RHE26)+`FPC`*'UE
M*>I]Y-_M#)H,((:(BG/2.*50VTO)E-'KL1XNR$A>EZ'%"Y]KYHW+B6)1E6AZ
M6%[Q%I!E-*_^B(F#/*^(`XH89`^K+*VA6CA$&6CX@%K17"V`=IFQ)(^#E@J&
M9I31+*MBQ(G6PYOK..,$3A++[(S5&[%A[BO>`UBG25.:ZZNE`JQ?'"S9\6-J
MI"=L_HKE>]?0XPA7*]&L$IB7H5Q%0BO&22$GT4S%1"R?RSV9)CG>DV<C\2"[
M&N4MR@^CZHRMJLO9W%J(%@\A+`^-("[VN$ZZPI:Q*Q)=;COTD#N"-`^,"5VK
M>F?R^`Y*DS"-()SQ,+ORX,Z*>4J2M6K'G6M#N6M_05_H(HGR+:ZC2`@<ZF5+
M\:'>&T/2J)P,S)T@&FEDAKN^8M'S`E+U8B]=*3`6YBM6';D*E>'^K-!"(ZR@
MPA'@_XD*Y_`RK9H<\Z2OX`+0^.G9!>0)T/X*^3RH>?X@V_@-\FTT_61%ZQA?
M']S2.UH@&],HT?C3&I2KB.C20>.>_8QA/<,.K7C1JVP+'&V?BQA"*FT)#?S1
M.X/`E][0L)'@/Y6,*[9!_Z,C*[.Q9H&*")V(]*$S?_8SX7BY'$L?(?ZT3P$I
M)(N=SQ$=A%%NJ&!N^>7NFG#N2/D,M."(+E52:G-79IIE+QZF"K>I.)[$".PU
M<W08Z(G;`;*W6:'&$],P1G()5HZ>UQ@)4343E2C5-4F*7>&2QXA,<"UIPC;C
MJ^@UDBL@<8R>7-T-"4N^6URCMBB7<`3^K5GZ$1D"I+9H-@_OJW`$MUY4HQ:!
MNPXGY9OQC"3O)4L2-KQP1KN!-88SC;K&<'C$J32GJ6(>.@XWN7^],'MZ%LZ.
M%*UCN55*/F]1H#N7BF$IV(`MJ8M3ZG9EEV<N9X$I$"N9(BAA24WR9R"ONIKK
M'RC!"W[LGXX#$YZL.DP?6CG?YC'Z"MQ*2+G`.96Z9UI1V4R'EIX$CEH&=&TV
M)H<6:+PH:)I2:/*X=:6E]883E&<R13G$:ZZ8S78;3>B+H!+7\VY9LJJ.C:C0
MB(W6H\BZ&S6#:A$%'!M7U0.=<QK&:!Y_=&??/P_H"+I=ETJ9B,7$P"Z/)+EF
M31E:B<=1S`?^*YO>"[*1R4TA)/8'R]SK\'*9'9/1O'>:HHF\MB:=->OW>C"Y
M!EZ/035)*9;:73M,"SS?&>&`@6BP+OCSV*N=53IA/^MN*8^R8)'Z6+/>TRWF
M*>#L#>3G.B)WDNX3XT,^5T.IN,C9'HCE/8K_\ALE^AT>5G3]95G#[I091T2]
MC)3N\B>[]14:8\0[A,(K,B<*'$)EK1[?\FW_3L&(S+@>ZQCN6?D4'>"A")L%
M;^QW>JZ?`.T#.UFHH.+1B0U((PW@[AHPW>#HUOHV3>^6^M$K_1T+.T3)B)T'
M+PW=2,2"8),\U0SWYF"#$E*\W[HY(HT/]-/N=I@`R6[%">(M0\#^SU`--#O9
M(<P*!C9U2:1`WZ@+##S\Y\BS11J=&*Z(J#"($M$`&$5\!MAJ-D<4W&4/"B>[
M#V]XW:\IFDCC>,^C_L"2CPIVO*,C2U*_69'679,(ZD"57SVKFP8G#%D=D722
ME5$CQ0.XY[>DWQRDYV<IAG@J9R3750L6%J]@KIJ0**]D2]I%,B)^+UI58>RA
MW2LD<B0Y%`$(!APT,)!`X0/"#QL@''#PP<$&!ATX/$A(,2$%"P\X1"`X\8'!
MA")'DBQI\B3*E"I7LB0)H$-+E!T8`'``,R;.G`@W.-3I\R?0H$(!/.RP<(,$
M```.2/@`84-"#P`B4)!PX(,%"PZS)NS^((%FPPX'E`*`D#"I4JU8LUI@FM6J
M`[(.KC(\>_7E5K4\T0)0VY4L`*M/K7Y82A:"39%O[XY5:C8AT0\1+%!X$#AB
MW[F/27*0P+#ITY>%,6N%6K2#`PM-LQ*=VW0AX<@(GW(0B)HPW+5<$:)&&/AJ
MPH5,G396:K$BPHP9!0*VVE@H].C2IU.OCI/#3>LD-6COCK*U40@/#FQ8"MHT
MP@@`.%B(\.&!!08>)F.4@#HLAYZ*FW[HS;:M!(M%`%Q['LQUE@4<X+660%JI
MQIM^"$F$D&!(W95?0HDEM%AA&+I$H5H02/"`!AHXX$!^'@28$'T=+`6!@>65
M^`"))DXVDTW^J&GTG@:M->0!!1'$)M)36$&@8P0&-J2;!5$)1!!AP7WF5$39
M9=ADE3R9->$'4;;TH$(1LB3:2+WE-!Q08)H$`5G`Q63!9BJIZ:5W":&94I%U
M[A1G23RU1*:>)3F`6'@4`/!`:N>)1-`''ECV@`=LII90CPQ`H!5,:+GI:$T8
M9C464V/-5=NAG!ZX4TT+?EJ3`Z9Z:*=2$EB5U)"::HB0J'=UJ92;A2FU$4T1
M=,2K34FU:E%<2Z%64WEQ;=#C4J1BJB--9@U:;*=#)E2DDJW&-5Y>8Z'76*@B
MN?C@4XWQAQ!%`#``'`--JDLG9S1))&F`K'X%4DT=J"?1O]FE>@#^IT>B2),$
M$7!0V4,C*0@`!4PU^RY-QR)D$VS!.E6354HAQ0!R5)[5J0,,1,```PZHUV17
MEHJ$5L051\KQ67$I;"]E'U"@@65Q,J"!!^_R&ML!-'G`KE(1YXMHT35Q"D"/
M)X:W;V/H+0ON6C`W#?-74[&I45F[VF0!JUWE57)?S:[7\TQ0!^I3SF_+/3?=
M)JD)78QU`P6?0T)*I)5!GAIJ&@#H^49>HI)I=>E,6;')T4APXNI9@DLY!%&&
M4]NW7M]??132MDI!U&J0#F@P4P>7:A`G?'Q^P/.2J75^UN8)D<C`!_$VU=%9
M`WXU4$&,A6SDY`W.=;EI%%#P%,8B'B3^T44(%7C\6@C!'C+/LKJXT(.3;47!
MW_KYI]4!!T`PH(+=DWVTWBN-967[\<L_W=U`0>OZ_"=Y!=9JB(7IW&'(QH`-
M"!`]H@D,6;22&`AH(`*#6I&Y>L:4Q+A&9!>;&F/ZUYQ>Y6DX"\F10ZRRD`U9
M8(0;DM1PIC2GN^QO*>/A5UHH92F__*8P=^J/!/UWG_-4)C#,PZ"+R&*7+BV)
M+2C4H`-B`YL$'L8A?H+06IJ7F+(D4$SYPXD'##<=[%SQ;5R,'W=6DL7YA9$E
M5=%1J_S&GB0>P$-!ZT!5)%(5R,P(3*AAG$!`]KN1*$\J3+F4@E*('HC`*38I
M\MM-Z)0GG@#^R8$=Z(T(-\,F7B%$*AT@'VBT,I]UQ>:,<W%0_20DGR<5I'(W
M[*-YC)="$SG%,SPAH(BNPJ4-)6DN\IG,2S!I2<#=A7O\>97Q6C8?3"UD,NGC
MCYG>1K:P$:E7)[G56F[XG3;=\$YYF@Y<DCD;9YXDE&]:UVRT^#)NG@F<(C'A
M2)Y(0NA`LR4+T29**G4I8W7L1+CAE:$$DD\.0,99KCI88-Z3KTBYJ6VS4E#)
M!+FAFL2R,&+K6&`4B1YCY>>1(20/G]#YGJF\ZSST'"+4W`7(];A*)$'Z`+G4
M=D.#NN50%61(L(34%X821EU1^9;Y:@*VDPW',B>+S;DL@R)-B2K^0I(B)@1J
M$Y=VH<B*WA$-B9J'F,`8J%26L4K%7!07<DF`5%AUVD@B8SZ)U>1=<3%=34KR
MLZ"12Z$D[-%\&&(3,4U5`@4C";ZJ=M<3(3!)/=M8$L]9$W*-1`(V>QK/7A<Q
MCXVD:DR1%J<\8YY^D>U$85U;J13S+0--#61C$0A?V_*KAU'@KD1:"LK6(ZTN
MFH0"XG28;%BK-P8&17+1R9ML]98PNQ9E(2)B:V(*%*^*V&0I$?D4Y1J'O,OR
MZH^F1-XU7^8[4KIU)[C<2UCH:E?=2::,'\`0(BG2/1-I`$Y24=_LB$00X!6V
M=LFI#$<\$KV$0&\\"2-8:I+TLZ1^+WS^D<N*>^"C6:<@-20-HL!<S%?)OCQF
MO.<\TDL"-"`#L2^W*S%47RQ<-\/NC;%"N9^&VZ<1GH2G+D]ATP,N-;FB'!"Y
M"ZRN;[`"J0G"Y*5'*0E!+M43\UBPDB83DI"R.Q(3)RO#=M(@6?B"J>$@,"VK
M,:=<8SQ.A_;0(/%YF''^TB;#RH5EPFEBF/Y+F-U(;S4%/H"+,G<4M'2@9TI^
M\/B*_-H0T[G.=KZS4"K:I=+`"0(4F$EBX>.>"A:WC@#"([JT&)E+.3>0YXFN
M2%`6-."9#[>VBY?NA$RD/W.7,VGT7)DSQV0P'1+*ZV74E*'F$!%I*7?PD]!-
MF#(@Z0UZ(<#^7.-_V_,>EDFO(E&%)6$$8K[FC:<\5#FO.?<TOEF;I#RBBPE-
M`(7G:5.[VF]#"Z0J"X&I-NE1G/(=BVFR`5!U%6$P=NAWS8/0CE(I*:$\*;F6
MA3F3H@AJV:1K7"Q0TI=Q3%W_%$M3`."JC_*;L*ENF[!R)Z]8-396CZ4)I'QZ
M+J*6321CX5EF-U0MK-#T*HVIZ$(,A2BO[ILWF5D+J2!%$G2VM6)Q28I[&C4\
M:].\YC;OHK2AHR`<\WI;WKTYT.V6[/DYNR_4)6YY8109@F0\Z$Y_.M2ADW.@
M8+CG*.%PU+/N3?F9T$P\M@F3_YOUL9.][&8?^Q>_J)*?4YOM*#'^X:0),ARP
M!UQZ![&`V\^N][W+5IK6F7I*XE)A*/ID+`=AB89N2"^Y#<9\%BH)F32JDKJH
MI&.O;@GE3;*@E;"\N4VA.[KW>GF^D[[TT9E)RE;6F`=$Q$"JX?+)FIHUFZ6,
M?6WC7'@:4A;+('0I!6M;&+V:E,=4]0&H7\_JF[;,#9#6Y%![%*G"J#"&G2C?
M#S>/S5AT$&`%9GPC@QC5//Q=FK2E8E&K)P`+I[:;L(DIG6*1NU!3XI<7?U?P
M,??`5KMBYI%?WNZ?*P,<'ME`0&IQ@/Z9'@(F8(BACNH0G\`YT&<81.MAS5NX
MEGRPGLEY!5(=`*0,4$885^+@4H7AT<[^[41BN(@&+MB.U)=MD9"NP8?`D=#C
M.%#Y?,9D;`!(N!=*242*6<!,>(K59<_S?`2+X)=:0$3C-5Y]H4_D,4\C089I
M2-5VA<5WM<JE5$3'(,Z$68P@)=@\N=[WF(Y(O$2$M0=^#9X"IJ$:M@\D8112
M*(51%`Y36$5O1-EBU*%IQ%GN?=XED0U,--G)90Z5Q!:*C<\;FD<0P>%?28]J
M7$561$@#/=`&&I9I:$NC3`6"P80=\AJ<]%LBRD:1"5(26@A@3-%-",=K;$8!
M215=+,2A*!A*-87E%8:<[1^)P09=%`>AC&&<D<6<K2$P!J-UM.%"%-M+((;O
MT.&J%<TP*:/^!<49+,U='T(-S]B14?D@<U"*KQ611I`'CW$)*MT$6P287_@8
M2(#6'MY(\*!;>JP'"=X2R^P2&[G:2#";*%J($MZ$,34A(YU4H\@1)?89IP6:
M)@6(+%X<SS";G<#(Z(3'])0C-*F*&0HC159D=Q"CG[F4)G64,YZ83G5D'N:%
MMDDC:_B34+W*^`54;$%?7HA<XJB+09$0IVR$F(#$^C3/]34B.[X.[G@58/&:
M3ZVC3;$+Q"4:K;A?^I5;7-S$Q+U?<K@+>S`4MVT4I!C+@]13X:2<[9W5+<*(
M4+F?Y5C)M:`<Q*&A19XE6J9E;L6-6K:E6[ZE`N:=_>36^^!8=<C^)5SFI5Z6
M'EFH7$DLWK(,T#DY%4E(T^:=1-$)!)UX26R=!%K`"$LXF_'MA_N`TSL19G"0
M!3I.F4+@ST_LD-`)XEZ.)FF^3608'\PLDP8`D$"$6O;T$LH(1,!\5GZ@C&>\
MW`"&$,F0WYZ`B%60#:+`'MGP1\O%(`=JHD%P!_=AH]L0A\Y4Q5UH1:D$3%(L
MYVWZD.7,)*FL1V_NF4V@F*S83/M9W&@E32591DAM55WM$*F4SZ]()Z1@2SN5
M)GW6YT]HYDWPC(H1T8&Q"TA<A1+E4E*8QH&9SA]MEX*@1C_2("PF9F=<&>#4
M3F3$W;N$#._\8P-1Q!8J2(5Q8%<146'^A(BX5&&DK,^!!@V<(,FNE2&J*`5H
M_8B0:$_AX,]YX8_R&)>E(*AKW"!RG-<RRAY;VJ>0#NF8I(?C,`OY=4Q)=$9#
M%8X378J[C(6H>48KXH4'$8H)C9"0$)%#W(:N1(;7W<F%!@V*(EB;7(Z1F8].
M]H69"1`L]L8?M:+!C)E:[(:6?MYPS&$O912;+:+.7-4!F5A#3)!I'.*#/*(N
M$JFB+JKF@4@N.4"-L)&P/4:+!$;E5$D<P='O#!O`^=E,6-+H-%+S]&;0(`6$
MSB-13"AUK<MQMI)30`2S:9-@FD^`I(^O><3RM$J`.,0?#:3!O&"=>IE9E.KQ
M;)(2\8DQ'IO^:+"2B%!CBG%:?L@:-LY%>>Q(5*$DHV8KH_;EM_W,T+@G=U8A
MKZA-1*0,'$'EQ]$=`6;86%+4J':F]+`1<*+J0SQ&6X$3AD%F?*0D39)GIZB-
M=)K%/KEK+*ZK#V:&=N9%=RJ0OQR*K+#03-V$2_ID?\24N\QH_[F&M+ADP!:%
MIBR>MH:LR&I'Y@E%"^)9R08%?>"56:8$F:3LR,:LS+(6S.H$>OZBAM4L3K3-
M?/K$RY+3S`:MT`XMT1:MT1XMTB:MTBXMTS:MTSXMU-HG8$PMU5:MU0+&)%VM
MUEIMUFZMUWXMV(:MV(XMV8YMUY8MU9XMVH[MT$6MV[XMW,:MW,[^+=W6K=W>
M+=[FK=[N+=_VK=_^+>`&KN#>K;^82\QQG.B<%'D!1G&T)EKPX3*91=9RDF-X
MP#(%U,9`97\TYR3Y(*_^RE:ZRP:8T)%"96!"Q>-F;O<Y1)<Q[N<>"@=42?4@
M;JG8Q,R$39Y0$5F,WN#V;M9)P+C]BF28!ID]Q)6ADPD%"`=Z@*.8"`KR"*2U
MJH@4K\A(`'<L3IC]H$TXK@`V!<^0+IR@;GEY[PLQ+XD4"0JR[GM5C_P)9FF$
MS6[L1D-Z!D*,1^Z&4RSZKOZ6'>XLF.4*8)*E&Y;(A8->Z`7MUM%D+7",:;SL
M[FR0!7?\C$0XRHKHR.&)!$40!OAFK0;^9/!5&+#JVH?Z/B?[IL8%MTYJQ"^W
MSI65="W^[B\,9UUO'&)X,*)B'`J\]N:6@K"&C!BD,3#U%@F<0(N1J4A3!2D&
MNU*#A2_Q?)=G@#!MV`;KB@Y,<(4%VPZ<U`8$9862%$6.Q,K]]E@,CS'0]88Q
MUO#L5FR;E=!FC%"I+J^C-(2>!4CT3N;T6EV1'$`$J-AQ/<;Q_&"7\$>EU@9,
MM`Y4Z'&EPK']0D6*CO`ZM2\C(Z'.&!E7M%ZQ-)@K21FDD3$G6QON3&S<7.ZA
M-$GZ``;I]HUC>"SH9NUFY*OEXK&+<NC%8-SJ(NYDBNM2[$JI3))`Y`<EJ0?N
M0D6W[&0)[R#^[)K0I,RND-@N,&]$&.=QVW:R-&N8]=8C/TTS-F=SW11N5QRN
M-G\S.(>S.(\S.9>S.9\S.J>S.I_SVGZMVK:S[L*S/,\S/=?SU;YS.^.S/5-M
M-*^S/_\S0`>T0`\T01>T01\T0B>T0B\T0S=TT?9L2<#3YL[<S?F=3LC;LG!G
M(LZ%4GASSHJ?0_NNAL!,7<%G?E#%>_!3OD$?3>!E;I&6[K4*>II(0?1,_2F$
M?(CAZU5A&J_%%M;97H1T#$.3?FY7B)`/#^X)L,8@M=E6["0/@HUO=T$3!/(&
MHK!Q_D)1D4"TW/`%-[')!0MU[_:PI)C8H6H2)NX)G6+F`DH0#UW^%;:D12&B
MBN%$P/EF-8AN->]>6YO\)>B(]>`FACQZZG#M&BI?,_>0(UMK&"JMTJH9UB7Q
M1Z`!!S(FAZQ<81K+1W?E3IV9B(0!]EC?1%`:;'R416^@6F<FK+6Q%&@TC;#8
M[DEZV^NTBF!>3545CC.B5"K7&9NT9G4(D1"!-M)27OT@<5OV,\TAM]0)]](2
M-SC5Y4J8[3Y_K7*CI3[/LZ_,<W4S-W=/ATM76]XU9G?K+63&A.#YA$17WC5+
M!S?C%=!:G&5.24Q8=)>L=TNTMT]('F20!%='CJS8]W@/[0&4G]-0%`8CS/!5
MK%)P0-5,'W&UHT048/*1G\>H)@=XYD_^`*]J2M7+D59[EDQ!U%7[E5M$:0Q.
MHTQM!@]4&LM$8+AC!N\KQH5XK(>[=I;7Y++8H`8&],6'MTM\6A7N<LR%![C1
M1L"X(0_I>#,)@FD9LF`G0LYH;&X*7N(*?L1^YD[+_@3N[*<4HBBEEA"B:,")
MQLMGX)&(I)E"Y)(#B?GOP,GW8#E.]"^5=^`&9$22-X^,FI#@.$`#F`^/YI=A
M5_'NJ,66:O9)3#?6[O-U(SJC-_IT+SK90OIT;S>>@=Z4:-0"E0<4L08$0^`6
M1VE>'")3?")IB'%0S##YL2)Q],R\J:N<TMBKZDJ8?9!8L`FN'(:II\0,?VQ1
MO$5GXOF>WKK^8SC``GQ0%-;%D:98`CU9KA-YS%KZ@A()-I;@^'!)T)PC/[U1
MKJZ%,0X'ET1JLZ.W0T0J(6T;IQF$5*BCNOJJ<\U$740&IF8B4TRJ4>$L29BQ
M-Y*D)I4.L`4[3U],L9_/M`*KKY':IX6[LX>LD0L2146)3X)IN#"<33+U/K6D
M1C:%ND"++&6Y3^".QFL;MQF4M*AK_[&I\,DZ9K!PJ"RXIL`YM$WR54.N:G2*
MM@&5D=E*P(^\C\_DP-&,H2?\S!Y`6-,9E$M'-0>%SC;;8F.P1Z_$T?]=GC4]
MT(]L>=?9ATX'?OM$TO?)TI\%@*]$UD^'>.?$U4^]V>?EV)^]VH?^;-JOO=LK
M:MN_O=S79]S/O=WO9=W?O=ZG)7!GV=[_/>`'ON`WFURT64>'\%A4Q,JT#*\U
MQL&V4;(<K"Q2ZE8PKFBDQN067>$,/N='1WFP'Z341B'I]C(%C9%)QND_JT18
M#L:3880-*[/,QFM<_NA?'."YO;]07GM/KH`%R>1>;NB?%8.+L.AJ?JR-5M'I
MQV-.FH1<;FIP*X04_Q+S<NS^2J8P'..V5%J4HE4\S4'XF90Y*&%@F/'M!I3V
MM5X6'=FPS!YG[6(U<+R8X.G3R@:<2[AN;A+1;WN`B8BD>8UU(D```$!A@T"!
M'Q`F5+B084.'#R%&E#B18D6+%S%FU+C^\:&$#1`<`)#P(<(&A!!,(NP`P((#
M#R@36K"`T,$&!P<^''AP0(*%D1H>?%S8@8')ED(5ZNSP`8($"10^;&`@,^;,
M#S41^OP`%*E,F!(T0,!)@8).#QX>:`"`\(#8GC.)>OBP]H,$GA`^=-@)`8!)
MNDA[VE7Z@<+;DT:M<E2\F+'%@DOG6HT`H:D%`!H.`(C`X($#JS=9\L5+X0&`
ME98Y9`:0V0(#!WAW<F`@MVE4TU<M5+[\N'%OW[^!!Q<^G"$#IA(\,.A@`2I3
M@S@MF^0K\(!E@0\X/$@J(;M=VP(=9&W^X8'UU0@C:$"8?(-VLN9[&GP@]T-W
MG%US&\3\@#O^2?4)#5J-)ZKBF@LANV9#2(/))'#I+X,8X,`N[V(*$#'B,,RP
M(=Z8FD^VW$9R`#3+*/#L.X%,\D`DM3([P(&15FK1,@@X"!"GVFK4@"@0KZKI
M-@V!#%+((8E,J(/PQ&)J`Z1@2BB"@92LRH.;LML.(0E1PDLAYA(J3TLG_TON
M@PAKHBHK"Z8\0+4K)<CR3)AR8PL""])3:"T+YAO0(*OH0I"^!5&*@(*_\(I@
MI`EQ"LDSJ^!,K,A'.>)0+X$B.&ZKU0#(T40`$[,.@ABSH[3&`Y*;L](/XJRM
MKNM>^@G3YR"-5=99:34220KB8C*EK1P@BH,F49U)JC1SNDF"".#^ZNM+E8I"
MM:9E<WI@J=H*"\_,8*-*D*1D95O*2Y,.V`Q<L>9#*[.3+!C040/KNBNOO38@
MBM`/V!-,VJ@6/0S;6OGMU]]_`0XX8.-`8@G5YJ8#`(((G4UX3LD\"JDHGC@(
M:;6"#$KI``8`P`XIA0956*X:H3*/)8BOM!@G"5B=+D+5'."`)('PHFM4P^P\
MD-3IH(+IW*BT;,D[ZVXRLU&!D4Y:Z:69;MHAL!:*0&:GJ:[:ZJNQSEKK63LX
M526OMPY;[+')+MOLL]%.6^VUV6[;[;?ACEONN>FNV^Z[\<Y;[[WY[MOOOP$/
M7/#!"2_<\,,13USQQ1EOW/''(8]<\LG^*:_<\LLQSUSSS6GE`#+A_N-<=,I[
M93GTC'H=\DB)DF1,/OH:HG##ZSX_":>)9#\L=XC,FR_WU1'Z6.>'5M(N(9YX
MNNA'AY*W%?-/']I@O(#351ULC:K_K>O%0*,K*_?2I6[U:VD*"<W2+J-`/=\!
M2#TI%',CJ@.6>]T8`+1$.K)&*.GOX,CV;_<]PH1O->/S"6<60A=IJ48[3U*.
M761S'H4DB2P&+-A('-B!"*J)8W:Y8$%>=(`(AHACZS)33>QBF<X0A6._DJ#.
M),"QZYG/6NF:D$+P=QG[N02$RR,)!TAS%8H)!%<,:*%#$F8:]'DM@I5J25[Z
M8B/\N61F(IG^RW,:A#$`1,AA[ZL=0]J$D;XP9"6[FMV11L(0565F*6P43D$B
M4D:$K*9!#S'/NK`7GHB8[R%TU"-3\-@[%9G1C<[B7@>`!<6*)8<#&E!.#1=R
MD[8DA"P+RD[%#K80Y61G2I[!)'-T@JH(,-(S6OHD!7Q"+"-ERB41<J0!G\(0
M"$%&18/4&;+:LQ"=],>"R%'.&+?5GE!ZT)>_VH`'+>`K24)+D#V)4$M6,C\+
M"*]=3EG)0CYB0.2E<2%D<=%5-A`!$?K0*YD29T^T%,V>0.0\$/#05!`R*+5P
MX(EE;&=Z+L.2C6DPGROCCX^6$AINAC$G/PI9:JC3IA(5+$)2$8G^H%!3GK[T
M+S,<`TK[:%3"D[3/`1QSCT"L@Q,W5O0R\HK`2<DC@=)\26(4I4X$I\D2XY#&
MI1PS"LTXIAS5I.2)EF%9IDK#ODS%<(OS:U\'5*,:OJ@I4S+,"G6".J4MH@JG
M19W33Z=6SWQN(#,A(:E:1%(:*F*D5XDD3P2DI4?30%(AO1(*:422'%`:9%DK
M,0A5"TJSY*TS+[U:J6H4YIW6=0FMP%MKL';'+ES^=#E;/*:+S*C+.5GP1ANP
M3%&PDI-#M:6R*+%+ZE#B5F:BZ2;M"L^1#$A-1+$K(=FLX3:[69H;AC:@M5O0
M:WK"DTE]BJT..8_!2**ES,S)D/9\3O'^H()2``F$`3SQD4$0N2<OTNM^Y9E*
M:X@JH5^VA@(UPA/+,N-=TT"``E-1BV7T`@%#%40NCWG-/*O+HX*VL2\/$)3Z
M\NG=5O['`5(;;WEEPH#UYE-%&O#,?\T+3#INM[EXRHJU1&(<M$YI4'0RU&Q>
M@^``0U-`+''`/.<8KODXH$1>6_!IYL02Y9H'`H-D`%@PU1YD^4@J>)Q(62-K
M&32Y4CFS058D._`1`UL*)!O`9$.4LQ[76.#(FA6E$$E,`14UF4ZJK-".&]EC
M#R`KL7W"TP$*TJW"V`59!4I(L]H2%V21-R[**4R9I[)9-L_&LVU))IF"/-IL
M><"9].Q5#57^BSS6!N]3/K9A\Q2$I-F&D\D^3`Y_7O84*1^6?++$"7`G$Y.E
M:K4@T#'.,1\*MM5L9GX`90J#&E)(N(+W0"@*XX$391D1=70N@%WJ:<+3)HN-
MT;T2*..JUW@;-K8)U$U=V$^!ZQE;2W#7<*0,2^A:0`4[%S<!>BI(PU@;A6(;
M+TE<ZH-C%%ZQ0F8UV@9)8OR(FSF%S"HM(=E<.ATCT[2I)2]!$>H0&=DIY_5&
M[5N7:$WJ1..LZH5L$<A3/#*;GZII)/B+`&H[2'!2B36`Z\D4OYWCF2ZS:E"=
M`>(6)21"C;ZO?3+C2RGY.*@(P72O;=$HRR`8<=$NQ$R&2F''_AS^K-,H9+7>
M(W3&#\W-O,CPG$J234B^R!_+>$"W'30@.V_T3JMT1D4![@!\/3VH]+:&GRU:
MB5-,K5Y5Z?(V\WS15#:FTC:]FKLY*J%FX*W$\N(7O0^@#(S;NU9?Y_=%P:;O
M_-PI3M,\"94.XF],]0+@C35%+6JA:E#DS@#\IB3=GFEN$`UYH$*-V'1"PW!I
M$H_VJ3C()P/1C@1'/>(2H9O:I;2,!IYH2):5\<4LFO></GR_L3,FEV?K?=8&
MZYLXK>T\DX)[\#C6JQR.Q$;&-\F3K'B>01490BX$#T'=*"_[8NPN*WD-;AR*
MP9@9;*)'_:I8,PK<Y(AH[_:SKV5$*NS^VW<\4VK9`/Y8.I/^<1^F<*SZJNIG
MBX!)-,)#V>XM\^H"+R9E/D**J$KGJ+BO((Y%`/]G/D)L`:<D,0A0W62".AYL
MZ%B&J]H'4P!/`OF"81HC1LY&!;4F^!@#?2)K=&8E,[;L>@"'H)"&Q&ID:GSC
M=*K&!_G%<_8&"&70(G(H!O\&!P5&J8+#YR3")BCB+BJ.(4("=BZ"FA2B1J"H
M??@,I!+BIY()/)B.4GB'F]RB+1Z+(MS'2A@C,YHCAZ:P,3!&6K`P9XIP;+9'
M;_(P2'PJJ9RDJ$1+*HR(G@1"`_#'UTI(UZQHIUHM_1#Q,F@BSUJB8^ACJ>B'
M!\GC3D8BHX+^S&N4@]$VD0/$:4J.YSHRSM<4A2<FH'UB+G\X)E,BZ)$@PSHP
M0U&Z<"#DY:(*I:B^L.0.T"GJ8S:2RD44IC12(R3<"19E;N288BPH8*F2ZA`C
MPR76D#B(1@1=`[@4`HXXXF>RK^"(!Y@8@AL;8U/@K2+,,2*N"EIX[O@:@L/B
M$"/DJ"(JB@J%SC&<4"6B"`D14"'FL:UL3'D8R9$`)"4"T31\@KA$B9'NYRY\
M27ZJ9(X`R5?N)R%$ZXD4\B-LP@,HP&M0Z4[T[UR`QT".A"H\R"2J<<K"PU!2
MR5C0$)DH4IJZQ,`@0R&_*;.`8B4\0"OPR8PVLB.O15OHA<?,HBC^4*DHI2<W
M[JQBU.1+=DEF/F(@IV*49D,@,!%#.JTN7G%/2D@UX&\$1<Z(K`*L6B(DV(=C
M#&XI5H)CNJLK06JEUE+%*N4!H.(QF.LM%:8U"",H(HYE7`FD.DIA(J/^*A*K
MA@TD.";]*L4O*V:+KBKYC"IU,"8_(@2KKN@$!P*F]#$DP`XW`O,!!E$`ST=A
M[.I40HIFZ$6LIL2C",,J)6:G+-,VNJK#;*K\_A+:1**F@.F@`K/;0&XJ"FRE
M^LBP*@2S\@P*-3(1K6)UI+`9K4TB0>N;+%(21\),/B)YD$(4#<0D1?*/UJ(D
M0Q(FW*?8DL<G!`MYZBPZ:VA^.,9%(,/^H6Q(2?(CYY"M`YO%R3XB*&''L)*G
M5V2B/Y<#FI1DYI)B3EQKCOCJBN)1./2R/CRLU@8,-3JMODZJ5^")/#3@&=\K
M4_IB4-(2BIA#P#P"VOQ,KO1)IFS)+L.G1!F@\2RONZ`MG-`J0T'BX;;*,YYQ
MCBSL,/L+U^!+1OL+D!ID2O@"D1#&F;H&TF*B5UBBO`9,+DZCO.K(,UX$O:;B
M1.OM2JTB1W1,CPJBQC:T1M"B)2JEP4K#PH(GQNPKP0HB.DXJ+9[1W33,_JAK
M3'M4II*4-#8F2XEP+J12R3J@6BP+)=R,-#3`P.@$RC1KSI+CB]9BLLBDK0;5
MP=*"T'[2-`W^HB>2:UA^Y<P\X%>XI"3J9.#(`\Q8:<MZ8I1<LLX@]9.8`Q7=
M$R'2PL"2!P+48CER3BN&,E#3Z%*O!1AE(U@="4#_,T0"M%4)=$S&)2IY+%%]
M)$>!I$'UJ]9V[5PF-`%K8U/FTS/L":GHXAN9JEK7HC[[(LP49N#L4@0)+C3X
M8E2J;19/SD1BC#0NE-UX="98@N)^Q$36T3GHZB1Z(CPR`P?A<3;OK8P&M@!;
M(GRJ;4D49D^`Z3%P;3VFPR;V3GIDBUL#A-W2]%S:1-J^]$?FLR66[0#F<=7D
M]8DRHR#4JSX=XC7\,)Y`3M8(U36NCCH<CCD5<294@YO68H1&DJK^7J,U!%,?
M2R]F$F@+%<X+YPVD[$H845-F/8Y^D(/B)D0D1"Y_:D@M&`#W(`.L&$Y)2H/4
MPF.*/@X%`9">$L/X>)8ZB#4^_9/)9"[/2K'D3B,:QW8NRJ@:W^@\8NB)R@W&
M+$,VQU6]+'0FJJY!-/;U/'2^H(BI&`_:G*7J3M3>>M4T^N)<ZNTR5&A,8#0Z
M/M8G1.13M@ICEJ+`6L+L0()T'>#T0/?<A/3SY`Y@N0ZM")9)(1?OH$@$RPO7
M&/;`PF=SH^-*./=!+Z557F0ES*Y!=NP`2H1SO113$E#R["]&0Y=Y`8HNJ7>,
MEO<U3D,YT&I,H+?`M$97>Z/%[K!6KA'^<+.68:^U361#+&6U8Y:LC/SR6V\C
MW)KJ1%.3-$63JOXC7<\%_ZA+6"+NLD(%-'OS'!'HVDA%8A"3-,UR)T&.7P_H
MJ/H'8)VC,K^$93M,,W<WO)AK8<_EP$H(__XQI&)O@RNF_3PJ`DQDIT*J8PN7
MI+X4@8.J*'+3_`30)+0/AA.3A0EC-@BX?.\Q??=&I<8D(#&D-:PP0RX4B:5X
MBM<F@OA60TA$2'B1BKFXB[WXB\$XC,4F>XC'!OF%C),&>H1D#\6XC1<GW1QB
MA7_C9RS"GCIM^((C?C*F(39%'%M+[QXB8?CQ(N38C0UY;TZP8B:8JLZUJ#+X
MBISBJ"1&`/G^`CN<2D&P36(D1`#7(ZI":C:9JC:M(U4J>()5L]6&*J<BTUM7
M(S<$>:=BD4]F,XWBE34?N388!*0Z:(I6LV,`D)65JL.\\I").6YJMS-L]>)J
M+89.X[\>K$:,]$[#9?Q25YGAM"FVJT/IPHFO%/9B=$TMH'KO>$[`%YG/JR\N
M5"YCB$@UK#5R(UW-=#)V),2:%%W7*IFAF;PTF$&,0_)R!)U;@G31B[RN:_3T
MES(:M)@5>FU4UM_FL?)8[,%L36./2:#'+2M.CNU,XV=B3V*E]V--=A];&?<*
M2F/#X@#9+=L"Y-M0!24P%[`""S?H65UM`XWD+6I=IJ)K3=U0)&7^H^UV"G8U
M@GBAB1IMCIFB0VQ*ZZXYCD+N*+I-BN?T<")Q^Z[:,G2;,>SU=*QPMS=DJX.<
MD]2D=:_AH'>=6S?RTF4J7%IY+\^^I"6=5_9G>JU;Z5*#-<]S_QEY2?=6M3>M
MA9=EZ))#BGJPQR:1D=HY0`(W'ED"^^>I29<8+3`309/M[C<A*IF".RP!;5A9
M0H.%*3J1'=@!5YG[WAES1;`O8GFF?V;]DK?\W&?LPBC\/#N(]X\Z)-"!HD@D
MR)&P>;NW<8<=F28=.>>*'2)H#6YZLB:Q,N)__LPJMQ"`R!!I*M:W+4()G4:X
M-\=]?DI#16(2L:._H`([[.JB+!D2F6;^?ZI%,V+Q2%YLI:3*>.(GR<RS/GHK
M6$;QCP#&8JE[OY.F&H&B*>0*24A6.>!;)N9RZ9QF^*S)>]+BPWB2)A.BDY:S
M,Z8)+Q!M=<3SBX@$V>*0+Y";OT&<5MQG/I/DJH+%003E3(:FD)5FM[QCWMKS
M`4&JDF?1"6?4P@>JLJY"PX>$PV,GED(\R&<E=50$5^>,4I_H2;+*P,F#Q9.&
M+%0D208"5OTSC8"B5(=R4\9L3K1#/_UC3)#&P%)5R,D<4MQG;+NVA(B6M[:"
M5&4"?[Z;:N3%*2Z-:[W6;*.*,!(.2B?88AX+>)A0ND&NS`F=5EK'?,6C<(XX
MN0N]T67ET(7^KI`D(D`HO=(M_=(Q/=,U?4$!ID^')(DT/=1%?=0O?=$=O='1
MUR*J4".,&W>N<C'8>((X_7B$[CI-_2$0;2'ZXR)B'2/J\&5Y_!V=XM5/W=&K
M8X>Z$&D38H181@%?$:'Z0FJ"2(\RR(@RA8'LQSHLJQ`[U3<\@A9%ZX+0>X,Z
MZL4NR!*9_9(%D4R,R"Y`KG^ZO;I/>R>0T1@O4;2(:C(DJ+%+B-P3^+T).*/C
MO=B+O21N\E(G:"GI0IVX+CO*23O/D>$MSL$VR>X20R@9@V`^(\\`7*W18YHZ
M`S/63J[<`E*;XIIJFDX^C">>*;&Y!.,G@E2K;CZ,LMXZ$M\OUI3^K*5$FA*7
M*/S`4X<GDWPD8)[@"[U^-A$[EP6TN-&``N2V*N.IF@O0%F[O,D:CS(HC5@<^
MP_U&=$)A,@OI2]S60:NT_B(\/J)^^,+@4#/K(6+KJW['96(DTC[/7API)CK/
MPCY)RLGN]J0Z-W&0C3[(D7Y`.1)L6G7A:RC)AA+29*91-318=J+3B!XR9A5)
M!)_7P^/RRX0RBN@I5`3.Q+Z(PN(N[DS*D2]02P2I8B@U$MNR,W\H-M]4W]8E
M;GY0[U[GI_,C1#]1RT,[RB.-%LE0HF3P'=W@`_\2*62$V$6;#BZE$+PU(U4F
M.D[C\@K&SJ/H.<(XP)9F"^;.1`*FQ+[^A$Z#.SKHQ9%/DEE?-38Y^Y]8(F8*
MY[0B;B^19E]\YR1.M,3_WZ-*K#;Y10#B`P,/'PH:/(@PH<*%#!LZ?`@QHL2)
M%"M:O(@QH\:-'#LR/$#!H\B$'"*,E*!A(X0#$S<XD%BR(LJ1(V/2O(DSI\Z=
M/'OZ_#D1`D&@%B5P&-G!I,:5+5]&-%HQ*5&*4*=:O8HUJ]:M7+MZ_0HVK-BQ
M9,N:/8LVK=JU;-NZ?0LWKMRY9%/2O8LWK]Z]?+%"``#`P@$)$`$\E&JP:M_%
MC!L[?GS6Y8<.#"Q(L`#@@0,)#`!$X-"Y,@`(+RU8<,!`PH/1'R1LP`Q``P<(
M'9Q"OHT[M^[^W1D]/+C\83`##J<E2.A@N.`##0!J?S#M0(/E#Q$T,/@`P8+!
M@;R[>_\.'K<'"0XLD)Z\F65SS@`.-"]]NH,$P(%?;NBL'<*&\/S[^_^/EGD%
M.2`<<>E]```%QQ'8W$`1Q#<=>A\LI\%+^@&(888:;LB3;X!),!AFFH&((',,
M9.<`!'^5YT`''CH`V@?,M2<0![9QB.-=''2`DUT]^9CC8P)B-)-!-@6)Y%>(
M%2140?0!<..%B;%4D&H8)8>0`P`0]!=@^V&T`00%;?`DCPD-)E%S07F9Y$BK
M`?#E14NV=I1!73Z)9YYZ[LEGGW[^"6B@@@Y*:*&&'HJHFD"YYM[^<*8=E-Q\
MY4$Y7X(D?N`!`PYL0)FF$00&&@#&J7=`9Y,2UAJ4?XF)W7X:_`88!0QHD"D#
MGH**'WL1_,52F`:5"N5XF5GF7GNP:5#L!F1J:29$+J':9K32XGB=HQ1P\`"D
M'[CD`06[?OGJI>991ED'V6F@H@64,=7>2YLFQZVW6%[X:D'A1G!`!`R8:P&Z
M^'JPV7%PLDHF8`2Z>YH'V7'&@779%;0OMOARH&AB]%%YT%\A3<MQQ_S5AIRV
M!AF&9ICZF4<IE6\.]Q*(8;:('8$(HJE?<B7_92=]KZWH\&FM'?`R?3(//":K
MP1&V$JL'G(?@?8$]"7/%55ZLD'$;>XS^==:W.3?<T@AJ&^^NS'507*_78>>S
MR^FN:P'%-),YI@/=?FKGEQXTY[.MSJF-;Y7J^;JMT30G?!G#UE&(FID/4MSL
M0Q5>II36DD_.UW7%<H"MR))R,-]J^I(HP<:EM@PT!*&Z!F5[2+O$ZN;SQNGY
M==[N77JHOZF'G'8%`_:VI,3R/N,!Q1JEJ=0/_34<Y<HO/U>1!3W:%@1`K@4M
M\]9?G]:<3;)%GERP)0I^^$]BC'WYYI^/?OKJK\]^^^Z_#W_\"TV?$_U8V>]!
MG&CEGY']\O_?D=J0:3^90IF7/)2@Y]#G`=^CD0-"<A\>F09J!MG=:&[$D$LY
M!$L-V=YD(I?^II](1B$$H@T&3:/!CE`@3G.:2`JAAY`(;=`Y`*QA`-\5$O>8
MQU6_$5,''G``Z&WJ.=K9%FKRQQKH)0=F19N,K0#`@605A&*6"F)F-M.9SX0&
M,^3I0)@X`ZL6!9&*(8G`EQR@I?G@"VD5&I:HIO8`8<$(-4^$S6L`@ZXT>N@!
MH8(B9M!8D,]0(%MHY-43ZP08TGC&0T9#36"*!40M06`U4?22N0"6&>I\"9)D
M?)Z6^&BJ`S@2-J'*#Z4*4BSA>.9YHSED*6T(RXD(\`'7B<"#Z$7+H6C@00LD
M"/1N6;KR*%$AOD*.?"P0L6P]IW7(-)!Q0J8<YGR@15^\5FF\M3/^@UA@8]$Q
MS]W>QL3DV$AA%9I;=`Z0K60^##L2**!)&+@>9)+-*:;Y2TE*:$S@$/&9@2%,
M=08D/%;=S0)Q9,`&*"!/;)G&)6;:YD$&:K3G6`@SXQ%E0$WSKSE2AS"9:EAJ
M!#:R?%H@HT.)I4D9(D`(5$>8=[J/+A]D`8!1Z5%W2V280*-/#E;0A_!Y4D%^
M.!H0O:0V)%I/9]PS32]"`$3%NF`'@"HFP(F1,*IKU5\>`$VO'2UP4T6.SO##
M%-*P!#I$M(]3=IFBR^`3/L\C%H(J%9@!*74#E4)3BR9('Q)=5:ECJA14GT<8
ML@I5J="Y6&`)0T-1J2>D\-$2FTX*V83^I!29"-UA8GP(Q$>YE(C/,4D!Q42!
MN'XM(<6$S[X.0@$*W"T[CCJ0I6J#U$V9!T0V,DB+4GLWOB853>T12G2R!41Q
MRDVMYNP`FDX[(0U4"`(4H,Q()^0ST[2V()GZ#<N6YASHH5`],I1KF(!()KN2
M39Y^JQ=X605>SZA6302%+NFHF9V14FF<$>#H<*Q35,82L6^1[2]"4GHWXEB6
MNET*R2\#JYWH5.D!K"J/D^2Z4PF99G@_[<RH1.1:$Z$H.ZH"'>_,2)DW.G2W
M5*T-E#:PFCBF:&K#A9*-C$N8X04/`OC98VTG#"7;_(:B+:H/9X,#)?6\J$[P
M#:UFIG-7P7S^Z%$I]L"(C0PC"S^O,R;\&7QUV)DX2@I5J<SO@,YC&MN5U+]D
MALN0+@(2A'QF*DQ9RP_57*>&=+?,=,;1F_1G$0^VT"=M7LL*#;)GA<R9+J)5
MT9T<^R%XB:E20OE>$3]@(P`P0#WTX='N&AR2<E+G4T5,E]#:B[;QV2NF;RI=
M6^_4SE)_S3=%C/2D2Q2X[Q'HT76VB/]V<NN+Y)HA_(/(CK2R:UU'Y-;!#G9/
M,HD<%>D/<(I&)X^6^JC:$%EW^](IX);C$NY$@`+E1/9H8(B9_.P'AA,:#V%`
M@ZY3Q\DXD!Z(8?KLX`A*.G_Q/8C<:BT1Y"CS/;9M'"M9`RE_*X3^AD4C^$)0
M;7`T/3@A""2?-@5CG"`?',];]0F_%:+PB*0TXPL!7):TRI`P&=PJF2'.KN[4
M*U8]2:5V*6`1$0II97X`H7EM8G*!B2E-I:3D(^7PDN<SFW$_>C8"*:D%#=@>
M[HR,N4:2.<TE8$:?O_&?\0.6'>/HFV1Q!HV9E)294JDE[6"&QIVQ4:1EKB8&
M]E1+!R!CJ$3)@`BD*(V\DEN*^UBG"QGS7:@1)92X^"GDLALTC`PQ[_(J/$EC
M"X\NQ@\JC9-%B\$H6QI0$)1J$_>0\%&BF4%@A3IS00^-:F8@`@P0.U/2ESS@
M6G*O>[`V5U1>8>I-RPW,:FB#']/7_73^P+IWJN;(@*MU)#`$79J4;*YHJKN\
M(##/'/,Q@Y!+UQ3@ST60:8!8[[82]$(P/*[1657/."G=27(WD_-GSF,*9+^M
M\D.G0#J`K<K*"OZ_62',;AR2CEK'X\V)Y\$:!W7ME%V8`33EP2H/@F+141M+
M]5FU\5SP=$Q,DE<+V#;M,DUP`R<',7[3P4M.!G'Z`2+6PGSJMP$D=33\-$77
MQ$</<DWGM"_*Y#/KE%H*]AXCE2E%I7`#)7-,0C'QM2DKX2YA4U0>-X(EQ($4
M15VQ84+9X5Q!:$3F9&P4`44,\``FLVPJ5S3.QD[1ECS31&W0%&'/XUG)HW!3
M6(7KQV09V'W^A#%XDP9^`]8:YU9MSR%S\3:'S+%^/P8_@^%5>&1+#:17F=%4
M/.4D_#>`+;)7!U%\/<4CS7%[0Y14"\@2^F%")$)6T*,?H+$C:,0C!+(ZAH$9
M!@4Q)057T?6!=(54S+<:$J`?B+8?@^%E@XA0HI%(+7(WVP981#1(HA(U1%5$
M..@:=54],P=U<6<C84(S-S.$1K.+Y+$TI6@?=65",+,2J[-5+R-P&V$8#&0R
M]!%56!@X,Y=(3D8?0[<:KV9MC607H5-QVV@!8=)`T::&0X=9@/&.;W@GM/$F
MVI$<]35%Y[A8K2%UAD%U>T@8R`4P<B-X!V!>/F,0^F=01L-OT-'^7D`$:3!S
M&0Z"&<JU>NOU()31(@O87+-B0@]HBDPR;DM8@6^S)?NB(%4BAQ$R@(,!@J52
M21;"BB5(/K`8D+45-Z9C&S#S*752D17"3KU8'B:!1BNI&D!350=A'13`B3\(
M3G-S&10#.$:Y5$:(*LZ17MB5(NI2&=88-DPD+;YW%1CD/FA"8;8$9*)"(DU6
M5ZC$.QXW=V4%5'$T-9VW(G\$)R%&//7Q5"F"'[EC=R7'5JV"*0=#,7VW.BD2
M6ET(5($Q9"_A'C2)BI>31?4UA9UW@@&9*C12&:$I2CQB'=I$92%F2S`S=QYB
M1JDS&%`V'6WV31&`53TVFW3E8LO2?]K^H9KE9WLN]A)01C&GP7O6^'LOQC'2
M@15!A&]FT6<:03%T,6+/,8P<\6?/J9W*$YT7$5JB%1?NT2R#MIWE:9[GB9[I
MJ1-16!&_!A;NJ9[QN3PCQQ%$*!*MF(T#IY88P7%U(Y__R3&,U'MF%QHAQARH
ML7BX=RM*!B>Z(GN29R/!UVZ29G@4XP&[Q&)_Q'5M@Q_`0A"-`AIE5RD*DD4F
M!D1>!VD1<#?2<1K!0GM0$GC&Q3O)@G7!U:!4"*`YJAM'Z"ZB9!#PI#`5>(3[
M<BXT1G_\1(1E.3T0J%:6D1)ATXH!E5&@5B,C%4_V\AL"8X,L\AP;8U"!P8(7
M.((U0T#WI3?^\6<:\X<M[*BC;0H9I8@TI<D>/LJ:=Y(VI?,DRW@0-\-$\G%4
M\*%^W'$S^!DTO-.5R3&`*.-:H#.(R@%U<O<VS7@RDN:C"/(DN\1+B.>FF]H8
M$9*,#[0@/IH=Q=F5I!,F"]DT$5669J(@L`4?%*,44,I08<)?&=<U8(89\U14
M6^J0!B$KR+1&V*&5K&@='4"B'H60:)0I9I)"G.JL>/$BLRE*&N8SC3D<JZ%1
M:C,\1668$,I$U,I6#`2A7G=3629#EP,?L5-4F'2BO&,O#4(!R;B9\Q&9E=0>
M;6D2V\H29OFL9<&>.I*?TC*=%Z$P!#M^/0$P%->O%=%`;S01D0;^(PNA</3Y
M,T7Q(0OQ'LB1&@H1G1#+.0Z7$#IU/""+$,<70]<Y3:-!<2/T$YCX)06#52$;
ML"CI$]]):S^Q&3\Q(Q&UL!<A&!6$L@TA,^C$2;'B=W-4>*#71CNX1P`CH:A4
MHQK@=>QQ06$7F.JB)3)C6RR!3N2Q2+<'9,-1'R5E8YWA(XH4F/L">K.!&7&&
M'92"&C0F:8>FB#FV=?NHHK$A7<%R$)LS2GMJ>HK8:5_"%*D5LFP7*FH+&&P+
M10GAMT_;L^GSLWWUL#N8A$-"IZ)TA%MB1/YFD@IF$`6)?^SX'L@(=0<`,)8A
M4TW7MUKJ3]9!'-_IMB;)N7;23LC%I"C^0VNU55^@FUSOIC_[4AQ7DUI?.E(^
M`XE/Z"T$`G(/6;L_)B5=Z[8C4X`_FJN7\1<WJ[QR]Z^1JS63NRU!NQ#G%[Z`
M`56?"HTY$[-^@Y<'49"#R*U4Z;4&,XD80[Y%58I8XJY34E8E6[]S"A]_43UH
M8ADA.:?`"VAF12+-^!NK^3:_0AC8F*1^]7`T^ROK%'`(XJ<66$\.NZ<13!HS
MZ[W+`[YT11%#ZP#IM6W?%*?E4:I8.B$8\[F-@TX>P&JV$;^FRU];2CXHO*O0
M<JL)$E&?6[(C^4P'0T3,-7[TU46MRB"*N1W.Q)`X^:MQ]\!Q4UQ$F%[CF2V4
M42>BV+Q.PI'^3NRC]20K8[:]_#K"Y=.PXMMQ6F)0Q&EAGUJ9/^J9U-5D:OPI
MK"&,^TH:IBMFV$H^+B%IJ(@@0W8Y_1<G-H9!BM0O<VN*K4AK6]8BU&H8\P&X
M:`0BOSDVP7?%+/9B1$B<#_DF;)AX+I9"J;,!X)K$+I&K?2N<(KS&LSS+'D3+
MMXS+N:S+N\S+O6P0Q.;+P>RL]AE.62++&/?"WKL[+?(F)H%J[I$MG/9OME$L
MZM(>D188R,&&!U@:XZ,F!IA7%O0EV/R.WUQ$&[L[7;BQE^F%4/,D2,>SPBR%
MB&MA[)J]M`<S7.1U+>)U&':WC,=V1SM.JSA%<XQZ$UI/ZY)&P%+^2F1T+#5$
M)F8R21X`&K,%9+"1*:+E+0C!8//7+C'6?^LA)G<#B4NU+>9LTNXQ-ED"TN+I
MA3)R1!$]39EV1.Z!,"?=B!ACTO*L$>UQ'TQ8&3#C<3-H)E#4@C?&,,/KJZ$%
M-)/6HTF9*5PBEE1*4DO)@)41S:AK@$RBO?&S.^$62"I"'_$J::%81/MH,:Z1
M.XW[4Y3"BIT5(28MT^`<*Q8T16R-TR\-3+NS><!DTYJ;UT\2)N7(TQ>A)I=G
M58((6JL83H/((+6('@N\BH>-OK1&C1GGBM`75G9U,;?G-%WM/C)M?6$-;;'A
M'OIR9(!KCS.W&FMMKUBV8D!$>.R4UP;^>!FQ(=IW_=KFG%L[9-39TMLKD72C
M*=,TPB1N7-@/$1NO`M05N33#&DX^.4T^V5%E,ZS+?:+8H;E*N1_-#2W\E2D&
M.)(<2"6X)6G*M9^AK2@37=$FC48ZE"`.)A#2E80HT1X?/1GW;46F(VHF33$:
MX%SN_2[^EK-K#>"5T4#B>9D)WAS9&]@ZC=S)W1"2!B>G,R$E%QB;R41IQ3O\
MS#O^?`"_2>$;0,>>4]"*!2VV8QP_W:%R6'(6%CS]J=YF,IG.3!C,X1[_+=^I
MI$V)A!QMU\QNDRG9H10"LM.5$D<FC>.B%G.`H:)('J1<G79A*>5>%%?%G5=T
M*^$383PT<6;^&4P3W;GE8]X=7>X1=Z809JX2)$OF;<X?O>86<'X;\*D0<HX0
M=KZ>;MXF;3P17D-1H*'&"4%N#N$>PD?H"=1O%O$LY$-N,BX10G40+-NL]O:\
M',OFU(O<^+D0@RZXCCX2]JGG'%+"$7X0,<*](]4B^.%XD))THA(KND)%>_PJ
MHV&@JBU%_68K#L!I7JLOARDF&@HB([JX+3XKF?)0M%>C(RI4B5LJMO*Q*&HQ
M(?Q%)9JU+6JYO`F+5.AUC:*A[05S(].9P]CAKX?8I(Q'(-HY<A3*2Y5%#QKJ
M.#+J%+$OY9%:4HD<'F""#^=^6,I/0V(:FSMF$#GHJ<XOZ!(Z+L7^0*\KO`<B
M(PPD7ZEK'/ABZ",H?_Q>J;]+-L81789N&/#5[^WT?PDQ,:H3.OAG+?AIU&-6
M3V(YNX*!,->D$,5+'*1!3G*SO$J%I/'\[AD2[T$Q4C\D/2WB+CK3Z8&U(MQZ
M>RA4CAB46`-/.U\4XA:":#ZSZ(I:6(;J,-/3C)@J'4<OIW\:.*672`C1\3BO
M'GJU-)G1.%'#DX/X.LQLFS$4'U#<5LGHC0BQBS@3'$H#PA[_-SJ_\P#2\Q(A
ME2R12T)/'20[8>V$-ZYEWO^>S`]IIDYOJDL5]6@#Q,Z4JZ>!451R7&?SRSB9
MD+V='J`*6RZI(+U*]A<X6]REHN4!7.3^LS@DWW:V<:OX"=:""]0M/SC[.:RW
M.EP)L[P[HZ>!+^IX0NI0R;FRDE0O(6:`BR;JBCL69AIUC!"I1/D_`_7.(3W8
M>I/I$3M8-BR$L=$'\9N;=N&?,ZV0G.OR,1C[.S(*E%9")LA-5NK%PY.D>3E>
M%V#7G^$>#!`?/AP`<$#"!P@;)``H*%!@!P8`(D0@"(##0@<>,'*P`,`!!`D'
M/@#H`,""0Y0I5:YDV=+E2Y@Q9<ZD6=/F39PY=>[DV=/G3Z!!:T+0(-0HSPT/
MCBYEVM3I4ZA1I4ZE"K1H5:`2'`CDT`&K598E17XE6];L6;1IU4;ML!4E@)0A
M7VYPBW!L2P?^%&;*G=D1``2$&UAN`/R6H4>:#@!X:,D!``,.#OTRO,L2KD,.
MBAU$7GHYL,.*#QBOI7GU:5?2.E$[79W:M5`'BA=&X!"10=L#$1U4`"!A(0`*
M(25$C.#AP=\/'6,[A"#;@E(*)P729>`!(@,'$4S6-@G1XP'N!AE2R.UQ]$BO
M#S1XY"[!>&_"$U->'N[@.``-PR5Z4/Q@(4B/.AA.*8$LL$`"Z20[R3L'1%JL
MOXX.$JC!@40[[H':L-/.P/XT&D^_")[[(+KYF!/L`X@BDT`OE$+C#P`"4X+@
ML+_&,D@E@E@$RC,(*N/)`:],7*G'"=M:;*:VG@(2I82&]'&GA/C^BFFAHC8X
MK"Z:WA/MI8H2?,TF!S2P``(//'O`@@:W<L!*AS3PSR`)2CKP@P@TN`U-YMR[
MS:*,'`JQ1X@Z@,`"#2"@B#_'-#H@Q*0$<O,`-4_\0(((W`ML4(@L*(Z!]?I\
M2Z`5':(@N#@!H"M(/I,+3L</'"L,)0-17$PN4Y<<";,8DXO@@S-O&[10/`=U
MU+]22\KL/(%X/-$"5E<J4P-;66I2*XD,\JNHDO"[D#LT_SJ.,VHCP&[.A+1C
M($*!FNOMO5<)@FRC<+&SDP'(@,2(H,TBLL!("C_X"+D/./6`@8H,<O`A>BT*
MC8*B,-07M,<N8B]>![H5S=[OV-.7W['^?@N..!%)W(!>R`H>T"/A)B;.(8S\
MFJY=RLJ+K3>)'`.NP(.('"CFB,YK],N;@+R1)/T@O3$AN,9$V>"1?C-I*[J8
M$RFA!R*(L4R&($@R),(4HVRKD-8L<,8&<Y:TP`<(.Q6ABJ=C*$B'Z!.)@N-\
M.WC&!\0Z#*2[C--J7U@7!/MN&$O"%26Y.)ST`,+F-%!I!VCEU6J5E"VP6904
M>AMON&44S#>Q)!!604UY[<B#`T1C8`,2)Z5@9...MO)$'O6<LTZ!('LN(PHJ
M?;VZM$G2=+.MF"WW`/X.Y&\L(#VCU"#([)1<5@&E>Y:VJI'W5/<'>/<=]C.W
M&I1X58]/WKW^?H<%G20^&;.R@S&C9R#4*"'UH/?UI_.^R0^L9,@"^:7.7V(B
MDTE>A9(E#8P#=A(@Q#`'M)@([2#`B5.:9+<8X46.:2:14,`X4A<(4``B'NA(
M@DJGP,'%9RQ;6]2^WH8FV7%E20A*"*;.M:LU0>!,)5H<M!!BMY&XB5<$R0S+
M[A(U"AQ)02@"FP4<(\0'$`2!(H%4Z<*WN,8I13T9E%P)*R<D%$%F4AT42!2M
M)*(H2NMS#C+(R$Q2H`.)1'$W`E*L%I>D'IFM(ZOCT=2\]D;##>0@A`D)'J/6
MM8K\)2%_I)#.FM<F!HPO6=-+DH$T9Y%S4>"/@@GDC0AY`#PZ#H;^>UODE:8V
M%LA)KFH$.F1S)CDUA7B2;[<29/\@P#_"/,0M!3F(!-%SG`..+DDCN5%*-@/!
MFO@2/X\9G^P^<AQQ"<=![]D,OD"HF).4B3,#!%4$4@@![F!H<-R")L',QC*&
MB&8A[7E/!`B3&V3)S3L3426,RC0IRD@)(1X)8>"8V#^/P.5"_'D571ZS`2T5
MD6N#B@A@RBDY;:(G;EF;$4.2DT[X=3")W>/`0-6X.&)*0#T^3(Z!=G5%.L)/
M.H44WP'(%*;;!(='(CP7&3V(K_M5"I3B&UD'1D6^=&V`(@4J3K\>Z1!Z*5!Z
M3KQ,)9_#.)(T1Z@^*IEY\+=3A*`16D7^#.I0=;6\#Y0)?AJ\E1?[%]/A+'!^
ML`Q;3J='EYSBLC!*-:>_.C"T48D516D4"%V+2:>&;1.90/O98`TKDSG-A4!D
MJHF8<#(M-DI@/0TI:4*WDE([LM0NFF%=Q#Z2+FQ2DS,5D=AF-)L0W;1%0/G$
MI#V/8]1`"J1W.RN(E12CRY)N=#,`;%5$MD3;TEX$JPQ%#L9XV5H+?:>,$EGK
MK2)ZU@"93"0+29EI#P8J]L@58@5)Z="\(Z$D4D8@!?LKMX9YV-2(!;WK=4EB
M6Z)>]JHE:D`ARE?<"Y3"SC>^^RU+:X1B&O[&Q+]1`7!/"AQ@G.BW)UHARWU]
M`M_^80G!$U;^B?_RECD)AT7"]9.)2&?B&00JL2PER=5CUW83G;GDO,FR*Y(R
M'+?S1HO",Z9QC5]#I%'1:F3TX@A#-."NS##`FQ;K5$A,MC*4#$QL>),`MV2&
M+L35*)\,B-&.Z]4!0E*99!PHV+6X93-6M0>;F+'-:I/K'F!:63E`BHA%.M(]
M6/D82(115Y/'\Q[?T*MB$.K-9K;5YA[CQR&XT<UY.@*!A&4F,S"R<:,=_>BI
MI*[)(#65\$0G'=UI4@-M"=:8%`)`M>8/5H.2`%PK=:@]^XM-E:-KJ!SRON%A
M&22O$QZBU3HZ5(]))3;4M4K"YX%!;>IVZX%?!!99DNKI#DNCF_/^+6U7&$T-
M;$6<%E]'_&7%CE1O=(-.DZK?@FP$I:ESD"9WN<W-$Y?&<22M=*.UB\3I@QBH
M?KN<GD/N4U-!_O&"*R$)O2O3RF9S#6JN7+>^]`U,!'JEAB@14$1<"JJ5'@9/
M=#Y5\?"TXG8WFT@]`B:"0+534<+E(W+$DR4?ILL8PMCB0.+<N5W^<IBS9'4#
M`0E3>SJJD3J@9,WI`*>U6*A/RZ_>9TT7FCQP:AN9#<1Q:_6_8ZK)#8R):VB5
M7\Z]FE>2,&=?YSI@<*BMD=)53$(WI\"Q+:YLE.1\36,*(4165*:P-\CGO%K/
MM4]:\N=H@*1,3'FRG%HQ+3XIYH,G?*/^*[(9VYI*SQV8[`%("R1.-Q2?1L[G
M=4'%HM1IQS_A)!==9M0YN$@W<ZE5#M_<*#3*-#Z<[4%)>W+9)F8>R#S0I"8`
M`X01I[X92XTOO;JVOBYHLM3V@/F(GV%41`,UGMM]]Y<K.=0!CQ9>^M.G?DH<
MK),0O82Q,U%P2KJ/E>^OI-<^N7[US7]^]`>E_#5AT+B1\F+]G27\:6?(V7BR
M_O3G7__[_\"!H>(!^^,_EQ@PF/"_E`!``4Q`!82@BNJ-OZHE%F.)12,8?PDH
M9/DGFK`C)B&,PXBZZ@"H`+R)W^@E]XN)R1`\.&J)-NL`[:"L"1$,!M"+[`.C
M]U*,U7F]]O+^DKBID@-:"@,T"@1<0"'DKR8)'=LB&,V($'/IG+89F1EYPHI0
M"#V3&6"#$3+RF+?QG"9QDXXHBH78@",[$QAI$(P"M!81#>.`%FQRD?[`)QF+
ME0.@`.ZX#9TS"69IFP.,D=]"B1#)#*6`C/OH%/.*"-.8$S>9D?)P$^2(PBR<
MC^H@#'9)OL6@C2'YGP=LB:5KC/O0P;[@1.NSJ2$,Q;-H0.$8%,>`%%6#"U-)
MB8X2%6N#B]OHJ&GKMC7)B$I1"2[DQ!H2#"ZLFN:SDU"C``7"D["R"*+Q$MQQ
MB`9YN&*$%J]`/E:9#!U1CV4<%(E8"3NQ)]L0K`,QD#T9C5$QG\W^$+%6>1-;
M*@D2.H@ZB<4S\<3><"=2`ZP0J965B)I,09`Q!)$Y/+25FQ^$FY`%H<.2\ICZ
M",0Z]`MN89=]BAQ]$D6'Q(J$J`TNTPJO*)O`2)J#.AS9>L5L80B6.IH;>4#(
MT4`3:<"H@R'10<6FP:JVN"2GXD,`:S:7Q)M$.J!8<8R&*XAF4XX<G(Y=>;6J
MN0BZ&9&Z*:6O68F+J*&MD3@:(4FFRPL`^1\A.S5G\8^3@)X/$C6ZZ[>2"I-A
MPT#<LB,W<;41T23'&Q1-T9[;P9-;?$BW_(HF&1.#,$5>NLB!\2DR:L(]N97;
M^#C<,!M;[""Q0A,-A`A5XY^2$I="`4;^Z4$>93,CKB3)U/&`V&DVR$0C8K2^
M@/0Z<6N<)`I`9BDII6"=)*.R_HM!'P*)X\$M/EP04]&:XNF@OBPI?NN_OW"O
M!SB7<VD)C:@85VH+6LE)@OB[U?J??RH8BTNEN:F;G>P6AO@CQP'%MYQ.IVB2
MY;$SG7.F$(J8UCL."E1%VK*;OPP,S2.C<B((2<&;SX`C.PD,T=,]W4(^'6Q!
MXI.U^!RHWZB,$UR/2$(363.02R,CA<2]E'@`O8"[>:H4Y.(JS/`:4'J:L'HM
M+O-(])0P^B`3"=6D)Q*_PB@;9:,5SAS.Z@B1.K(I/.R1$<TV-`F)U*3(QDE+
MG)&AHY-.ZJS^4:EP#*F8P:<8O]1PK,$"MI]X#P?$Q^ZA%?X<GUOR"/\4+:ZX
MC^(@F^=@KD(B#F^2-8*PO>0R+91I2!OM4J8(+T\4BO9[BOL(P7+[00CB42]=
M4YA+D>3PE,SIP;?@09F`%L:0#Y5PRKY:$J^1F.YX3A+R2);PL)%()\8@B`OD
M%1:LB.+PJ#GY#0M@U&S)B#XMF+"2,01ZH`]CQ9#PDCW:`)N)G,.P$>-,#F@[
MB-\`U8C(F0")B3)E+_^A$5F=55JM55N]55S-55W=55[M55_]56#5U1)<K^=(
MD?;PCD+!4T<$0`S]"PXH#OP@R0A@F(P@+WW1)"]IBU@\.RP+D9S^X0"&X4WL
M$(S+N+#F\))$JI;SL0M-.HC;$*I<^U9NK;C9]#Z=H\RZ"0_1*PC=@#)\>DZ4
MJ`[HTP!6@3YD:12(`(QVE8S><<S285.(%<+FT`L;2A3;2M2F@<=AXR--$2PE
MTP"_4HJ.^$ECDC5!@@M..XF0R$T7'+4Y.8Q8Y!0)$Q-":1);69*A82*;C960
M`(QB*B9,%8@_.8!HZT_J"#4VBI2E>YWM8S&ZH(!5_;@6N9DS*8QBHA)=PE*,
M]5(6%)'UO(D<`2A!90D]K<2C#`N2C5B<J(TBV2RQ+<$'*3NG>0Y*\:8\W95A
MJDN>5(EF.UDFXMF[8("5N+=[HA-FZ<#^[<H:P5B2T<G9MMA9E7TX3_*4H,6:
MO_`X;\M;6MDW=`)8R7@,$.J*R[(H@+2`U_LKPVP+CC@(\E!;4(FZ-XJ2#U$,
M<<D(`J6M*+2EO1)2:-&7.Y2.]B@/QN`?0O,(V;A&=W)=G!BFBAVX'?JB]8A'
MV=+-M!VO@_"K>/M,ONV`5O1&#^"`09%!V.&5"A/<K*(/4-,5/C0.P`H8Z+N+
M&ZD.\,6=3#)<D360/0S:$[HA?SF7;`DUIN)<YF#!E6!!W"&3T/23AFE`*G)7
MREP=#*FE<'5=P94]\#V1L?P=XRBY`Y4?.XK5&/FILQQ9K<N4&*DH(&D0I?#*
M`E(5Y;V)83K^UH'+C;V+0-$1+6*+01R1$/**MP.14SZM/TC-ENJ(POMRM=0Y
MC#,A$'141B"MB.T4KQN!5"@FXA=9)L\M402Z"M^`)B>CC,333LRH$QU<",C@
M%I`BLS?2W5J*PON(*GMRW=Q[@(103CRJ20RTPY>Y5-9ASO]$C+;-(S`:3V5B
MXQ<&0CE%)A\]K$4^Y$9[R>,@MA4=KLP,*P^6CM=+-9#82>W-JGL<9(LL9!QT
M9%(N95&L8-=,"BD=KDLBU8+XX,.($RIM3M'ABE7]*^(-Y;N:(!<V9;4(0@0#
MYIL09@$;5J@@P)H@9N65+!JC1%_F$G)T"2Y5,1L\2;+5P5CM#9G^(#&7B-5_
MB1@A;19](DG@A!1C7B(F*=5=,U-HCN.<.#88KAAU.V0"IK!Z?F:7.%=_.=Y&
M_0L&$0^'>0SOL`A8.0A%;"TTZXW?]3[`\`Z_B*)"ZP]L`B9D?;57F9;\:&B^
M^KB#9(B.\F<-2F$8$8\4UI=&C+`PZB<Q7"8R-!6*>9%<<=,5"<,M.S+[\#'C
M72WB.3D$XA4Y]*:LH5U\'FI'JPT?8F&X4\?3"3=@NPHQK)[N3)PQV;JB)6&&
MEI71@+M(69+&46IRC%67.@P[&0T-2-NP&6$`-=R0CK94NT.T3C*K'(C;H&/I
M0"WN]0\-3AM,36!+#D98LS7IT9%PI`O^^^F=:MPU5^$0`"T5HFYL&@NO6MGE
MII&XP2D,X;0XE4C*YV,;Z=C;./VG5C8;FHQ*"/WLH#+5#^P_LS;G%YW;D":2
MD-B;YE2)WBR3:6VW'J&1T^+`"[L<;GLE@'LEHNR-19*EODV)X!`7VI#GH7-L
MYV8O!=(594JLK3$ZZL(-S/83UY0WJL:AP[6_7$H2R#P:*$HW"5DQ0VZ21:GE
M]T4<UD9+ZE[KHLK,V9:,#A4JB\@YN_9+\2GO01.C/$/:FTNKQFS1XO:>XT8)
M.]&D%`90RWMN"#^L!BH)91*MP<&((\6[UG/0*UW5=@+0'@SOK="MSKN00K'P
MJTX7AH",*KS^&?=N-H)01.()FT6+HOR$\57LJ_LP:,%MO(6H"/'DJ>@K$(R2
MKM.[J\I+4-S;B)T4T(*P&MQ0KDR,<"JO\JC@#W9^";YFBOFSB4:V<C`/\[*8
MK$2.B>%\BBX7<S7O4F1&TSI=<SB/\_A2C*VE"<2TZ$O<8??>XY3(\Q:SBSP-
M4SD?=$*?"9T3J<M-]))&=*T!-"`C4-MBO7V"%/.X79V;GR-4%V-[&D8;",WP
M$.+A&-P[R"4,(X\F2-K%#E`_9U&,51HM=%A/##%1Q_6`1J_TZF3C".=CD1K:
MNLAX)S7AX`GYL4MSE5)1FVA!Q5K,*;%+GN+1M&21%'"3C@P&'V'^[]+PKAJ]
M.)-7CW5O+]FY+0C9+DX(-9#+P./`8%S!>*><07<)XE,B><U]NC"0'*3FV+B:
MM)5/_:?'(9O30G<;!>'<@+YO+WB8T.)D85"$=ZJ=V[#&<5-VSRH)DR"ZC'?"
M\&]G8G:VIF^ON,O@X'<5U:!0@K_IS"7^6(]I-7B59PD@$2VXN/$.0'$#(:W\
MQ"Y)EQ.SJ7F[,@C'T+EXEQ./DATF_^BR^9H@22(Q<JJ'8N7\G&:'S.1G)>B5
MG_K#PE&JGXM8/DT(O'JN7PLP[?J^T%2P'WNR!YHS%]M@37NU7WNV;WNW?WNX
MCWM@)?FRK_O]4V:[SWN]]XG7\8OZA(G^LE6Q3I_`!^T>0&Z)2=M[Q2=T09$H
M:C02B#[U\<@:-C+I'!>S-=9+&FF.\'"RB`#?Q0_]..?92F&,BBFJX<3<7-S<
M/[SKHLN4PFC%C02,?F.4[$D>`DEMT=]]*Y>2Y_"\Z4+%?E=2=>.ECKP,=8_]
M$-:U?A.;"LRGT^9]Z8_PD,@,KP@WMA;^D`?0`';7SN&U5]'+AZO]K=.98KKS
MZ4__H>990R6>D;:X\ZPTQ0C)L76]5_EH@LFE?OLRWTHLW5=_@/@@<"#!@@8/
M(DRH<"'#A@X?0HPH<2+%BA8O8LQHL,.#A!X<;-`H\@.'""-/HDRI<B7+EBY?
MPHPI<R9-@A3^0A;4````A)H,)7#P*?3DSIT=+.P$N:$H`PX2`%#XP```3H%(
M`1P86!2``PA%)5@%T.'#TPX=J'*8:O(J``E>=T)@^\`#P:T...XT6;"H`PYL
M`9#=R>'L`0\/X'YPX.##`<`?D(ZU^Y;GTIUS"4X&()>N5+"-LSJP8)BKA\I<
M35-EZG<KZJI#7\.6.#@V2PVT8=J^K37KAZ59)3!8.M8!A:</..QTK9G"XH'"
M/T#P#(#N@]"!)9S=0`&`3K_-H8.UNOAL;N=BH<]-:V%OU@=QOWO0_"`"80GI
M&1QP@+6QP.KK>Y\7G7EF,?!?75E9,!YW'VC@``,>-+98:#KI9,'^<P".A6%B
M%"0XH&X:'2#!4B%Y4.!D&XP&%71?96;6@ALP,)8%?X5'T%\A-B0!;PM!X!I"
M$'#V00=Z%:3C0D8^%IX%-:*T04\+G;?!=Q5UX`".`^EX'ED[CN38AT7%Q8!`
MR)EV''":3>4C=$\*]-QD4:4E)5D,!$=58W$]5I231<T(9I!MGJ>90!&P*1!6
MCQ4(9F(,8$=8@00I9B5@<3;G)I_/14#D;GG"15<$%D!P0(3Y67#6`U&99B%K
M11W'5H];?7A1B$M%U1BH(6GP@%M"/G!`CT(Z]NMC70'8TXR]/7F70<?F1]I3
MRI*T4W$'(%7=F1&D!0!^7-WE)'"Z<M7^`;4?`=!1!#@A!Y4$^D4PVG&+S:BC
M5PXHJ=]<SV989;GY/;:DM`=,]92Z:GD58KCX+J7?6##2F98&)0K46+D=3`5`
M4!^,!D&5(59+;X18Z2AQ55[IVFVHE@'<UK]3A=;6LQPX&-50AR(Z9FHP=^06
MG1%056135VD8'5*V%2?5!NLFV#.H6'4HD(#B(2<S0<\)^@&A["':M$`=`'<7
M5@6>U1:]$.CW0='!!5TCIIH:BF!?*L9WU,D`/WIT6Q?B;;$#'6E]8:P6S?J`
MF)G>RJ#@G&E`Z%=.X\2`!C$Z&=JQ3BK$K(0=6B`SJ`))8,'/]&+GY0,:]&BR
M!!3`_!@%YTK^F6'F5CTI0>@6F/0`YDMV&$&]T&&N>;M6POM?K@=T)%"NLF<'
M0>J@PKOZ`<@M+-:2$D1P@-086RQ6YU:!]:F5P'F7Y0%2ZA@C!\5+Z8'N)@L4
MGP7%&\XO2%0YX,'J#I0G%,V^S:F3N"!#@&=(<0T%FE(0-X%%,5+YRKI*1)7J
MN$]K3QM68#+D(0C<QT!M6Y/6=&(]L8#L,O2B5V46N!.P('!`)=+@!CM4EAN)
MQ2N9$XM[\I8AX7RF;UKZ6T5F%<`&S>A$#S(>H3:0EHO]2B<[L9#R&+4>RB6$
M66`Y&6)XQ1,=C<=C']#>5'S5.F^)"DS*(ED'H(B7Z&2E+0BZG8[^P+(D[O5+
M45O:4O"6]KW'S,M(5*'B5GBBK"@MQDF/@T!N[":6X'&.3U8BFY`\%J@L%25B
MGEE7&7LD,!S9$4>OPE'D+*B_'5U%*>>Q5ERR5Y7X)&5J`0*+!\74&T;!BRHP
M"I<$^=(ABC%)0W@!`-NV:)FC;*4#;RD55CSPEG=-D2JNA%%I`L07TQ1J4[=D
M%)YX)Y:EE.HPLM02:AHS%O]L16([X1(/'^)#SW&H<)SK"4>\B$?&\>Z5E-O.
M$Z-9$"GR;DIFHT!\PA2^-!9G8Z7;`*ATE#J!W"57'^@5%"G`3YZDD78+]9SZ
M<%<_W5FE([;3)^T^`K"*2N][<4N0'IW^=-"#6LT"T'ME!QPJ%5<N='R'[!<<
M&QFBSV5)`\<#F"?3MSZ"8E"F(1KI'5^5OOMYLIQ*72I3FXH2'\;'+^K$V%NB
M\BN/0F<#9^$,_I)53X0FE:::-"1O*.8R:I5+B]S15ER>@I2N&.F2YUIHN3SP
M.B$%3(_N,B97EF0P>HF')X&A&;EZ-:_W\1(_8#E,!!B5QK/X"V3C3(O"7LD`
M9:UN(-NISO+^,YJ^?*]C6=+/T<+8EH'P3%=OA<!F0[/8Q(X5KER!65B=:MO;
MXC:WNF7(YGIX/:M=#"8?49-+"(F1WC[D4[M=+G.;Z]SG(D2;Q(4(D`8RI)@H
MT9XN6==%I.O^$+-""[KB'2]Y;5N:,24U?R\Y;WEI,AOA3E<C[VTO?>MKWX0@
M:5E^%5:;0I7+@V@`,E!:R+$.`D6MU!:>&,DO0\BUHRJY)+Q993!*0%;@A%SI
M(-4]B+Q*>]\/@[B]6)Q*G]8*4:[HL6!`"5C*ZC>0N7!E/RACF?M</)!T;<=B
M`1N-B`)(I!C?%%Q]*24'1/8M@N!88J>RC:[R0^*$-45:S@D5D:JT5VTVB,18
MDM95`KP3#4CL>5WL"Y91_%>GJ&4@83XRQ@Y3/LTD)V&2U9+IU!*B;,DNS06>
MD4[4=[(1\C+$@A[T;K$H*@A4,UY>+*E_XT*Q#H%D3#W!BIRP!^G^R@07=E8!
M5:D*U"['D68WY+M)_58G0ZETX'RGNV>AXI,X5>?GT'%!#G('PH`'6+!*$K6=
M0!QJ)5_EQ#W_P5.)./"X3VV@.AERJ"7S8S_=A:Y]37G<JJWRZ?>A^GS50P['
M#&2ZT(7(T0R(SEE(@KY/T:_#R/,2H=OM;AYBL9*SG-%^/;S'$(UQK)+<8F3(
M.L7*D/.,,QJC=0"TPT>*"H6(;DO83ACPPUA2,`6:ELF4=1>(HQ8X%MJ:%F=$
M`3>S#W:G>3*)FW,:L'Z\+<U6N!XY;JC\;H\QH>-+9+H]$-.E$=]C(5L:#27M
M3%%/W3U_-]&+'IMX.VET0*QWY\C4Z$[^OU%8..).KA@*LJQ")9H.C:"X)0H2
M#!J(ZDT^*J$*6*(,47CKVI*I,$&"=$2KE)</S9!8*,3Q77<H.B$GJM+WIE,'
M&9L!GZ)8:!83G6:76G=#+S:U06F2.\9H4'&W.4*!JL=P=SI46_1Y?PI4(*%O
MWNBB'[U,WJ[$,'XO-0K3S(K5^&]);Y&TK8VZ<%*3+Q:CJ2VC.5>HAAA[JL1U
MMJ6S@,1D]]BM!:RU?A'3VY'C(+/6Z"KVX;B[LI6ID-.UL:<_?9BSE2"S`MWU
MLVUYQ,:9W]WCJ/B4!5EC<++:R[?>^)L_GV;?IH$VJC'TY9PO<_EO$?6B%T4`
MH%,-((,4G8W^/<2&U80"3@1RD%Y&7!A3W8A!\!=#-,9OG83F,82$-5M#9)C,
M:86&Q=>`25BL?*#^38U_W5Q8!=-#X)E#[!!NL%!]Y=@,/J!$,&!3'<M>`0B]
M7!:6.8AFI`O/<`?$F95M8!N'',:[]`N;\4R,!`_9M`6.\=BW6`F=)(K'K%F:
MX17K=4RSM`SU:$OT]$7`M`\0DIB[(,6ZZ(=*D5C*T(44@@6^.,BZU-429HO%
M$`2/51^=.(``R>&=D=@:XHO38(5^U,_;J`CGM5E=.<AE\<1A7$SUG%TC<D<0
MJDIEW>!%^-]*=.(F%N!,'`O>,4ZU[=.OQ<63T%OW(`5GG`7,X%W^\)ABST!8
M$$G`"JGBIZV:I!Q%$77.M#%*M`$+A(!/@LC/4FR1:_2(N&6:KQT:W@$&*E)B
M:,!/=!1;\^!/ZSQ&[4!&S%G;"G%CC,0%Z5CCYTUC5#5/?QUC:$335\0BF,U%
M<'`(04"833#'H6U;#$K$&UE@>-1C09R@3V@@002D",)$!5;$#FT,)3'7@0W%
ML1A)@75@RE&2DPA<9&G&E,Q'D_6++(+2VD5A5H0*Q,6<D0`/LB#>RPT=A/E*
M%HT58"`%VF35&.$$1>)<'"5&)>F'^0V$YO$1V>Q<N6C>P-$4EOQ'1+K0^"":
M2.*;GF"%'#E);)U1"'+.&MT%CMS%A57^27#9I$Y&1E+986/5#QWJQU-X3UW1
M(2SM"R+"HKUP1HA<BYK]4L5<3(KHA'ZTI!I-!9Y1`)-YG[Y8B<U`!<>D58O9
M);=4TK>(S$"(5AIE"Q2.VU3$2,6\E<AXGYKI!P99C,C(V6,NY%V\#";V9%FF
MS%7(E(.4)LIDIB2V"1;2EK=<EKV,E<`4!\'0S$.N!RE.V`$T"'B8C-JMHLLQ
MIF;@W8-\"I*<'05`@'&""@7@TD-Y76!>84LIY]%X3N"1'TL68U$M17*&QS)V
M6E#TIMY5$C3FI)-4S[XYC7,VQ7<DE$;%8E%:6V+$IXXX"6L]&O7LB-X<D`J6
M3@3,'2/&HKC^)-!1_$>R!==X5F0`Q1U8WL2#;)3JX`^HU%@^2:@&:*/\D(KA
M_0=<"N-`1)7VL)!#4=JXW6*!=$378<M\%(9K8=4[R=SG'&.O5:?I1(7Y%$^Q
MD=30+52#E(?MB&B/X.@Y1DP\:H?GI!J+KM1$?0_P/!LJ]N2)O@_CC=ODP8_[
M&.D\8@CMV&B&OI[AK)M#"L4.+B%G/(6.@%\$F`STS<AGH13V<,!>'59^;4=3
M')84=IKN,99)MAC7J-&:K>1B$&9UQ!9K:<O%/,4+=N'U5=)>=87)9(OMU,AR
M"LHE*4N9XF$=A<?N5=]BV">BO6'KS85LT0QD_=M=F"$C.BJ!YF3^@6G3>:0I
MI$(B6!X`A/WD58(%Z\417(S1ODP1J;A1A\J?EQA2+1H(10:*3V+ESCU.YNPD
M5S#EUD!<2]K4OU%DZ21FK<)*(S62'G'-F)G%F?!+$(E3C"7'OF7E7_S1MQXB
MOG$24!Z8LF*'R5D<)UU2@1:8G'02&*U(K_R;'3':H"5;3%2:1=3:4`SD1`18
M1"3L<Z$IA[HGJ\H'DZZ@0ODK=)"*1N4&7/*HU1FK\1C>4^B4>[!GU(4GV6Q`
M>F[CBZK=37F')BGH0!545D0>B.)4W`44\+34O([KK=2LRJH9OB*IY"&'[FQ,
MDSH;4L5KR9YHX,W:U5G=LN9KC/B:Y?'^ID;YRD?XSXXFHW;1%V$0K#Y%A'?%
M1L,6%SDYU\-.V#CAZA8E34]8ZC>52]21RE2P"<?JG_(ATJ(^X1Z%*DF8H><`
M[AU"*_*YWA?^JEKH#IS!5584WW!6AYSI1)4F%%NQT5-.X51<!@BFJ_I!8DR^
MA\Z%9B7UY-]V'U<HEMFDU1NE:VO2$E>@$5V]RVDPEF/Q6]4\X">B!'MM8N].
M!#]V28:8K48<K,%Z;5,-+Y*Q&T,4K'/]8TM0V(^,H$A$X$$`;^7\5T\6!=I&
MT0GYKD7PKD8`X/5JA)8DKT60;7>=ZVZ=;PU"1/,V%\7L)6W.A6$LIM5$Q7&P
M6.(N"([IB&C^J<5C1DB="=D-H2[,HB&E3J9@2)QF9,R*`-8<?0UIY)&1W9J"
M!09H^6$DZJ'9A.+W.D3UAH5@/837/*]$1$D+&D3T0D2*<*]"G/`**H1I&!"6
MO'#UB)-T!$GS+H_W@O!%G`77",^I>!R.1DR,"%M^8NQT:!I97"=)?>CH8*NW
MH$XZ\@ZW?:FO_6@WTMLTOI'W6$UX7-[E+(;NX*@IO@5()![^$$^)'&GGW>8/
M0X1@E*FA?!.8)4>VA$C.L0Q2D$W&%-89?ADFRMG"L`DSX8^;A:5=$C+JG@\)
MDP58I$4?7I8`A>5EP0R.=1EHSI9H(@OG?!\8W>]"!:;3!`79Y";^MPQ$@RQ&
M7\HQ1ABK'24.ND42]@!HOOWJ=YP1%G7K8XGK%*.1."7+<(Q55[)KSPX<7_")
M&XEQSOVJ&V5&?DF=PK5MZQ($3+UR",\(-W*.[M#%D%H(1V)%1YBP:UE-@X25
M,_I*/D9/*JEI7.CBAZHSW-%:]^2&[VWC1(FC!9#.Z3!3K["CT_R'D][/H0'*
M3K1GMAJQ#>^;PRQ&C&@-MPI.'&<S1!AK2'U$_=0L:EE,UP')2=)H/SVQ6N6L
M%X'$S+[I%6/%1ROH791T'=$.;_`CS*B/&$_>%"5(3=>L-.,$V56S@0K$$,%/
M1?.67\GG8_2*7>`$_.7D(0F,9I!1KX'^G%?RVR>;AW56Y>9U92<EQF3\!SXC
MI:<JI=J&RL511LF]:\A1#D;AW+9F=4ZJ+MOV!KT(UO-B,U%_5_#4KM68Q.,:
MCYC@&6#RB^$:7V-NT>2V%>/&[B79S/,A8LHP*F+?CJUHKIL^2WC(V6R:V0GQ
M]):!%JM:L\@4)%[;R#9/%$DHRR]FR.`Y$18WM:Z%A\5F14M7TJ>LE$.2S:<\
M7F!>HF]6TM.2K^P`;GV.=:T:7GZHG>.P<M*J*>E^LAN?-!IM-$/37[%MX^?0
MXT-3!VF[Q%U11/%2A`-R-]$U1J[452+5E>=J1F87Z*.Z:1W':B6M7SL/<HF8
MM^+QF^)"JB/^'T9?2.L2=>J6@)&MY@?TG1XG?S8405&"O)]I,8F1I%_Q0)8J
M6Y>@)D<,CW=&>!-%I&]%N&^&@WA3B7>(DWB)FSAW?_B)J_B*LWB+N_B+PWB,
MR_B,TWB-V_B-XWB.Z_B.\WB/^_B/`WF0"_F0$WF1&_F1(WF2*_F2,WF,A^]+
MZ*["PE>34WGY%D6")02&4\1H(UASZ0=G*-H^9J]!<*`V>N"#\X:8KH0()PEC
MCGF5P[F7X!D<&D]4<(AD+N3:AE=JHD47>5^(U&]2;Y,FWI:[/`6;\&J@%:)@
M3HO;NJ6]!(;ML`S=9"&"PXR6&2[NI%58RA"DWQRC0!S#M"<#%$?^N#RAG]X%
M)M*Q8.418]I+$MH@G"<YBT#=4$.,[VV4)O6.FG4$.">;%Y].$2<I.^>6>3+F
M]+RB%<.H'N5=@:.V,6$;+]).Z3`WE&[-=+@L%">/F=]<@-FS]*BI!BS/=H3$
MN*-B<((Q1HG'$M.TK%>YE^!R0?0*KHEK40EST#;<R27&]DK`+*OK5^864K);
MF&,N).]R1`4KR0`;Y_++?4I)6CLWMU)KE01L5(/54W=()PES3`JSR<3+,K<Y
M',W(1KK[N_<DU.42@[]TUA:>0>#(SV8>;PR58E1B2BWI;1G[INE12N^32-.:
MQL+G6+(N3S';PZ]QQ&LG3J61(&'M"O+^(XQ0YUT<5'(R$E@Y27`^N[HC=8\B
M1:R7O)'+^?X6!'(8F^6F^FDP]KZIMQO.;??T]0G-=V[M%;N-RN:E?1>*2(R]
MK>QZP+,,/<N@.JJ_)IMHIV&#$&)M;DY^EN>$2VJ/4YTZ!=M64GGW=^1'\+`(
M5E1]_>9S_@&)[>\>[T+`KTL,;.>;?JS\11^I_NJS?NN[ONM_OD^,_MBNKT3,
M_DJ`[>DC^0>O!.]+A.\?Q),G1)3[!/#K_O&/UTR!U;)444^^<';OA99KK\,Q
M288MKR!3]*;M<?X9)$I(_T%HR?4C__B7EQ_3B=[`3+ET>80&45GBF!X[R#N7
MI1_7#Q[2)3S^U0>4@>$:GCKG2#*$`@0`"!T8`#!X`()!!P<.`&#`X8%!#0`<
M<"AHX<,'BPX[.&`@(2*$C!XB`M`0@2-*!AT[`GAPH"``#@T!;-A`$4"'#Q8`
M2)!`D8.$`QF)%C5Z%&E2I4N9-G7Z%&I4J5.I5K5Z%6M6K5NY=JV:,Z<$"PL=
MZ"0J(8($#QUW6H"@EH';C!$L;'C@0$/'MQX>YG1@(<*'!SP[B,V8T*!0"1`L
M<`!PP,$'!S<_U"S*P`-1"Q(^T`7@P8*%`V(WP^1@@4)&"A0@;(APP(.#S$0?
M:,"[N;.&HJLM5][PH2/@V`T+6U@)\;5CLS5E4PCL%7ITZ=.I5[?^?AU[=NU-
M_;8MF_"!V8P67D8.#6$H^I"3,Y;5F_YF1Z'>VQ[>8'&FA+*21W]H#6`GAW[[
M`+.S#`)@K+9&"TTH`%6+:+$-'#CPM\(*@JRP`S'Z@`((>6)@@P\AFT\H\W@Z
M<+^<,GJ,LPU$V@[&&&6<D<8:;;S1JNY"^^L!P8;B8#^Q,*,+`@H(DH`"#P"@
MBR#W'"B2("6#"VPP$^W;";W%&F/1OYOXZH`"SC[P2:.XQ&0KM`5+>ZBAR-YJ
M[;7=).@(0]R(LLT_"58*<T\(_HI@.!-7FFO+Y23TP#D<%5V4T48=??31)TTL
M*Z('9OO))0\2^LM/!`GJ::.Q.M#K(LG^_"3))2#KZ_*#X21PS*/^6GN2`H<X
MR*B#DBQ`M:+(&E)3*)HVBB`MF0JR](.)&&"L+%YO_9386A^2%LC87(),P<0L
MFM"L)W^J:#Y(Q1V7W'+-/3=&]+9R#-VG8ANPW7CEG9?>>NU52EVL:D7PWJ(F
M$JC?@`4>F.""#3X8X8057ICAAAU^&.*()9Z8XHHMOACCC#7>F.../?X8Y)!%
M'IGDDDT^&>6455Z9Y99=?AGFF&6>F>::;;X9YYQUWIGGGGW^&>B@A1Z:Z**-
M/AKII)5>FNFFG7X:ZJBEGIKJJA5&[,"LM=Z:ZZZ]_AKLL,4>F^RRS3X;[;35
M7EOMR*Q^&^[^N.6>F^ZZ[;X;[[SUWIOOOOW^&_#`!1^<\,(-/QSQQ!5?G/'&
M'7\<\L@EGYSRRBV_'//,-=^<\\X]_QSTT$4?G?329<2:[=157YWUUEU_'7;6
MW3:=]MIMOQWWW'7?G??>??\=^."%'Y[XXHT_'OGDE5\^8-V8?[[>$U]$:C^B
MJI<>JHY<1$JT5Z'__E$5:_MV)ELK*FBEZL77X-L.-L+013T9>!+!'BG`:,+$
MP-]_4;34.M0Y#T%-]6I3/?]Y0%6HH8M=RA(_(TUF(#*1349ZU"/^71!'Y.F/
MBQPD&0L]IGKC><F!_#2@!K[E`-H3R0,B8,'\]02#,8P1D'0BEN;^1(!-?DH+
MG?9#PS$EB%!-"A$*51B@#7&``@?8D`R9F!U,68I\POJ+0YAEEB=Z`%,'"!5/
MO)7"LB!(2;=J"P7@U40S(LPN9U1CPSKP&*6<B&VHB]T<Z4C".M[Q:^)9XQ[Y
MV$<__A&0@13D(`E92$,>$I&)5"1V.*#'13YR*])C2U-:0\G9?$")D-0D4L0W
MEIO$JB"R*<E$''!"/3V@?4IT#`!2(YL0;A*2!]3+EK#%'@ZQ1D(=<&`"G3-$
MHD3`>;`4I@9+J9.%<*8U'>K)K'2)0IH(Q#TA694P(>E#&S+&,;+"TYLD-$2A
MJ*H]8$I23D)#S4T^$4BP8H"L8+*D8G'^$85C.D@$-O`IS@#SE>:$);NL<H#4
M%&5V^A3FOI98%0A<,I.:P>-"&=I0A\YQ*`*5Z$0I6E&+7A2C&=7H1CG:48]^
M%*0A%>E(H1?,ZC1241XH(U%0VBZ3DO0Z7]P0!!BC(4P:Y`$<N(E!XI(USH#D
M,/]$4-8B^H&=&L1/3IDD4[;'E`X\)R,)C4HELZ.BHP"KJ/8)%U>>6A2I2F6I
M*TJ*56':E2_VJ(V,P0A!+/(;3[[(,$WE"WL2\AL'E3.LVR-(0<K7&VN%IRP3
M>DE,@F(0UG!I5A^1I@3N8UC)7&I"..Q56U32II%`"%4Y#24#1EB3$VF@4VJI
MU$9D\DD5A6;^(AZ@"Z8Z]9Q/ZF=)J)J>GI:TD?1-Z"<1"-680B21QT85IZO\
MYP884%P@,2`""PDE3QI4$].:A2:C*0A4RQJ5LYXF`FH%3ES^*1@X/L2H+W(+
M;MXBF[L6E"AZ#8MQW&?!7`+G3\-9;T8T\``7R4I"&L`-,!F`I5\Z#TG$)0FV
M0M,;J@HG+E3B"193<YP',.8P<`&,=]>;'!6YAB<2`M:<.M@:G[1QOP#F,&UL
MH]^#+@DVLNDOA.=B4B7));WD3&Y>R"(9RCC8PCKA"P<T\)$15U<J,M5@30T2
MFNX.1B1IR4A32X(9.-5J/.A=LDC0!,<.NT0^0RE16]Q"D?LB,Y?^F$)09'(%
ML'*.R8O^(7"!0415PZ"9/D)I(X4NHBX_#65'WM&)BOA"++1@M3)$\?!0>F)3
M.(?E0F7I#TX.$AGB\NO,&\!4F5\DH?`Z";]@0=&>=3+)GA`:R$%NHT7LJUU<
M@6@G$&P5JK='W,.XI9X%B3)2]"HH/=;71_&M<8$[\%:$O*LL=F++:J1T9CF[
M"2:J96^8#AR8/WDW,O,9E&`T8!LH)1C:E"T4!>,2%T!W6-*$MM-9"!TF'G9@
MT7&"+[7Q=.:7W"0"X]0)<<6):3`#:-IT4<ZJ>?P14(<:*E_TKHO.'-5CZ52\
MCA8)DJ+ZX-\T9-9YI;*):"(FP:3*E=?^,E%$<`CB"4VF61$YWW9A",R,'+M+
MFT*-K7YRV=B.-MI#J?B_$'*1S":P,?.S*@4J8I+1M.G?\IS/9T0NQJ$KJXJ+
MWHBE^DOSW*C&)>>#H5%#R1(Z@?E)%=^65:,[=(`_[%U7D<!+`ZJ=?+5K[$8I
M>U(L_766_6MZ5>DJ4;YJ]JR>:^Y1E3*MU^YV[;RT1H#_>W1:.I7"-T7P,E+I
M=!)_E,7[G2D`RF=V)C0;R4/7XD79:7B,0M:E;#6\84T*'*&8U?Y<R?$EN;N@
MP_VMU1.E@VIWI'72E/FBB%ZI$,3]40H.>>[UI)1@E*;!C84@#:2&`NRCB(58
MR!&:P&LC/@'^6(#T,Z'N?5;00UE-IB>D1<.B2B@%:5#W$P*9S,:F5+.VL5!X
M<A?(4(24V#\Y9RR"Q>6?DB+-#9:M:#*83QL$7LJ"L.@.`)-/,.POL(Z%0S9D
M+#(%4Y(H)ECD?8:N(U#%)$ZI*%#K,W2+?F""KZ*OR@QB]GP/]O@#(4*LX3HC
MQ?B"0'B)X7K#P03-`M@J]B2/(;*$Q>@.E6XETPY`0F`,P<@#S1Z#N%QD2J#M
M!A4*I[#(.$ZCQB"(X(RB0#+"!5-CT`9-@/Y)292$0-K+>MJH.(C"P4X"(G@)
M+T9M@E+-/S:DO@Z@1VIO@5")T)9J-1A.\SPCEW1OO1B#K4RD]TC^L/,\*'X,
MK3]>R"[<\)GB242RY@N[I`8%,4L>#;U.,-,X+23>K#\:9,^,T`'F8T>:23-V
M92'0C,R.*>5L(OT(!*%(:#ZN,-PZ2-)$4-,,X@NM!#BRAB]0(Q'W@X4L:"<X
M(S2ZS!1KSY8H,#*4R2?NKL_2(@)4J,KV`SW\<.\`,=!.:-RBZIZ*:BP:8W:$
MXDOXQ)'XL"^*XO*^K#;P)"-0#2%^;3),HKZ(#4&<+1,;HMI*[0BK!!1G3<"$
MQ`GQJS7.L1OI[R&Z$3Z$`@MG`@+>#2RZ4/9LD2$/8S+`R8.,2#,J:")Z;1B[
MATD^HE#PPDV2\2@>H-MF4/=,1!SKCR[^_I`:V\-/FLE9L+%,,L4Q;B6+YH-:
M*HZEQ"_0K*<EO\SI@`LH6J(=)R36>@)57N.G&J(@ZFG,SN^$0G$NDK']3-'#
M3.(@B*+,^*4FM>S3!DU8:N4N@`0]]"><'!(GC>/D&DW'9$(S"F*%EF2=..-7
M7N4BGDL`W8D"B8+G'(/&/*XMHL\_*$(T>F,E,\;SL@+&!B:--,/VN.*@"O-F
M#M,J2F*E[J6-LNH:(7->&N].S(4SK^+P<"0T-?-C%B+N:"U+S&H$KZ*IH&/0
M`FXUI^+TC(*J2)-C+-#:ZD<@/N5$'DP"Q:^=TI!\/"(U9.M3),BV/H64'B(D
M]LH!4"+G$"3^.,NO*(:3`5(C.0GK,TXB+:>H$R-+MMHI,]XG^`;S6D))4URB
MN4Q(,"A@ZT1)(@13(J(K5`Q0LZ2S("[)-@MF-4QSOQ9L)$P"!V<P+B*#/0!H
MQL;CG@C#ALS"_S1E2_YS)1@#M%XC-A)$U=+KAO#"*/RO./XB[1#4PSCL/WTQ
M#A<"(0(40P\E+6+0/QQ#K0QT0%:C-2!LQWK,0O%"MU@HQ81P/PT&&4U3S!(D
M%A\C2Z`1OS"I15HR+8ML4CZHEHP):Q)$*%SDA?S1JY:T>J#41%BC0#:(IL*M
M,H;4XFSIA(J4G>02=50#+9"+O#8`&5M#$MV&T4R"NZZT,7_T7K;;23].\$PB
M0R'744L(XDV-:D/-0M@F98=J#)L0Y$_1S$74#4LU%%&2RRS,;=>VQ+5NZ#4=
M%2:#:'Z:*5"Q3K7TY-:NLY2TZ2/_L=H\HM_4S3\F0U+S5$_K!5HL53<G"RQ[
M;C.B+TGEJ5?,PEDFY4.812,H@CF!(N9<9.G(JR$(HSM]*%FH*$'*:3`,!%P^
MK3)X9=Q"Y81V]4U10@[)4DD.H(78:;J*A>;H\UA`H[^:-2EKM6?XR:#T$RKX
CPEZM@R[D-7`(*D8Z,3L^9?+XE6`+UF`/%F$35F'Y)B```#L_
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
